archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.3713e-09,1.3349,1.271,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.3713e-09,1.2134,1.0942,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,2.457e-10,1.1211,1.0503,1,1
1,GO BLEB ASSEMBLY,2.559e-11,1.0785,1.1365,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,4.7449e-12,0.96188,0.98102,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.5677e-09,0.95468,0.8148,1,1
1,GO RESPONSE TO INTERFERON ALPHA,1.736e-11,0.94538,0.97677,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.8695e-12,0.8783,0.8845,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,5.6451e-10,0.87087,0.88074,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.5688e-10,0.8707,0.78237,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.4148e-09,0.86697,0.74559,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,9.3752e-12,0.85385,0.89275,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,4.5526e-11,0.83357,0.76238,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,2.7614e-08,0.80729,0.79581,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.5043e-10,0.80044,0.75803,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,3.2685e-12,0.79442,0.80224,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.1099e-11,0.78394,0.74405,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.1403e-10,0.77658,0.71191,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,1.6407e-09,0.77043,0.70829,1,1
1,GO RESPONSE TO INTERFERON BETA,1.069e-09,0.7641,0.79339,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,6.0205e-08,0.74199,0.64528,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.3697e-11,0.73729,0.78075,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.6514e-08,0.73395,0.73454,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.069e-09,0.72006,0.67822,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.2682e-10,0.7199,0.72638,1,1
1,GO MEMBRANE RAFT ORGANIZATION,8.2903e-10,0.71729,0.71575,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.0791e-07,0.71097,0.76554,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.3291e-12,0.7102,0.78712,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,2.3853e-09,0.7071,0.62093,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.1064e-09,0.70279,0.66287,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,2.65e-07,0.70084,0.63266,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9558e-11,0.69835,0.68489,1,1
1,GO TOLERANCE INDUCTION,4.1815e-08,0.69693,0.59693,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,1.3039e-08,0.69617,0.61955,1,1
1,GO FIBRINOLYSIS,6.8406e-11,0.69142,0.66769,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.4553e-09,0.68817,0.60587,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.9514e-07,0.68406,0.61618,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,4.4749e-10,0.67427,0.65866,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.6717e-09,0.67121,0.55812,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,7.3803e-06,0.66496,0.59197,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,3.1098e-10,0.66384,0.63874,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2058e-07,0.65907,0.53248,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.9624e-10,0.65585,0.5903,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,1.484e-09,0.65527,0.65545,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.8389e-10,0.65456,0.59803,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.559e-11,0.65415,0.70424,1,1
1,GO NEUTROPHIL HOMEOSTASIS,5.5078e-11,0.64981,0.68395,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.1595e-09,0.64945,0.57524,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.65e-07,0.64239,0.56291,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0546e-09,0.63922,0.73344,1,1
1,GO DETECTION OF BIOTIC STIMULUS,1.0964e-09,0.63769,0.57516,1,1
1,GO CYTOLYSIS,5.3617e-10,0.63425,0.55242,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,4.3774e-08,0.63403,0.61507,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,3.5427e-10,0.63372,0.58034,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.3024e-10,0.63083,0.61528,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,4.2042e-09,0.62964,0.63034,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,4.5922e-10,0.62528,0.60953,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.9805e-09,0.62356,0.73852,1,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,3.094e-05,0.62121,0.50405,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.3419e-09,0.61823,0.577,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,6.757e-10,0.61671,0.55631,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.9465e-08,0.61583,0.60672,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.9432e-10,0.61352,0.54801,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.1064e-09,0.60722,0.59458,1,1
1,GO RESPONSE TO INTERLEUKIN 18,1.3878e-06,0.60675,0.5973,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,5.6594e-11,0.60601,0.54883,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.8286e-11,0.60549,0.62457,1,1
1,GO ELASTIC FIBER ASSEMBLY,2.0879e-07,0.60307,0.68482,1,1
1,GO LEUKOCYTE AGGREGATION,2.2775e-07,0.60051,0.53643,1,1
1,GO T CELL EXTRAVASATION,9.1793e-10,0.5992,0.60639,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4893e-11,0.59818,0.62956,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.2348e-10,0.59261,0.55645,1,1
1,GO SKIN MORPHOGENESIS,2.9602e-08,0.59022,0.63515,1,1
1,GO MUCUS SECRETION,3.7356e-07,0.59007,0.56595,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,8.4871e-11,0.58697,0.58321,1,1
1,GO DETECTION OF OTHER ORGANISM,3.5794e-07,0.58671,0.5282,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,9.9705e-11,0.58656,0.53856,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.3933e-10,0.58542,0.54701,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,9.8716e-08,0.58244,0.55055,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,5.8698e-06,0.58243,0.43067,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.6205e-11,0.58198,0.60463,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,2.9805e-09,0.57967,0.54397,1,1
1,GO ZYMOGEN INHIBITION,7.2202e-11,0.57815,0.62498,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.1706e-10,0.57782,0.55407,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,4.719e-07,0.57762,0.55051,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.1398e-10,0.57076,0.564,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.6567e-07,0.56913,0.52078,1,1
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,6.2175e-05,0.56687,0.57596,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.0295e-08,0.56675,0.52541,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,3.3228e-08,0.56552,0.48873,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.5893e-10,0.56365,0.55699,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,1.2441e-09,0.56182,0.52561,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,3.9941e-08,0.56129,0.51935,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,5.7923e-10,0.56085,0.6488,1,1
1,GO ZYMOGEN ACTIVATION,1.6514e-08,0.55839,0.51032,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.7687e-09,0.55686,0.51962,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.9514e-07,0.55196,0.53669,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.2359e-09,0.55179,0.63381,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3737e-10,0.54967,0.59158,1,1
1,GO PLASMINOGEN ACTIVATION,4.9069e-08,0.54878,0.50771,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,5.6451e-10,0.54741,0.46478,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,6.1583e-08,0.54554,0.52273,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7319e-10,0.54169,0.4804,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.4177e-11,0.54131,0.568,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.0279e-11,0.54006,0.50068,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.8118e-09,0.53796,0.51208,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.4341e-05,0.53746,0.42682,1,1
1,GO EPIBOLY,1.0804e-10,0.535,0.56937,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,5.4982e-08,0.53483,0.5211,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,1.3671e-08,0.53438,0.60896,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,9.1996e-11,0.53355,0.5407,1,1
1,GO ETHANOL OXIDATION,0.0012005,0.53318,0.36495,1,1
1,GO INTERLEUKIN 1 PRODUCTION,9.4157e-10,0.53216,0.46804,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.4586e-08,0.53213,0.5344,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,8.9047e-09,0.53129,0.54945,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.9069e-08,0.53095,0.46309,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,7.0017e-09,0.53066,0.55927,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.5386e-08,0.5305,0.54091,1,1
1,GO DNA DEAMINATION,2.1338e-07,0.52855,0.50641,1,1
1,GO TYPE 2 IMMUNE RESPONSE,5.7923e-10,0.52853,0.53722,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,3.192e-10,0.52591,0.58909,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.5066e-09,0.52567,0.50528,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.8262e-08,0.52247,0.41666,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.4157e-10,0.5222,0.47046,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4586e-08,0.52194,0.45152,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.4305e-07,0.52123,0.44349,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,2.5868e-06,0.52077,0.42104,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.2253e-10,0.52047,0.43834,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.7e-09,0.52014,0.49319,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,7.1726e-09,0.51904,0.47492,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.9078e-09,0.51857,0.43215,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,6.0205e-08,0.51718,0.48916,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,2.9602e-08,0.51713,0.45683,1,1
1,GO GERMINAL CENTER FORMATION,4.2444e-07,0.51667,0.45957,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,3.2859e-07,0.51488,0.5221,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.3082e-09,0.5141,0.48551,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.1414e-12,0.51324,0.5268,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.8856e-08,0.51305,0.46697,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.6782e-07,0.51068,0.48807,1,1
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0020092,0.51007,0.31711,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,2.8369e-09,0.50857,0.56119,1,1
1,GO REGULATION OF FIBRINOLYSIS,1.7721e-08,0.50829,0.4908,1,1
1,GO ENDODERM FORMATION,1.3024e-10,0.50804,0.52441,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,2.6981e-08,0.50737,0.45194,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,2.5359e-06,0.50552,0.52723,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00011406,0.50551,0.42986,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,5.1351e-07,0.50522,0.49478,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.6435e-08,0.50519,0.44906,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,1.6407e-09,0.50442,0.45544,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.785e-11,0.50337,0.54722,1,1
1,GO T CELL MEDIATED IMMUNITY,3.9309e-10,0.50319,0.44136,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,9.2321e-08,0.50224,0.47596,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.1595e-09,0.50161,0.48207,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.2434e-08,0.50054,0.46589,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.4334e-08,0.49855,0.47923,1,1
1,GO ENTRY INTO HOST,7.2202e-11,0.49716,0.46028,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,5.1304e-06,0.49703,0.48117,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3228e-08,0.49619,0.45115,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,2.4837e-07,0.49516,0.45445,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.2058e-07,0.49476,0.4945,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9546e-09,0.49459,0.43533,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.7687e-09,0.49381,0.44672,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,5.6487e-06,0.4905,0.48299,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4586e-08,0.48977,0.44927,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,9.404e-07,0.48893,0.45218,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.8135e-09,0.48774,0.45395,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.785e-11,0.48761,0.45528,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,2.856e-06,0.48741,0.39157,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.2169e-06,0.48685,0.44243,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.9558e-07,0.48659,0.39947,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,8.7184e-11,0.48653,0.4791,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,5.1356e-08,0.48649,0.40357,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.4452e-09,0.48595,0.42527,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.1121e-10,0.48559,0.49348,1,1
1,GO ENDODERM DEVELOPMENT,2.6581e-10,0.48542,0.45733,1,1
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00011218,0.4849,0.37681,1,1
1,GO PEPTIDE CROSS LINKING,8.3066e-07,0.48449,0.4022,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.3228e-08,0.48436,0.40756,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,3.0296e-10,0.48294,0.45917,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.634e-09,0.48285,0.37148,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,2.402e-08,0.48254,0.48571,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.5027e-08,0.48238,0.46159,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.7797e-11,0.48157,0.52605,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.9805e-09,0.47933,0.51342,1,1
1,GO APOPTOTIC CELL CLEARANCE,2.6306e-11,0.47931,0.55238,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.9403e-11,0.47866,0.45497,1,1
1,GO INTERLEUKIN 13 PRODUCTION,9.0235e-07,0.47758,0.44478,1,1
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.016938,0.47735,0.20306,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.0296e-10,0.47624,0.47234,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.969e-07,0.47618,0.38827,1,1
1,GO CELLULAR DEFENSE RESPONSE,2.8271e-07,0.47445,0.33426,1,1
1,GO INTERLEUKIN 8 PRODUCTION,8.0815e-10,0.47394,0.43531,1,1
1,GO PROTEIN ACTIVATION CASCADE,1.8135e-09,0.47334,0.44826,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,4.9361e-06,0.47226,0.38399,1,1
1,GO DEFENSE RESPONSE TO VIRUS,3.7319e-10,0.47219,0.41601,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.2328e-07,0.47094,0.35749,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.0017e-09,0.47066,0.47034,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.0811e-07,0.47056,0.36118,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,5.7536e-08,0.46869,0.43439,1,1
1,GO POSITIVE REGULATION OF COAGULATION,2.0398e-08,0.46835,0.40788,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.2129e-08,0.46703,0.54925,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00064263,0.46694,0.32366,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.892e-08,0.46573,0.52638,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,1.5217e-09,0.46555,0.41563,1,1
1,GO PROSTATIC BUD FORMATION,0.00011986,0.46553,0.42236,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.9705e-11,0.46534,0.49305,1,1
1,GO CERAMIDE CATABOLIC PROCESS,2.0398e-08,0.46532,0.43761,1,1
1,GO RESPONSE TO TUMOR CELL,1.2027e-05,0.46479,0.35547,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.402e-08,0.46397,0.4156,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.2785e-11,0.46382,0.46888,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.0817e-11,0.46255,0.53888,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.2328e-07,0.46251,0.48572,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8673e-09,0.46231,0.39524,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.4076e-07,0.46207,0.51422,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,2.8886e-07,0.4615,0.38877,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.8359e-10,0.46144,0.41678,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,3.0302e-06,0.46098,0.56309,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.1996e-11,0.4608,0.48602,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.0554e-07,0.46068,0.43539,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.9613e-05,0.45917,0.41631,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.7041e-11,0.45891,0.4902,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.4796e-08,0.45841,0.38384,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,2.2397e-08,0.45799,0.54327,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.5713e-07,0.45619,0.45796,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00046872,0.45478,0.3235,1,1
1,GO PINOCYTOSIS,8.2903e-10,0.4543,0.42137,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,9.4341e-06,0.45409,0.35563,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,2.538e-07,0.45362,0.43989,1,1
1,GO LATERAL MESODERM DEVELOPMENT,3.1729e-08,0.45317,0.4579,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.8573e-08,0.45265,0.48285,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.2784e-08,0.4526,0.38676,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.2785e-11,0.45236,0.49488,1,1
1,GO REGULATION OF COAGULATION,8.2864e-09,0.45211,0.4278,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.8753e-10,0.45171,0.4241,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.3376e-10,0.45136,0.43958,1,1
1,GO RESPONSE TO PROTOZOAN,5.77e-09,0.45128,0.45953,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,6.8396e-06,0.45109,0.45358,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.0565e-09,0.45016,0.38091,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.6542e-10,0.45005,0.41833,1,1
1,GO PROSTATE GLAND MORPHOGENESIS,0.00018923,0.45,0.39398,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,4.31e-06,0.44801,0.38399,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,5.8856e-08,0.44704,0.50075,1,1
1,GO BONE TRABECULA MORPHOGENESIS,1.0557e-05,0.44492,0.44645,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,5.6085e-05,0.44466,0.42198,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,3.6435e-08,0.44442,0.45286,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,2.8262e-08,0.44405,0.58062,1,1
1,GO REGULATION OF CELL KILLING,7.969e-07,0.44288,0.32143,1,1
1,GO AMYLOID FIBRIL FORMATION,3.6877e-06,0.44264,0.44706,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.457e-10,0.44229,0.39757,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,5.2445e-07,0.44219,0.3878,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,6.4805e-11,0.44136,0.45452,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,6.6066e-07,0.44065,0.39229,1,1
1,GO HIPPO SIGNALING,9.4407e-08,0.4403,0.44805,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,5.2359e-09,0.44003,0.41138,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.8976e-09,0.43994,0.5143,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,1.8594e-09,0.43944,0.47835,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,2.9859e-05,0.43928,0.31711,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,1.5052e-06,0.43922,0.48815,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.1097e-10,0.439,0.48709,1,1
1,GO CHEMOKINE PRODUCTION,3.0811e-07,0.43853,0.33424,1,1
1,GO INTERLEUKIN 2 PRODUCTION,3.0296e-10,0.43792,0.39579,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,8.8282e-08,0.43757,0.3782,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.8976e-09,0.43749,0.39496,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.8976e-09,0.43742,0.35886,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,2.0879e-07,0.43682,0.40462,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.1456e-06,0.43646,0.32404,1,1
1,GO B CELL MEDIATED IMMUNITY,4.8673e-09,0.43627,0.42029,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,2.0429e-07,0.43593,0.42962,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00012804,0.43593,0.46115,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.4434e-08,0.43578,0.37011,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.1375e-05,0.43479,0.44192,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.3376e-10,0.43454,0.45805,1,1
1,GO VIRAL GENOME REPLICATION,2.9515e-10,0.43446,0.40856,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.2926e-08,0.43444,0.4169,1,1
1,GO RESPONSE TO INTERLEUKIN 15,5.7582e-06,0.43442,0.3309,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,2.0983e-10,0.43415,0.49227,1,1
1,GO INTERLEUKIN 17 PRODUCTION,3.0295e-08,0.43381,0.37765,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0010558,0.43321,0.34255,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,2.5884e-05,0.43312,0.40155,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,9.7998e-07,0.43295,0.38521,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.634e-09,0.43253,0.35192,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.7614e-08,0.43252,0.5081,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.4184e-05,0.43187,0.31199,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.9926e-08,0.43155,0.47198,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.4003e-08,0.431,0.42432,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.0781e-08,0.43007,0.41844,1,1
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0033799,0.42958,0.2886,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,2.0776e-06,0.42847,0.44463,1,1
1,GO INTERFERON ALPHA PRODUCTION,3.1004e-08,0.42722,0.3573,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.7614e-08,0.4263,0.35563,1,1
1,GO VASCULOGENESIS,1.3737e-10,0.42595,0.44119,1,1
1,GO RESPONSE TO THYROID HORMONE,6.8396e-06,0.42573,0.3401,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.8161e-07,0.42569,0.4967,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.6994e-06,0.4256,0.44492,1,1
1,GO BIOLOGICAL PHASE,2.6914e-06,0.42453,0.48253,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,1.8723e-07,0.42403,0.36672,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,1.5576e-05,0.42396,0.2957,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.6881e-08,0.42389,0.37218,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.1312e-09,0.42383,0.42019,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.0983e-10,0.42369,0.42054,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.2143e-08,0.4235,0.42801,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.1579e-08,0.42319,0.40618,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.8856e-08,0.42311,0.35055,1,1
1,GO TRABECULA FORMATION,2.1196e-06,0.42307,0.39282,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,6.4699e-07,0.4228,0.42079,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00014362,0.42262,0.32634,1,1
1,GO REGULATION OF PINOCYTOSIS,1.5372e-07,0.42219,0.35566,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,8.2864e-09,0.42204,0.52025,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,1.0212e-06,0.42154,0.33317,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1338e-07,0.42077,0.32609,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.5412e-09,0.42058,0.41759,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,3.2894e-09,0.42012,0.42871,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00031414,0.41999,0.45442,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.5794e-07,0.41946,0.32425,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,4.4285e-07,0.41873,0.48707,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.4434e-08,0.41797,0.482,1,1
1,GO RETINAL METABOLIC PROCESS,8.5858e-05,0.41781,0.34341,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.0565e-09,0.41739,0.37593,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,2.65e-07,0.41738,0.35309,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.4807e-06,0.41698,0.46943,1,1
1,GO RESPONSE TO HYPEROXIA,6.2993e-08,0.41686,0.38832,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.2894e-09,0.41685,0.43371,1,1
1,GO MONONUCLEAR CELL MIGRATION,5.8856e-08,0.41598,0.32914,1,1
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0062877,0.41524,0.30579,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,8.6328e-08,0.41507,0.44417,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,4.2271e-06,0.41488,0.30949,1,1
1,GO SERTOLI CELL DEVELOPMENT,2.1338e-07,0.41485,0.42801,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.7488e-06,0.41463,0.3241,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.3351e-08,0.41424,0.40871,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,3.247e-08,0.41421,0.36237,1,1
1,GO AMYLOID BETA CLEARANCE,2.457e-10,0.41418,0.39997,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.9078e-09,0.41377,0.36619,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,8.1138e-06,0.41329,0.39765,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,7.2964e-10,0.41317,0.46103,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,7.1726e-09,0.41193,0.46447,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,1.0004e-06,0.41188,0.39294,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,4.3946e-06,0.41119,0.39745,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,1.3671e-08,0.41104,0.35932,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.9905e-10,0.411,0.38059,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.3999e-08,0.41072,0.36007,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,3.4516e-10,0.41066,0.45408,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.7721e-08,0.4104,0.46733,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.6205e-11,0.40957,0.47072,1,1
1,GO MACROPHAGE MIGRATION,7.6792e-10,0.40928,0.36247,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,3.8983e-07,0.40916,0.47686,1,1
1,GO REVERSE CHOLESTEROL TRANSPORT,0.00016629,0.40908,0.34867,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,6.9323e-10,0.40866,0.34976,1,1
1,GO REGULATION OF TRANSPOSITION,1.439e-07,0.40837,0.44405,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.0296e-10,0.40765,0.38173,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,3.6293e-09,0.4074,0.43062,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.3467e-08,0.40718,0.40968,1,1
1,GO RESPONSE TO VIRUS,2.5223e-10,0.4071,0.36244,1,1
1,GO MONOCYTE CHEMOTAXIS,5.4701e-07,0.40685,0.32907,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,8.2864e-09,0.40638,0.34724,1,1
1,GO T CELL CYTOKINE PRODUCTION,5.4967e-09,0.40591,0.35107,1,1
1,GO CD40 SIGNALING PATHWAY,1.5604e-09,0.40542,0.42721,1,1
1,GO CELLULAR RESPONSE TO DSRNA,2.9371e-11,0.40501,0.44584,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.8886e-07,0.40468,0.35639,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,1.9393e-05,0.40431,0.43701,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.4749e-10,0.40426,0.47975,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.5066e-09,0.40396,0.31786,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,2.6386e-06,0.40356,0.31561,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6109e-10,0.40314,0.3717,1,1
1,GO SALIVARY GLAND DEVELOPMENT,1.3671e-08,0.40293,0.47338,1,1
1,GO T CELL APOPTOTIC PROCESS,2.801e-10,0.40285,0.36863,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.658e-10,0.4019,0.33058,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.6823e-09,0.40164,0.36885,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.8389e-10,0.4014,0.42034,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,4.3946e-06,0.40062,0.42644,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,3.1312e-09,0.40057,0.3159,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.3737e-10,0.40009,0.39123,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.4407e-08,0.39979,0.30838,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.2253e-10,0.39955,0.39232,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,7.5266e-09,0.39944,0.43542,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.064e-06,0.3993,0.39737,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.1041e-08,0.3989,0.4531,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026858,0.39878,0.2882,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.5239e-09,0.39868,0.45128,1,1
1,GO GAP JUNCTION ASSEMBLY,3.357e-07,0.39815,0.42148,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,3.2094e-09,0.39801,0.35668,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.1552e-07,0.39789,0.39153,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.0429e-07,0.39763,0.4014,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,4.4749e-10,0.39721,0.34984,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.0565e-09,0.39708,0.36978,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,8.7184e-11,0.39644,0.47595,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.3467e-08,0.39601,0.43412,1,1
1,GO PROSTANOID METABOLIC PROCESS,2.3784e-07,0.39593,0.34494,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.8149e-08,0.39531,0.34818,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,6.4592e-06,0.39508,0.39315,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.9546e-09,0.39491,0.37205,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,2.856e-06,0.39472,0.41455,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.2886e-07,0.39421,0.44344,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.6828e-05,0.39383,0.31653,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00038422,0.39318,0.3174,1,1
1,GO I KAPPAB PHOSPHORYLATION,1.2759e-09,0.39304,0.35744,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.6514e-08,0.39302,0.38863,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,5.9498e-07,0.39279,0.41754,1,1
1,GO GLAND MORPHOGENESIS,1.2886e-07,0.39245,0.39929,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.439e-07,0.39202,0.34311,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.8359e-10,0.39199,0.34229,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.5266e-09,0.39189,0.37625,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,9.2585e-06,0.3909,0.43195,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.6407e-09,0.39081,0.3994,1,1
1,GO HYPOTONIC RESPONSE,1.0424e-06,0.39073,0.32803,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,1.6986e-10,0.3904,0.34475,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,2.8925e-08,0.39038,0.52043,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.2784e-08,0.38992,0.32155,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00016629,0.38972,0.33526,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,2.0879e-07,0.38946,0.36773,1,1
1,GO MACROPHAGE PROLIFERATION,1.0424e-06,0.38884,0.42623,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.2094e-09,0.38873,0.32614,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,4.1456e-06,0.38871,0.36181,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.3946e-06,0.38847,0.30145,1,1
1,GO HYALURONAN METABOLIC PROCESS,1.887e-11,0.38842,0.39764,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,5.3747e-08,0.38805,0.3527,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,2.1595e-09,0.38754,0.36672,1,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034692,0.38704,0.22898,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.4334e-08,0.38692,0.36178,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.0881e-08,0.38682,0.35327,1,1
1,GO STEROID ESTERIFICATION,9.1829e-05,0.38667,0.32795,1,1
1,GO INTERFERON BETA PRODUCTION,4.7501e-09,0.38659,0.34596,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.9805e-09,0.38634,0.31807,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.9432e-10,0.38619,0.44441,1,1
1,GO IMMUNE EFFECTOR PROCESS,1.6001e-09,0.38614,0.31899,1,1
1,GO PROSTATE GLAND DEVELOPMENT,6.0759e-07,0.38591,0.41232,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.6761e-05,0.38554,0.38833,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.6418e-07,0.38552,0.34626,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,1.3039e-08,0.38549,0.30395,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,8.4877e-09,0.38516,0.33759,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.3376e-10,0.38513,0.36682,1,1
1,GO INNATE IMMUNE RESPONSE,2.0546e-09,0.38488,0.33561,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.3268e-09,0.38455,0.46864,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.3214e-05,0.38449,0.24521,1,1
1,GO COLLAGEN CATABOLIC PROCESS,3.1004e-08,0.38388,0.36611,1,1
1,GO COMPLEMENT ACTIVATION,1.5386e-08,0.38379,0.48045,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.5239e-09,0.38374,0.35629,1,1
1,GO NATURAL KILLER CELL ACTIVATION,5.0922e-10,0.38321,0.34912,1,1
1,GO VAGINA DEVELOPMENT,6.0565e-09,0.38294,0.42862,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2538e-08,0.38283,0.36231,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.9872e-09,0.38277,0.33022,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.4877e-09,0.38267,0.40241,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.4296e-07,0.38243,0.38336,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0020367,0.38237,0.2331,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.892e-08,0.38219,0.35324,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.65e-07,0.38181,0.39065,1,1
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0025277,0.38083,0.33592,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5756e-08,0.38049,0.38404,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.5794e-07,0.38009,0.32981,1,1
1,GO MUSCLE CELL FATE COMMITMENT,1.9989e-07,0.37959,0.35268,1,1
1,GO T CELL PROLIFERATION,1.1535e-07,0.37946,0.29515,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,5.332e-06,0.37924,0.36729,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,2.3239e-05,0.3785,0.41635,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,4.9228e-07,0.37846,0.36844,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,3.4296e-07,0.37801,0.35976,1,1
1,GO HEME METABOLIC PROCESS,1.484e-09,0.37783,0.37542,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.8135e-09,0.37749,0.37213,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.5756e-08,0.37731,0.38362,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9926e-08,0.37644,0.36165,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.4415e-08,0.37616,0.35469,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.2444e-07,0.37604,0.31714,1,1
1,GO PLATELET AGGREGATION,1.069e-09,0.37589,0.39563,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.0364e-06,0.37566,0.34445,1,1
1,GO GRANULOCYTE CHEMOTAXIS,1.3878e-06,0.37563,0.28133,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.5606e-08,0.37559,0.32946,1,1
1,GO PIGMENT ACCUMULATION,4.4285e-07,0.37475,0.38972,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,8.5867e-06,0.37464,0.43105,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,1.1316e-06,0.37433,0.43181,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,1.0169e-05,0.37432,0.48041,1,1
1,GO RESPONSE TO HYDROPEROXIDE,0.001118,0.37431,0.29382,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.3853e-09,0.37419,0.39372,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.6129e-08,0.37417,0.33718,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.9116e-09,0.37413,0.38513,1,1
1,GO REGULATION OF PLATELET ACTIVATION,1.0756e-05,0.37398,0.38341,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00046165,0.3738,0.2839,1,1
1,GO AMINE CATABOLIC PROCESS,8.1138e-06,0.37345,0.32028,1,1
1,GO PLATELET DEGRANULATION,8.6937e-09,0.37342,0.40293,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.2328e-07,0.37323,0.33328,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,6.8348e-09,0.37306,0.42364,1,1
1,GO FIBROBLAST MIGRATION,8.7237e-10,0.37299,0.37907,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,9.6538e-08,0.37278,0.52055,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.0079e-05,0.37254,0.35345,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.5359e-06,0.37244,0.29202,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,8.2903e-10,0.37173,0.34815,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.2094e-09,0.37144,0.37604,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.3671e-08,0.37125,0.42332,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.6129e-08,0.37094,0.35004,1,1
1,GO COLLAGEN METABOLIC PROCESS,2.7e-09,0.37081,0.42582,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,7.0522e-08,0.37068,0.30843,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,4.6356e-09,0.36988,0.35237,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,1.6129e-08,0.36929,0.34119,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,3.1312e-09,0.36829,0.42695,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.0546e-09,0.36777,0.31208,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.1533e-09,0.36763,0.33466,1,1
1,GO MACROPHAGE DIFFERENTIATION,9.3415e-09,0.36727,0.35291,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,9.404e-07,0.36664,0.29094,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.1579e-08,0.36659,0.35888,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,8.5043e-10,0.36607,0.34984,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,7.0522e-08,0.36585,0.29292,1,1
1,GO PROTEIN OXIDATION,9.4959e-05,0.36495,0.37407,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.0964e-09,0.36465,0.34373,1,1
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00010852,0.36463,0.24949,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,8.3013e-05,0.36443,0.34783,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,4.1403e-10,0.36423,0.40135,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.8839e-05,0.36395,0.31164,1,1
1,GO RESPONSE TO ANGIOTENSIN,1.2131e-09,0.36393,0.37723,1,1
1,GO GRANULOCYTE MIGRATION,6.7411e-08,0.36376,0.30008,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.6386e-06,0.36342,0.31517,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6514e-08,0.36299,0.33949,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.064e-06,0.36287,0.43071,1,1
1,GO RESPONSE TO DSRNA,6.8348e-09,0.36267,0.3233,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.5526e-11,0.36265,0.40975,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.8369e-09,0.36257,0.33305,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.4112e-09,0.36242,0.31732,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,6.2169e-06,0.3624,0.29978,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,2.4528e-05,0.36228,0.29533,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,2.2824e-05,0.36163,0.32086,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.5713e-07,0.36148,0.29468,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,6.2565e-10,0.36134,0.35935,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.1282e-07,0.36092,0.3275,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.0781e-08,0.36072,0.30696,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.2281e-06,0.36066,0.36006,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.9136e-07,0.36063,0.37204,1,1
1,GO RESPONSE TO CYTOKINE,1.2131e-09,0.3601,0.30068,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,2.0776e-06,0.3599,0.32555,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.471e-07,0.35971,0.4129,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,6.895e-08,0.35951,0.38517,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.402e-08,0.35925,0.33357,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,4.9069e-08,0.35914,0.29944,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.0898e-09,0.35864,0.38822,1,1
1,GO MACROPHAGE CHEMOTAXIS,8.4877e-09,0.3585,0.35848,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.3355e-07,0.35808,0.29796,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.00014839,0.35803,0.30573,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.0781e-08,0.35755,0.36913,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,1.1858e-08,0.35744,0.41121,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,3.5794e-07,0.35716,0.33631,1,1
1,GO CYTOKINE PRODUCTION,5.1101e-09,0.35711,0.30008,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.3599e-06,0.35635,0.35816,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,3.6162e-06,0.35625,0.3474,1,1
1,GO FOAM CELL DIFFERENTIATION,3.9872e-06,0.35615,0.34572,1,1
1,GO INTERLEUKIN 12 PRODUCTION,2.3239e-05,0.35577,0.26474,1,1
1,GO AORTIC VALVE DEVELOPMENT,9.5999e-07,0.35523,0.37657,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.3325e-06,0.35511,0.34485,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,9.6538e-08,0.35457,0.33812,1,1
1,GO MYOBLAST FUSION,1.5037e-07,0.3544,0.38984,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.0815e-10,0.35373,0.41847,1,1
1,GO PHOSPHOLIPID HOMEOSTASIS,5.4184e-05,0.35322,0.29111,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,3.7282e-08,0.35288,0.37773,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.4472e-05,0.35264,0.31266,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.8347e-06,0.35258,0.34941,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,2.9078e-09,0.35241,0.37926,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,4.2271e-06,0.35238,0.38893,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,3.9035e-08,0.35219,0.33917,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,6.9323e-10,0.35216,0.35979,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,5.8856e-08,0.35211,0.40773,1,1
1,GO NAD BIOSYNTHETIC PROCESS,0.0022095,0.35194,0.22282,1,1
1,GO TRANSPOSITION,2.1338e-07,0.35186,0.38716,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,8.9047e-09,0.35177,0.31469,1,1
1,GO INTERLEUKIN 10 PRODUCTION,0.0047798,0.35177,0.20682,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.5386e-08,0.35146,0.31732,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.0898e-09,0.35133,0.3461,1,1
1,GO WOUND HEALING,8.2864e-09,0.35102,0.32167,1,1
1,GO ALPHA BETA T CELL ACTIVATION,4.2444e-07,0.35037,0.29945,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.2534e-06,0.35031,0.33907,1,1
1,GO RESPONSE TO BACTERIUM,1.4334e-08,0.35026,0.29552,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,4.6881e-08,0.35011,0.40905,1,1
1,GO MITRAL VALVE DEVELOPMENT,8.3013e-05,0.35003,0.35469,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.3351e-08,0.34875,0.32387,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00030449,0.34809,0.33548,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,5.6451e-10,0.34806,0.32544,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.5794e-07,0.34777,0.36479,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00080175,0.34772,0.27848,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,7.3772e-08,0.34686,0.30341,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,3.6162e-06,0.34684,0.37302,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,5.2538e-08,0.34671,0.35823,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.2271e-06,0.34609,0.29081,1,1
1,GO ENAMEL MINERALIZATION,4.3946e-06,0.34608,0.41519,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,9.0235e-07,0.34581,0.31566,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,8.3066e-07,0.34576,0.32574,1,1
1,GO REGULATION OF STEROL TRANSPORT,4.1025e-09,0.34525,0.36362,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.3256e-05,0.34486,0.34004,1,1
1,GO VIRAL LIFE CYCLE,4.8076e-11,0.34442,0.3373,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.2303e-06,0.34423,0.31365,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.0279e-08,0.34413,0.37569,1,1
1,GO T CELL MIGRATION,7.2129e-08,0.34404,0.32691,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.6654e-06,0.34397,0.40572,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.5756e-08,0.34356,0.31212,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,7.8911e-05,0.3429,0.27473,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.6487e-06,0.34267,0.32202,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.6579e-07,0.34231,0.33035,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.6514e-08,0.34213,0.35277,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.7309e-08,0.34185,0.29536,1,1
1,GO NECROTIC CELL DEATH,6.7411e-08,0.34179,0.31176,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,1.8701e-05,0.34168,0.28649,1,1
1,GO COPPER ION TRANSPORT,2.3274e-07,0.34161,0.31613,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.1307e-08,0.3413,0.37965,1,1
1,GO NEUTROPHIL MIGRATION,1.8053e-06,0.3412,0.26427,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,3.9613e-05,0.3412,0.29713,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00063314,0.34114,0.33829,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2534e-06,0.34083,0.39613,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,8.1623e-05,0.34081,0.24464,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.1456e-06,0.34079,0.37134,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,7.9617e-06,0.34031,0.31013,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,8.7502e-06,0.34021,0.34047,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.7195e-09,0.34,0.2823,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.2954e-05,0.33936,0.26186,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00065224,0.33931,0.30988,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,2.7452e-06,0.33923,0.33653,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.0881e-08,0.33886,0.31722,1,1
1,GO TISSUE REMODELING,9.9803e-06,0.33882,0.27732,1,1
1,GO STORE OPERATED CALCIUM ENTRY,5.0323e-06,0.33859,0.27193,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,3.4003e-08,0.33833,0.29575,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.8793e-06,0.33825,0.32647,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,9.1205e-09,0.33803,0.33281,1,1
1,GO LEUKOCYTE PROLIFERATION,3.6567e-07,0.33796,0.28121,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,6.0991e-06,0.33784,0.35357,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.3196e-05,0.33769,0.32555,1,1
1,GO PHAGOCYTOSIS,8.7237e-10,0.33721,0.3391,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,1.1794e-07,0.33708,0.30109,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,5.9432e-10,0.33697,0.319,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.9602e-08,0.33695,0.30877,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.9044e-05,0.33609,0.29934,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.9078e-09,0.33564,0.27861,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.1338e-07,0.33543,0.29684,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,6.4699e-07,0.33542,0.35391,1,1
1,GO REGULATION OF CELL ADHESION,1.2281e-06,0.33535,0.26252,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,8.6328e-08,0.33484,0.30505,1,1
1,GO PULMONARY VALVE DEVELOPMENT,7.2497e-05,0.33467,0.36437,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.2286e-07,0.33449,0.30112,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,3.2631e-05,0.33446,0.3138,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.2604e-07,0.33404,0.35631,1,1
1,GO DENDRITIC CELL MIGRATION,0.00049802,0.33394,0.25957,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.1579e-08,0.33362,0.29874,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00043435,0.33352,0.21653,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,2.1196e-06,0.33337,0.39324,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.8793e-06,0.33288,0.30494,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.1726e-09,0.3328,0.30504,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,3.9064e-09,0.33275,0.35637,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.9064e-09,0.33227,0.41646,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.2482e-05,0.33224,0.31237,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00024819,0.3322,0.24005,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,2.5884e-05,0.33199,0.34486,1,1
1,GO LYMPHANGIOGENESIS,7.0522e-08,0.33198,0.37473,1,1
1,GO INFLAMMATORY RESPONSE,1.5372e-07,0.33188,0.273,1,1
1,GO MEMBRANE INVAGINATION,5.2359e-09,0.33157,0.33266,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.0278e-07,0.33129,0.36345,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,1.0094e-07,0.33101,0.31632,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.5164e-08,0.33092,0.40335,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.5756e-08,0.33082,0.3026,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,5.3562e-07,0.33072,0.36285,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,6.9711e-06,0.33072,0.3944,1,1
1,GO FOCAL ADHESION ASSEMBLY,1.2143e-08,0.33048,0.37875,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.2482e-05,0.33041,0.25964,1,1
1,GO EMBRYO IMPLANTATION,5.1356e-08,0.33014,0.33971,1,1
1,GO ARGININE METABOLIC PROCESS,3.0811e-07,0.33012,0.33312,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,7.2129e-08,0.33011,0.30975,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,7.6446e-07,0.32964,0.29132,1,1
1,GO LIPOPROTEIN LOCALIZATION,2.1621e-05,0.3296,0.31265,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4334e-08,0.32922,0.30031,1,1
1,GO PHAGOCYTOSIS RECOGNITION,1.2792e-06,0.32914,0.35306,1,1
1,GO SERTOLI CELL DIFFERENTIATION,4.9361e-06,0.32883,0.32902,1,1
1,GO ODONTOGENESIS,2.9859e-05,0.32883,0.25963,1,1
1,GO CELL ACTIVATION,9.5677e-09,0.3288,0.26773,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.6162e-06,0.32873,0.30445,1,1
1,GO P38MAPK CASCADE,5.02e-08,0.32834,0.31222,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0002443,0.32831,0.31194,1,1
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0075485,0.32821,0.28352,1,1
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.00029976,0.32802,0.23877,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,3.6567e-07,0.32773,0.36079,1,1
1,GO DEFENSE RESPONSE,1.9465e-08,0.32756,0.26641,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,4.4807e-06,0.32755,0.31712,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.8262e-07,0.32749,0.34331,1,1
1,GO LUNG MORPHOGENESIS,4.6578e-06,0.32704,0.34031,1,1
1,GO KERATINOCYTE PROLIFERATION,0.00015083,0.32676,0.32272,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.2775e-07,0.32585,0.29523,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,2.971e-06,0.32573,0.24374,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6981e-08,0.32561,0.31694,1,1
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0046604,0.32559,0.22673,1,1
1,GO RESPONSE TO UV B,1.6761e-05,0.32553,0.33488,1,1
1,GO LENS FIBER CELL DEVELOPMENT,3.5646e-05,0.32548,0.31643,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.7078e-07,0.32526,0.30759,1,1
1,GO INTERFERON GAMMA PRODUCTION,1.3468e-07,0.32525,0.29727,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,1.3174e-07,0.32521,0.32279,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0043184,0.32511,0.31925,1,1
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0010865,0.32498,0.23182,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00020178,0.32479,0.31117,1,1
1,GO CELL SUBSTRATE ADHESION,2.2697e-09,0.32473,0.37314,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.00017457,0.32471,0.2899,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,9.3381e-05,0.32465,0.24166,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.1806e-05,0.32459,0.27935,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,2.0776e-06,0.32424,0.31027,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.8419e-06,0.32417,0.31475,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,8.7316e-05,0.32398,0.27974,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.0804e-10,0.32386,0.387,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.7687e-09,0.3236,0.31204,1,1
1,GO NIK NF KAPPAB SIGNALING,1.6109e-10,0.32345,0.32462,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,9.7991e-09,0.32307,0.34534,1,1
1,GO COPPER ION HOMEOSTASIS,4.1025e-09,0.32303,0.3534,1,1
1,GO CELL MATRIX ADHESION,2.2926e-08,0.32298,0.33627,1,1
1,GO INTERACTION WITH HOST,3.192e-10,0.32296,0.33072,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00049053,0.3226,0.22612,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.3082e-09,0.3226,0.31814,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,2.0364e-06,0.32259,0.29166,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,3.4773e-06,0.32252,0.27361,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.004e-09,0.32248,0.31449,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,4.7501e-09,0.32218,0.3809,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.2444e-07,0.322,0.31561,1,1
1,GO IMMUNOGLOBULIN SECRETION,4.31e-06,0.32171,0.30232,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0020092,0.32145,0.28205,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.2434e-08,0.32145,0.31427,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,3.6877e-06,0.32093,0.26444,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,1.2534e-06,0.32092,0.37224,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.3946e-06,0.32087,0.29527,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,4.4807e-06,0.3208,0.35127,1,1
1,GO OSTEOBLAST DEVELOPMENT,6.4592e-06,0.32077,0.28076,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,8.6937e-09,0.32072,0.27159,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,8.6328e-08,0.32068,0.32989,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.9465e-08,0.32062,0.26247,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,9.0235e-07,0.3205,0.29209,1,1
1,GO GLIAL CELL ACTIVATION,2.65e-07,0.32034,0.31618,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.3806e-05,0.32032,0.29908,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,8.4877e-09,0.31987,0.33083,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,9.795e-06,0.31978,0.25753,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,4.1456e-06,0.31973,0.30725,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.1316e-06,0.31972,0.31099,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.2534e-06,0.3197,0.33237,1,1
1,GO PODOSOME ASSEMBLY,1.8419e-06,0.31956,0.36506,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.3468e-07,0.31909,0.32068,1,1
1,GO CELLULAR RESPONSE TO VIRUS,3.1004e-08,0.31908,0.30405,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00029052,0.31885,0.30804,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,1.1316e-06,0.31878,0.32796,1,1
1,GO MYOBLAST PROLIFERATION,0.0013633,0.31835,0.22266,1,1
1,GO T CELL ACTIVATION,6.0205e-08,0.31832,0.28731,1,1
1,GO NEUTROPHIL CHEMOTAXIS,7.8911e-05,0.31783,0.23363,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.3351e-08,0.31781,0.35704,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,2.5164e-08,0.31771,0.34092,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,1.7706e-05,0.31741,0.33689,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00023294,0.31729,0.30507,1,1
1,GO REGULATION OF PROTEIN MATURATION,2.0437e-10,0.3171,0.32722,1,1
1,GO COAGULATION,7.5266e-09,0.31664,0.29635,1,1
1,GO STEROL TRANSPORT,6.6066e-07,0.31654,0.26452,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1064e-09,0.31643,0.32806,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.9465e-08,0.31642,0.28846,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.0001862,0.31632,0.24834,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,2.8814e-05,0.31521,0.35762,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00059648,0.31517,0.23146,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0527e-08,0.3151,0.29767,1,1
1,GO GAMMA DELTA T CELL ACTIVATION,0.019312,0.31486,0.18171,1,1
1,GO TRABECULA MORPHOGENESIS,1.5865e-05,0.31469,0.27518,1,1
1,GO REGULATION OF CELL ACTIVATION,1.2058e-07,0.31462,0.26564,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0022701,0.31439,0.32965,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,8.2686e-06,0.31431,0.32626,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,2.2015e-05,0.31417,0.2819,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,3.4296e-07,0.31407,0.26078,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,4.4148e-09,0.314,0.29028,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.6761e-05,0.31375,0.30777,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,2.2926e-08,0.3135,0.31479,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,2.6386e-06,0.31349,0.29579,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,3.4796e-08,0.31337,0.3578,1,1
1,GO RESPONSE TO ESTROGEN,7.1121e-10,0.31318,0.32787,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.7586e-05,0.31299,0.25467,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00036124,0.31282,0.28289,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.001235,0.31257,0.32767,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,2.7312e-05,0.31244,0.39297,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.00058763,0.31243,0.28506,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.0781e-08,0.31218,0.27576,1,1
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00019541,0.31192,0.27523,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,2.7668e-07,0.31173,0.28659,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,1.3325e-06,0.31149,0.32084,1,1
1,GO ENDOTHELIAL CELL MIGRATION,3.1004e-08,0.31144,0.3363,1,1
1,GO MUSCLE CELL MIGRATION,6.7105e-06,0.31101,0.28656,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001803,0.3107,0.24321,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.5864e-07,0.31049,0.34315,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.6782e-07,0.31041,0.35859,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00033955,0.31036,0.25969,1,1
1,GO REGULATION OF WOUND HEALING,1.5372e-07,0.31035,0.33072,1,1
1,GO TISSUE MIGRATION,6.4434e-08,0.31031,0.31898,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.9558e-07,0.3101,0.31427,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,5.0323e-06,0.31006,0.29512,1,1
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,6.6578e-05,0.3097,0.28187,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.7e-09,0.30955,0.29661,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,9.819e-05,0.30947,0.32055,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,3.1494e-05,0.30925,0.35977,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.895e-08,0.3092,0.34913,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,6.0205e-08,0.30854,0.35418,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.3784e-07,0.30839,0.29393,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,7.0522e-08,0.30831,0.29475,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0012177,0.30809,0.31271,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,4.3355e-07,0.30791,0.39881,1,1
1,GO GALACTOSE METABOLIC PROCESS,6.4592e-06,0.3078,0.31702,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.2505e-06,0.30762,0.32866,1,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00013016,0.30747,0.27078,1,1
1,GO TRACHEA DEVELOPMENT,1.8363e-05,0.30734,0.33989,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,1.6994e-06,0.30694,0.29817,1,1
1,GO TISSUE REGENERATION,1.5372e-07,0.30649,0.285,1,1
1,GO CELLULAR EXTRAVASATION,3.1479e-07,0.30646,0.277,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,3.8246e-05,0.30639,0.33247,1,1
1,GO RESPONSE TO VITAMIN,1.7071e-05,0.30634,0.25855,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.4415e-08,0.30607,0.26223,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.7442e-10,0.30597,0.32909,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.6881e-08,0.30596,0.3335,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,4.5558e-05,0.30582,0.33281,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,9.4341e-06,0.30523,0.27051,1,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.0068504,0.30477,0.24379,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.5027e-08,0.30471,0.26909,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.5164e-08,0.30456,0.32988,1,1
1,GO RESPONSE TO SALT STRESS,3.9941e-08,0.30426,0.31266,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.8348e-09,0.30426,0.30124,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.8856e-08,0.30413,0.27396,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.1316e-06,0.30412,0.29916,1,1
1,GO SYNCYTIUM FORMATION,2.6981e-08,0.30411,0.35862,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.2926e-08,0.30408,0.24893,1,1
1,GO POSITIVE CHEMOTAXIS,4.8839e-05,0.30397,0.2534,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,3.4296e-07,0.30393,0.25998,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.2118e-07,0.30379,0.29298,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.0879e-07,0.30371,0.29873,1,1
1,GO RESPONSE TO CORTICOSTEROID,1.2281e-06,0.30364,0.2405,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5277e-10,0.30312,0.31081,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,6.0079e-05,0.30298,0.28326,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,2.4837e-07,0.30251,0.34091,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.2604e-07,0.30249,0.30611,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.4407e-08,0.30196,0.31139,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00049053,0.30182,0.27053,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.3784e-07,0.30156,0.33794,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,9.2321e-08,0.30124,0.2943,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.3948e-05,0.30123,0.26129,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.9035e-08,0.30119,0.28232,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,4.7172e-05,0.30114,0.27856,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00017457,0.30096,0.31049,1,1
1,GO CELL CHEMOTAXIS,2.2958e-06,0.30083,0.25572,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.00091404,0.30077,0.26023,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,4.2444e-07,0.30066,0.29375,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,3.9872e-06,0.30065,0.31087,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00055343,0.30061,0.25664,1,1
1,GO REGULATION OF T CELL ACTIVATION,2.4305e-07,0.30061,0.2737,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,2.0478e-05,0.3005,0.26831,1,1
1,GO RESPONSE TO INTERLEUKIN 1,2.6581e-10,0.30046,0.29664,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,3.8983e-07,0.30044,0.26701,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,5.9056e-05,0.30036,0.33672,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.8271e-07,0.30036,0.343,1,1
1,GO REGULATION OF CELL SHAPE,4.719e-07,0.29983,0.27364,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.2058e-07,0.29973,0.37398,1,1
1,GO RESPONSE TO RETINOIC ACID,1.9558e-07,0.2986,0.27986,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.471e-07,0.29854,0.29933,1,1
1,GO CHOLESTEROL STORAGE,0.0007901,0.29824,0.29083,1,1
1,GO VASCULATURE DEVELOPMENT,3.1729e-08,0.29784,0.29414,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,5.2538e-08,0.29784,0.31795,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.5753e-08,0.29769,0.28142,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,9.4341e-06,0.29753,0.30105,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.3999e-08,0.29738,0.26717,1,1
1,GO INTERACTION WITH SYMBIONT,2.6362e-08,0.29727,0.27002,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,5.8262e-07,0.29725,0.28094,1,1
1,GO REGULATION OF GASTRULATION,1.0036e-08,0.29723,0.30883,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.6881e-08,0.29708,0.31201,1,1
1,GO ACTIN FILAMENT NETWORK FORMATION,0.02128,0.29698,0.19938,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.439e-07,0.29647,0.32024,1,1
1,GO CELLULAR RESPONSE TO IRON ION,2.7804e-05,0.29625,0.30839,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.2058e-07,0.29608,0.29623,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0013826,0.29601,0.27629,1,1
1,GO RIG I SIGNALING PATHWAY,2.7614e-08,0.29569,0.31823,1,1
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0005618,0.29564,0.26242,1,1
1,GO PLASMA MEMBRANE FUSION,0.0098086,0.2956,0.21071,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,2.2958e-06,0.29527,0.26778,1,1
1,GO LEUKOCYTE MIGRATION,4.6578e-06,0.29522,0.24802,1,1
1,GO SPROUTING ANGIOGENESIS,2.402e-08,0.29517,0.32628,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,7.4873e-07,0.29514,0.36043,1,1
1,GO REGULATION OF CELL CELL ADHESION,1.9563e-06,0.29502,0.25197,1,1
1,GO BONE GROWTH,1.4454e-06,0.29488,0.36419,1,1
1,GO LIVER REGENERATION,1.3761e-09,0.29433,0.32174,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.1165e-05,0.29412,0.29857,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,9.6538e-08,0.29402,0.24607,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0021505,0.29381,0.22172,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,5.3747e-08,0.29364,0.31344,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,7.2414e-06,0.29354,0.30393,1,1
1,GO CHOLESTEROL EFFLUX,1.5372e-07,0.29354,0.2841,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.996e-06,0.29334,0.29407,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,4.31e-06,0.29327,0.28188,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,3.2057e-05,0.29276,0.29083,1,1
1,GO CELL KILLING,2.971e-06,0.29224,0.26044,1,1
1,GO REGULATION OF MAST CELL ACTIVATION,0.00022565,0.29181,0.25032,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00095459,0.29142,0.19679,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.8793e-06,0.2914,0.26665,1,1
1,GO RESPONSE TO X RAY,3.1729e-08,0.29137,0.37214,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,9.7998e-07,0.29136,0.27371,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.4356e-06,0.29114,0.31223,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,9.028e-08,0.29111,0.25486,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0043737,0.29106,0.28388,1,1
1,GO RESPONSE TO VITAMIN D,0.0099244,0.29105,0.19361,1,1
1,GO RESPONSE TO WOUNDING,1.9014e-08,0.29091,0.2881,1,1
1,GO CHONDROCYTE DEVELOPMENT,2.913e-06,0.29082,0.32091,1,1
1,GO LIPID STORAGE,1.9465e-08,0.29078,0.26928,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.4148e-09,0.29074,0.30915,1,1
1,GO GLOMERULUS DEVELOPMENT,5.3256e-05,0.29021,0.32731,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,5.1304e-06,0.28999,0.29768,1,1
1,GO STEM CELL DIVISION,0.00022208,0.28991,0.241,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,9.8716e-08,0.28983,0.33688,1,1
1,GO MYOBLAST DIFFERENTIATION,9.1205e-09,0.28969,0.32298,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,7.8911e-05,0.28921,0.25742,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.4356e-06,0.28914,0.25751,1,1
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.0256e-05,0.28907,0.22045,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,7.6446e-07,0.28903,0.29487,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,1.8419e-06,0.28852,0.26714,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.2046e-07,0.28852,0.26551,1,1
1,GO HUMORAL IMMUNE RESPONSE,6.7724e-05,0.28847,0.25614,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,8.1138e-06,0.2884,0.27141,1,1
1,GO OSTEOBLAST DIFFERENTIATION,8.6328e-08,0.28836,0.28326,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00027716,0.28829,0.28465,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.7154e-07,0.28817,0.34285,1,1
1,GO ASTROCYTE DEVELOPMENT,1.1034e-07,0.28817,0.33187,1,1
1,GO ERK1 AND ERK2 CASCADE,9.3415e-09,0.28802,0.29504,1,1
1,GO LYMPHOCYTE ACTIVATION,6.4434e-08,0.28775,0.25973,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,1.0756e-05,0.28746,0.23638,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.1086e-06,0.28744,0.3618,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.6066e-07,0.28739,0.22143,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.6362e-08,0.28724,0.30122,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.2058e-07,0.28709,0.32174,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,2.6386e-06,0.287,0.28733,1,1
1,GO RENAL FILTRATION,0.00067188,0.28659,0.32279,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0027747,0.28655,0.21216,1,1
1,GO HAIR FOLLICLE MATURATION,2.8814e-05,0.28612,0.30403,1,1
1,GO REGULATION OF OSSIFICATION,1.5576e-05,0.286,0.24612,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.0169e-05,0.28594,0.31467,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,4.0314e-05,0.28578,0.22398,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.0014022,0.28577,0.23556,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.5164e-08,0.28566,0.28629,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00029052,0.28541,0.29536,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.8149e-08,0.28526,0.2893,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,7.3476e-09,0.28514,0.29801,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.00013899,0.28493,0.23084,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,9.3381e-05,0.28464,0.26622,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1535e-07,0.28457,0.27699,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.6994e-06,0.28457,0.25928,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.0429e-07,0.28441,0.27328,1,1
1,GO ASTROCYTE ACTIVATION,2.3274e-07,0.28372,0.3043,1,1
1,GO T CELL CHEMOTAXIS,2.4861e-06,0.28346,0.24715,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,7.2497e-05,0.28339,0.31551,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,3.8924e-05,0.28331,0.26947,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,8.1361e-07,0.28329,0.27554,1,1
1,GO REGULATION OF B CELL ACTIVATION,1.0169e-05,0.28326,0.24645,1,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00059648,0.28314,0.25648,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.00095459,0.28305,0.21883,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,8.0712e-08,0.28283,0.29631,1,1
1,GO RESPONSE TO MANGANESE ION,1.2733e-08,0.28253,0.27817,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,4.719e-07,0.28235,0.25975,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,1.1245e-09,0.28219,0.27518,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,5.3562e-07,0.28192,0.31498,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.6321e-06,0.28181,0.30136,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,1.1282e-07,0.28125,0.3215,1,1
1,GO LYMPH VESSEL DEVELOPMENT,8.4262e-06,0.28098,0.34684,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.8396e-06,0.28092,0.25388,1,1
1,GO RESPONSE TO DEXAMETHASONE,4.4771e-05,0.28092,0.22238,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.2397e-08,0.2805,0.29,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,7.5001e-05,0.27995,0.27452,1,1
1,GO TUBE MORPHOGENESIS,1.1789e-06,0.2798,0.23533,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.337e-06,0.27973,0.22742,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,6.0205e-08,0.27965,0.27933,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.3415e-09,0.27922,0.31804,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,6.5837e-06,0.27906,0.26811,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,7.5217e-06,0.27906,0.27541,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.538e-07,0.27878,0.28429,1,1
1,GO REGENERATION,3.2094e-09,0.27876,0.25804,1,1
1,GO REPLICATIVE SENESCENCE,0.00019229,0.27874,0.26469,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,2.3239e-05,0.27867,0.2723,1,1
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0025961,0.27867,0.2218,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.8419e-06,0.27855,0.26976,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,1.1588e-05,0.27841,0.24604,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,5.02e-08,0.27805,0.24421,1,1
1,GO PLATELET ACTIVATION,4.5233e-07,0.27786,0.28097,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00082553,0.27772,0.27448,1,1
1,GO LEUKOTRIENE METABOLIC PROCESS,0.028852,0.27769,0.14072,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.4586e-08,0.27767,0.29445,1,1
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0005618,0.27738,0.21663,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.658e-10,0.27726,0.3041,1,1
1,GO SEQUESTERING OF METAL ION,1.6457e-05,0.27726,0.2187,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,7.333e-07,0.27704,0.25289,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.0879e-07,0.27697,0.26983,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,1.0212e-06,0.27677,0.29,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.6881e-08,0.27667,0.2597,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.3274e-07,0.27658,0.25278,1,1
1,GO OSTEOBLAST PROLIFERATION,0.0041031,0.27625,0.23255,1,1
1,GO NEGATIVE T CELL SELECTION,2.9332e-05,0.27623,0.30543,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,2.011e-05,0.27615,0.25819,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,8.4415e-08,0.2759,0.25621,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.332e-06,0.27573,0.3481,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,1.4677e-08,0.27549,0.26343,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.7316e-05,0.2754,0.27299,1,1
1,GO LYMPHOCYTE MIGRATION,2.2775e-07,0.27531,0.27316,1,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.0011503,0.27527,0.26299,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.1789e-06,0.27526,0.28838,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.9069e-08,0.27466,0.29032,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00095459,0.27458,0.22936,1,1
1,GO LEUKOCYTE HOMEOSTASIS,3.5038e-07,0.27433,0.27019,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,2.5934e-07,0.27397,0.293,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,9.9844e-05,0.27392,0.23692,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2434e-08,0.27363,0.29307,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.0781e-08,0.27352,0.28561,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,1.9563e-06,0.27347,0.33224,1,1
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,2.0853e-05,0.27336,0.23639,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.6158e-05,0.2733,0.28829,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.5794e-07,0.27314,0.26372,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00011033,0.27313,0.28644,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.6514e-08,0.27306,0.26781,1,1
1,GO KERATINOCYTE MIGRATION,1.2328e-07,0.27277,0.27443,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,3.1479e-07,0.27273,0.32111,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,1.6994e-06,0.27262,0.23946,1,1
1,GO BONE DEVELOPMENT,3.4098e-06,0.27241,0.24145,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.3769e-07,0.27221,0.27506,1,1
1,GO REPLACEMENT OSSIFICATION,7.1274e-05,0.27218,0.29385,1,1
1,GO OSSIFICATION,2.6386e-06,0.27206,0.23437,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.2759e-09,0.27199,0.29162,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,6.0991e-06,0.27189,0.27968,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,2.402e-08,0.27188,0.29185,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,4.1815e-08,0.27129,0.34084,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0018006,0.27126,0.22023,1,1
1,GO PERICARDIUM DEVELOPMENT,0.00015331,0.27115,0.26467,1,1
1,GO TONGUE DEVELOPMENT,0.00045468,0.27097,0.25968,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.7154e-07,0.27089,0.30156,1,1
1,GO REGULATION OF LIPASE ACTIVITY,8.0712e-08,0.27029,0.2606,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00023294,0.27021,0.36979,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038478,0.26956,0.18025,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,9.6562e-05,0.26953,0.25838,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,1.3948e-05,0.26944,0.25536,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,4.6202e-07,0.26923,0.25359,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.475e-06,0.26882,0.27596,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.5037e-07,0.26872,0.28434,1,1
1,GO OSTEOCLAST DIFFERENTIATION,5.2538e-08,0.26834,0.263,1,1
1,GO IRON ION HOMEOSTASIS,1.5027e-08,0.2683,0.25321,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.402e-08,0.26829,0.27347,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0021505,0.26818,0.20571,1,1
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0047198,0.26793,0.22638,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.2784e-08,0.26792,0.28918,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,1.5674e-06,0.26769,0.23234,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,1.4076e-07,0.26767,0.29257,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.0322e-07,0.26766,0.23537,1,1
1,GO REGULATION OF LIPID STORAGE,3.2859e-07,0.26746,0.25314,1,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00039622,0.26743,0.19836,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.8983e-07,0.26732,0.2417,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.1119e-05,0.26658,0.2332,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.0811e-07,0.26651,0.27276,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.3599e-06,0.26624,0.281,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.8262e-07,0.26618,0.23291,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.3946e-06,0.26591,0.28638,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,7.892e-08,0.26582,0.25001,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,5.3562e-07,0.26569,0.22203,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.7804e-05,0.26561,0.2442,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,2.0364e-06,0.26549,0.353,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.2733e-08,0.26546,0.28996,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,1.5674e-06,0.26509,0.2512,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.6202e-07,0.26487,0.25451,1,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00028155,0.26484,0.22647,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.00028155,0.26451,0.20706,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.0811e-07,0.26439,0.33878,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,4.7172e-05,0.26437,0.268,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0062108,0.26432,0.22071,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,7.0522e-08,0.26425,0.24767,1,1
1,GO AORTA DEVELOPMENT,0.00067188,0.26388,0.22817,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.719e-07,0.26336,0.24163,1,1
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.00064263,0.26318,0.28336,1,1
1,GO GENITALIA MORPHOGENESIS,0.00053704,0.26305,0.28502,1,1
1,GO GASTRULATION,2.5164e-08,0.263,0.29055,1,1
1,GO REGULATION OF DEFENSE RESPONSE,7.7166e-08,0.26298,0.24033,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.0017e-09,0.2629,0.28043,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.00038422,0.26279,0.19777,1,1
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.010769,0.26268,0.19922,1,1
1,GO INTERLEUKIN 6 PRODUCTION,0.0001862,0.26255,0.21643,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00010673,0.26238,0.2046,1,1
1,GO LEUKOCYTE CHEMOTAXIS,6.0079e-05,0.26237,0.22842,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.3772e-08,0.26209,0.30683,1,1
1,GO CARDIOBLAST DIFFERENTIATION,1.5014e-05,0.26202,0.2907,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,7.6657e-06,0.26197,0.25801,1,1
1,GO MYOTUBE DIFFERENTIATION,0.00013673,0.26173,0.18857,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.2716e-05,0.26156,0.24094,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0001803,0.26145,0.24846,1,1
1,GO LIVER MORPHOGENESIS,0.00027716,0.26135,0.27937,1,1
1,GO CERAMIDE TRANSPORT,1.5293e-05,0.2612,0.27299,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00025617,0.26108,0.30816,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,6.337e-06,0.2609,0.30059,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,6.8348e-09,0.26083,0.34616,1,1
1,GO ERBB SIGNALING PATHWAY,8.8389e-07,0.26011,0.22989,1,1
1,GO LIPID IMPORT INTO CELL,0.00019229,0.26009,0.22073,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.7687e-09,0.26007,0.2868,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,7.2414e-06,0.26005,0.24852,1,1
1,GO STRESS FIBER ASSEMBLY,4.31e-06,0.25989,0.26407,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,7.1819e-07,0.25949,0.27744,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00011033,0.25938,0.30563,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,3.6162e-06,0.25918,0.2801,1,1
1,GO TUMOR NECROSIS FACTOR SECRETION,4.5558e-05,0.25894,0.20803,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,7.3739e-05,0.25883,0.29774,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.9563e-06,0.25882,0.23862,1,1
1,GO RECEPTOR CATABOLIC PROCESS,1.2328e-07,0.25849,0.32006,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.2058e-07,0.25849,0.26277,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.4454e-06,0.25821,0.30406,1,1
1,GO ACTIVATED T CELL PROLIFERATION,6.545e-05,0.25813,0.21406,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.6579e-07,0.25809,0.26607,1,1
1,GO FAT CELL DIFFERENTIATION,6.2175e-05,0.25788,0.19147,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.00011218,0.2578,0.19895,1,1
1,GO BONE REMODELING,4.4771e-05,0.25773,0.2569,1,1
1,GO ARTERY DEVELOPMENT,0.00013899,0.25773,0.23962,1,1
1,GO RESPONSE TO VITAMIN A,0.00024819,0.25764,0.21082,1,1
1,GO INTERLEUKIN 4 PRODUCTION,4.7488e-06,0.25737,0.2538,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,1.5014e-05,0.25732,0.25579,1,1
1,GO REGULATION OF BONE DEVELOPMENT,6.9711e-06,0.25693,0.28369,1,1
1,GO TOOTH MINERALIZATION,3.9613e-05,0.25675,0.31147,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.1351e-07,0.25669,0.23204,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00021511,0.25648,0.18888,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.00084997,0.25629,0.17215,1,1
1,GO EPITHELIAL CELL PROLIFERATION,1.4741e-05,0.2561,0.22997,1,1
1,GO ANIMAL ORGAN REGENERATION,3.6361e-10,0.25583,0.31431,1,1
1,GO LYMPHOCYTE COSTIMULATION,6.4592e-06,0.25578,0.24986,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,3.2631e-05,0.25575,0.21752,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,4.9228e-07,0.25574,0.28076,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,2.342e-06,0.25572,0.2748,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,5.7059e-05,0.25565,0.22146,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,5.3562e-07,0.25548,0.35353,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,1.8701e-05,0.25536,0.2325,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,9.5999e-07,0.25524,0.24241,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,8.1138e-06,0.25504,0.26126,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,5.1356e-08,0.255,0.2521,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,3.9102e-06,0.25496,0.30558,1,1
1,GO MESENCHYME MORPHOGENESIS,0.00061456,0.25477,0.2365,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.2482e-05,0.2547,0.28284,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,2.2926e-08,0.25434,0.26473,1,1
1,GO LAMELLIPODIUM ORGANIZATION,2.1234e-05,0.25383,0.22129,1,1
1,GO PEPTIDE CATABOLIC PROCESS,2.4837e-07,0.25374,0.28387,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,1.9989e-07,0.25371,0.34164,1,1
1,GO ASYMMETRIC CELL DIVISION,1.3948e-05,0.2537,0.26601,1,1
1,GO CELL REDOX HOMEOSTASIS,2.4837e-07,0.25362,0.21985,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.5001e-05,0.25319,0.19088,1,1
1,GO ASTROCYTE DIFFERENTIATION,7.5001e-05,0.25312,0.21712,1,1
1,GO LEUKOCYTE DIFFERENTIATION,4.1552e-07,0.25307,0.24296,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00013673,0.25284,0.27164,1,1
1,GO REGULATION OF HEMOPOIESIS,1.0036e-08,0.25267,0.24717,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,8.4424e-05,0.25267,0.26892,1,1
1,GO FOREGUT MORPHOGENESIS,6.5837e-06,0.25258,0.28873,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,8.3013e-05,0.25256,0.23329,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,2.3661e-05,0.25184,0.25607,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.7706e-05,0.25147,0.26219,1,1
1,GO FACE DEVELOPMENT,9.2585e-06,0.25134,0.27277,1,1
1,GO CELLULAR RESPONSE TO LIPID,1.439e-07,0.25111,0.22496,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,5.0323e-06,0.25107,0.22171,1,1
1,GO TRANSEPITHELIAL TRANSPORT,4.3236e-05,0.25106,0.20516,1,1
1,GO MESENCHYMAL CELL PROLIFERATION,0.0087156,0.25035,0.2023,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00017457,0.24979,0.21308,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,7.0337e-07,0.24958,0.23692,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0004e-06,0.24937,0.24,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0025617,0.24929,0.24202,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.332e-06,0.24918,0.22734,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,7.2414e-06,0.24917,0.29347,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.5906e-08,0.24914,0.25053,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,3.4098e-06,0.24889,0.28969,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.8416e-06,0.24834,0.25419,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0005133,0.24806,0.25268,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,9.086e-06,0.24801,0.21719,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,1.0169e-05,0.24798,0.24127,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.3325e-06,0.24791,0.32001,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00099681,0.24787,0.23276,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.6487e-06,0.24786,0.28285,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,1.1794e-07,0.24721,0.24861,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.0811e-07,0.24708,0.26329,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00013016,0.24702,0.2192,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,6.2175e-05,0.24686,0.21999,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,5.7582e-06,0.24679,0.23567,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,7.7586e-05,0.24673,0.26931,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.7999e-05,0.24669,0.21775,1,1
1,GO REGULATION OF BODY FLUID LEVELS,1.3325e-06,0.24631,0.21834,1,1
1,GO MUSCLE FILAMENT SLIDING,9.404e-07,0.24625,0.25137,1,1
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0095807,0.24604,0.21432,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8886e-07,0.24591,0.27224,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.6877e-06,0.24546,0.24265,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,3.5022e-05,0.24539,0.2524,1,1
1,GO NEUROINFLAMMATORY RESPONSE,7.6283e-05,0.24522,0.22645,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0003557,0.24514,0.23912,1,1
1,GO SECRETION BY TISSUE,0.00058763,0.24512,0.17831,1,1
1,GO DETOXIFICATION,1.9044e-05,0.24504,0.18438,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,1.9175e-06,0.24495,0.27467,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,3.8347e-06,0.24455,0.24356,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.6914e-06,0.24454,0.35162,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.5934e-07,0.24451,0.27987,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.5424e-05,0.2443,0.29497,1,1
1,GO TUBE DEVELOPMENT,1.3442e-05,0.24428,0.20083,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.0007786,0.24425,0.17805,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,7.333e-07,0.24416,0.27315,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.8161e-07,0.24385,0.28158,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0019285,0.24382,0.19944,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.1041e-08,0.24303,0.26076,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,8.5867e-06,0.24299,0.21236,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.3239e-05,0.24289,0.25452,1,1
1,GO ACUTE PHASE RESPONSE,0.00040235,0.24261,0.1918,1,1
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0001179,0.24259,0.22656,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,9.9803e-06,0.2425,0.23998,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,6.7105e-06,0.24201,0.2658,1,1
1,GO VESICLE CARGO LOADING,1.7693e-06,0.24195,0.25646,1,1
1,GO CELLULAR RESPONSE TO VITAMIN,0.013093,0.2418,0.24446,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,2.856e-06,0.24165,0.2837,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.9872e-06,0.24122,0.22098,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.357e-07,0.24097,0.22486,1,1
1,GO NEURAL CREST CELL MIGRATION,0.00046165,0.24079,0.21642,1,1
1,GO MACROPHAGE ACTIVATION,0.00022927,0.2405,0.22919,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,1.6654e-06,0.24047,0.25593,1,1
1,GO BIOLOGICAL ADHESION,7.1274e-05,0.24039,0.19249,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.7605e-06,0.24021,0.23425,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001422,0.24002,0.21988,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,7.6446e-07,0.23975,0.24895,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,6.7724e-05,0.23962,0.23337,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,4.1815e-08,0.2395,0.26889,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00026438,0.23938,0.23267,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0012705,0.23923,0.30408,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,9.4341e-06,0.23922,0.32935,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,1.6761e-05,0.23907,0.2741,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00095459,0.23902,0.2176,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0031247,0.23889,0.18969,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.0395e-05,0.23871,0.23849,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.001118,0.2386,0.20341,1,1
1,GO TERPENOID METABOLIC PROCESS,0.0005211,0.23856,0.17305,1,1
1,GO MESENCHYME DEVELOPMENT,9.795e-06,0.2383,0.20996,1,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0099244,0.23787,0.2462,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.022686,0.2377,0.13408,1,1
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00014129,0.23766,0.23533,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,7.2414e-06,0.23765,0.27033,1,1
1,GO REGULATION OF GTP BINDING,0.0011021,0.23761,0.23971,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,3.2784e-06,0.23731,0.25291,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.0212e-06,0.23725,0.20445,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00057029,0.23721,0.23443,1,1
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.022446,0.23693,0.18129,1,1
1,GO DECIDUALIZATION,0.00024045,0.2365,0.2968,1,1
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.00029511,0.23641,0.19488,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,9.03e-05,0.23639,0.2247,1,1
1,GO PROTEIN TARGETING TO VACUOLE,3.7605e-06,0.23608,0.22943,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,7.3803e-06,0.23607,0.24745,1,1
1,GO T CELL DIFFERENTIATION,5.6487e-06,0.23599,0.22527,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0005056,0.23589,0.22885,1,1
1,GO PROTEIN PROCESSING,1.8793e-06,0.23582,0.2066,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.6761e-05,0.23574,0.23256,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0056958,0.23571,0.17231,1,1
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00087508,0.23564,0.21833,1,1
1,GO REGULATION OF STEM CELL DIVISION,0.028852,0.23551,0.13148,1,1
1,GO CYTOKINE SECRETION,0.0011021,0.23496,0.17827,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.8983e-07,0.23466,0.22564,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.7668e-07,0.23463,0.27128,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.3236e-05,0.23455,0.20637,1,1
1,GO B CELL ACTIVATION,2.4371e-06,0.23452,0.23897,1,1
1,GO PROTEIN KINASE A SIGNALING,1.8053e-06,0.23452,0.20992,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,1.5014e-05,0.23442,0.23124,1,1
1,GO PIGMENT GRANULE ORGANIZATION,1.8053e-06,0.23432,0.28102,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,6.4592e-06,0.23406,0.24527,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,7.969e-07,0.23368,0.26252,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00024045,0.23346,0.23591,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,5.7536e-08,0.23284,0.26883,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.7582e-06,0.23274,0.25872,1,1
1,GO PLACENTA DEVELOPMENT,5.7582e-06,0.2326,0.21747,1,1
1,GO MYELOID CELL HOMEOSTASIS,3.4003e-08,0.23216,0.23678,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.8983e-07,0.23206,0.24607,1,1
1,GO HEPARIN METABOLIC PROCESS,9.1829e-05,0.23174,0.30383,1,1
1,GO POSITIVE REGULATION OF OSSIFICATION,0.00043435,0.2317,0.24045,1,1
1,GO CELLULAR RESPONSE TO NUTRIENT,0.02945,0.23161,0.17831,1,1
1,GO RESPONSE TO CORTICOSTERONE,0.011411,0.23161,0.1655,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,7.0337e-07,0.23156,0.27842,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,5.5864e-07,0.23151,0.24338,1,1
1,GO REGULATION OF PROTEOLYSIS,9.2321e-08,0.23093,0.21239,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.6487e-06,0.23084,0.22961,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,1.9393e-05,0.23068,0.22165,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.6321e-06,0.23064,0.22615,1,1
1,GO REGULATION OF LIPID TRANSPORT,8.7502e-06,0.23049,0.21989,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,2.6386e-06,0.23047,0.18852,1,1
1,GO RESPONSE TO ISCHEMIA,1.2027e-05,0.23044,0.22001,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0047798,0.23013,0.25567,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,9.404e-07,0.23006,0.21007,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0028492,0.22997,0.18364,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,9.0235e-07,0.22954,0.22416,1,1
1,GO REGULATION OF CHEMOTAXIS,2.9332e-05,0.22938,0.20451,1,1
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.01016,0.22923,0.25368,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0016806,0.22905,0.21761,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,5.8262e-07,0.229,0.20246,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,9.6129e-06,0.2289,0.22055,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.7051e-07,0.22884,0.24033,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,5.7051e-07,0.22871,0.23452,1,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.00076726,0.2286,0.21517,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0034692,0.22858,0.23591,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,5.1304e-06,0.22817,0.30289,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00069207,0.22812,0.18211,1,1
1,GO CELLULAR RESPONSE TO X RAY,3.3214e-05,0.2276,0.31988,1,1
1,GO RESPONSE TO UV C,0.00020504,0.22753,0.22182,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,3.9102e-06,0.22693,0.27309,1,1
1,GO RESPONSE TO LIPID,3.2784e-06,0.22638,0.19728,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00011033,0.22635,0.2183,1,1
1,GO AMYLOID BETA FORMATION,2.3239e-05,0.2263,0.24359,1,1
1,GO BONE MORPHOGENESIS,7.105e-06,0.22581,0.25968,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,2.1621e-05,0.22574,0.23166,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,2.9859e-05,0.2257,0.31652,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,1.3325e-06,0.225,0.28511,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0020929,0.22479,0.16386,1,1
1,GO LIPID OXIDATION,1.3693e-05,0.22459,0.1934,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.1789e-06,0.22412,0.27149,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.001955,0.22409,0.21994,1,1
1,GO AMELOGENESIS,0.0011341,0.22407,0.22954,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,9.2585e-06,0.22392,0.22595,1,1
1,GO HORMONE CATABOLIC PROCESS,0.051595,0.22383,0.16719,1,1
1,GO RESPONSE TO PROGESTERONE,0.00030449,0.22382,0.24061,1,1
1,GO RESPONSE TO NUTRIENT,4.0314e-05,0.22375,0.20142,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,2.0853e-05,0.22356,0.35651,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0010408,0.22346,0.24917,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.2954e-05,0.22323,0.2237,1,1
1,GO INTEGRIN ACTIVATION,0.00016361,0.22294,0.23466,1,1
1,GO FATTY ACID BETA OXIDATION,1.5865e-05,0.22292,0.19577,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00062378,0.22284,0.23318,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0016122,0.22276,0.18578,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.1086e-06,0.22254,0.21836,1,1
1,GO CARTILAGE DEVELOPMENT,2.8886e-07,0.2225,0.25819,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,4.9069e-08,0.22248,0.23168,1,1
1,GO REGULATION OF LIPID LOCALIZATION,1.8053e-06,0.22219,0.21942,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,1.6457e-05,0.222,0.23208,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,2.4861e-06,0.22157,0.19812,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00013673,0.22092,0.20874,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00016901,0.22088,0.24,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,4.3997e-05,0.22055,0.29255,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,7.1726e-09,0.2205,0.24741,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.3256e-05,0.22024,0.22413,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,8.0256e-05,0.22012,0.23157,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,7.969e-07,0.22011,0.21423,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,1.3056e-06,0.22003,0.19488,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,5.8049e-05,0.21999,0.21517,1,1
1,GO RESPONSE TO TESTOSTERONE,2.0364e-06,0.2197,0.26239,1,1
1,GO RESPONSE TO STEROID HORMONE,1.3442e-05,0.21962,0.19162,1,1
1,GO REGULATION OF LIPID KINASE ACTIVITY,2.8305e-05,0.21954,0.20882,1,1
1,GO PROTEIN ADP RIBOSYLATION,9.03e-05,0.21943,0.21391,1,1
1,GO PORE COMPLEX ASSEMBLY,6.2175e-05,0.21937,0.19574,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.0035146,0.21924,0.22932,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.0088198,0.21874,0.1759,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,9.819e-05,0.21871,0.22953,1,1
1,GO FATTY ACID HOMEOSTASIS,0.0062108,0.21865,0.19205,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,5.7059e-05,0.21854,0.27227,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0027381,0.21841,0.20102,1,1
1,GO MYELOID CELL DIFFERENTIATION,6.0205e-08,0.2182,0.23096,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.2015e-05,0.2178,0.1958,1,1
1,GO RESPONSE TO GROWTH HORMONE,0.00091404,0.21758,0.23245,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00011596,0.21752,0.24768,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00068191,0.21742,0.17719,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,6.8888e-05,0.21723,0.20775,1,1
1,GO SYMBIOTIC PROCESS,1.2759e-09,0.21707,0.21116,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,2.2824e-05,0.21704,0.2388,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,4.719e-07,0.21698,0.21053,1,1
1,GO BONE MATURATION,0.014658,0.21684,0.13214,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,3.094e-05,0.21666,0.19654,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,1.4472e-05,0.2165,0.21753,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,7.105e-06,0.216,0.20644,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.5001e-05,0.21583,0.23701,1,1
1,GO BIOMINERALIZATION,0.00095459,0.2156,0.18587,1,1
1,GO RESPONSE TO FATTY ACID,0.020385,0.21533,0.12359,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00015331,0.21531,0.19901,1,1
1,GO PLATELET MORPHOGENESIS,1.4207e-05,0.21523,0.27406,1,1
1,GO REGULATION OF PROTEIN IMPORT,4.6578e-06,0.21512,0.23574,1,1
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.002631,0.21434,0.24816,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,3.4773e-06,0.2143,0.23293,1,1
1,GO HINDLIMB MORPHOGENESIS,0.0018508,0.21364,0.19758,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,7.969e-07,0.21339,0.20096,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,1.0861e-06,0.21333,0.23028,1,1
1,GO UV PROTECTION,0.0026663,0.21326,0.21182,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,5.3562e-07,0.21325,0.26737,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001235,0.21306,0.15916,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,1.0557e-05,0.21303,0.18547,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.9136e-07,0.21236,0.20504,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,4.4285e-07,0.21224,0.2337,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.8886e-07,0.21217,0.2077,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00014839,0.21214,0.20769,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,9.2585e-06,0.21212,0.19707,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.3599e-06,0.21193,0.23696,1,1
1,GO PROTEIN KINASE B SIGNALING,5.0278e-07,0.21183,0.21957,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.8053e-06,0.21151,0.18813,1,1
1,GO ARTERY MORPHOGENESIS,0.0038478,0.21134,0.194,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,6.8396e-06,0.21134,0.24929,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00041488,0.21122,0.24168,1,1
1,GO FLUID TRANSPORT,7.5001e-05,0.21087,0.23162,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,6.4592e-06,0.21075,0.21235,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.5027e-08,0.21053,0.21057,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00010497,0.21045,0.21352,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.758e-05,0.21041,0.23609,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,4.0314e-05,0.21033,0.21424,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.00020504,0.20987,0.20585,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,7.0072e-05,0.20967,0.18779,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0016122,0.20944,0.31049,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,2.2416e-05,0.20925,0.20235,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1.8032e-05,0.20922,0.21116,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.4741e-05,0.2092,0.20206,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,1.2281e-06,0.20917,0.22478,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.3784e-07,0.20908,0.19577,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.5239e-09,0.20898,0.22604,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.001422,0.20892,0.17969,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4091e-05,0.20886,0.22233,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,3.9102e-06,0.20885,0.19408,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0029256,0.20872,0.22934,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,3.2859e-07,0.20832,0.22643,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.3599e-06,0.20813,0.21288,1,1
1,GO ERAD PATHWAY,7.333e-07,0.20786,0.19698,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.0322e-07,0.20785,0.21128,1,1
1,GO REGULATION OF HEART GROWTH,0.00016098,0.20778,0.18348,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00010852,0.20778,0.18729,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,2.8814e-05,0.20775,0.20513,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.4305e-07,0.20765,0.26069,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,5.332e-06,0.20764,0.21066,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.758e-05,0.20759,0.16752,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0016122,0.20752,0.21428,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,4.8839e-05,0.20746,0.20915,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.8701e-05,0.20744,0.2452,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4454e-06,0.20739,0.2031,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,5.3747e-08,0.20724,0.20411,1,1
1,GO MESODERM MORPHOGENESIS,1.1086e-06,0.20722,0.23281,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,5.1446e-05,0.20703,0.24394,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0010259,0.20688,0.16818,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00039622,0.20677,0.19291,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,1.3442e-05,0.20649,0.20619,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,5.7051e-07,0.20607,0.20254,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.1794e-07,0.20599,0.20586,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.0054192,0.20596,0.2304,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00012388,0.20577,0.24457,1,1
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00035024,0.20569,0.20854,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.4163e-06,0.20559,0.24955,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0023637,0.20544,0.15976,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00031414,0.20525,0.22492,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00071283,0.20509,0.15846,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.2487e-05,0.20482,0.22362,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00039622,0.20476,0.23648,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.9332e-05,0.20475,0.25557,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,2.4861e-06,0.2045,0.22791,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.2631e-05,0.20446,0.21399,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,6.0759e-07,0.2044,0.21477,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,1.536e-06,0.20436,0.205,1,1
1,GO CELL CELL ADHESION,0.00086244,0.20424,0.15962,1,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.028556,0.2041,0.13407,1,1
1,GO CELL MOTILITY,9.6562e-05,0.20406,0.16686,1,1
1,GO HEART VALVE DEVELOPMENT,6.2175e-05,0.20397,0.26323,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,2.3891e-06,0.20378,0.20042,1,1
1,GO TRACHEA MORPHOGENESIS,6.4592e-06,0.20358,0.32338,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,5.2344e-05,0.20357,0.22163,1,1
1,GO RESPONSE TO ANTIBIOTIC,2.8886e-07,0.20348,0.22758,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.6782e-07,0.20334,0.21475,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0062877,0.20281,0.13983,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00020178,0.20266,0.19916,1,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011022,0.20218,0.16649,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,3.2146e-06,0.20204,0.20006,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00073415,0.20203,0.17829,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,4.5822e-08,0.2019,0.20669,1,1
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0034692,0.20177,0.29395,1,1
1,GO ETHER METABOLIC PROCESS,0.00046165,0.20127,0.20094,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00013016,0.20106,0.1871,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.001955,0.20066,0.16771,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0022095,0.20065,0.18248,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.402e-08,0.20057,0.19885,1,1
1,GO BODY MORPHOGENESIS,0.00034485,0.20044,0.21952,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,1.5293e-05,0.20018,0.16995,1,1
1,GO NEPHRON DEVELOPMENT,0.0023321,0.19986,0.18185,1,1
1,GO BONE MINERALIZATION,0.014658,0.19982,0.16014,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.7172e-05,0.19975,0.16804,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,3.8161e-07,0.19926,0.17587,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,7.6446e-07,0.19925,0.25556,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,1.4741e-05,0.19912,0.19757,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,2.8001e-06,0.1991,0.2477,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.032278,0.19896,0.099665,1,1
1,GO RESPONSE TO BMP,0.0032078,0.19888,0.16309,1,1
1,GO OVULATION,0.01251,0.19871,0.15138,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00044103,0.19855,0.17493,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,8.3066e-07,0.19846,0.21251,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,6.4592e-06,0.19836,0.19485,1,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0051547,0.198,0.15551,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.00010673,0.19757,0.22044,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,7.5217e-06,0.19746,0.22413,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,7.3739e-05,0.19735,0.19027,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.1829e-05,0.19723,0.23946,1,1
1,GO SELECTIVE AUTOPHAGY,1.439e-07,0.19719,0.21707,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,7.2414e-06,0.19712,0.20149,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0069343,0.19709,0.10868,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,7.333e-07,0.19696,0.19602,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.8305e-05,0.19659,0.24065,1,1
1,GO GLIAL CELL MIGRATION,0.0005133,0.19636,0.19554,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.001483,0.19613,0.15517,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,1.0557e-05,0.19592,0.26502,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00029052,0.19577,0.19393,1,1
1,GO AUTOPHAGOSOME MATURATION,7.333e-07,0.1957,0.2124,1,1
1,GO REGULATION OF MAPK CASCADE,2.7452e-06,0.19554,0.19683,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.00072342,0.19527,0.21038,1,1
1,GO ACTIVATION OF JNKK ACTIVITY,0.0013633,0.19521,0.18966,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,1.6321e-06,0.19515,0.1903,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00047589,0.19508,0.16309,1,1
1,GO EXOCYTOSIS,1.6158e-05,0.19484,0.17576,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,5.3562e-07,0.19479,0.19815,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,2.4861e-06,0.1946,0.18736,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,9.819e-05,0.19452,0.17509,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0063654,0.19436,0.18434,1,1
1,GO VIRAL TRANSLATION,0.0039992,0.19421,0.16621,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,8.9166e-06,0.1942,0.22259,1,1
1,GO NUCLEOSIDE SALVAGE,0.0023637,0.19402,0.17998,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.0029645,0.19358,0.1376,1,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0038977,0.19347,0.24926,1,1
1,GO RECEPTOR RECYCLING,0.00029511,0.19294,0.15891,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00014362,0.19281,0.17865,1,1
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.026838,0.19231,0.145,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.337e-06,0.19231,0.21197,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.010041,0.19221,0.17961,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0050269,0.19211,0.16598,1,1
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.001955,0.1921,0.17349,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.094e-05,0.19208,0.22238,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00054518,0.19198,0.1727,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.0776e-06,0.19198,0.20501,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,4.31e-06,0.19195,0.17114,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0066039,0.19177,0.16665,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,6.7411e-08,0.19144,0.20453,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0078263,0.1913,0.14553,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.0554e-07,0.19125,0.20193,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.5576e-05,0.191,0.19303,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,6.6578e-05,0.19098,0.16633,1,1
1,GO HISTONE H2B UBIQUITINATION,0.00091404,0.19075,0.15814,1,1
1,GO VESICLE TARGETING,3.1494e-05,0.19062,0.16808,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00059648,0.19039,0.20386,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.0013255,0.19031,0.17908,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.00049802,0.1903,0.17674,1,1
1,GO REGULATION OF CELL POPULATION PROLIFERATION,9.4959e-05,0.19028,0.15526,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,6.2169e-06,0.19026,0.23493,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00062378,0.1901,0.22002,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.3803e-06,0.19006,0.20053,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00048316,0.18993,0.20678,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00084997,0.18992,0.19747,1,1
1,GO RESPONSE TO IONIZING RADIATION,1.9563e-06,0.18989,0.20777,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.0027747,0.18957,0.1637,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.1119e-05,0.18952,0.17584,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.9613e-05,0.1895,0.2351,1,1
1,GO RESPONSE TO CHEMOKINE,2.8001e-06,0.18942,0.21129,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,3.2784e-06,0.18937,0.19263,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.017894,0.18935,0.10192,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00011033,0.18933,0.16924,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,5.7059e-05,0.18922,0.17948,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.8793e-06,0.18914,0.20243,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.5386e-08,0.18873,0.20785,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.536e-06,0.1885,0.19237,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.7154e-07,0.18844,0.20512,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00010152,0.18833,0.20319,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.332e-06,0.18823,0.17946,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.2631e-05,0.18783,0.1631,1,1
1,GO RESPONSE TO GROWTH FACTOR,4.3236e-05,0.18779,0.17235,1,1
1,GO MANGANESE ION TRANSPORT,0.00029052,0.18751,0.19835,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00039018,0.18726,0.19301,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,9.2585e-06,0.1872,0.25693,1,1
1,GO TOXIN TRANSPORT,0.0005133,0.18671,0.16381,1,1
1,GO RENAL VESICLE DEVELOPMENT,0.016027,0.18632,0.14871,1,1
1,GO ORGAN GROWTH,2.1234e-05,0.18613,0.20192,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0016806,0.18574,0.16183,1,1
1,GO MUSCLE ADAPTATION,0.00069207,0.18574,0.1572,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.00040235,0.1857,0.19265,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.475e-06,0.1856,0.18105,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.7385e-05,0.18549,0.18758,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00016629,0.18534,0.18566,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.012227,0.18531,0.27958,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.6914e-06,0.18513,0.21057,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.1165e-05,0.1851,0.17019,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9044e-05,0.18503,0.19601,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.6578e-06,0.18501,0.17716,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00036686,0.18448,0.16706,1,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.020605,0.1844,0.17487,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,5.0323e-06,0.18438,0.23459,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.3946e-06,0.18421,0.19807,1,1
1,GO AUTOPHAGY OF NUCLEUS,1.9393e-05,0.18413,0.22701,1,1
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00034485,0.18398,0.18783,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00031414,0.18379,0.20847,1,1
1,GO TISSUE HOMEOSTASIS,0.00075607,0.18372,0.14068,1,1
1,GO RESPONSE TO OXYGEN LEVELS,8.2686e-06,0.18355,0.16788,1,1
1,GO FATTY ACID TRANSPORT,0.00016361,0.1835,0.15786,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.00015331,0.18334,0.19903,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.8032e-05,0.1833,0.24909,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.9872e-06,0.1833,0.17834,1,1
1,GO TISSUE MORPHOGENESIS,1.0169e-05,0.18311,0.17894,1,1
1,GO LIPID HOMEOSTASIS,0.00010852,0.18306,0.16565,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,7.1274e-05,0.18276,0.16756,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00029052,0.18262,0.16942,1,1
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00033432,0.18255,0.17427,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017176,0.18244,0.21074,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00092737,0.18243,0.18116,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,3.2146e-06,0.18237,0.24274,1,1
1,GO PIGMENT METABOLIC PROCESS,6.4592e-06,0.18235,0.18363,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.00027284,0.18229,0.15092,1,1
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.001422,0.18222,0.13956,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.5999e-07,0.18219,0.2328,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.5837e-06,0.18218,0.22228,1,1
1,GO REGULATION OF PROTEIN BINDING,1.7385e-05,0.18217,0.16602,1,1
1,GO RESPONSE TO OSMOTIC STRESS,7.2414e-06,0.18205,0.18229,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,6.3249e-05,0.18202,0.18087,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.1552e-07,0.18177,0.22635,1,1
1,GO RESPONSE TO AMYLOID BETA,0.02915,0.18165,0.12292,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,1.3693e-05,0.18162,0.20438,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001568,0.18157,0.24202,1,1
1,GO HEART MORPHOGENESIS,0.00083767,0.18143,0.15638,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00036124,0.18134,0.22479,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,7.6657e-06,0.18131,0.23481,1,1
1,GO REGULATION OF URINE VOLUME,7.1819e-07,0.18129,0.24511,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.00025617,0.18128,0.18694,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.9056e-05,0.1812,0.18694,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,5.2303e-06,0.1812,0.20992,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.001568,0.18119,0.20284,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.00013451,0.18089,0.16205,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,1.4741e-05,0.17993,0.18496,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00046165,0.1799,0.21322,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.031953,0.17976,0.10344,1,1
1,GO MATURATION OF LSU RRNA,0.041789,0.17973,0.12361,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.010279,0.17968,0.16177,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00036124,0.17968,0.19079,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00018323,0.17964,0.16324,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0023957,0.17964,0.15986,1,1
1,GO ENDOTHELIUM DEVELOPMENT,0.0020646,0.17963,0.17597,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0028118,0.17954,0.17886,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00011406,0.17932,0.15974,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,8.4424e-05,0.17929,0.17387,1,1
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.011949,0.17899,0.1831,1,1
1,GO GTP METABOLIC PROCESS,0.00033955,0.17898,0.19269,1,1
1,GO CELL CELL RECOGNITION,5.4982e-08,0.17881,0.1929,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,6.2175e-05,0.17871,0.1771,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.2303e-06,0.17835,0.17637,1,1
1,GO RESPONSE TO MECHANICAL STIMULUS,0.0090315,0.17828,0.14496,1,1
1,GO PENTOSE METABOLIC PROCESS,0.0030038,0.17827,0.16847,1,1
1,GO ANIMAL ORGAN FORMATION,0.0014022,0.17826,0.16638,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.00069207,0.17811,0.13257,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.3256e-05,0.17791,0.16068,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,7.105e-06,0.17761,0.17825,1,1
1,GO REGULATION OF RESPONSE TO STRESS,3.8161e-07,0.1776,0.17434,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.5884e-05,0.17757,0.20145,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0021798,0.17688,0.17991,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0013069,0.17679,0.17466,1,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.01251,0.17676,0.12325,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,9.03e-05,0.17675,0.15627,1,1
1,GO MAINTENANCE OF LOCATION,5.0278e-07,0.17675,0.17759,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.1446e-05,0.17658,0.19346,1,1
1,GO FEMALE GENITALIA DEVELOPMENT,0.010522,0.17649,0.15032,1,1
1,GO SARCOMERE ORGANIZATION,0.014332,0.17607,0.14445,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00026438,0.17606,0.19084,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,9.9844e-05,0.17599,0.20561,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00052901,0.17595,0.2077,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00029511,0.17591,0.17511,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,5.8856e-08,0.17587,0.19879,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.000662,0.17586,0.18616,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.2482e-05,0.17575,0.16124,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,7.7586e-05,0.1753,0.13822,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.4098e-06,0.17524,0.19081,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00015838,0.17506,0.15205,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,9.2585e-06,0.17491,0.17826,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0059116,0.17473,0.16739,1,1
1,GO CELLULAR RESPONSE TO FATTY ACID,0.02174,0.17417,0.13693,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00030449,0.17413,0.14827,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0021798,0.17405,0.18517,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,2.4091e-05,0.17384,0.19693,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00010323,0.17372,0.17397,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,2.5884e-05,0.17372,0.16249,1,1
1,GO LYSOSOMAL TRANSPORT,3.094e-05,0.17356,0.17833,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,2.3784e-07,0.17356,0.21005,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00010673,0.17344,0.16485,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.719e-07,0.17335,0.17747,1,1
1,GO CYTOKINETIC PROCESS,1.5014e-05,0.1733,0.20078,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.0049019,0.17329,0.15676,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00027716,0.17299,0.15961,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,2.2824e-05,0.17292,0.20671,1,1
1,GO HISTONE PHOSPHORYLATION,0.00016098,0.17269,0.14626,1,1
1,GO HEART DEVELOPMENT,0.00018323,0.17263,0.15848,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0010865,0.17238,0.18372,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.010279,0.1723,0.17178,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00011406,0.17228,0.17452,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.0278e-07,0.17218,0.2069,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00022208,0.17218,0.15605,1,1
1,GO MESODERM DEVELOPMENT,4.3946e-06,0.17215,0.17783,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00064263,0.17202,0.19778,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,2.6352e-05,0.17199,0.16886,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00080175,0.17153,0.16717,1,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0019023,0.17143,0.1741,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5994e-06,0.17139,0.1926,1,1
1,GO REGULATION OF ORGAN GROWTH,3.8347e-06,0.1713,0.21466,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0011836,0.1711,0.20299,1,1
1,GO CELL AGING,3.7605e-06,0.17097,0.17263,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,1.0958e-05,0.17089,0.17881,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.2344e-05,0.17065,0.19634,1,1
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.031953,0.17042,0.14758,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0038478,0.16991,0.19192,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.0905e-06,0.16985,0.17875,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,6.5837e-06,0.16972,0.16208,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,8.9166e-06,0.16969,0.24861,1,1
1,GO MYELOID CELL DEVELOPMENT,0.0072795,0.16944,0.15618,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,7.6283e-05,0.16942,0.1788,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,3.628e-05,0.1694,0.16338,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.6386e-06,0.1692,0.1974,1,1
1,GO REGULATION OF CELL AGING,1.5865e-05,0.16877,0.17868,1,1
1,GO POSITIVE REGULATION OF JNK CASCADE,0.00159,0.16874,0.14395,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0010558,0.16874,0.17306,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00040235,0.16871,0.13799,1,1
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.017699,0.16864,0.12215,1,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0021215,0.16862,0.18412,1,1
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0081133,0.16851,0.14729,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,4.5558e-05,0.16845,0.1766,1,1
1,GO LAMELLIPODIUM ASSEMBLY,7.5001e-05,0.16837,0.19027,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00012186,0.16829,0.16571,1,1
1,GO MRNA TRANSCRIPTION,4.8839e-05,0.16784,0.23518,1,1
1,GO RESPONSE TO HORMONE,0.00013673,0.16768,0.14236,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.011678,0.16765,0.15178,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.9393e-05,0.1676,0.17914,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00024819,0.16744,0.16061,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0047198,0.16741,0.16192,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.00024819,0.16739,0.13715,1,1
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.03902,0.16737,0.12231,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00099681,0.1671,0.14512,1,1
1,GO GOLGI VESICLE BUDDING,6.2175e-05,0.16705,0.15308,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.0958e-05,0.16674,0.16354,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.2015e-05,0.1664,0.17457,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.035336,0.16619,0.12225,1,1
1,GO VIRAL RELEASE FROM HOST CELL,6.337e-06,0.16584,0.1887,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00099681,0.16549,0.18383,1,1
1,GO RESPONSE TO KETONE,0.00033955,0.16518,0.15934,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.00049053,0.16511,0.16524,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0027381,0.16506,0.15224,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.0022701,0.16501,0.15116,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.00011596,0.1649,0.13545,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,4.5558e-05,0.16489,0.14637,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.014823,0.1645,0.1738,1,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.012087,0.16446,0.13059,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00054518,0.16418,0.18174,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00013673,0.16416,0.21028,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0022701,0.16414,0.16461,1,1
1,GO LIPID CATABOLIC PROCESS,2.2015e-05,0.16395,0.15996,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00020504,0.16389,0.18038,1,1
1,GO REGULATION OF CELL DEATH,8.9166e-06,0.16373,0.15144,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,3.3214e-05,0.16344,0.1862,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0056255,0.16315,0.13526,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00075607,0.16308,0.14947,1,1
1,GO CELLULAR RESPONSE TO ATP,5.9056e-05,0.16285,0.1559,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6578e-06,0.16277,0.17178,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00011986,0.16268,0.13611,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.030368,0.16262,0.15675,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00010673,0.16259,0.13448,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.000662,0.16239,0.14705,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,2.7804e-05,0.16232,0.18493,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,6.3249e-05,0.16216,0.19981,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.1304e-06,0.16215,0.154,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,3.8924e-05,0.16214,0.16493,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0015463,0.16206,0.12891,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00048316,0.16201,0.13547,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.0010558,0.162,0.15952,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0032078,0.16197,0.16545,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,8.4805e-07,0.16185,0.17301,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.01829,0.16181,0.12137,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.4592e-06,0.16168,0.16141,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0099244,0.16166,0.15697,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,3.2162e-07,0.16156,0.17984,1,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0020092,0.16153,0.13511,1,1
1,GO AGING,4.3946e-06,0.16146,0.16631,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0017277,0.16143,0.1261,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00010852,0.16124,0.1747,1,1
1,GO HEART GROWTH,0.00020504,0.16104,0.17048,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,7.5001e-05,0.16093,0.14385,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00035024,0.16082,0.15281,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.001442,0.16059,0.1616,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.1494e-05,0.16054,0.21256,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,5.1446e-05,0.16052,0.16496,1,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00049802,0.16033,0.15005,1,1
1,GO ANION HOMEOSTASIS,0.0001179,0.16029,0.19041,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,5.2303e-06,0.16017,0.15802,1,1
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001955,0.16015,0.16706,1,1
1,GO LIPID MODIFICATION,0.00022208,0.15986,0.13686,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,8.1623e-05,0.15954,0.18838,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.4959e-05,0.15945,0.13804,1,1
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.0020929,0.15927,0.17675,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.013394,0.15926,0.11611,1,1
1,GO NEURAL TUBE FORMATION,0.002702,0.1591,0.15319,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00046872,0.15905,0.17183,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.00072342,0.159,0.18008,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0001862,0.15888,0.13919,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00052901,0.15884,0.17221,1,1
1,GO STEM CELL DIFFERENTIATION,3.4773e-06,0.1588,0.17704,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.0905e-06,0.15855,0.17532,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0011836,0.15844,0.13888,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00010323,0.15809,0.15365,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.1338e-07,0.15786,0.2,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.00032408,0.15771,0.18647,1,1
1,GO MULTI ORGANISM LOCALIZATION,1.6761e-05,0.15768,0.19395,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,4.7488e-06,0.15766,0.20912,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.1026e-05,0.15763,0.1584,1,1
1,GO GENITALIA DEVELOPMENT,0.0034692,0.15757,0.13327,1,1
1,GO ENDOCYTIC RECYCLING,0.0022095,0.15745,0.13741,1,1
1,GO NEGATIVE CHEMOTAXIS,0.014172,0.15732,0.16311,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0062877,0.15711,0.20383,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,8.4424e-05,0.15707,0.15439,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.3997e-05,0.15707,0.15376,1,1
1,GO REGULATION OF VASOCONSTRICTION,6.7724e-05,0.15702,0.22118,1,1
1,GO MYOFIBRIL ASSEMBLY,0.02915,0.15671,0.12013,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,5.5127e-05,0.15647,0.17112,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00011218,0.15644,0.12904,1,1
1,GO RESPONSE TO ESTRADIOL,0.00037835,0.15628,0.1595,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0015463,0.15627,0.15757,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.001483,0.15612,0.1408,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0022095,0.15586,0.15709,1,1
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0021215,0.15581,0.18805,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0032501,0.15575,0.15666,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.0020367,0.15561,0.13192,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,9.2585e-06,0.15547,0.15038,1,1
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.051111,0.15541,0.11459,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00061456,0.15506,0.20965,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00028155,0.15501,0.14252,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.014332,0.15487,0.11802,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.001568,0.15476,0.18726,1,1
1,GO NEPHRON TUBULE FORMATION,0.05357,0.15474,0.15497,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.012653,0.15457,0.13377,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0024281,0.15456,0.14717,1,1
1,GO BODY FLUID SECRETION,6.545e-05,0.1545,0.16421,1,1
1,GO REGULATION OF PHOSPHORYLATION,5.2344e-05,0.1544,0.13828,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00096848,0.15423,0.13415,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.009139,0.15401,0.18591,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.6657e-06,0.15379,0.16208,1,1
1,GO ENDOCYTOSIS,0.00013673,0.15378,0.13893,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.9613e-05,0.15352,0.17684,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.00026438,0.15341,0.14163,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,1.2954e-05,0.15337,0.15522,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.003607,0.15333,0.15538,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.0364e-06,0.15325,0.15799,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00015083,0.15258,0.21454,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,9.9844e-05,0.15233,0.15059,1,1
1,GO VIRION ASSEMBLY,1.3442e-05,0.15214,0.15653,1,1
1,GO VACUOLAR TRANSPORT,5.4184e-05,0.15209,0.14858,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.0020646,0.15204,0.20426,1,1
1,GO JNK CASCADE,0.00084997,0.15181,0.12999,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00052901,0.15151,0.12815,1,1
1,GO REGULATION OF JUN KINASE ACTIVITY,0.0077327,0.15135,0.12921,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,7.7586e-05,0.15126,0.14792,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.4972e-05,0.15117,0.14674,1,1
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00063314,0.15101,0.15727,1,1
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0035605,0.151,0.15595,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,9.404e-07,0.15097,0.18587,1,1
1,GO RESPONSE TO PEPTIDE,0.00013232,0.15083,0.13303,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00012388,0.15058,0.16197,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00074504,0.15026,0.15048,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.003166,0.14991,0.15449,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00022565,0.1498,0.16075,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,7.7586e-05,0.14978,0.14773,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,1.064e-06,0.14977,0.17222,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0074579,0.14961,0.12198,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,6.3249e-05,0.14946,0.13723,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00013673,0.14945,0.13976,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.014172,0.14944,0.16703,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00022565,0.14925,0.13901,1,1
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0026663,0.14924,0.12452,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0012886,0.14923,0.13597,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.7804e-05,0.1492,0.15891,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00060545,0.14913,0.18625,1,1
1,GO PEROXISOMAL TRANSPORT,5.2344e-05,0.14909,0.16409,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.01499,0.14907,0.1892,1,1
1,GO PROTEIN MATURATION,7.8124e-06,0.14905,0.15637,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.02174,0.14892,0.12126,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0005789,0.1488,0.1254,1,1
1,GO MEMBRANE DISASSEMBLY,0.036048,0.14852,0.12918,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00046872,0.14839,0.15035,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.016386,0.14817,0.20357,1,1
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.020828,0.14798,0.094257,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.0032078,0.14773,0.1801,1,1
1,GO MUSCLE TISSUE DEVELOPMENT,0.013546,0.14767,0.099304,1,1
1,GO DNA DEMETHYLATION,0.022686,0.14734,0.11919,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,1.1165e-05,0.14716,0.14555,1,1
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.017506,0.14703,0.11297,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0010259,0.14692,0.15523,1,1
1,GO PEROXISOME ORGANIZATION,6.545e-05,0.14651,0.15316,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00037257,0.1458,0.23328,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.6352e-05,0.14568,0.14901,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,9.795e-06,0.14529,0.13427,1,1
1,GO CELL VOLUME HOMEOSTASIS,0.0038977,0.14528,0.1251,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00020504,0.14518,0.14177,1,1
1,GO PIGMENT CELL DIFFERENTIATION,0.034984,0.1451,0.10467,1,1
1,GO CELL CELL SIGNALING BY WNT,0.00039622,0.14501,0.13342,1,1
1,GO CELLULAR RESPONSE TO ALCOHOL,0.026286,0.145,0.12171,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00014839,0.14434,0.13881,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00091404,0.14431,0.15613,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0050904,0.14387,0.1247,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0056255,0.14375,0.14469,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.6321e-06,0.14358,0.16821,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00034485,0.14333,0.13122,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0077327,0.14297,0.13531,1,1
1,GO PROTEASOME ASSEMBLY,0.0050269,0.14272,0.14278,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0025277,0.14222,0.1303,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0052854,0.14206,0.12038,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0018508,0.14194,0.11852,1,1
1,GO MUSCLE HYPERTROPHY,0.018091,0.14178,0.11486,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00016361,0.14138,0.13706,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00025215,0.14052,0.17809,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0013255,0.14039,0.15371,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0077327,0.14029,0.18337,1,1
1,GO VACUOLE ORGANIZATION,6.7105e-06,0.14022,0.16534,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.7172e-05,0.14007,0.16468,1,1
1,GO COPII COATED VESICLE BUDDING,8.0256e-05,0.14001,0.14868,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.3249e-05,0.13995,0.16503,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,5.6487e-06,0.13986,0.16585,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00036686,0.13972,0.1167,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.0053519,0.13962,0.13645,1,1
1,GO ESTROUS CYCLE,0.028852,0.13961,0.17177,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.023668,0.13948,0.11779,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00020504,0.13941,0.13073,1,1
1,GO L GLUTAMATE IMPORT,0.023173,0.13935,0.12293,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,2.6352e-05,0.13935,0.1562,1,1
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.016752,0.13931,0.098457,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.026561,0.1392,0.17257,1,1
1,GO CELL JUNCTION DISASSEMBLY,0.0016122,0.13915,0.2058,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.032607,0.13873,0.17004,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.00020835,0.13853,0.20629,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0037498,0.13847,0.13702,1,1
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.016752,0.13811,0.1167,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0034692,0.13801,0.11481,1,1
1,GO RESPONSE TO STEROL,0.0043737,0.13786,0.1607,1,1
1,GO APOPTOTIC PROCESS,2.6352e-05,0.13779,0.1367,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.014494,0.13777,0.13379,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00022208,0.13766,0.13744,1,1
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.011022,0.13763,0.099795,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,1.3948e-05,0.13742,0.14063,1,1
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.0012005,0.13731,0.14988,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0038478,0.13708,0.14498,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0005133,0.13697,0.12788,1,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.02915,0.13695,0.12091,1,1
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0060595,0.13691,0.1274,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.00044103,0.13687,0.12206,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00011596,0.1365,0.15257,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.6158e-05,0.13644,0.14946,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0861e-06,0.13636,0.14009,1,1
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0020367,0.13604,0.15247,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0072795,0.13563,0.14517,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.0050904,0.13561,0.13819,1,1
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.0013443,0.13556,0.13025,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00046165,0.1354,0.11985,1,1
1,GO GOLGI VESICLE TRANSPORT,2.7452e-06,0.13537,0.14821,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0074579,0.13533,0.095615,1,1
1,GO ENDOSOME ORGANIZATION,0.00011596,0.135,0.14006,1,1
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,9.3381e-05,0.13484,0.19825,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.032938,0.13478,0.12531,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.0011021,0.1344,0.11358,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0030436,0.1343,0.15288,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0007786,0.13424,0.13395,1,1
1,GO TAXIS,0.0071051,0.13421,0.11761,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0010558,0.13382,0.12064,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.0085105,0.13306,0.12258,1,1
1,GO SULFATION,0.0050269,0.13298,0.18907,1,1
1,GO CELLULAR RESPONSE TO UV,0.00022565,0.13293,0.14459,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00025617,0.13266,0.13231,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00034485,0.13263,0.17087,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00011986,0.13243,0.13891,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019023,0.13219,0.13769,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00020504,0.13218,0.12452,1,1
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0099244,0.13218,0.15256,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.003654,0.13211,0.11478,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.033948,0.13211,0.10341,1,1
1,GO PROTEIN DESTABILIZATION,0.0083098,0.13207,0.11122,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.4959e-05,0.1317,0.13533,1,1
1,GO RUFFLE ORGANIZATION,0.0001179,0.13158,0.16674,1,1
1,GO POSITIVE REGULATION OF NEURON DEATH,0.02174,0.13148,0.10035,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,9.6129e-06,0.13122,0.12846,1,1
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00035024,0.13109,0.17333,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.4741e-05,0.13097,0.15727,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0025961,0.13084,0.17767,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00032916,0.13078,0.14797,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00090088,0.13056,0.15212,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,6.1119e-05,0.13,0.14504,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.3693e-05,0.12982,0.12887,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,9.03e-05,0.12961,0.1519,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00013016,0.1296,0.1515,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.001776,0.12955,0.13494,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0076401,0.12953,0.16092,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0021215,0.12924,0.11801,1,1
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0032928,0.12914,0.12781,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00084997,0.1289,0.13632,1,1
1,GO ANIMAL ORGAN MATURATION,0.044722,0.12874,0.10968,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00040857,0.12855,0.14411,1,1
1,GO TONGUE MORPHOGENESIS,0.026838,0.12854,0.17458,1,1
1,GO BLASTOCYST FORMATION,0.00091404,0.12827,0.12618,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.01829,0.12812,0.10909,1,1
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.051595,0.12812,0.093971,1,1
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.016938,0.12786,0.098926,1,1
1,GO RESPONSE TO UV,0.00010497,0.12762,0.14408,1,1
1,GO RESPONSE TO PROSTAGLANDIN E,0.012653,0.12755,0.12638,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.024173,0.1275,0.10018,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.034636,0.12744,0.10792,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.5014e-05,0.12714,0.12187,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00059648,0.12707,0.12708,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0033799,0.12684,0.10335,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.030368,0.12683,0.11094,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001235,0.12682,0.12953,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00011986,0.1267,0.13089,1,1
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.040187,0.12657,0.10633,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00029976,0.1265,0.11486,1,1
1,GO STEROL METABOLIC PROCESS,0.0076401,0.1263,0.1148,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0077327,0.12627,0.12548,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,2.206e-06,0.12616,0.13845,1,1
1,GO AMINE METABOLIC PROCESS,0.0018508,0.12591,0.10223,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0002117,0.12591,0.14164,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.012798,0.12585,0.13016,1,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.0071918,0.12552,0.13116,1,1
1,GO RESPONSE TO ACTIVITY,0.028852,0.12534,0.086246,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0017277,0.12519,0.13607,1,1
1,GO REGULATION OF GENE SILENCING,0.0035146,0.12518,0.11962,1,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.051111,0.12506,0.15152,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0024281,0.12482,0.1164,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.054582,0.12476,0.093381,1,1
1,GO MITOTIC CYTOKINESIS,0.016938,0.1247,0.10618,1,1
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.016568,0.12416,0.11992,1,1
1,GO RNA DECAPPING,0.00029976,0.12411,0.15524,1,1
1,GO DNA DEALKYLATION,0.0010558,0.12404,0.15244,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00042777,0.12389,0.1334,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,8.1623e-05,0.12352,0.13633,1,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0018764,0.12314,0.11886,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.2015e-05,0.1231,0.12408,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.7586e-05,0.12273,0.12678,1,1
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.020385,0.12231,0.10632,1,1
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.044292,0.1223,0.086827,1,1
1,GO MATURATION OF 5 8S RRNA,0.051111,0.12202,0.097526,1,1
1,GO RNA DESTABILIZATION,0.00096848,0.12161,0.16668,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.0015463,0.12147,0.12796,1,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.010645,0.12131,0.12585,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00088789,0.12115,0.17419,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0025617,0.1211,0.089189,1,1
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0051547,0.12083,0.12026,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00012594,0.12064,0.12458,1,1
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0077327,0.12005,0.11264,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0068504,0.11939,0.14078,1,1
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0032078,0.11934,0.10799,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.6654e-06,0.11925,0.13978,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.024947,0.11923,0.12407,1,1
1,GO OVULATION CYCLE,0.0066851,0.11911,0.13319,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00019541,0.1189,0.14198,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.5001e-05,0.11877,0.13398,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0098086,0.11858,0.13737,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.9803e-06,0.11856,0.17984,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,4.7172e-05,0.11843,0.13699,1,1
1,GO SPERM EGG RECOGNITION,0.0035146,0.11811,0.099761,1,1
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.020828,0.11801,0.10213,1,1
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.026561,0.11797,0.090766,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.001568,0.11793,0.11693,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00099681,0.11791,0.15418,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0021215,0.11744,0.1108,1,1
1,GO ACETYL COA METABOLIC PROCESS,0.026561,0.11743,0.11164,1,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.033608,0.11731,0.088569,1,1
1,GO MUSCLE CELL DEVELOPMENT,0.032938,0.11719,0.10447,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.033608,0.11715,0.077683,1,1
1,GO REGULATION OF BINDING,6.7724e-05,0.11713,0.13293,1,1
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0099244,0.11699,0.12569,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0032501,0.11684,0.12069,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0062108,0.1163,0.11661,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.025475,0.11569,0.12256,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.027686,0.11567,0.10296,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00018323,0.11559,0.13737,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0094686,0.11548,0.12674,1,1
1,GO REGULATION OF CELL DIFFERENTIATION,0.021053,0.11455,0.09197,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0059852,0.11423,0.12349,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,6.1119e-05,0.11421,0.13946,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.044292,0.11406,0.077885,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00083767,0.11401,0.1174,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0054192,0.11386,0.11018,1,1
1,GO PROTEIN FOLDING,0.0016122,0.11372,0.12435,1,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.052575,0.11277,0.064705,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0034692,0.11254,0.10507,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0024281,0.11195,0.13578,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.545e-05,0.11187,0.11465,1,1
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0137,0.11177,0.088849,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.016752,0.11161,0.091915,1,1
1,GO WHITE FAT CELL DIFFERENTIATION,0.026838,0.11119,0.11004,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.001704,0.11104,0.10338,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.030994,0.11066,0.1251,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0037498,0.11064,0.13151,1,1
1,GO RESPONSE TO ALCOHOL,0.044722,0.11045,0.083613,1,1
1,GO REGULATION OF BLOOD PRESSURE,0.031631,0.11013,0.093838,1,1
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.031311,0.10879,0.099931,1,1
1,GO VIRAL GENE EXPRESSION,0.036048,0.10876,0.099057,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0034692,0.1084,0.11343,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011022,0.10832,0.1012,1,1
1,GO RESPONSE TO HEAT,0.00054518,0.1082,0.13005,1,1
1,GO RNA 5 END PROCESSING,0.015501,0.10815,0.13001,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0068504,0.10814,0.15656,1,1
1,GO HISTONE DEACETYLATION,0.036409,0.10803,0.078669,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0058389,0.10769,0.095508,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.034984,0.10718,0.088655,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00060545,0.10708,0.11287,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.0012705,0.10677,0.13792,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00067188,0.10673,0.11414,1,1
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.058247,0.10659,0.10258,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0022396,0.10652,0.079528,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0002117,0.10636,0.12712,1,1
1,GO MEMBRANE ORGANIZATION,0.0016347,0.10603,0.10062,1,1
1,GO REGULATION OF MRNA BINDING,0.047827,0.10579,0.12794,1,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.003166,0.10558,0.15105,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.014823,0.10541,0.12063,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,6.6578e-05,0.1054,0.12445,1,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.01128,0.10521,0.1103,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0005618,0.10516,0.14795,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.012798,0.10492,0.12225,1,1
1,GO MATURATION OF SSU RRNA,0.040981,0.10472,0.11894,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00059648,0.10468,0.11861,1,1
1,GO RESPONSE TO TOXIC SUBSTANCE,0.0086125,0.10457,0.099193,1,1
1,GO VIRAL BUDDING,0.0052197,0.10438,0.1166,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0099244,0.10404,0.096758,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00084997,0.10394,0.12222,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.055609,0.10332,0.097679,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.00090088,0.10251,0.10186,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.043444,0.10242,0.082109,1,1
1,GO RESPONSE TO ATP,0.00031414,0.10235,0.14218,1,1
1,GO TRANSLESION SYNTHESIS,0.017506,0.10187,0.075219,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.003654,0.10175,0.10531,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00069207,0.1014,0.10384,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0020929,0.10132,0.1085,1,1
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.039406,0.10125,0.10814,1,1
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.016568,0.1007,0.11888,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.01585,0.10061,0.10988,1,1
1,GO SPINDLE LOCALIZATION,0.053071,0.10041,0.076546,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.007921,0.1002,0.09558,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.004964,0.10003,0.093471,1,1
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0034243,0.10002,0.11324,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00071283,0.098852,0.11081,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0019023,0.097322,0.092614,1,1
1,GO CELLULAR SENESCENCE,0.00037835,0.097218,0.1333,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.011678,0.097073,0.10397,1,1
1,GO REGULATION OF AUTOPHAGY,0.00013232,0.096837,0.11711,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.020385,0.096797,0.074003,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.017699,0.096514,0.080933,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.010041,0.096196,0.1156,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.05063,0.095889,0.10012,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0022095,0.095586,0.1098,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0050904,0.095051,0.1102,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,6.4341e-05,0.095033,0.11688,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0016575,0.094481,0.10722,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.004964,0.094432,0.11549,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.001442,0.09431,0.090255,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.0020929,0.094199,0.12601,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00049802,0.09399,0.10143,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0042095,0.093263,0.09521,1,1
1,GO MUSCLE SYSTEM PROCESS,0.036048,0.091856,0.093396,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00036686,0.09146,0.11657,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0030038,0.090949,0.08845,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0021798,0.090621,0.12257,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.053071,0.090088,0.079601,1,1
1,GO RNA MODIFICATION,0.013546,0.089833,0.10019,1,1
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.033608,0.089332,0.086528,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.003166,0.089036,0.11136,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.037139,0.087666,0.16515,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,0.00026024,0.087626,0.096159,1,1
1,GO LACTATION,0.03902,0.0876,0.10449,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,6.5837e-06,0.087489,0.11894,1,1
1,GO TEMPERATURE HOMEOSTASIS,0.054582,0.087392,0.082879,1,1
1,GO NCRNA PROCESSING,0.044722,0.087071,0.090639,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.012367,0.087067,0.091664,1,1
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.012945,0.087035,0.090617,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00032916,0.086648,0.10426,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.040582,0.086579,0.073111,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0043184,0.086488,0.10839,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.022686,0.086425,0.084481,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00014362,0.085899,0.10165,1,1
1,GO PROTEIN TETRAMERIZATION,0.0018256,0.085308,0.10634,1,1
1,GO POSTREPLICATION REPAIR,0.032278,0.085072,0.057463,1,1
1,GO POSITIVE REGULATION OF TRANSPORT,0.046921,0.085049,0.078669,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.014494,0.084141,0.10781,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00016629,0.083944,0.10285,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00054518,0.08044,0.10156,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.03006,0.080389,0.088722,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.006444,0.079945,0.090944,1,1
1,GO RNA CATABOLIC PROCESS,0.0081133,0.079154,0.088978,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0010259,0.079067,0.13927,1,1
1,GO CYTOSKELETON ORGANIZATION,0.016752,0.078314,0.084658,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.033271,0.078029,0.098448,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.02915,0.077539,0.081989,1,1
1,GO HYPEROSMOTIC RESPONSE,0.026838,0.077136,0.10482,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.037509,0.075794,0.091205,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.03068,0.075613,0.070466,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.033948,0.07455,0.081042,1,1
1,GO SULFATE TRANSPORT,0.028852,0.074455,0.07826,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0016575,0.074108,0.090936,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.012227,0.073759,0.064865,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.024428,0.073003,0.058542,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0078263,0.071005,0.070446,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.012798,0.066101,0.084664,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.017699,0.060814,0.10685,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.010645,0.060771,0.066583,1,1
1,GO MITOTIC CELL CYCLE,0.056652,0.060694,0.049342,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.043866,0.060511,0.05012,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.015329,0.060441,0.10987,1,1
1,GO REGULATION OF CELL CYCLE,0.028264,0.059944,0.049158,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.017315,0.059592,0.083323,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0078263,0.057242,0.091669,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.016752,0.053135,0.093418,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.047827,0.052149,0.066199,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.017315,0.048522,0.054929,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.043025,0.047312,0.066367,1,1
1,GO PROTEIN TARGETING,0.016027,0.045624,0.072565,1,1
1,GO INTRACELLULAR TRANSPORT,0.017506,0.041724,0.061346,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.044292,0.040076,0.066968,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.1138e-06,1.1399,0.92949,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,9.6129e-06,1.0171,0.77768,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.2162e-07,0.84435,0.70768,1,1
2,GO ETHANOL OXIDATION,2.7e-09,0.80203,0.71618,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.4967e-09,0.7945,0.68621,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2032e-06,0.78282,0.56488,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.9979e-12,0.76804,0.68656,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,2.9515e-10,0.742,0.79167,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011596,0.70795,0.51213,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.1415e-11,0.70261,0.70139,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,8.1361e-07,0.6728,0.53769,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.2505e-06,0.65479,0.47747,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,6.8885e-07,0.64804,0.4918,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,8.2686e-06,0.63941,0.54892,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.4472e-05,0.62562,0.51997,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.0983e-10,0.62367,0.60385,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.8983e-07,0.61908,0.50231,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00014362,0.60494,0.43994,1,1
2,GO MYOBLAST MIGRATION,9.1829e-05,0.60232,0.46945,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,4.3236e-05,0.60207,0.43202,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,4.2784e-08,0.5671,0.59519,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.0395e-05,0.55099,0.38667,1,1
2,GO OTIC VESICLE DEVELOPMENT,1.0958e-05,0.54837,0.4452,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00022565,0.54289,0.43885,1,1
2,GO PROSTATE GLAND GROWTH,1.2328e-07,0.54015,0.54587,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.0557e-05,0.53917,0.4366,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.6881e-08,0.53648,0.53613,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,2.5424e-05,0.52966,0.4614,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.2497e-05,0.52925,0.36589,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,2.7804e-05,0.52533,0.4497,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00015083,0.52421,0.40367,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.538e-07,0.50851,0.42478,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,7.0522e-08,0.50566,0.42751,1,1
2,GO BIOLOGICAL PHASE,1.9393e-05,0.49531,0.46756,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,4.8416e-06,0.49523,0.48952,1,1
2,GO RESPONSE TO INTERFERON BETA,0.0023009,0.48709,0.34599,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,8.0712e-08,0.48315,0.48561,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.8573e-08,0.47966,0.40772,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,5.3747e-08,0.4796,0.44042,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,7.105e-06,0.4777,0.35642,1,1
2,GO RESPONSE TO INTERLEUKIN 18,0.00028155,0.47489,0.45097,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00016361,0.4735,0.40511,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,9.3415e-09,0.47132,0.47772,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00011218,0.47017,0.34593,1,1
2,GO HEPATOCYTE DIFFERENTIATION,4.8839e-05,0.46922,0.37562,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.2416e-05,0.46892,0.34176,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011406,0.46802,0.32735,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.6487e-06,0.46103,0.41307,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.6487e-06,0.46084,0.31849,1,1
2,GO ETHANOL METABOLIC PROCESS,2.7078e-07,0.45901,0.45912,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,1.0322e-07,0.45776,0.43457,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,8.4415e-08,0.4577,0.37956,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00036124,0.45474,0.39693,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00075607,0.44476,0.34791,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,8.5858e-05,0.44424,0.45287,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2954e-05,0.44371,0.3957,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,8.0815e-10,0.4403,0.4308,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00042128,0.4345,0.33992,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0037498,0.43376,0.32365,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,9.4959e-05,0.43142,0.38413,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.010279,0.42987,0.2855,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00014129,0.42863,0.29781,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,9.4959e-05,0.4251,0.36691,1,1
2,GO TOLERANCE INDUCTION,0.0012177,0.4234,0.32058,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.2046e-07,0.41927,0.40582,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,7.3739e-05,0.41555,0.327,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,1.9014e-08,0.41151,0.39571,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.2058e-07,0.41072,0.38681,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.4773e-06,0.40971,0.4084,1,1
2,GO PROSTANOID METABOLIC PROCESS,6.2046e-07,0.40967,0.37765,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00011986,0.40847,0.28544,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.040981,0.4073,0.44961,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00011033,0.40595,0.33886,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.00058763,0.40545,0.34556,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,4.7501e-09,0.40492,0.40354,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.4972e-05,0.40165,0.33352,1,1
2,GO LYSINE METABOLIC PROCESS,0.00044103,0.40056,0.39712,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,8.2864e-09,0.40012,0.41236,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0013443,0.39992,0.31607,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00053704,0.39963,0.29778,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.5014e-05,0.39682,0.26634,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019541,0.39569,0.38902,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00014129,0.39465,0.34609,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.2281e-06,0.3932,0.3811,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0012177,0.39278,0.31603,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,5.2445e-07,0.39188,0.3349,1,1
2,GO PSEUDOPODIUM ORGANIZATION,4.2487e-05,0.39162,0.39085,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00017176,0.38948,0.37982,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,5.3256e-05,0.3882,0.31699,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.5022e-05,0.38788,0.27472,1,1
2,GO ETHER METABOLIC PROCESS,1.7154e-07,0.38754,0.37326,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.02e-08,0.3846,0.3689,1,1
2,GO NEURAL CREST FORMATION,0.0001862,0.38384,0.29769,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.7071e-05,0.3815,0.3126,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00014599,0.37924,0.33389,1,1
2,GO T CELL MEDIATED IMMUNITY,1.1165e-05,0.3752,0.28555,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010673,0.37446,0.38735,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.0083098,0.37295,0.20406,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00046872,0.37291,0.2555,1,1
2,GO DENDRITIC CELL MIGRATION,6.7105e-06,0.3712,0.32133,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.4098e-06,0.36988,0.33605,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00096848,0.36876,0.33673,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.9056e-05,0.36822,0.27659,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,4.6578e-06,0.36793,0.35394,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.0072795,0.36738,0.24738,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,6.4699e-07,0.36667,0.38896,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.0278e-07,0.36654,0.38285,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,5.0563e-05,0.36564,0.35189,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0002443,0.36541,0.24581,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00017457,0.363,0.36803,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.971e-06,0.36211,0.33691,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00084997,0.36134,0.27962,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0071051,0.36113,0.27657,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00022565,0.35807,0.23474,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.5756e-08,0.35752,0.33786,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00033432,0.35632,0.26244,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00010673,0.35571,0.3532,1,1
2,GO LIMB BUD FORMATION,0.0030038,0.35508,0.3839,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5684e-06,0.35206,0.29734,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00025215,0.35171,0.33754,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0054192,0.35167,0.25191,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00012186,0.3509,0.29756,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.3174e-07,0.35033,0.31645,1,1
2,GO REGULATION OF DNA METHYLATION,9.795e-06,0.34986,0.27926,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00052901,0.34942,0.36165,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.00011596,0.34827,0.30381,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0002443,0.34754,0.31989,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00014362,0.34709,0.26569,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.1623e-05,0.34408,0.26385,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.4184e-05,0.34233,0.28588,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0001179,0.34147,0.31543,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,6.0759e-07,0.341,0.29979,1,1
2,GO OXYGEN TRANSPORT,0.0039992,0.34048,0.29455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7922e-07,0.34027,0.34881,1,1
2,GO REGULATION OF CELL KILLING,0.00015838,0.33785,0.2316,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,5.2344e-05,0.33694,0.28641,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0010259,0.33666,0.32933,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00031907,0.33551,0.2922,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,6.4341e-05,0.33457,0.23905,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0001862,0.33438,0.26766,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,6.8396e-06,0.33376,0.40703,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,2.4371e-06,0.32941,0.32607,1,1
2,GO PSEUDOURIDINE SYNTHESIS,1.8142e-08,0.32893,0.36163,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00034485,0.32884,0.36142,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00039018,0.3281,0.27341,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0035605,0.32803,0.32099,1,1
2,GO HAIR FOLLICLE MATURATION,8.5858e-05,0.32699,0.30939,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,8.1623e-05,0.32595,0.27847,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00088789,0.32543,0.34933,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0020646,0.32518,0.32199,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0020092,0.32517,0.23243,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,4.6578e-06,0.32386,0.29913,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00063314,0.32092,0.23983,1,1
2,GO INTERLEUKIN 2 PRODUCTION,1.2534e-06,0.31751,0.30012,1,1
2,GO RETINAL METABOLIC PROCESS,0.032938,0.31697,0.21049,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,6.7724e-05,0.31591,0.35594,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.020166,0.31549,0.24896,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,2.7804e-05,0.31429,0.28863,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0027747,0.31062,0.21778,1,1
2,GO T CELL CHEMOTAXIS,4.9694e-05,0.31025,0.24847,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.048285,0.30942,0.19665,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,6.895e-08,0.3093,0.37954,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.00084997,0.30833,0.24113,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0002443,0.30793,0.23982,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00014129,0.30682,0.25633,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0029645,0.30668,0.21698,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,8.1623e-05,0.30648,0.23261,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,3.3214e-05,0.30608,0.24699,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00046165,0.30599,0.29666,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,2.6914e-06,0.30441,0.40081,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,2.2824e-05,0.30378,0.28151,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00020835,0.30255,0.24414,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0022396,0.30077,0.17961,1,1
2,GO RESPONSE TO TUMOR CELL,4.8839e-05,0.29956,0.27503,1,1
2,GO PORE COMPLEX ASSEMBLY,4.6881e-08,0.29879,0.28767,1,1
2,GO CHONDROCYTE PROLIFERATION,0.00011986,0.29824,0.34548,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.0557e-05,0.29794,0.2626,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031414,0.2976,0.22847,1,1
2,GO GAS TRANSPORT,0.0012886,0.29756,0.27527,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0032078,0.29687,0.30247,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00016361,0.29646,0.20905,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0032078,0.29594,0.21079,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00039622,0.29534,0.26517,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.996e-06,0.29493,0.29245,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.4837e-07,0.29477,0.30018,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,3.4003e-08,0.29368,0.33294,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.9989e-07,0.29351,0.27387,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.2281e-06,0.29339,0.27264,1,1
2,GO ACTIN FILAMENT SEVERING,0.0035605,0.2925,0.30535,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001776,0.29235,0.18462,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0086125,0.29159,0.21755,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.001235,0.2914,0.19831,1,1
2,GO PENTOSE METABOLIC PROCESS,2.7668e-07,0.29136,0.37104,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,2.5359e-06,0.29111,0.26006,1,1
2,GO MRNA MODIFICATION,2.5424e-05,0.29099,0.23816,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,2.6914e-06,0.29082,0.35041,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.6352e-05,0.29012,0.26262,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00067188,0.28868,0.30671,1,1
2,GO AMINE CATABOLIC PROCESS,5.2344e-05,0.28765,0.29298,1,1
2,GO RIG I SIGNALING PATHWAY,6.9711e-06,0.28749,0.24152,1,1
2,GO MATURATION OF LSU RRNA,1.0756e-05,0.28726,0.30285,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0039992,0.28716,0.20635,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.022686,0.28707,0.21974,1,1
2,GO MONONUCLEAR CELL MIGRATION,6.545e-05,0.28666,0.23866,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0020092,0.2863,0.2062,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,1.2716e-05,0.28588,0.32684,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.0017517,0.28553,0.32238,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.03429,0.28435,0.17832,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00068191,0.28417,0.19879,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00015838,0.28322,0.22496,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0002117,0.28237,0.2213,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0062877,0.28232,0.24771,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0013069,0.28148,0.30183,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.00064263,0.28137,0.2238,1,1
2,GO AMP METABOLIC PROCESS,0.00012804,0.28135,0.2827,1,1
2,GO BLASTODERM SEGMENTATION,0.0018764,0.28049,0.2584,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,5.9498e-07,0.2803,0.26333,1,1
2,GO MATURATION OF SSU RRNA,1.0958e-05,0.27944,0.26556,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.00098255,0.2794,0.21681,1,1
2,GO FIBROBLAST ACTIVATION,3.4098e-06,0.27918,0.31054,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.00027284,0.27851,0.22574,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.819e-05,0.27783,0.22374,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0048405,0.27782,0.24031,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00016098,0.27678,0.29256,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074504,0.27653,0.24875,1,1
2,GO RETINOL METABOLIC PROCESS,3.3214e-05,0.27647,0.23788,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00031907,0.27571,0.23987,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0070192,0.27531,0.28609,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0137,0.27527,0.1828,1,1
2,GO IMP METABOLIC PROCESS,0.0011836,0.27507,0.27145,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,1.3948e-05,0.27505,0.23617,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0012005,0.27469,0.21872,1,1
2,GO CHROMATIN DISASSEMBLY,2.8305e-05,0.27415,0.2258,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.0076401,0.27389,0.18324,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0046018,0.27282,0.19464,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.016938,0.27274,0.13737,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.5884e-05,0.27161,0.23768,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00057029,0.27153,0.22608,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.0065235,0.2714,0.3098,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00014599,0.27139,0.24031,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.6994e-06,0.27128,0.28844,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0047198,0.27105,0.19368,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0012886,0.27088,0.20095,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.4098e-06,0.27057,0.29845,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00012594,0.27054,0.25862,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.2482e-05,0.27013,0.23629,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0015249,0.26985,0.20301,1,1
2,GO PEPTIDE CROSS LINKING,0.0032928,0.26977,0.22216,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.2497e-05,0.2697,0.27606,1,1
2,GO NEUROBLAST DIVISION,0.0021505,0.26904,0.27102,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0010113,0.26838,0.20883,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0073682,0.26577,0.19389,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0018764,0.26534,0.19018,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.011e-05,0.26523,0.26487,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0074579,0.26436,0.14286,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00010152,0.26329,0.23918,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0095807,0.26327,0.29382,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00037835,0.26276,0.25592,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0005056,0.26171,0.25044,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00091404,0.26167,0.17546,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00073415,0.26129,0.22759,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,6.0079e-05,0.26082,0.29346,1,1
2,GO RRNA MODIFICATION,2.2775e-07,0.26051,0.25483,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011836,0.26035,0.18256,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.5576e-05,0.25989,0.26168,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.039795,0.25966,0.17192,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0010865,0.25941,0.19264,1,1
2,GO MICROVILLUS ASSEMBLY,0.0060595,0.25892,0.22247,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.0256e-05,0.25857,0.20326,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.001235,0.25819,0.16876,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,1.2792e-06,0.25817,0.21589,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0083098,0.2576,0.23041,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.013856,0.25731,0.15294,1,1
2,GO LAMELLIPODIUM ORGANIZATION,5.2344e-05,0.25701,0.20307,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,1.2032e-06,0.2565,0.27086,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00048316,0.25624,0.23663,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0096941,0.25594,0.21697,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.00061456,0.25573,0.23645,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00067188,0.25558,0.20187,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,6.6578e-05,0.25411,0.2293,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00069207,0.25408,0.19997,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019857,0.25403,0.23499,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.004156,0.25323,0.17129,1,1
2,GO FOREGUT MORPHOGENESIS,0.014332,0.2532,0.1999,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,5.5412e-06,0.25227,0.23417,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,3.6162e-06,0.25224,0.2514,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0001803,0.25091,0.22111,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00065224,0.2506,0.17115,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0011836,0.24957,0.17318,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.020166,0.24936,0.19826,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.045591,0.24929,0.12818,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0023009,0.24864,0.17156,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,2.6828e-05,0.24819,0.22646,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00027716,0.248,0.18326,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,1.0004e-06,0.24695,0.24171,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,3.4409e-05,0.24691,0.24748,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00019229,0.24645,0.2777,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.1588e-05,0.24563,0.22396,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0040509,0.24554,0.18439,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,6.0079e-05,0.2445,0.21171,1,1
2,GO CYTOPLASM ORGANIZATION,0.00015838,0.24355,0.30516,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0023321,0.24346,0.24272,1,1
2,GO INTERACTION WITH SYMBIONT,7.0072e-05,0.24291,0.19828,1,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.049681,0.24254,0.12389,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0018006,0.24251,0.28336,1,1
2,GO GTP METABOLIC PROCESS,9.7998e-07,0.24237,0.27304,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,8.3013e-05,0.24207,0.27739,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00024819,0.24195,0.21955,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0018764,0.24175,0.19261,1,1
2,GO REGULATION OF LIPASE ACTIVITY,6.8396e-06,0.24155,0.20843,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0041031,0.24154,0.16502,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.042197,0.24152,0.15637,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.000286,0.24151,0.21721,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,1.8363e-05,0.24145,0.2334,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.01128,0.24099,0.15978,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.013093,0.24085,0.18329,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.011949,0.24062,0.1943,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.022928,0.24034,0.1587,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0018508,0.24017,0.18914,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.048285,0.24001,0.19417,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00014599,0.23966,0.22436,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.02945,0.23958,0.16538,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00038422,0.23892,0.19561,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,3.3435e-06,0.23888,0.26512,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.013394,0.23865,0.20518,1,1
2,GO ARACHIDONIC ACID SECRETION,8.9166e-06,0.23859,0.24481,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00072342,0.23844,0.24049,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00012388,0.23803,0.25643,1,1
2,GO VIRAL TRANSLATION,6.2169e-06,0.23799,0.27665,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.019312,0.23717,0.15727,1,1
2,GO L SERINE METABOLIC PROCESS,0.0030839,0.23674,0.22613,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0050904,0.23665,0.16012,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,8.1623e-05,0.23636,0.2039,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0085105,0.23593,0.15428,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00087508,0.23575,0.18476,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.001422,0.23575,0.24645,1,1
2,GO MICROVILLUS ORGANIZATION,0.0078263,0.23561,0.22717,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,1.2281e-06,0.23499,0.21425,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00046165,0.23465,0.18522,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.00063314,0.23422,0.21746,1,1
2,GO NEPHRON TUBULE FORMATION,0.00159,0.23411,0.25754,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.018898,0.2341,0.18156,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.00040857,0.23397,0.2026,1,1
2,GO ASYMMETRIC CELL DIVISION,0.0062108,0.23341,0.17517,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00022565,0.23208,0.20764,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00037835,0.23112,0.27241,1,1
2,GO NEGATIVE T CELL SELECTION,0.0037985,0.23096,0.14296,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0022095,0.23092,0.16398,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,3.8983e-07,0.23083,0.26736,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.0030436,0.23048,0.24844,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.032607,0.22952,0.19011,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,2.3661e-05,0.22951,0.25886,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.3249e-05,0.22905,0.19288,1,1
2,GO LEUKOCYTE PROLIFERATION,0.001422,0.22859,0.15689,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.021053,0.22815,0.15148,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0020929,0.22804,0.16055,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.019523,0.22802,0.20853,1,1
2,GO CORNIFICATION,0.0038478,0.22783,0.2584,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0039992,0.22761,0.21869,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0050269,0.22735,0.17508,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.00012388,0.2273,0.23894,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.8049e-05,0.2272,0.31394,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.001704,0.22712,0.17655,1,1
2,GO SECRETION BY TISSUE,0.0066851,0.22673,0.15123,1,1
2,GO ZYMOGEN ACTIVATION,0.032278,0.22665,0.18769,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0059852,0.22651,0.17299,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0093576,0.22647,0.20996,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0029645,0.22614,0.2704,1,1
2,GO RNA 5 END PROCESSING,3.0302e-06,0.22583,0.23005,1,1
2,GO RNA DECAPPING,0.00086244,0.22535,0.15408,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.012367,0.22519,0.17102,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.1234e-05,0.22497,0.24781,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.042609,0.22488,0.14353,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.001442,0.22466,0.15366,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.0042636,0.22404,0.18658,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00088789,0.22399,0.16573,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.032938,0.22385,0.129,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00017176,0.22274,0.16913,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,1.2027e-05,0.22221,0.19632,1,1
2,GO AMINO ACID ACTIVATION,2.3891e-06,0.22213,0.2325,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,5.0563e-05,0.22202,0.22946,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.057711,0.22199,0.13033,1,1
2,GO MRNA METHYLATION,0.014013,0.22165,0.15098,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010497,0.22144,0.22132,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.0037016,0.22141,0.15928,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.010769,0.22136,0.15082,1,1
2,GO RESPONSE TO X RAY,0.0005618,0.22115,0.23321,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0014022,0.22112,0.17557,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00088789,0.2211,0.23362,1,1
2,GO RESPONSE TO PROTOZOAN,0.010279,0.2207,0.17968,1,1
2,GO ZINC ION HOMEOSTASIS,0.0083098,0.22068,0.20242,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0022701,0.2205,0.34814,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0081133,0.21997,0.19349,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.9332e-05,0.21967,0.1958,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,6.337e-06,0.21967,0.23343,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.8246e-05,0.21964,0.20169,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.6654e-06,0.2195,0.22719,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0016122,0.21949,0.16203,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0081133,0.2186,0.18712,1,1
2,GO MIRNA METABOLIC PROCESS,4.3997e-05,0.21765,0.17925,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00054518,0.21764,0.17932,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.022446,0.21759,0.12387,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,1.2027e-05,0.21727,0.22434,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.001704,0.21701,0.19268,1,1
2,GO STEM CELL DIVISION,0.010645,0.21656,0.17691,1,1
2,GO ALDITOL METABOLIC PROCESS,1.7693e-06,0.21651,0.302,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0033361,0.21605,0.24503,1,1
2,GO PROTEIN DEMANNOSYLATION,0.012367,0.21571,0.14016,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0037985,0.21547,0.19165,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015249,0.21517,0.2253,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0020367,0.21505,0.18552,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00010497,0.21494,0.191,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0005133,0.21446,0.15914,1,1
2,GO ERYTHROCYTE MATURATION,0.0022701,0.21444,0.24586,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.006444,0.21415,0.17905,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,6.3249e-05,0.21392,0.20245,1,1
2,GO B CELL HOMEOSTASIS,0.015159,0.21388,0.1451,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.059331,0.21384,0.13508,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.000662,0.21374,0.2176,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017277,0.21241,0.24964,1,1
2,GO PODOSOME ASSEMBLY,0.015329,0.21218,0.19838,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.045591,0.21195,0.11217,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00099681,0.21158,0.14327,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.00080175,0.2114,0.16144,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017894,0.2114,0.14681,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00026438,0.21129,0.19349,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00039018,0.21098,0.1878,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0015463,0.21094,0.20648,1,1
2,GO RENAL VESICLE DEVELOPMENT,0.018693,0.21094,0.14247,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.014013,0.21076,0.19118,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.795e-06,0.21053,0.22209,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00064263,0.21049,0.18455,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00031907,0.21047,0.16738,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.010522,0.20991,0.12519,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00096848,0.20988,0.18043,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.404e-07,0.20952,0.20918,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00015083,0.2094,0.19351,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.00016098,0.20926,0.21618,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0013826,0.20853,0.16556,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.012367,0.20852,0.15464,1,1
2,GO RNA INTERFERENCE,0.00057029,0.20812,0.18129,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0065235,0.20782,0.15162,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.012653,0.20766,0.12553,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0013633,0.20757,0.15953,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00098255,0.20756,0.1875,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.012945,0.2066,0.13591,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00021857,0.20568,0.19589,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00029976,0.20479,0.16682,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0005133,0.20468,0.17177,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0050904,0.20447,0.18336,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00086244,0.20441,0.15914,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,2.6828e-05,0.20436,0.2293,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.004964,0.20419,0.19278,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.024428,0.20413,0.14409,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0023637,0.20409,0.17274,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00095459,0.20392,0.22355,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.016568,0.20374,0.12116,1,1
2,GO VESICLE CARGO LOADING,0.0058389,0.20374,0.13736,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,9.03e-05,0.20366,0.19431,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.5022e-05,0.20362,0.23541,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.00073415,0.20354,0.19447,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0095807,0.20352,0.21731,1,1
2,GO HIPPO SIGNALING,0.0070192,0.2035,0.23381,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.008211,0.20339,0.14254,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,7.8911e-05,0.20318,0.16698,1,1
2,GO B CELL APOPTOTIC PROCESS,0.0042095,0.20317,0.1619,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00081356,0.20235,0.17001,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.00012186,0.20193,0.21091,1,1
2,GO HISTONE H4 DEACETYLATION,0.0033799,0.20062,0.183,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0016347,0.20055,0.16507,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0019819,0.20051,0.17032,1,1
2,GO PIGMENT METABOLIC PROCESS,0.0016347,0.19989,0.1488,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,3.8983e-07,0.19982,0.17759,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0030038,0.19964,0.15622,1,1
2,GO HISTONE H3 K9 ACETYLATION,4.1751e-05,0.19952,0.19905,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.00071283,0.19942,0.19674,1,1
2,GO T CELL PROLIFERATION,0.00088789,0.19929,0.16905,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.016938,0.19903,0.13383,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.013394,0.19845,0.14707,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.01995,0.19843,0.20424,1,1
2,GO TRNA CATABOLIC PROCESS,0.036772,0.19773,0.18921,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0022095,0.19749,0.17208,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.030994,0.19737,0.12931,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0050269,0.19723,0.13215,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0073682,0.19701,0.14403,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.033948,0.19602,0.12367,1,1
2,GO TRACHEA DEVELOPMENT,0.016205,0.19579,0.17182,1,1
2,GO TONGUE MORPHOGENESIS,0.049681,0.19564,0.18135,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.8701e-05,0.19525,0.2624,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.012227,0.19518,0.17557,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0047798,0.19444,0.14772,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0040509,0.19436,0.16677,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00030928,0.19436,0.18712,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00025215,0.19423,0.17525,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.0038977,0.1941,0.15143,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0028872,0.19369,0.18371,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,2.9332e-05,0.19358,0.19354,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.018693,0.19298,0.10689,1,1
2,GO B CELL PROLIFERATION,0.002631,0.19269,0.15997,1,1
2,GO TRNA METABOLIC PROCESS,9.4341e-06,0.19267,0.17578,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00071283,0.19266,0.14973,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.0049019,0.19204,0.16741,1,1
2,GO GASTRIC ACID SECRETION,0.00028155,0.19128,0.20123,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.001955,0.19092,0.16222,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0015038,0.19063,0.148,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0044864,0.1904,0.1502,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0137,0.19037,0.17596,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00044103,0.19028,0.15932,1,1
2,GO CARNITINE SHUTTLE,0.0010865,0.18982,0.20183,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0068504,0.1898,0.18726,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.009139,0.18967,0.15932,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00080175,0.18961,0.2045,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00045468,0.18937,0.20885,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.00011986,0.1892,0.17551,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00016361,0.18907,0.15572,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0083098,0.18891,0.12176,1,1
2,GO NUCLEOTIDE SALVAGE,0.046031,0.18881,0.14755,1,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.047372,0.18869,0.1919,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0023009,0.18866,0.16587,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.020828,0.18817,0.15395,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013443,0.18757,0.20761,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02521,0.18748,0.13147,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.041383,0.18726,0.095104,1,1
2,GO NUCLEAR PORE ORGANIZATION,2.8814e-05,0.1872,0.23703,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.8839e-05,0.18716,0.14759,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0081133,0.18702,0.17271,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0012705,0.1866,0.15435,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00023294,0.1863,0.22053,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0087156,0.18626,0.1302,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00096848,0.18617,0.20241,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.004156,0.18597,0.18055,1,1
2,GO B CELL MEDIATED IMMUNITY,0.0083098,0.18508,0.15898,1,1
2,GO T CELL CYTOKINE PRODUCTION,0.00039622,0.18478,0.18627,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0020646,0.18407,0.1672,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00026024,0.18363,0.19103,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0096941,0.18298,0.16471,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0021505,0.18229,0.18626,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0052197,0.18181,0.18778,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0022701,0.18176,0.19524,1,1
2,GO CELL AGGREGATION,0.00035024,0.18121,0.23492,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.015159,0.18106,0.10271,1,1
2,GO INTERACTION WITH HOST,0.0094686,0.1807,0.13783,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0032501,0.18056,0.13375,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.0027747,0.18043,0.18562,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.017894,0.18037,0.17789,1,1
2,GO VIRAL GENE EXPRESSION,8.2686e-06,0.18007,0.19957,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0076401,0.18002,0.146,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.01128,0.17995,0.18002,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.014013,0.17889,0.18519,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.012367,0.17864,0.21981,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.0025961,0.17794,0.15407,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0081133,0.17777,0.15598,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0028118,0.17766,0.13855,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0034243,0.17758,0.13634,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.02174,0.17743,0.2089,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.016386,0.17732,0.18565,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.026561,0.17676,0.16675,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00027284,0.17655,0.17377,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0050904,0.17649,0.16263,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.054074,0.17644,0.1142,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.2497e-05,0.17627,0.18657,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00024045,0.17604,0.21668,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00042128,0.17587,0.1862,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0016347,0.17582,0.13155,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014624,0.1757,0.14514,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.02174,0.17557,0.14778,1,1
2,GO REGULATION OF HAIR CYCLE,0.011151,0.17516,0.16886,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0043737,0.17482,0.16315,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.00069207,0.17475,0.19969,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,3.0395e-05,0.17449,0.14771,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0024941,0.17444,0.16499,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.0011021,0.17435,0.15723,1,1
2,GO CELL KILLING,0.0025961,0.17367,0.14944,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.013856,0.17357,0.13235,1,1
2,GO URETER DEVELOPMENT,0.016386,0.17355,0.16012,1,1
2,GO FATTY ACID TRANSPORT,0.0013633,0.17343,0.1263,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00034485,0.17296,0.18204,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.017699,0.17289,0.11633,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0058389,0.17277,0.23233,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.027401,0.17274,0.14702,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00076726,0.17259,0.18245,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0021215,0.17258,0.14426,1,1
2,GO DETOXIFICATION,0.00019541,0.17242,0.18123,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.011544,0.17201,0.13015,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.05357,0.17184,0.11793,1,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.028264,0.17109,0.15848,1,1
2,GO RESPIRATORY BURST,0.0065235,0.17103,0.16983,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0022095,0.17028,0.12418,1,1
2,GO PIGMENT GRANULE ORGANIZATION,0.00086244,0.17002,0.21796,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.020385,0.16989,0.13591,1,1
2,GO SNORNA 3 END PROCESSING,0.0022701,0.16936,0.16081,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.012227,0.16925,0.15185,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00028155,0.16898,0.2811,1,1
2,GO SYMBIOTIC PROCESS,0.00044103,0.16831,0.13049,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0015038,0.16822,0.16838,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00075607,0.16813,0.15019,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001704,0.16808,0.19156,1,1
2,GO HISTONE H2B UBIQUITINATION,0.0048405,0.16794,0.13408,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0020367,0.16784,0.16443,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.0043737,0.16755,0.16011,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0047798,0.16745,0.13953,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.017894,0.1673,0.10346,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.001118,0.16723,0.21004,1,1
2,GO DNA LIGATION,0.0013069,0.16717,0.16561,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.004156,0.16711,0.19287,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0094686,0.16683,0.14219,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,7.3739e-05,0.16678,0.19862,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.012087,0.16666,0.14147,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.017894,0.16651,0.10762,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.012798,0.16638,0.12437,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.031311,0.16626,0.10122,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0104,0.16616,0.12178,1,1
2,GO PLATELET MORPHOGENESIS,0.002702,0.16566,0.19367,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00030449,0.16552,0.17515,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.019104,0.16529,0.14514,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0015249,0.16512,0.14727,1,1
2,GO CYTOKINE PRODUCTION,0.010522,0.16511,0.12607,1,1
2,GO REGULATION OF GENE SILENCING,0.00011596,0.16507,0.14156,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.030368,0.16496,0.15146,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.027686,0.16496,0.12782,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.049212,0.16492,0.15484,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.001442,0.16487,0.1515,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.020605,0.16469,0.11797,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00011218,0.16448,0.14771,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00072342,0.16427,0.19028,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,3.2146e-06,0.164,0.17903,1,1
2,GO LIPID IMPORT INTO CELL,0.028556,0.164,0.12706,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00039018,0.16373,0.14956,1,1
2,GO MACROPHAGE MIGRATION,0.013093,0.16343,0.1323,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00033955,0.16343,0.15317,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0049019,0.16342,0.18478,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,2.4972e-05,0.16321,0.16287,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00015838,0.16275,0.14306,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.006444,0.16273,0.12924,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.020605,0.16268,0.16867,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.014013,0.1626,0.1409,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0005211,0.16249,0.16465,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0043184,0.16242,0.17289,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.018693,0.16183,0.11197,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0043737,0.16176,0.13841,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0048405,0.16173,0.16833,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,2.5868e-06,0.16133,0.20115,1,1
2,GO REGULATION OF CELL ACTIVATION,0.007921,0.16114,0.12207,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.014823,0.16095,0.12264,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0099244,0.16078,0.11506,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.006444,0.16052,0.15522,1,1
2,GO VIRAL LATENCY,0.057711,0.1605,0.089262,1,1
2,GO OXIDATIVE DEMETHYLATION,0.0094686,0.16045,0.093425,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.0042636,0.16028,0.1151,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.031953,0.16016,0.11146,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,6.337e-06,0.16002,0.18373,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.031953,0.15994,0.097681,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.022446,0.15977,0.11574,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0095807,0.15968,0.12684,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.033948,0.15954,0.13474,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.011544,0.15939,0.11852,1,1
2,GO TERPENOID METABOLIC PROCESS,0.046921,0.15936,0.10202,1,1
2,GO TISSUE REGENERATION,0.037882,0.15887,0.12152,1,1
2,GO INTERFERON BETA PRODUCTION,0.014823,0.15872,0.15037,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017125,0.15818,0.15108,1,1
2,GO CHEMOKINE PRODUCTION,0.0084096,0.15805,0.15303,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.3256e-05,0.15791,0.16551,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.023668,0.1579,0.31617,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,7.0072e-05,0.15723,0.17754,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.007921,0.15717,0.131,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0041031,0.15708,0.13134,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00032408,0.15699,0.16922,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.027118,0.15697,0.13083,1,1
2,GO VIRAL LIFE CYCLE,0.0081133,0.15694,0.13576,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.016752,0.15687,0.15878,1,1
2,GO INNATE IMMUNE RESPONSE,0.0028872,0.15686,0.15388,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.024687,0.15682,0.11346,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.022686,0.15681,0.099783,1,1
2,GO TRNA TRANSPORT,1.4207e-05,0.1568,0.18282,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0032078,0.15676,0.13478,1,1
2,GO ERBB SIGNALING PATHWAY,0.0080166,0.15664,0.12071,1,1
2,GO REGULATION OF CELL MATURATION,0.010041,0.1564,0.12876,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.013243,0.15603,0.12832,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.037882,0.15588,0.11139,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0066851,0.15586,0.17505,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.057179,0.15582,0.084018,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0052197,0.1558,0.14572,1,1
2,GO GOLGI LOCALIZATION,0.006444,0.15561,0.14824,1,1
2,GO KERATINIZATION,0.033608,0.15555,0.15855,1,1
2,GO RESPONSE TO BACTERIUM,0.03068,0.15529,0.090211,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.040981,0.15526,0.087715,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.027686,0.15501,0.1391,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0020367,0.15478,0.14966,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.056652,0.15461,0.14116,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0030436,0.15397,0.20135,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,5.6085e-05,0.15395,0.16436,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.009139,0.15366,0.12414,1,1
2,GO T CELL ACTIVATION,0.0098086,0.15363,0.12747,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.01128,0.15306,0.16354,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.034636,0.15305,0.10494,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00098255,0.15299,0.15004,1,1
2,GO BLASTOCYST FORMATION,3.5022e-05,0.15292,0.17715,1,1
2,GO AXIS ELONGATION,0.024173,0.15274,0.19875,1,1
2,GO EPIDERMIS DEVELOPMENT,0.049212,0.1526,0.1237,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.01251,0.15256,0.14423,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.022686,0.15239,0.16889,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00010852,0.15173,0.14465,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,9.3381e-05,0.15168,0.15476,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00031907,0.15154,0.17126,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0029256,0.15126,0.17034,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.01128,0.15121,0.11758,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.021053,0.15116,0.12248,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.01585,0.15115,0.13985,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0062108,0.15104,0.14766,1,1
2,GO LIPID OXIDATION,0.020166,0.15098,0.10104,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.009139,0.15092,0.14213,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00020504,0.15088,0.24662,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.011151,0.15072,0.1116,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0068504,0.15028,0.14311,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.056652,0.15011,0.18164,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0046018,0.15005,0.13349,1,1
2,GO TOXIN TRANSPORT,0.012798,0.14998,0.11764,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0011836,0.14989,0.13452,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.016938,0.14974,0.10902,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00044781,0.14953,0.17263,1,1
2,GO RESPONSE TO GONADOTROPIN,0.010895,0.14946,0.15791,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00065224,0.14941,0.15025,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.026561,0.14913,0.090598,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0023009,0.14912,0.13026,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0022396,0.14884,0.11529,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0020367,0.14871,0.12789,1,1
2,GO V D J RECOMBINATION,0.058787,0.14797,0.13533,1,1
2,GO SPROUTING ANGIOGENESIS,0.02521,0.14776,0.12067,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0020929,0.14751,0.1482,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.020166,0.14735,0.12816,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00023667,0.14706,0.1311,1,1
2,GO RESPONSE TO VIRUS,0.01849,0.14687,0.1284,1,1
2,GO RESPONSE TO CYTOKINE,0.01829,0.14684,0.1101,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.01128,0.14673,0.16269,1,1
2,GO MITOCHONDRIAL TRANSLATION,7.6657e-06,0.14672,0.20107,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.038258,0.14663,0.16361,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.020828,0.14651,0.13458,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.042609,0.14646,0.14249,1,1
2,GO OVULATION,0.0054192,0.14634,0.16489,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0092477,0.14595,0.14663,1,1
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.059879,0.14568,0.090821,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0058389,0.14526,0.17074,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00031907,0.14519,0.1674,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.040582,0.14487,0.11908,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.039795,0.14484,0.097465,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0053519,0.1448,0.11878,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031631,0.14468,0.1229,1,1
2,GO RRNA TRANSCRIPTION,0.00047589,0.14443,0.18204,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0019285,0.14421,0.16734,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.013243,0.14418,0.12592,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00058763,0.14404,0.13442,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.8246e-05,0.144,0.15575,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.01251,0.14399,0.16645,1,1
2,GO SNORNA METABOLIC PROCESS,0.0021505,0.14392,0.14575,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00039622,0.14366,0.13597,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00015331,0.14352,0.20328,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.8814e-05,0.14339,0.15846,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.051595,0.14296,0.12982,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0029256,0.14292,0.12197,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.00023294,0.14267,0.1318,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00031907,0.14262,0.13059,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0041031,0.1425,0.12175,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0050904,0.1425,0.13722,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.03006,0.14222,0.10682,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,9.086e-06,0.1416,0.15322,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.0007786,0.14155,0.14324,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.047827,0.14148,0.072705,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.034636,0.14125,0.095463,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.054074,0.14124,0.14033,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.030994,0.14106,0.12152,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00069207,0.14054,0.15645,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00024045,0.14045,0.1601,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.016205,0.14,0.11204,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.028852,0.13999,0.15085,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0083098,0.13987,0.19271,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.020828,0.13978,0.092421,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.016938,0.13964,0.095113,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0044298,0.13952,0.12241,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.003654,0.13932,0.11289,1,1
2,GO T CELL DIFFERENTIATION,0.016752,0.13897,0.11964,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.011949,0.13886,0.12176,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.01585,0.13881,0.12959,1,1
2,GO AEROBIC RESPIRATION,0.00013899,0.13876,0.15265,1,1
2,GO PRIMARY MIRNA PROCESSING,0.00022208,0.13876,0.22605,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0083098,0.1386,0.1143,1,1
2,GO NUCLEAR MIGRATION,0.048285,0.13838,0.10718,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.02945,0.13694,0.11465,1,1
2,GO NUCLEUS LOCALIZATION,0.047827,0.13687,0.098322,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0011836,0.13668,0.10771,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.036048,0.13655,0.1044,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.03902,0.13653,0.098128,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0054192,0.13649,0.12789,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0029256,0.13641,0.11971,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.024173,0.13638,0.099424,1,1
2,GO SPERM EGG RECOGNITION,0.001776,0.13631,0.11433,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.019104,0.13595,0.14181,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.0018256,0.13538,0.15303,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.02915,0.13528,0.10107,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.1026e-05,0.13464,0.15255,1,1
2,GO B CELL DIFFERENTIATION,0.028264,0.1343,0.10904,1,1
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.039406,0.13422,0.12454,1,1
2,GO REGULATION OF HEMOPOIESIS,0.013394,0.13396,0.12395,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0001803,0.13394,0.15702,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0016122,0.13389,0.13013,1,1
2,GO FEVER GENERATION,0.02915,0.13387,0.12391,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.021973,0.13374,0.097208,1,1
2,GO LYMPHANGIOGENESIS,0.034984,0.13374,0.14307,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0023321,0.13341,0.1376,1,1
2,GO RNA POLYADENYLATION,0.0071051,0.13316,0.11271,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.056652,0.1331,0.093024,1,1
2,GO LYMPHOCYTE ACTIVATION,0.016752,0.13303,0.10651,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00029052,0.13293,0.14431,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.031953,0.13293,0.087996,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.00018923,0.13274,0.18761,1,1
2,GO SNRNA PROCESSING,4.7172e-05,0.13265,0.18975,1,1
2,GO RESPONSE TO UV,0.035691,0.13247,0.089377,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.01829,0.13232,0.1234,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.03006,0.13215,0.092468,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.035691,0.13185,0.10725,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.054074,0.13178,0.082177,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.022928,0.13135,0.086723,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.013394,0.13123,0.11561,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.018898,0.13082,0.094702,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0023957,0.13065,0.10656,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0057669,0.1306,0.19628,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.012087,0.13053,0.13936,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.014823,0.13053,0.098427,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.046474,0.13026,0.089965,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0055559,0.1302,0.15083,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.010769,0.13005,0.13573,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0011668,0.12974,0.17919,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.011544,0.12974,0.12342,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.041383,0.12895,0.10075,1,1
2,GO LIPID HOMEOSTASIS,0.054582,0.12883,0.07279,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0056958,0.12856,0.12066,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.003166,0.12803,0.11043,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.023419,0.12771,0.10716,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0040509,0.12767,0.14733,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.035691,0.12741,0.11078,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.024428,0.12727,0.095043,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0013826,0.12722,0.13017,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.039406,0.12721,0.23365,1,1
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.010522,0.12676,0.10332,1,1
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.024173,0.1267,0.15408,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0014022,0.12669,0.11263,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.05063,0.12665,0.096332,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00042777,0.12635,0.11103,1,1
2,GO MRNA TRANSCRIPTION,0.024428,0.1262,0.1291,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.034984,0.12619,0.1069,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.024947,0.12606,0.15939,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.057711,0.12588,0.097366,1,1
2,GO CELL ACTIVATION,0.044722,0.12555,0.085708,1,1
2,GO MRNA CLEAVAGE,0.0013255,0.12413,0.11692,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.059879,0.12376,0.091871,1,1
2,GO RNA CATABOLIC PROCESS,6.9711e-06,0.1237,0.14057,1,1
2,GO HISTONE DEUBIQUITINATION,0.0029645,0.12369,0.12546,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.01128,0.12354,0.097604,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.057711,0.12346,0.16679,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.033948,0.12342,0.080464,1,1
2,GO DEFENSE RESPONSE,0.037139,0.12322,0.091324,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.015501,0.12314,0.15744,1,1
2,GO GMP METABOLIC PROCESS,0.0093576,0.12311,0.13517,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.01995,0.12311,0.15707,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.013546,0.12298,0.11867,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0013826,0.12292,0.15702,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.017315,0.12289,0.14109,1,1
2,GO NCRNA CATABOLIC PROCESS,0.0018508,0.12279,0.15652,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0037985,0.1227,0.13813,1,1
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.024428,0.12268,0.087691,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0019023,0.12262,0.14408,1,1
2,GO RESPONSE TO SALT,0.0015038,0.12233,0.16739,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.052083,0.12233,0.07614,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.027686,0.12219,0.094469,1,1
2,GO PROTEIN SUMOYLATION,0.0034692,0.12211,0.11139,1,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.052575,0.122,0.11491,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0050904,0.12188,0.14972,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.044292,0.1215,0.082987,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00013899,0.12112,0.13153,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0071051,0.12111,0.11652,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0059116,0.12082,0.10186,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.0055559,0.12082,0.13622,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.036772,0.12049,0.097472,1,1
2,GO LIPID MODIFICATION,0.052575,0.12047,0.068614,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.049212,0.12031,0.082144,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.052083,0.12014,0.09793,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0028872,0.11957,0.10298,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011678,0.11939,0.091889,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.03006,0.11934,0.15807,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.01585,0.11916,0.085113,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0020367,0.11896,0.14,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.022446,0.11893,0.11178,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0025617,0.11865,0.13243,1,1
2,GO RNA PROCESSING,0.00013016,0.11861,0.13168,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0016122,0.11843,0.15754,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00031414,0.118,0.13123,1,1
2,GO MRNA 3 END PROCESSING,0.0042636,0.11776,0.10942,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.01251,0.11764,0.11322,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.019735,0.11713,0.10887,1,1
2,GO GOLGI RIBBON FORMATION,0.043444,0.117,0.10677,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.014172,0.11677,0.12101,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.011544,0.11656,0.14841,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.057711,0.11623,0.13777,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0010408,0.116,0.096378,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.014658,0.11563,0.099643,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.022928,0.11538,0.095971,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.003166,0.11532,0.13799,1,1
2,GO RNA 3 END PROCESSING,0.00041488,0.11492,0.12535,1,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.01849,0.11479,0.10828,1,1
2,GO INTERLEUKIN 4 PRODUCTION,0.043025,0.11474,0.11007,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.054582,0.11464,0.12728,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.037509,0.11433,0.107,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.03006,0.11426,0.1241,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0071918,0.11423,0.085551,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.024428,0.114,0.096683,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0072795,0.1137,0.11632,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0049019,0.11285,0.10599,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0030839,0.11268,0.10188,1,1
2,GO GENE SILENCING,0.00086244,0.11207,0.097349,1,1
2,GO TELOMERE ORGANIZATION,0.0010558,0.11197,0.12001,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0011021,0.11196,0.11426,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0089251,0.11129,0.12406,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.033271,0.11085,0.076008,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011503,0.11022,0.099844,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0060595,0.1099,0.10436,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.048746,0.10935,0.071681,1,1
2,GO THYMUS DEVELOPMENT,0.010522,0.10927,0.11885,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0032928,0.10901,0.15651,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00059648,0.109,0.11573,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.011022,0.10875,0.10684,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046921,0.10868,0.089126,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.041789,0.10858,0.085552,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0013633,0.10856,0.13143,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0025617,0.10829,0.15363,1,1
2,GO HUMORAL IMMUNE RESPONSE,0.055609,0.10818,0.073587,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.033271,0.10805,0.10292,1,1
2,GO DNA GEOMETRIC CHANGE,0.003654,0.10804,0.1011,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.012945,0.10777,0.084891,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.024687,0.10759,0.11534,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.013394,0.10752,0.092805,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.028264,0.10746,0.085034,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.03006,0.1073,0.091101,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.015159,0.1072,0.11896,1,1
2,GO CELLULAR RESPONSE TO UV,0.040981,0.10697,0.090822,1,1
2,GO DNA METHYLATION,0.00044781,0.1064,0.13088,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.041383,0.1056,0.069619,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.00099681,0.10556,0.12425,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0104,0.10514,0.090121,1,1
2,GO PROTEIN IMPORT,0.020828,0.10467,0.089503,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.003654,0.10454,0.1374,1,1
2,GO BASE EXCISION REPAIR,0.0070192,0.10396,0.093589,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.00027716,0.1037,0.12228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0013443,0.10287,0.10692,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.041383,0.10274,0.079178,1,1
2,GO PROTEIN TRIMERIZATION,0.043444,0.10264,0.11216,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.047372,0.10223,0.16375,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00095459,0.10197,0.11671,1,1
2,GO RNA LOCALIZATION,0.0012527,0.10183,0.12341,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.048285,0.10178,0.11067,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0023009,0.10162,0.10859,1,1
2,GO MRNA METABOLIC PROCESS,0.00025215,0.10154,0.10918,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.026013,0.10148,0.10177,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0086125,0.10119,0.090908,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.024687,0.10096,0.08698,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.025475,0.10025,0.14781,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.056652,0.10004,0.10263,1,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.002631,0.099873,0.10597,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.003166,0.099708,0.13149,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0067673,0.09938,0.098422,1,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.026013,0.099241,0.14089,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.014823,0.099178,0.0782,1,1
2,GO NUCLEAR EXPORT,0.0040509,0.098678,0.1077,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.03902,0.098398,0.08083,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.024173,0.098045,0.088226,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.052083,0.097849,0.077655,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.037882,0.0969,0.14125,1,1
2,GO P BODY ASSEMBLY,0.021509,0.096494,0.086751,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.054074,0.096059,0.091986,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.027118,0.096049,0.071731,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.019735,0.095665,0.090277,1,1
2,GO PROTEIN NEDDYLATION,0.050154,0.095017,0.069818,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0084096,0.094868,0.089126,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.021053,0.094432,0.072786,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0033799,0.094227,0.087973,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0030038,0.094214,0.10686,1,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.024687,0.094026,0.10103,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001776,0.093906,0.096704,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.01829,0.093043,0.089265,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0027747,0.092938,0.10844,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.028556,0.092569,0.081229,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013093,0.092562,0.11797,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.027118,0.09249,0.078662,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.015329,0.092385,0.071716,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.016752,0.092208,0.10315,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0037985,0.092169,0.094515,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.042197,0.091906,0.099605,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0042095,0.091689,0.10262,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.012367,0.091641,0.11523,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.003654,0.091633,0.10452,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0025277,0.091447,0.10441,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0096941,0.091346,0.087655,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.018091,0.091343,0.081195,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.046031,0.090853,0.069765,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.03902,0.090798,0.068964,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.027686,0.09047,0.063307,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.0043737,0.089921,0.10241,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.011544,0.089803,0.085881,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.045155,0.08966,0.058926,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022396,0.089403,0.11497,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0021798,0.089383,0.092932,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.028852,0.089219,0.10871,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.046474,0.08915,0.061497,1,1
2,GO OXIDATION REDUCTION PROCESS,0.012798,0.088925,0.081292,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.015501,0.088898,0.083124,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0022095,0.088455,0.1124,1,1
2,GO LIPID METABOLIC PROCESS,0.042197,0.088194,0.065971,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.059879,0.088184,0.064263,1,1
2,GO ACTIN NUCLEATION,0.01849,0.087995,0.089454,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.051595,0.087818,0.085195,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.045155,0.087715,0.056813,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.043444,0.08713,0.084388,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0075485,0.086636,0.088735,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.056652,0.086536,0.085572,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0050269,0.085291,0.089855,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.009139,0.084902,0.082026,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.0092477,0.083728,0.086342,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02521,0.083652,0.085121,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.055609,0.082851,0.058311,1,1
2,GO MRNA TRANSPORT,0.0071051,0.082327,0.10214,1,1
2,GO CELLULAR RESPIRATION,0.0047198,0.082182,0.10082,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.009139,0.082075,0.10431,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.01128,0.081755,0.081947,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.019523,0.081721,0.10117,1,1
2,GO HISTONE H3 ACETYLATION,0.016568,0.081112,0.065968,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.043025,0.080232,0.092159,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.047827,0.079469,0.064667,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.037139,0.079094,0.09157,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0026663,0.078772,0.10982,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.001071,0.078298,0.11914,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.011151,0.077585,0.11489,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.048746,0.076384,0.056681,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.021973,0.076131,0.074813,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0059116,0.076058,0.082081,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.01499,0.075108,0.09999,1,1
2,GO STEROL METABOLIC PROCESS,0.026838,0.074496,0.092815,1,1
2,GO RNA SPLICING,0.010522,0.073221,0.080738,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.02915,0.073023,0.086375,1,1
2,GO DNA MODIFICATION,0.014013,0.071855,0.086048,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.010645,0.071156,0.14114,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.016752,0.071061,0.086033,1,1
2,GO MRNA PROCESSING,0.010279,0.07078,0.081304,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.027686,0.070137,0.071921,1,1
2,GO PEROXISOME ORGANIZATION,0.044292,0.068713,0.070119,1,1
2,GO CHROMATIN REMODELING,0.01585,0.068231,0.070045,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.013394,0.068135,0.083426,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.034984,0.067925,0.083119,1,1
2,GO METHYLATION,0.022209,0.066418,0.067296,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.039406,0.066375,0.10178,1,1
2,GO DNA METABOLIC PROCESS,0.040187,0.065778,0.049685,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.028556,0.065146,0.064267,1,1
2,GO MITOCHONDRION MORPHOGENESIS,0.056128,0.064108,0.084292,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.016938,0.063571,0.070358,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.016938,0.061803,0.096822,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.037139,0.06048,0.063804,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.026286,0.058075,0.083677,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.028852,0.052671,0.070758,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.026561,0.048577,0.078258,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.033948,0.046281,0.064668,1,1
2,GO POLYOL METABOLIC PROCESS,0.048746,0.040413,0.083395,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,5.9432e-10,0.9096,0.85476,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.8573e-08,0.79065,0.70829,1,1
3,GO SYNAPSE MATURATION,9.5999e-07,0.60479,0.52994,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,1.7154e-07,0.59681,0.69532,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,7.892e-08,0.56159,0.50752,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,3.2162e-07,0.55042,0.51181,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.6657e-06,0.54817,0.46085,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.3784e-07,0.54047,0.5477,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,7.8124e-06,0.52729,0.43095,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,6.6066e-07,0.5246,0.4849,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.1165e-05,0.51794,0.44516,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,1.8032e-05,0.51306,0.49752,1,1
3,GO RESPONSE TO L GLUTAMATE,6.3569e-09,0.51224,0.47974,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,1.8793e-06,0.50362,0.4183,1,1
3,GO SECRETORY GRANULE LOCALIZATION,1.1165e-05,0.49975,0.40287,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,2.9805e-09,0.48601,0.47636,1,1
3,GO DENSE CORE GRANULE TRANSPORT,0.00015083,0.48584,0.39269,1,1
3,GO POSTSYNAPSE ASSEMBLY,4.2271e-06,0.43111,0.45002,1,1
3,GO SYNAPTIC VESICLE MATURATION,3.6877e-06,0.42834,0.43331,1,1
3,GO GLYCINE TRANSPORT,0.0011021,0.42547,0.32714,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.5753e-08,0.41566,0.45162,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,1.0169e-05,0.41289,0.44449,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,6.7461e-07,0.40191,0.33344,1,1
3,GO CYTOPLASMIC TRANSLATION,1.1789e-06,0.39893,0.33767,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1.2281e-06,0.39535,0.36981,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,1.155e-06,0.39179,0.38481,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00037835,0.38668,0.34584,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.0036e-08,0.38257,0.43748,1,1
3,GO DENTATE GYRUS DEVELOPMENT,3.4098e-06,0.38012,0.42905,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.8001e-06,0.37872,0.36267,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,1.5014e-05,0.3786,0.35523,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,6.5837e-06,0.37728,0.46404,1,1
3,GO MYOBLAST PROLIFERATION,8.2543e-08,0.37653,0.35533,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,6.545e-05,0.37603,0.35177,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.2824e-05,0.37453,0.33593,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,0.0039992,0.37324,0.28244,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,3.0395e-05,0.37181,0.32725,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010323,0.3693,0.39505,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,1.0557e-05,0.36892,0.36668,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,5.2445e-07,0.36549,0.3884,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00018923,0.36395,0.34967,1,1
3,GO IMP METABOLIC PROCESS,5.8698e-06,0.35782,0.38108,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.6001e-09,0.35748,0.36129,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,1.1588e-05,0.3571,0.32278,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,1.9393e-05,0.35513,0.31258,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.001422,0.3539,0.28595,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.0011503,0.35385,0.34164,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00092737,0.35357,0.31582,1,1
3,GO SUCKLING BEHAVIOR,1.996e-06,0.35143,0.37546,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,5.3562e-07,0.3502,0.30823,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.5127e-05,0.34852,0.3481,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,8.5867e-06,0.34409,0.3281,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,1.4741e-05,0.34094,0.35367,1,1
3,GO TRANSLATIONAL INITIATION,1.5865e-05,0.34035,0.28988,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,2.971e-06,0.33968,0.37049,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00052901,0.33772,0.27966,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00021857,0.33749,0.30708,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.3039e-08,0.33426,0.31962,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.00040857,0.33284,0.41664,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00021857,0.33121,0.28677,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00091404,0.32914,0.31891,1,1
3,GO L GLUTAMATE IMPORT,7.1274e-05,0.32803,0.22995,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00010323,0.327,0.30513,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0011021,0.32663,0.3038,1,1
3,GO MATURATION OF LSU RRNA,2.1624e-06,0.32595,0.34098,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.4091e-05,0.32564,0.37471,1,1
3,GO UV PROTECTION,5.0323e-06,0.3233,0.33007,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00025215,0.32325,0.30863,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.0057669,0.31812,0.33349,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.8305e-05,0.31605,0.27717,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.01016,0.31423,0.21864,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.2032e-06,0.31255,0.35709,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,4.2271e-06,0.31191,0.31204,1,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,3.0811e-07,0.31092,0.3596,1,1
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.0039481,0.31033,0.25863,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.1588e-05,0.30354,0.32803,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.6386e-06,0.30291,0.347,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.9613e-05,0.3023,0.27489,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,2.0776e-06,0.30213,0.3112,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.8262e-08,0.30175,0.29023,1,1
3,GO RIBOSOME ASSEMBLY,5.7582e-06,0.30149,0.31976,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00017457,0.30054,0.36723,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,5.1304e-06,0.29917,0.3572,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,4.2271e-06,0.29798,0.28711,1,1
3,GO REGULATION OF MRNA BINDING,5.1304e-06,0.29533,0.29232,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.3693e-05,0.29433,0.30348,1,1
3,GO REGULATION OF VESICLE FUSION,1.5293e-05,0.29422,0.31486,1,1
3,GO PHAGOCYTOSIS RECOGNITION,4.5558e-05,0.29263,0.25369,1,1
3,GO REGULATION OF NEURON MIGRATION,0.0032078,0.29166,0.19409,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.7605e-06,0.29117,0.30531,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0066851,0.29027,0.19142,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0361e-05,0.28934,0.28827,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.00020835,0.28778,0.29887,1,1
3,GO OXYGEN TRANSPORT,0.027973,0.28705,0.26886,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,3.628e-05,0.28572,0.33177,1,1
3,GO NEUROTRANSMITTER REUPTAKE,8.7316e-05,0.28365,0.2575,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.7172e-05,0.28352,0.28936,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1026e-05,0.28262,0.26007,1,1
3,GO CGMP METABOLIC PROCESS,0.0005618,0.28074,0.29579,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.7586e-05,0.28003,0.28132,1,1
3,GO ADULT HEART DEVELOPMENT,0.00010323,0.27979,0.32536,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.008211,0.27885,0.23492,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.00012388,0.27851,0.254,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.1807e-07,0.27806,0.33329,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0025617,0.27803,0.23792,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00015583,0.27794,0.26041,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00017176,0.27781,0.22739,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0023321,0.27701,0.22789,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00092737,0.27668,0.35521,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.0018764,0.27627,0.24529,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0018256,0.27604,0.28683,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,9.9844e-05,0.27537,0.24692,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00026858,0.27519,0.28646,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00055343,0.27512,0.24003,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,2.4371e-06,0.27407,0.26648,1,1
3,GO DIVALENT METAL ION EXPORT,1.2027e-05,0.27331,0.34992,1,1
3,GO TELOMERASE RNA LOCALIZATION,1.1588e-05,0.27049,0.27764,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,2.4528e-05,0.26911,0.22085,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.0046018,0.26878,0.3052,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00038422,0.26818,0.27158,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,9.795e-06,0.26686,0.28549,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,3.6877e-06,0.26669,0.32321,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,4.0314e-05,0.26473,0.34631,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0001803,0.26233,0.20895,1,1
3,GO AMP METABOLIC PROCESS,0.00069207,0.26201,0.22378,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.0047198,0.26158,0.19168,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,9.086e-06,0.26093,0.29708,1,1
3,GO VIRAL TRANSLATION,9.2585e-06,0.26067,0.27334,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00054518,0.25908,0.22368,1,1
3,GO NEURON PROJECTION ORGANIZATION,1.5293e-05,0.25763,0.24534,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013856,0.25643,0.20673,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,6.6578e-05,0.25529,0.25504,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.6487e-06,0.25501,0.25839,1,1
3,GO SIALYLATION,0.00094089,0.25456,0.33229,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00060545,0.25403,0.18237,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00021511,0.25392,0.24565,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0007901,0.25214,0.34617,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,7.8124e-06,0.25213,0.24995,1,1
3,GO MATURATION OF SSU RRNA,2.9859e-05,0.25207,0.27057,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.00074504,0.252,0.21501,1,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.011022,0.25165,0.22015,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.5646e-05,0.25077,0.26399,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,1.1165e-05,0.2487,0.23915,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00013451,0.24847,0.27342,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0018508,0.24754,0.26009,1,1
3,GO NEURON REMODELING,0.00036124,0.24532,0.23291,1,1
3,GO REGULATION OF RNA BINDING,1.4207e-05,0.2453,0.23934,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0002117,0.24492,0.25956,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,2.8814e-05,0.24372,0.26298,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0001179,0.24364,0.25057,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00061456,0.24034,0.27949,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00054518,0.24032,0.24187,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,2.2015e-05,0.23925,0.19328,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00046165,0.23846,0.17173,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0030436,0.23818,0.24299,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00014839,0.23769,0.24756,1,1
3,GO PROTEIN TRIMERIZATION,6.2175e-05,0.23732,0.24317,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,5.1446e-05,0.23698,0.30186,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00064263,0.23564,0.19343,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00025617,0.23505,0.24019,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.037882,0.23383,0.13919,1,1
3,GO GTP METABOLIC PROCESS,2.3661e-05,0.23303,0.23066,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.000662,0.2319,0.19493,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,3.8246e-05,0.23042,0.28037,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.003607,0.2302,0.21496,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.000286,0.22997,0.1912,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.055609,0.22909,0.19368,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00014362,0.2287,0.1798,1,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,9.819e-05,0.22649,0.22424,1,1
3,GO GLUTAMATE SECRETION,6.545e-05,0.22525,0.25031,1,1
3,GO REGULATION OF LYASE ACTIVITY,8.1138e-06,0.22457,0.227,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00019857,0.22432,0.23687,1,1
3,GO GAS TRANSPORT,0.008211,0.22391,0.24152,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0063654,0.22332,0.18742,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0030038,0.2233,0.18405,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.024947,0.2233,0.21826,1,1
3,GO NEUROTRANSMITTER UPTAKE,0.00017741,0.22189,0.21312,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0026663,0.22175,0.19433,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0088198,0.22067,0.14294,1,1
3,GO NAD METABOLIC PROCESS,5.332e-06,0.22049,0.27192,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.027686,0.22017,0.15168,1,1
3,GO ARGININE METABOLIC PROCESS,0.0012527,0.21847,0.23254,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.00094089,0.21843,0.25468,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.6158e-05,0.21449,0.21815,1,1
3,GO VIRAL GENE EXPRESSION,0.00035024,0.21417,0.20067,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.026286,0.21363,0.17013,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00049802,0.21317,0.22071,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.00033432,0.21315,0.18776,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.031953,0.21296,0.15045,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.00049802,0.2129,0.20133,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,9.6129e-06,0.21246,0.24909,1,1
3,GO STRESS GRANULE ASSEMBLY,0.00054518,0.21173,0.16717,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00018323,0.21165,0.20592,1,1
3,GO MATURATION OF 5 8S RRNA,0.00054518,0.21149,0.22443,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.028852,0.21143,0.1801,1,1
3,GO LONG TERM MEMORY,0.00012186,0.21073,0.21807,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.9749e-05,0.20869,0.26044,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.014013,0.20784,0.14496,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,3.628e-05,0.20646,0.24244,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0057669,0.20576,0.17659,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00022565,0.20568,0.22061,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0013255,0.20565,0.23734,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.001704,0.20442,0.16341,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0062877,0.20442,0.1765,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.000662,0.20437,0.20358,1,1
3,GO TRNA MODIFICATION,0.00015083,0.20381,0.1947,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00011218,0.20338,0.21263,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0018508,0.20295,0.31973,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.001442,0.20009,0.17119,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0025617,0.19995,0.19299,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00029052,0.19927,0.1826,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0042095,0.19918,0.16467,1,1
3,GO TRANSLATIONAL ELONGATION,2.9859e-05,0.19918,0.19693,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00096848,0.19832,0.18099,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.024428,0.19764,0.13143,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0005056,0.19737,0.22032,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.019312,0.197,0.14356,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0046018,0.1969,0.16532,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.017506,0.19657,0.30451,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.0364e-06,0.19608,0.1867,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00071283,0.19565,0.22805,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.020166,0.1955,0.14649,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.001442,0.19547,0.18582,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,8.1623e-05,0.19541,0.18411,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0094686,0.19518,0.18162,1,1
3,GO SYNAPSE ORGANIZATION,0.0011503,0.19487,0.16042,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,9.0235e-07,0.19461,0.2147,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00041488,0.19441,0.17532,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0031247,0.19393,0.21233,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,2.8814e-05,0.19346,0.2191,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,8.3013e-05,0.19346,0.17006,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00049802,0.19325,0.20556,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0050904,0.19177,0.16181,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00098255,0.19097,0.20973,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.013243,0.19072,0.18377,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.015501,0.19003,0.18346,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00047589,0.18927,0.20218,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,2.3661e-05,0.18922,0.21986,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.001118,0.18921,0.14265,1,1
3,GO LEARNING,0.00045468,0.18889,0.18721,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.018898,0.18866,0.21344,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0021505,0.1868,0.17756,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00019857,0.18668,0.20621,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,7.5217e-06,0.18627,0.21251,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0028872,0.18564,0.18223,1,1
3,GO CGMP MEDIATED SIGNALING,0.00069207,0.18494,0.18436,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.003654,0.18408,0.20976,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.9393e-05,0.18299,0.18885,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00016098,0.18276,0.21671,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.031953,0.18276,0.12415,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.051111,0.18235,0.16063,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00042128,0.18026,0.23637,1,1
3,GO SNORNA 3 END PROCESSING,0.00045468,0.17915,0.26062,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00055343,0.17885,0.16037,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.000286,0.17882,0.21165,1,1
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0046018,0.17823,0.17929,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00059648,0.17774,0.13719,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00048316,0.17771,0.17844,1,1
3,GO AMINO ACID IMPORT,0.0051547,0.17753,0.16108,1,1
3,GO SHORT TERM MEMORY,0.011411,0.17752,0.24394,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,0.00019229,0.17684,0.17648,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.1588e-05,0.17664,0.18614,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00080175,0.17657,0.21224,1,1
3,GO AEROBIC RESPIRATION,0.00088789,0.17633,0.14511,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0137,0.17599,0.1302,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.001704,0.1759,0.17926,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.001568,0.17563,0.18516,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001568,0.17561,0.1979,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0054872,0.17509,0.15731,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00052901,0.17496,0.17535,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,5.5127e-05,0.17434,0.17108,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,6.0079e-05,0.1737,0.20097,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00023667,0.17274,0.17545,1,1
3,GO MITOCHONDRION LOCALIZATION,0.00034485,0.17266,0.161,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.036409,0.17218,0.13588,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00031907,0.1715,0.15968,1,1
3,GO TRANSLATIONAL TERMINATION,0.0019285,0.17057,0.17019,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00060545,0.1702,0.18748,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0075485,0.17007,0.20261,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00036686,0.16976,0.18437,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00020504,0.16969,0.2328,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0084096,0.16968,0.14021,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00036124,0.16946,0.2102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0056255,0.16863,0.17037,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.010522,0.16851,0.15256,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00013451,0.1682,0.14094,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0055559,0.16814,0.16533,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00014839,0.16797,0.18296,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.002702,0.16687,0.1788,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0060595,0.16675,0.16001,1,1
3,GO WALKING BEHAVIOR,2.6352e-05,0.16663,0.24272,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0011341,0.16652,0.15321,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00016361,0.16602,0.18705,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.028556,0.16512,0.12284,1,1
3,GO RIBOSOME BIOGENESIS,0.00014839,0.16477,0.22195,1,1
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.000662,0.16466,0.16832,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.035691,0.16441,0.12993,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,3.6924e-05,0.16383,0.18569,1,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0029256,0.16381,0.1775,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00036686,0.16307,0.15045,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.00027716,0.16285,0.14831,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0025617,0.16263,0.13204,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00014129,0.16211,0.16922,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0042095,0.16184,0.17274,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00010673,0.16141,0.18363,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.012945,0.16087,0.13799,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.001704,0.16081,0.16835,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.001776,0.16069,0.19557,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0052197,0.16042,0.1675,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0029645,0.16033,0.19131,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.024428,0.15919,0.12325,1,1
3,GO FATTY ACID HOMEOSTASIS,0.0035146,0.159,0.21555,1,1
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.0076401,0.15874,0.14365,1,1
3,GO RRNA TRANSCRIPTION,9.9844e-05,0.15853,0.19119,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0032078,0.15851,0.17084,1,1
3,GO DENDRITE SELF AVOIDANCE,0.052575,0.15847,0.14649,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0046018,0.15833,0.18758,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00059648,0.15782,0.19519,1,1
3,GO DENDRITIC TRANSPORT,0.003654,0.15769,0.2015,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00045468,0.15716,0.1582,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.0054872,0.15658,0.11122,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007901,0.15607,0.14074,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0020092,0.15594,0.15902,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046018,0.15591,0.15974,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00036686,0.15566,0.15658,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0013255,0.15536,0.13943,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0018508,0.15498,0.1777,1,1
3,GO MRNA MODIFICATION,0.00096848,0.15496,0.20133,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0035146,0.15437,0.15798,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,6.1119e-05,0.15423,0.17178,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.0052197,0.15364,0.18943,1,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0062877,0.15351,0.15232,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00060545,0.15304,0.12686,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0074579,0.1528,0.15129,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0049019,0.15279,0.14886,1,1
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.045155,0.15278,0.134,1,1
3,GO RRNA METABOLIC PROCESS,0.00021857,0.1516,0.20087,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00022927,0.15137,0.1358,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0032501,0.15134,0.16347,1,1
3,GO L AMINO ACID TRANSPORT,0.00039622,0.15072,0.18111,1,1
3,GO NADH METABOLIC PROCESS,0.00014599,0.15067,0.22574,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0024609,0.15067,0.14397,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0010408,0.15054,0.16055,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.052575,0.15049,0.11417,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0042636,0.14951,0.14544,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.00019229,0.14828,0.19233,1,1
3,GO TRNA METHYLATION,0.0014022,0.14767,0.16995,1,1
3,GO NUCLEOTIDE SALVAGE,0.016027,0.14715,0.19626,1,1
3,GO CRISTAE FORMATION,0.0087156,0.14711,0.1757,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.010041,0.14471,0.14339,1,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.01016,0.14454,0.09972,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.024947,0.14423,0.12484,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0038478,0.14422,0.16271,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0011021,0.14282,0.13211,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0011836,0.14229,0.14647,1,1
3,GO ONE CARBON METABOLIC PROCESS,0.0058389,0.14147,0.13023,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.0054192,0.14014,0.15559,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.00040857,0.14,0.14788,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.0005211,0.13985,0.11753,1,1
3,GO ASSOCIATIVE LEARNING,0.0030038,0.13978,0.14064,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0071051,0.13922,0.17094,1,1
3,GO GLUTAMINE METABOLIC PROCESS,0.00019229,0.13921,0.18283,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.011678,0.13851,0.14375,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.0016122,0.1382,0.17428,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.003166,0.13796,0.14612,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.027118,0.13742,0.16842,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0016575,0.13736,0.13045,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0054872,0.13712,0.15312,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0060595,0.13671,0.18808,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0028872,0.13635,0.11802,1,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.033608,0.13558,0.11286,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00028155,0.13531,0.12115,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0022095,0.13454,0.17754,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.013093,0.13452,0.22321,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00016901,0.13428,0.11703,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0087156,0.1337,0.1653,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0056255,0.13243,0.15864,1,1
3,GO RRNA MODIFICATION,0.0055559,0.13235,0.18879,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00088789,0.13232,0.19621,1,1
3,GO SNORNA METABOLIC PROCESS,0.00068191,0.1318,0.25612,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.018091,0.13179,0.13307,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,9.03e-05,0.13178,0.13535,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.013856,0.13176,0.14718,1,1
3,GO RNA POLYADENYLATION,0.0048405,0.13097,0.1086,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0023957,0.13056,0.13597,1,1
3,GO LIPID IMPORT INTO CELL,0.057711,0.13029,0.1092,1,1
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.053071,0.12954,0.13189,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.017125,0.12938,0.10754,1,1
3,GO IMPORT INTO CELL,0.00029052,0.12911,0.15057,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0019819,0.12859,0.13646,1,1
3,GO RNA SURVEILLANCE,0.0095807,0.12831,0.12988,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0059852,0.12816,0.154,1,1
3,GO TRANSEPITHELIAL TRANSPORT,0.0048405,0.12673,0.11772,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0098086,0.12655,0.13409,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0040509,0.12626,0.26271,1,1
3,GO CELLULAR RESPIRATION,0.0012177,0.12581,0.13213,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0005618,0.12431,0.17042,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0007901,0.12415,0.12421,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00026438,0.1227,0.14206,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.012945,0.1224,0.12158,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.051111,0.12233,0.11222,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0075485,0.12228,0.13048,1,1
3,GO NCRNA PROCESSING,0.00069207,0.121,0.1692,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.010522,0.12096,0.17371,1,1
3,GO DNA REPLICATION INITIATION,0.010769,0.12053,0.11103,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.016205,0.11879,0.11611,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0014624,0.11781,0.12075,1,1
3,GO CARDIAC CONDUCTION,0.01016,0.11707,0.12511,1,1
3,GO PROTEIN NITROSYLATION,0.02128,0.11535,0.14589,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0028492,0.11532,0.12127,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0027381,0.11358,0.10539,1,1
3,GO HEPARIN METABOLIC PROCESS,0.033271,0.11319,0.1775,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.001422,0.11258,0.10167,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00030449,0.11192,0.14803,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.035691,0.11137,0.099931,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.059879,0.11099,0.11313,1,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.016752,0.11054,0.22655,1,1
3,GO L SERINE METABOLIC PROCESS,0.044722,0.10917,0.1836,1,1
3,GO PROTEIN DENEDDYLATION,0.019104,0.10901,0.10719,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013394,0.10852,0.11772,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0085105,0.10829,0.13736,1,1
3,GO AMINO ACID TRANSPORT,0.00031907,0.10689,0.14924,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0018764,0.1068,0.10621,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.01995,0.10669,0.13075,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0078263,0.10565,0.10498,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.049681,0.10515,0.15515,1,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.055093,0.10449,0.085949,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.012945,0.10428,0.11378,1,1
3,GO PROTEIN TARGETING,0.00018923,0.10423,0.10706,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.011022,0.10421,0.13834,1,1
3,GO STRIATUM DEVELOPMENT,0.02915,0.10375,0.13698,1,1
3,GO TRNA PROCESSING,0.0019023,0.10318,0.14935,1,1
3,GO RNA METHYLATION,0.010645,0.10199,0.11648,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0039481,0.10159,0.084411,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010769,0.10112,0.11358,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.031953,0.10104,0.084703,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.013243,0.09994,0.10593,1,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038977,0.099347,0.12327,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0024281,0.09899,0.11501,1,1
3,GO RNA CATABOLIC PROCESS,0.0019285,0.098794,0.11387,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0058389,0.098576,0.11707,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0039992,0.098384,0.14874,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0013633,0.097699,0.10468,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001422,0.096822,0.12609,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.0059116,0.095731,0.095634,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,0.039406,0.093694,0.10117,1,1
3,GO NCRNA METABOLIC PROCESS,0.0022701,0.093617,0.1418,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0089251,0.093316,0.093553,1,1
3,GO CELLULAR RESPONSE TO PH,0.026286,0.089654,0.088471,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0034243,0.089074,0.10898,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0089251,0.088621,0.10951,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.013243,0.088318,0.10959,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0056255,0.087987,0.11832,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.035336,0.087572,0.088305,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0019285,0.087544,0.092663,1,1
3,GO RNA 5 END PROCESSING,0.0075485,0.086892,0.16784,1,1
3,GO PROTEIN TETRAMERIZATION,0.0030038,0.085451,0.10137,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.020166,0.085321,0.092135,1,1
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.012945,0.08497,0.082242,1,1
3,GO RRNA METHYLATION,0.036048,0.084319,0.128,1,1
3,GO MRNA METABOLIC PROCESS,0.0022701,0.084215,0.091646,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0063654,0.084136,0.092821,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.022686,0.083937,0.075104,1,1
3,GO ALDITOL METABOLIC PROCESS,0.0086125,0.083306,0.16118,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.0062877,0.082565,0.098041,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.0030839,0.08019,0.086243,1,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0084096,0.079687,0.10692,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0060595,0.079548,0.11393,1,1
3,GO TRNA METABOLIC PROCESS,0.0096941,0.079414,0.11687,1,1
3,GO ATP METABOLIC PROCESS,0.0012886,0.079302,0.099512,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.001776,0.079265,0.093195,1,1
3,GO RNA 3 END PROCESSING,0.048285,0.077498,0.062448,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.026013,0.077404,0.10573,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.048746,0.077223,0.11175,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0025617,0.076384,0.076664,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.043444,0.075522,0.069459,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.049681,0.074889,0.10294,1,1
3,GO RNA PROCESSING,0.0046018,0.074425,0.097125,1,1
3,GO LIVER REGENERATION,0.027686,0.07353,0.094596,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.015674,0.071946,0.081507,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.037139,0.071098,0.073784,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.013093,0.070825,0.11381,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.05357,0.070009,0.1065,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.044292,0.069455,0.068897,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.037139,0.069225,0.071347,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.015501,0.069013,0.091671,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.056128,0.068078,0.061617,1,1
3,GO REGULATION OF PROTEIN TARGETING,0.041789,0.058196,0.078185,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.049681,0.056692,0.081669,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.034636,0.054784,0.0623,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.011544,0.048769,0.11452,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.027401,0.048088,0.073835,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.1456e-06,0.74456,0.77586,1,1
4,GO HISTAMINE SECRETION,4.719e-07,0.65521,0.52931,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,9.4407e-08,0.637,0.64574,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.484e-09,0.60984,0.56425,1,1
4,GO HISTAMINE TRANSPORT,6.0205e-08,0.56642,0.51063,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,7.3772e-08,0.55505,0.51836,1,1
4,GO RENAL ABSORPTION,1.9563e-06,0.53281,0.47794,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.9805e-09,0.51594,0.53862,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,2.402e-08,0.51578,0.60448,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,2.0429e-07,0.50612,0.48057,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00040235,0.48753,0.47855,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.2697e-09,0.48541,0.486,1,1
4,GO O GLYCAN PROCESSING,5.2359e-09,0.4821,0.43727,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.6321e-06,0.47892,0.46648,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,3.357e-07,0.47832,0.54781,1,1
4,GO REGULATION OF PLATELET AGGREGATION,5.2445e-07,0.47817,0.47268,1,1
4,GO INTESTINAL LIPID ABSORPTION,8.8389e-07,0.46933,0.5539,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,5.2303e-06,0.46888,0.47272,1,1
4,GO TOLERANCE INDUCTION,0.00032408,0.46743,0.37491,1,1
4,GO RESPONSE TO TYPE I INTERFERON,8.1623e-05,0.46672,0.3697,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,2.2416e-05,0.46287,0.45614,1,1
4,GO RESPONSE TO MAGNESIUM ION,3.1479e-07,0.46075,0.44884,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,1.1097e-10,0.45921,0.46758,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,8.5867e-06,0.45346,0.41641,1,1
4,GO REGULATION OF ANOIKIS,4.9069e-08,0.45255,0.46096,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013899,0.4524,0.33477,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,6.3359e-07,0.45097,0.39626,1,1
4,GO INTESTINAL ABSORPTION,3.2894e-09,0.45071,0.49325,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00011986,0.44934,0.39833,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,1.734e-06,0.44372,0.44354,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0018006,0.44167,0.32628,1,1
4,GO MUCUS SECRETION,0.00022565,0.43751,0.43693,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.0868e-08,0.42876,0.45853,1,1
4,GO TOXIN METABOLIC PROCESS,3.247e-08,0.42701,0.43336,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,5.2344e-05,0.42605,0.32987,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,4.4749e-10,0.42255,0.47664,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,2.0879e-07,0.42191,0.41778,1,1
4,GO GERMINAL CENTER FORMATION,0.00012804,0.41715,0.31777,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00020835,0.41659,0.33971,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,2.7312e-05,0.41466,0.36858,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0012527,0.41352,0.31132,1,1
4,GO NEURONAL ACTION POTENTIAL,1.8723e-07,0.41146,0.42863,1,1
4,GO REGULATION OF PLATELET ACTIVATION,2.0776e-06,0.4107,0.37549,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0034243,0.40842,0.26327,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,9.9844e-05,0.40123,0.35823,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.0004e-06,0.39864,0.42108,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00086244,0.39809,0.3667,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,4.3774e-08,0.39622,0.39495,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,7.7586e-05,0.39621,0.39082,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00063314,0.39453,0.37004,1,1
4,GO ADHESION OF SYMBIONT TO HOST,1.6654e-06,0.3903,0.41439,1,1
4,GO ADRENAL GLAND DEVELOPMENT,4.719e-07,0.39021,0.38585,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,1.5293e-05,0.38969,0.35187,1,1
4,GO RESPONSE TO PAIN,4.9872e-09,0.38479,0.40112,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00011596,0.38436,0.37425,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.9175e-06,0.38051,0.33773,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.0086125,0.37834,0.34647,1,1
4,GO REGULATION OF VASCULOGENESIS,2.8001e-06,0.37805,0.37425,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,2.3239e-05,0.37733,0.40287,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00012594,0.37448,0.34365,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00016901,0.37304,0.30234,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,2.4528e-05,0.37115,0.32621,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,7.6657e-06,0.37097,0.47675,1,1
4,GO RESPONSE TO INTERFERON BETA,0.0028872,0.3703,0.27557,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.00030928,0.36911,0.29698,1,1
4,GO LIPID DIGESTION,2.0478e-05,0.36828,0.44129,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,4.5684e-06,0.3669,0.42804,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.8262e-07,0.36556,0.44782,1,1
4,GO CORNIFICATION,1.4163e-06,0.36514,0.33537,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,6.3249e-05,0.36457,0.41479,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00014599,0.36284,0.32594,1,1
4,GO RESPONSE TO DIETARY EXCESS,4.8198e-07,0.3628,0.359,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,5.0323e-06,0.35983,0.28852,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00033955,0.3588,0.34681,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.00025215,0.35807,0.33711,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,9.4407e-08,0.35758,0.35198,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.00034485,0.35661,0.32498,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,3.7195e-09,0.35655,0.33903,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.7502e-06,0.35651,0.31678,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.5127e-05,0.35298,0.32676,1,1
4,GO RESPONSE TO COLD,3.6435e-08,0.35248,0.32589,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,5.9498e-07,0.35228,0.36135,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.2631e-05,0.35024,0.28224,1,1
4,GO CELLULAR RESPONSE TO ZINC ION,0.015501,0.34881,0.34617,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00015583,0.34862,0.32139,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8924e-05,0.34776,0.31762,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,7.9617e-06,0.34689,0.37203,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,3.4409e-05,0.34497,0.41012,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.8032e-05,0.34437,0.32329,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00047589,0.34408,0.29117,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.1316e-06,0.34272,0.31213,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.00013673,0.3421,0.29471,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,6.2169e-06,0.3419,0.36052,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.00013232,0.34131,0.29936,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00070238,0.33844,0.28118,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00012186,0.33842,0.33698,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.00057029,0.33836,0.31244,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.001071,0.33796,0.26274,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.9175e-06,0.33725,0.47148,1,1
4,GO RESPONSE TO EPINEPHRINE,1.5865e-05,0.33656,0.38373,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,3.3806e-05,0.3343,0.2757,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.6457e-05,0.33302,0.29927,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0012705,0.33207,0.26668,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,2.1338e-07,0.33114,0.38215,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.8983e-07,0.33109,0.35457,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0020367,0.33051,0.23309,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,7.1274e-05,0.33018,0.37063,1,1
4,GO LEYDIG CELL DIFFERENTIATION,8.4424e-05,0.32661,0.36812,1,1
4,GO KERATINIZATION,2.3274e-07,0.32596,0.31995,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0020092,0.3258,0.27501,1,1
4,GO REGULATION OF DENDRITE EXTENSION,9.0235e-07,0.32556,0.34844,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,2.2139e-09,0.32395,0.36322,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0014022,0.32314,0.26975,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.1304e-06,0.32305,0.37478,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,1.1806e-05,0.32302,0.32468,1,1
4,GO RESPONSE TO REDOX STATE,9.0235e-07,0.32225,0.29282,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,4.6578e-06,0.32173,0.32915,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.6352e-05,0.3206,0.3263,1,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.045591,0.31996,0.21471,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.4528e-05,0.3183,0.26995,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,7.105e-06,0.31745,0.31544,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00042777,0.31693,0.31601,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0017277,0.31691,0.23228,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,4.3946e-06,0.3156,0.39235,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.8049e-05,0.3148,0.39824,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,1.0861e-06,0.31444,0.39773,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,4.1026e-05,0.31425,0.30781,1,1
4,GO REGULATION OF BONE REMODELING,1.7154e-07,0.314,0.3192,1,1
4,GO ACTIN FILAMENT SEVERING,2.0478e-05,0.3138,0.33124,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.011e-05,0.31328,0.26264,1,1
4,GO DOPAMINE TRANSPORT,9.7998e-07,0.31319,0.39524,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.4415e-08,0.31148,0.30677,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00029511,0.31133,0.38269,1,1
4,GO ANOIKIS,9.2321e-08,0.31118,0.35436,1,1
4,GO LIPID TRANSLOCATION,8.6328e-08,0.31058,0.32294,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00015083,0.30893,0.28205,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00032408,0.30863,0.28335,1,1
4,GO REGULATION OF DOPAMINE SECRETION,1.5865e-05,0.30766,0.41156,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.913e-06,0.30739,0.36746,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,5.0563e-05,0.30728,0.37246,1,1
4,GO REGULATION OF NEURON MATURATION,7.8124e-06,0.30718,0.28841,1,1
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,9.3381e-05,0.30705,0.35794,1,1
4,GO REGULATION OF TISSUE REMODELING,4.719e-07,0.30694,0.30191,1,1
4,GO MYELIN MAINTENANCE,0.00040857,0.30583,0.31298,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.6457e-05,0.30579,0.34456,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00080175,0.30357,0.26121,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,2.7452e-06,0.30274,0.29349,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.5713e-07,0.3025,0.32133,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.0014624,0.30182,0.34881,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0085105,0.30169,0.2139,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,1.2482e-05,0.30158,0.261,1,1
4,GO RESPONSE TO COPPER ION,0.00016901,0.30152,0.33903,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00026024,0.30147,0.3468,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0019819,0.30032,0.21918,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,3.628e-05,0.29987,0.3651,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0047798,0.29979,0.24224,1,1
4,GO CELLULAR DEFENSE RESPONSE,6.8396e-06,0.29954,0.25927,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,4.7172e-05,0.29915,0.35217,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.2775e-07,0.29883,0.29021,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00013899,0.29872,0.31861,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,2.4371e-06,0.29784,0.29041,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,3.2859e-07,0.29687,0.29898,1,1
4,GO SUPEROXIDE ANION GENERATION,9.6562e-05,0.29673,0.26834,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0086125,0.2965,0.2888,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00075607,0.29633,0.21433,1,1
4,GO RESPONSE TO FORSKOLIN,0.00159,0.29629,0.25274,1,1
4,GO REGULATION OF RESPIRATORY BURST,8.4415e-08,0.29563,0.34401,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,9.4959e-05,0.29429,0.28885,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,2.3274e-07,0.29304,0.3116,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,1.2027e-05,0.29273,0.30359,1,1
4,GO VITAMIN D METABOLIC PROCESS,4.7999e-05,0.29136,0.30039,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,4.5684e-06,0.29069,0.27333,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.00041488,0.2898,0.30718,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.010895,0.28936,0.20959,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00049053,0.28923,0.24892,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,7.2414e-06,0.28908,0.26931,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,7.8124e-06,0.28904,0.27452,1,1
4,GO STEROID HORMONE SECRETION,0.00038422,0.289,0.22588,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.2057e-05,0.28866,0.28733,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,3.0302e-06,0.28844,0.2981,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.2824e-05,0.28801,0.28609,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00016629,0.28796,0.32618,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0022396,0.28766,0.23657,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00072342,0.28745,0.31415,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.5858e-05,0.28594,0.28493,1,1
4,GO B CELL APOPTOTIC PROCESS,1.8419e-06,0.28551,0.29351,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0056958,0.2851,0.18797,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,4.7172e-05,0.28497,0.30767,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,3.3806e-05,0.28454,0.2887,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,1.5052e-06,0.28453,0.29923,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.0395e-05,0.28408,0.30508,1,1
4,GO BLOOD VESSEL REMODELING,6.3249e-05,0.28331,0.24608,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00010852,0.28225,0.2689,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.7312e-05,0.2822,0.24174,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.2146e-06,0.28201,0.31399,1,1
4,GO ZYMOGEN ACTIVATION,0.00015083,0.28172,0.26606,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.017506,0.2808,0.29122,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0040509,0.28058,0.2678,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,1.5674e-06,0.28042,0.27786,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,6.6066e-07,0.28034,0.32601,1,1
4,GO MICROVILLUS ORGANIZATION,3.5022e-05,0.28026,0.32312,1,1
4,GO RESPONSE TO LITHIUM ION,2.9514e-07,0.27969,0.3574,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0037985,0.27955,0.17977,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00016901,0.27938,0.2293,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00038422,0.27936,0.2076,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,6.2046e-07,0.27894,0.2809,1,1
4,GO VASODILATION,1.6457e-05,0.27862,0.24987,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0023009,0.27851,0.20493,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.2824e-05,0.27833,0.3603,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.00011986,0.27788,0.30311,1,1
4,GO PLASMA MEMBRANE FUSION,0.00021511,0.27786,0.28349,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.5994e-06,0.27745,0.27598,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.4771e-05,0.27743,0.25376,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00019541,0.27704,0.26575,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0279e-08,0.2769,0.32926,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00012804,0.27624,0.26669,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0002443,0.27569,0.36895,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00041488,0.27548,0.30258,1,1
4,GO RESPONSE TO STEROL DEPLETION,3.2859e-07,0.27548,0.32314,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00017176,0.27499,0.20787,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0010259,0.27493,0.30461,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0015038,0.27488,0.19539,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0024281,0.27419,0.21537,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,5.02e-08,0.27418,0.29667,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,5.8856e-08,0.27363,0.33789,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,4.3997e-05,0.27353,0.26543,1,1
4,GO DETECTION OF CALCIUM ION,7.2414e-06,0.2725,0.35507,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.5684e-06,0.27144,0.27625,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,2.0478e-05,0.27126,0.27326,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.00061456,0.26982,0.20127,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.008211,0.2698,0.19195,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.001235,0.26969,0.24871,1,1
4,GO SEQUESTERING OF ACTIN MONOMERS,0.0066851,0.26863,0.22376,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,9.2585e-06,0.26776,0.2682,1,1
4,GO CATECHOLAMINE UPTAKE,8.1623e-05,0.26775,0.29103,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.155e-06,0.26758,0.2644,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.00091404,0.26752,0.22187,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.7059e-05,0.26691,0.22862,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,9.4341e-06,0.26664,0.30668,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,6.6066e-07,0.26656,0.27056,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0013069,0.26644,0.27182,1,1
4,GO TISSUE REMODELING,6.0991e-06,0.26568,0.24704,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0025277,0.26562,0.27224,1,1
4,GO APICAL JUNCTION ASSEMBLY,7.8052e-07,0.26548,0.27956,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,3.9613e-05,0.26544,0.27104,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00025215,0.26519,0.25346,1,1
4,GO REGULATION OF ACROSOME REACTION,0.00090088,0.26516,0.22224,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00044781,0.26454,0.20751,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0013443,0.26448,0.2444,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,9.9844e-05,0.26371,0.31058,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,6.4341e-05,0.26364,0.24731,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.1138e-06,0.26313,0.29367,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0026663,0.26261,0.22625,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0057669,0.26198,0.27464,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.001442,0.26194,0.23255,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,4.7172e-05,0.26152,0.22054,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,2.5424e-05,0.26151,0.27415,1,1
4,GO PHAGOSOME ACIDIFICATION,9.1205e-09,0.26134,0.28792,1,1
4,GO RESPONSE TO GONADOTROPIN,1.3442e-05,0.26125,0.22692,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,3.628e-05,0.26114,0.26922,1,1
4,GO REGULATION OF CELL KILLING,0.00052901,0.26052,0.20689,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0099244,0.26025,0.23865,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0005618,0.2601,0.25964,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00015083,0.26008,0.20734,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.8363e-05,0.26,0.24905,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,9.6129e-06,0.2591,0.23889,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.8888e-05,0.25904,0.34108,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0045438,0.25877,0.21319,1,1
4,GO REGULATION OF ICOSANOID SECRETION,1.1282e-07,0.25872,0.28493,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0030038,0.25872,0.25666,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0021505,0.2587,0.19288,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.013546,0.25795,0.21838,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012804,0.25784,0.20977,1,1
4,GO BONE RESORPTION,9.5999e-07,0.25762,0.2647,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0074579,0.25718,0.14931,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,2.4091e-05,0.257,0.25085,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0032078,0.25695,0.16758,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00082553,0.2569,0.2605,1,1
4,GO REGULATION OF MYOBLAST FUSION,6.3249e-05,0.25682,0.25809,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,8.8796e-05,0.25658,0.21132,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1624e-06,0.25649,0.32578,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,1.8363e-05,0.2564,0.24925,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0044298,0.25605,0.30273,1,1
4,GO DIET INDUCED THERMOGENESIS,1.0169e-05,0.25599,0.24263,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.0104,0.25584,0.19576,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0083098,0.25576,0.16508,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00044781,0.25568,0.25508,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0030038,0.25556,0.19932,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0020929,0.25546,0.2001,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.8924e-05,0.25532,0.41121,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.010769,0.25476,0.30944,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,3.9872e-06,0.25428,0.30839,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.5867e-06,0.25426,0.36038,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0005056,0.25411,0.26853,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,3.4098e-06,0.25395,0.25581,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.012227,0.25384,0.22638,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00016629,0.25321,0.27802,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00011033,0.25293,0.19542,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,3.5646e-05,0.2529,0.22258,1,1
4,GO REGULATION OF COAGULATION,0.0001862,0.25201,0.23548,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.7668e-07,0.25197,0.2504,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0050269,0.25178,0.31453,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.0026663,0.25165,0.20693,1,1
4,GO REGULATION OF B CELL PROLIFERATION,2.8305e-05,0.25152,0.22926,1,1
4,GO STEROID ESTERIFICATION,0.0022095,0.251,0.25027,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.7804e-05,0.2507,0.22733,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.00088789,0.2495,0.19692,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.00015583,0.24867,0.32141,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00029976,0.24841,0.2186,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,2.0853e-05,0.24803,0.25063,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00065224,0.24777,0.28573,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00022927,0.24752,0.23551,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.00068191,0.24608,0.25443,1,1
4,GO EOSINOPHIL MIGRATION,0.00036686,0.24593,0.3001,1,1
4,GO RESPONSE TO ACIDIC PH,0.00040857,0.24587,0.27661,1,1
4,GO DOPAMINE METABOLIC PROCESS,3.9872e-06,0.24544,0.29187,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00095459,0.24516,0.24764,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00054518,0.24467,0.22035,1,1
4,GO RESPIRATORY BURST,1.9393e-05,0.24454,0.25577,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.004156,0.2439,0.1645,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.012087,0.24384,0.17962,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00019541,0.24339,0.29479,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00063314,0.24335,0.2521,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0013255,0.24323,0.25365,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,8.7316e-05,0.24293,0.22474,1,1
4,GO BONE REMODELING,4.8416e-06,0.2427,0.25277,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00090088,0.24263,0.27898,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,3.5038e-07,0.24222,0.26213,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0022701,0.24208,0.29568,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.001776,0.24197,0.17157,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.9989e-07,0.24153,0.26584,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,4.6359e-05,0.24143,0.20285,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,3.6877e-06,0.24101,0.24917,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00059648,0.24074,0.17917,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.5424e-05,0.24039,0.23405,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0026663,0.24034,0.28792,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.001235,0.23993,0.18795,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0017277,0.23973,0.20726,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.00014839,0.23967,0.21458,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.9393e-05,0.23925,0.22281,1,1
4,GO DIGESTIVE SYSTEM PROCESS,4.2444e-07,0.23904,0.23395,1,1
4,GO PANCREATIC JUICE SECRETION,0.0019819,0.23894,0.17323,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00013673,0.23861,0.20819,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0038478,0.23829,0.18339,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.9872e-06,0.23788,0.2315,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.6538e-08,0.23788,0.28169,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0021215,0.23751,0.21521,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0030839,0.2374,0.25098,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00042128,0.23712,0.20449,1,1
4,GO PHAGOSOME MATURATION,6.5837e-06,0.23708,0.22719,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,1.734e-06,0.23689,0.22414,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,1.7706e-05,0.23689,0.23062,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.027686,0.23632,0.14298,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,3.094e-05,0.23606,0.26133,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0047198,0.23595,0.15615,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00060545,0.23568,0.24719,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,4.1026e-05,0.23563,0.24259,1,1
4,GO HAIR CELL DIFFERENTIATION,0.000286,0.23549,0.19389,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0028118,0.23505,0.18467,1,1
4,GO INOSITOL METABOLIC PROCESS,0.0001179,0.235,0.21794,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,3.9872e-06,0.23461,0.23548,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.0337e-07,0.23423,0.2813,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0022095,0.23414,0.16827,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,1.8363e-05,0.23413,0.2204,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.9393e-05,0.234,0.24098,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.00038422,0.2339,0.26182,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0037016,0.23375,0.20989,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.012087,0.23331,0.17043,1,1
4,GO N GLYCAN PROCESSING,0.0018256,0.23327,0.24754,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016205,0.23309,0.16069,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.000662,0.23259,0.20777,1,1
4,GO MAST CELL ACTIVATION,1.6761e-05,0.23245,0.26477,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0056958,0.23215,0.14238,1,1
4,GO ETHER METABOLIC PROCESS,6.545e-05,0.23197,0.20429,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.6457e-05,0.23166,0.21829,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00022927,0.23166,0.19892,1,1
4,GO NEURON CELL CELL ADHESION,0.042609,0.23146,0.19989,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0016806,0.23124,0.24206,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0005056,0.23111,0.33217,1,1
4,GO DNA DEAMINATION,0.0010113,0.23108,0.30253,1,1
4,GO SECRETION BY TISSUE,0.00019229,0.23102,0.20254,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.000662,0.2309,0.20918,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.012227,0.23058,0.13262,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,5.3256e-05,0.23044,0.26578,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0035605,0.23033,0.20567,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.00020835,0.23012,0.31868,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00010852,0.23006,0.20377,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.001955,0.22982,0.24964,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0053519,0.22981,0.18497,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,5.4184e-05,0.22978,0.24524,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00016098,0.22957,0.2135,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,9.2585e-06,0.22928,0.25176,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0024609,0.2292,0.20474,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.5646e-05,0.22908,0.26581,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0071051,0.22906,0.18974,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.2169e-06,0.22898,0.2273,1,1
4,GO WATER HOMEOSTASIS,1.5052e-06,0.22889,0.25837,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027716,0.22869,0.21113,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0010259,0.22866,0.20372,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.6924e-05,0.22843,0.18919,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00046165,0.22842,0.21502,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.5674e-06,0.22842,0.30605,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,3.628e-05,0.22836,0.20434,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,2.856e-06,0.22821,0.22401,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0083098,0.22819,0.17023,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.010645,0.2278,0.19633,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.013093,0.22768,0.13724,1,1
4,GO GLYCOSYLATION,2.3784e-07,0.22757,0.22576,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.3997e-05,0.22658,0.22261,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,4.9361e-06,0.22645,0.22683,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,6.7724e-05,0.2263,0.22029,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,7.1274e-05,0.22589,0.20035,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.00010152,0.22589,0.29813,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2604e-07,0.2258,0.23115,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.00084997,0.2257,0.19226,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.0055559,0.22556,0.1894,1,1
4,GO SNARE COMPLEX ASSEMBLY,1.8363e-05,0.22553,0.24155,1,1
4,GO GAP JUNCTION ASSEMBLY,0.0016575,0.22548,0.24294,1,1
4,GO MYOBLAST FUSION,0.00027284,0.22542,0.21243,1,1
4,GO REGULATION OF ACTION POTENTIAL,4.7172e-05,0.22542,0.23776,1,1
4,GO MEMBRANE DEPOLARIZATION,1.5014e-05,0.2253,0.22725,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00016629,0.22523,0.28361,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.8701e-05,0.22504,0.24623,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,4.9361e-06,0.22485,0.25546,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,5.9498e-07,0.22478,0.20715,1,1
4,GO PHOSPHOLIPID TRANSPORT,8.1361e-07,0.22471,0.23527,1,1
4,GO DIGESTION,7.8052e-07,0.22468,0.2334,1,1
4,GO PROTEIN DEMANNOSYLATION,4.5558e-05,0.22463,0.2624,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00064263,0.22435,0.25023,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00013016,0.2243,0.17902,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.3442e-05,0.22423,0.29433,1,1
4,GO MAGNESIUM ION TRANSPORT,7.9617e-06,0.22415,0.27014,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00013673,0.22394,0.21114,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.0011836,0.22372,0.24297,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00053704,0.22365,0.18526,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0093576,0.22344,0.20158,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00031414,0.22335,0.23588,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,9.819e-05,0.2232,0.23762,1,1
4,GO KERATINOCYTE DIFFERENTIATION,7.2414e-06,0.22318,0.2279,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00022927,0.22278,0.22491,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00042777,0.22263,0.22102,1,1
4,GO PLATELET DEGRANULATION,0.00030928,0.22255,0.20807,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00023667,0.22252,0.3288,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.016027,0.22233,0.13818,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.4701e-07,0.22217,0.21621,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.2027e-05,0.22194,0.19002,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.00023294,0.22177,0.19204,1,1
4,GO RESPONSE TO INTERLEUKIN 2,4.2487e-05,0.22173,0.22277,1,1
4,GO LYTIC VACUOLE ORGANIZATION,1.3351e-08,0.22139,0.26793,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,9.2118e-07,0.22134,0.28281,1,1
4,GO VACUOLAR ACIDIFICATION,5.2445e-07,0.22116,0.24845,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.043444,0.22107,0.14517,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00068191,0.22099,0.20744,1,1
4,GO ALANINE TRANSPORT,0.010522,0.22047,0.14773,1,1
4,GO CELL KILLING,0.00027284,0.22042,0.18486,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00022565,0.22031,0.27852,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0022701,0.22031,0.24513,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.020605,0.22027,0.16962,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0002443,0.22012,0.22623,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.002702,0.22002,0.2255,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00046872,0.21989,0.20097,1,1
4,GO RESPONSE TO LEPTIN,2.9859e-05,0.21946,0.21172,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00012186,0.2191,0.29096,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00022208,0.2189,0.2404,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,2.0478e-05,0.21882,0.2126,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,5.5127e-05,0.21878,0.29216,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00030928,0.21877,0.21471,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,8.3013e-05,0.21859,0.27939,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0047198,0.21857,0.16788,1,1
4,GO LUNG CELL DIFFERENTIATION,0.0010408,0.2185,0.27663,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,3.094e-05,0.218,0.23876,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.00013451,0.21784,0.23583,1,1
4,GO AMYLOID FIBRIL FORMATION,0.0066039,0.21767,0.19016,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0027747,0.2174,0.20004,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,1.8318e-07,0.2173,0.21802,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00014362,0.21722,0.19395,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0054872,0.21716,0.19785,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.1026e-05,0.21684,0.19816,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0050904,0.21671,0.22287,1,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00071283,0.21669,0.25304,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.018693,0.21619,0.14877,1,1
4,GO METHIONINE METABOLIC PROCESS,8.8796e-05,0.21609,0.19656,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00011986,0.21579,0.24028,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,5.2344e-05,0.21559,0.22477,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,6.7724e-05,0.21531,0.19393,1,1
4,GO PLASMINOGEN ACTIVATION,0.0074579,0.21502,0.19993,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,1.1034e-07,0.21441,0.21689,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.012798,0.21424,0.15994,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,5.02e-08,0.21415,0.2251,1,1
4,GO TRANSCYTOSIS,0.00020504,0.21359,0.19903,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,5.1446e-05,0.21353,0.19659,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0003557,0.21307,0.21504,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00012388,0.21304,0.19067,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.5684e-06,0.21302,0.25995,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0011503,0.21276,0.2181,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0013826,0.2125,0.21797,1,1
4,GO RESPONSE TO GROWTH HORMONE,1.8363e-05,0.2123,0.25415,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,8.8796e-05,0.21208,0.21018,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,2.342e-06,0.21205,0.22403,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00059648,0.2119,0.25556,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00015331,0.21056,0.22206,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,1.1588e-05,0.21006,0.21906,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00042128,0.2098,0.18538,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,5.8049e-05,0.20973,0.21355,1,1
4,GO REGULATION OF ACTIN NUCLEATION,8.9166e-06,0.2094,0.2385,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0002443,0.20939,0.22626,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.0013633,0.20895,0.17777,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,3.3214e-05,0.20895,0.27274,1,1
4,GO REGULATION OF WOUND HEALING,2.8305e-05,0.20894,0.23606,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00012388,0.20886,0.19051,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0012005,0.20856,0.21401,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00031414,0.20825,0.2119,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,4.8416e-06,0.20823,0.19872,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0015038,0.20817,0.19936,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00012594,0.20795,0.30733,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0039481,0.20775,0.17571,1,1
4,GO DIOL METABOLIC PROCESS,3.2057e-05,0.20765,0.25879,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.010645,0.20744,0.17362,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.00057029,0.20738,0.16835,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0019023,0.20737,0.17691,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.0016347,0.20716,0.1642,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00042777,0.20619,0.18384,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.004156,0.20617,0.1595,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.0011668,0.2061,0.20589,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.0302e-06,0.20601,0.187,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00068191,0.20573,0.22277,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.01499,0.20563,0.16457,1,1
4,GO REGULATION OF B CELL ACTIVATION,0.00015083,0.20546,0.17271,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,5.5864e-07,0.20545,0.23158,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0027381,0.20527,0.18279,1,1
4,GO ORGANELLE MEMBRANE FUSION,3.9872e-06,0.20473,0.19402,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00013673,0.20471,0.17481,1,1
4,GO INNATE IMMUNE RESPONSE,0.00019857,0.20469,0.16515,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,2.4371e-06,0.20456,0.23449,1,1
4,GO B CELL MEDIATED IMMUNITY,0.0021215,0.20453,0.15447,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.00016098,0.20452,0.20654,1,1
4,GO GDP METABOLIC PROCESS,0.001776,0.20434,0.22388,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.8814e-05,0.2043,0.19711,1,1
4,GO TRANSFERRIN TRANSPORT,5.2538e-08,0.20427,0.24397,1,1
4,GO MALE MEIOSIS I,0.024687,0.20408,0.21959,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0054192,0.20406,0.16615,1,1
4,GO REGULATION OF HEART RATE,2.2824e-05,0.20397,0.20207,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.9941e-08,0.20395,0.23091,1,1
4,GO B CELL PROLIFERATION,0.00014839,0.20378,0.18563,1,1
4,GO CYTOPLASM ORGANIZATION,0.00072342,0.20377,0.21482,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.545e-05,0.20376,0.18233,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,7.8911e-05,0.20372,0.23261,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.8814e-05,0.20367,0.19681,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.6828e-05,0.20334,0.19864,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,1.2027e-05,0.20333,0.21021,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,3.3214e-05,0.20251,0.22171,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,4.4771e-05,0.20247,0.24144,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.00082553,0.20243,0.17364,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,8.9166e-06,0.20235,0.18374,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,1.3196e-05,0.20218,0.19817,1,1
4,GO INTEGRIN ACTIVATION,3.1494e-05,0.20217,0.23136,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00013673,0.20213,0.26964,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00074504,0.20189,0.17081,1,1
4,GO MEMBRANE FUSION,3.2784e-06,0.2018,0.18988,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0018508,0.20162,0.14611,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0028492,0.20148,0.13728,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00072342,0.20137,0.17764,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0022095,0.20132,0.25089,1,1
4,GO CHEMOKINE PRODUCTION,0.01128,0.2013,0.13061,1,1
4,GO FUCOSYLATION,0.00083767,0.20128,0.18295,1,1
4,GO REGULATION OF FERTILIZATION,0.00020178,0.20128,0.18096,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.007921,0.20057,0.1949,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0023957,0.20055,0.19873,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.0068504,0.20027,0.17528,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.013243,0.20002,0.17978,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00030928,0.19977,0.2026,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.536e-06,0.19972,0.2136,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00052901,0.19954,0.22114,1,1
4,GO PLATELET ACTIVATION,0.00061456,0.1995,0.17451,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0010558,0.19922,0.16115,1,1
4,GO RESPONSE TO WATER,0.00012804,0.19914,0.25748,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00032916,0.19912,0.20711,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0051547,0.19885,0.2064,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00095459,0.19884,0.17435,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,9.03e-05,0.19869,0.19358,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,3.8924e-05,0.19841,0.22672,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.5022e-05,0.19833,0.16502,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0030038,0.19832,0.21107,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013232,0.19811,0.16143,1,1
4,GO RESPONSE TO INSECTICIDE,0.0062108,0.19793,0.21625,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00049802,0.19787,0.27359,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.00019857,0.19777,0.15001,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.0007901,0.19762,0.1603,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.4098e-06,0.19761,0.19925,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0025617,0.19747,0.21183,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00037257,0.19745,0.22201,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.011411,0.19718,0.15226,1,1
4,GO ENTRY INTO HOST,0.00082553,0.1971,0.19363,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.2631e-05,0.19709,0.19244,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0037985,0.19688,0.19402,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,9.7998e-07,0.19686,0.23037,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.006444,0.19673,0.18531,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.4207e-05,0.19671,0.26731,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.00015838,0.19662,0.19773,1,1
4,GO PROTEIN DEGLYCOSYLATION,0.00014839,0.1965,0.2429,1,1
4,GO RESPONSE TO METAL ION,6.2046e-07,0.19609,0.17994,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.8796e-05,0.19589,0.23044,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.00019541,0.19582,0.27407,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.0052197,0.19575,0.14605,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.00035024,0.19556,0.18513,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00044781,0.19547,0.19845,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00039622,0.19534,0.16682,1,1
4,GO REGULATION OF BLOOD PRESSURE,1.9044e-05,0.19533,0.16545,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.013394,0.19524,0.13793,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00017741,0.1952,0.19588,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0011021,0.19469,0.15933,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.049681,0.19429,0.16582,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0069343,0.19426,0.14124,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00032916,0.19402,0.20302,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.0089251,0.19386,0.20765,1,1
4,GO TRANSPOSITION,0.00048316,0.1938,0.26051,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.6567e-07,0.19375,0.22144,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,1.2281e-06,0.19356,0.20712,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00159,0.1934,0.17858,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00024045,0.19305,0.19631,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0010865,0.19295,0.21082,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.819e-05,0.19292,0.16385,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00033432,0.19268,0.19463,1,1
4,GO CERAMIDE METABOLIC PROCESS,3.5461e-06,0.19258,0.19969,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.002702,0.19254,0.22862,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,7.6657e-06,0.19253,0.18602,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00041488,0.19247,0.17691,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,6.7724e-05,0.19229,0.17936,1,1
4,GO RESPONSE TO INACTIVITY,0.021509,0.19219,0.18559,1,1
4,GO SKIN DEVELOPMENT,8.7316e-05,0.19205,0.18136,1,1
4,GO GROOMING BEHAVIOR,0.0052197,0.19205,0.16401,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0002117,0.19204,0.19646,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0005056,0.19203,0.17413,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00059648,0.19198,0.18939,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0021215,0.19188,0.19324,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00037835,0.19173,0.16161,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00015583,0.19159,0.16146,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,5.3256e-05,0.19116,0.18377,1,1
4,GO VIRAL GENOME REPLICATION,0.00049802,0.19093,0.17409,1,1
4,GO RESPONSE TO TUMOR CELL,0.0060595,0.19068,0.19865,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014839,0.19052,0.19061,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.5127e-05,0.19013,0.18307,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010558,0.19005,0.15543,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.00057029,0.19002,0.19675,1,1
4,GO REGULATION OF VESICLE FUSION,0.0062108,0.1899,0.20318,1,1
4,GO PROSTAGLANDIN SECRETION,0.0017277,0.18987,0.16783,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001483,0.18959,0.14086,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0060595,0.18934,0.16061,1,1
4,GO MICROVILLUS ASSEMBLY,0.016568,0.18907,0.1747,1,1
4,GO AMYLOID BETA FORMATION,0.0066851,0.18899,0.14902,1,1
4,GO LIVER MORPHOGENESIS,0.00052901,0.18894,0.2275,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.001442,0.18888,0.19155,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.03e-05,0.1886,0.18787,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.014332,0.18853,0.18906,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0011341,0.18846,0.18026,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,0.0023957,0.1884,0.20263,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0037985,0.18827,0.14264,1,1
4,GO LEUKOCYTE MIGRATION,6.7724e-05,0.18826,0.18146,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042777,0.18826,0.24417,1,1
4,GO REGULATION OF TRANSPOSITION,0.0024609,0.18814,0.24386,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,5.6085e-05,0.18812,0.16703,1,1
4,GO INSULIN SECRETION,6.8885e-07,0.18786,0.19807,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0019285,0.1876,0.19481,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00019229,0.18742,0.15762,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00057029,0.18737,0.24637,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.002702,0.18724,0.13205,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0077327,0.1872,0.14245,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.0235e-07,0.18696,0.22336,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00033955,0.18691,0.16569,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,2.0478e-05,0.18648,0.24234,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.011022,0.18635,0.15683,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00075607,0.18619,0.17962,1,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00010673,0.18613,0.21171,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00016361,0.1861,0.18351,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.001118,0.18607,0.17805,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,0.00010152,0.18604,0.19514,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.4341e-06,0.18603,0.21983,1,1
4,GO BONE CELL DEVELOPMENT,0.012227,0.1857,0.14537,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0044298,0.18544,0.14226,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.0756e-05,0.1854,0.1906,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0024609,0.18515,0.14517,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.9102e-06,0.18511,0.17173,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0011341,0.18509,0.14369,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0035605,0.18494,0.15533,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.012087,0.18477,0.12355,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.001483,0.18473,0.14794,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0012005,0.18436,0.18053,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0027747,0.18433,0.21716,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0035605,0.18415,0.16511,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00026024,0.18407,0.27183,1,1
4,GO PROTEIN HYDROXYLATION,0.0044864,0.18406,0.18924,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,3.152e-06,0.18351,0.195,1,1
4,GO AMYLOID BETA CLEARANCE,0.0046018,0.18337,0.15293,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.00011033,0.18269,0.21504,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0028492,0.18268,0.15075,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00035024,0.18225,0.15912,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0025617,0.18223,0.17681,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0093576,0.18221,0.12343,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.2497e-05,0.182,0.15807,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0077327,0.18183,0.24032,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.004964,0.18177,0.15995,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0020929,0.18172,0.15709,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,4.3997e-05,0.18154,0.19432,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.052575,0.18146,0.12057,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0018006,0.18135,0.14757,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0032501,0.18122,0.13016,1,1
4,GO STEROL HOMEOSTASIS,0.00070238,0.18102,0.18233,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00088789,0.18089,0.18431,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.8363e-05,0.18086,0.22666,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,2.3661e-05,0.18066,0.18166,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0012527,0.18061,0.17372,1,1
4,GO STEROID METABOLIC PROCESS,1.2253e-05,0.18061,0.1928,1,1
4,GO ENDOCRINE PROCESS,0.00029511,0.18036,0.16813,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.020605,0.18012,0.14842,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00018323,0.18002,0.1912,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.8796e-05,0.18,0.18859,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00072342,0.17993,0.17182,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,3.3806e-05,0.17967,0.19168,1,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.0067673,0.17965,0.17446,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00159,0.17964,0.17681,1,1
4,GO MANNOSYLATION,2.2416e-05,0.17954,0.20721,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0030436,0.17935,0.14234,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.00027284,0.17933,0.15506,1,1
4,GO PIRNA METABOLIC PROCESS,0.038637,0.17919,0.15599,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.023919,0.17918,0.17923,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0049019,0.17905,0.13254,1,1
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0025961,0.17904,0.22829,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00055343,0.17858,0.16399,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0030038,0.17834,0.1619,1,1
4,GO RESPONSE TO CADMIUM ION,0.0029256,0.17783,0.17761,1,1
4,GO STEROL TRANSPORT,0.00033432,0.17762,0.17981,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0001803,0.17758,0.20688,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,9.03e-05,0.1775,0.22307,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0033361,0.17747,0.22474,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,6.7724e-05,0.17737,0.17919,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0053519,0.17733,0.12931,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,6.4341e-05,0.17718,0.1683,1,1
4,GO CATECHOLAMINE SECRETION,0.00021857,0.17717,0.28119,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0005133,0.17705,0.17319,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0041031,0.17699,0.14399,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00013899,0.17692,0.18592,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0013443,0.1769,0.19827,1,1
4,GO POLYOL CATABOLIC PROCESS,0.00033955,0.17675,0.1642,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0010865,0.17661,0.14978,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.042197,0.17653,0.10926,1,1
4,GO PLATELET AGGREGATION,0.00026438,0.17652,0.21481,1,1
4,GO NEURON MATURATION,0.0028492,0.17649,0.16672,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00052901,0.17642,0.17783,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,4.2271e-06,0.17636,0.19911,1,1
4,GO STEROL METABOLIC PROCESS,2.3239e-05,0.1763,0.18127,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00070238,0.17625,0.20471,1,1
4,GO ENERGY HOMEOSTASIS,0.001235,0.17624,0.1864,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00016361,0.17621,0.15383,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00019857,0.17619,0.2251,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,2.3239e-05,0.17614,0.25099,1,1
4,GO MUSCLE ADAPTATION,0.00012594,0.17611,0.17346,1,1
4,GO RESPONSE TO PH,0.00014362,0.17611,0.19327,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,5.4184e-05,0.17611,0.18701,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0067673,0.17608,0.14268,1,1
4,GO PODOSOME ASSEMBLY,0.033608,0.17576,0.13417,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.016205,0.17545,0.12602,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.0015463,0.17528,0.21079,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,2.7312e-05,0.17513,0.18821,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.00020504,0.17511,0.19433,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00031907,0.17505,0.19054,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.036048,0.17486,0.16866,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.0028492,0.17478,0.19088,1,1
4,GO DEFENSE RESPONSE,0.00011406,0.17438,0.15536,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00054518,0.17419,0.19639,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0007901,0.17385,0.22896,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00096848,0.17361,0.15423,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0025277,0.1736,0.14327,1,1
4,GO EXOCYTIC PROCESS,0.00010152,0.1735,0.19561,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0023009,0.17349,0.14597,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,2.1338e-07,0.17345,0.18303,1,1
4,GO PIGMENTATION,0.00054518,0.17342,0.12995,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.00032916,0.17341,0.22314,1,1
4,GO POSITIVE CHEMOTAXIS,0.0028118,0.17301,0.14293,1,1
4,GO LIPID EXPORT FROM CELL,0.00098255,0.17295,0.16713,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.020605,0.17287,0.14118,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00063314,0.17277,0.159,1,1
4,GO NERVE DEVELOPMENT,0.01128,0.17276,0.15508,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00013232,0.17267,0.15031,1,1
4,GO SODIUM ION HOMEOSTASIS,0.00073415,0.17265,0.1396,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0026663,0.17255,0.14552,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.5461e-06,0.17254,0.20722,1,1
4,GO RENAL SYSTEM PROCESS,0.0022396,0.17242,0.15294,1,1
4,GO ZINC ION HOMEOSTASIS,0.015329,0.1724,0.1931,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,2.1621e-05,0.17196,0.1678,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00014129,0.17193,0.15615,1,1
4,GO LIPID LOCALIZATION,2.5868e-06,0.1719,0.19374,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,7.0072e-05,0.17173,0.18737,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.026838,0.17149,0.16467,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0020646,0.17137,0.14804,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.0067673,0.17134,0.13722,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00047589,0.17099,0.14901,1,1
4,GO AMELOGENESIS,0.044292,0.17098,0.15674,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0054872,0.17092,0.17569,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00036124,0.17058,0.13782,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00096848,0.17049,0.14644,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.0005211,0.17048,0.15397,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00032916,0.1704,0.17373,1,1
4,GO EPIDERMIS DEVELOPMENT,0.00011986,0.1704,0.17152,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00067188,0.16998,0.16077,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00069207,0.16995,0.14725,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00016098,0.1699,0.17601,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0070192,0.16982,0.13209,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.0019285,0.16977,0.16077,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.3325e-06,0.16974,0.16716,1,1
4,GO MUSCLE HYPERTROPHY,1.9749e-05,0.16973,0.19688,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.0058389,0.16966,0.15821,1,1
4,GO AMINE TRANSPORT,8.1623e-05,0.16965,0.23992,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.012087,0.16963,0.14922,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.016752,0.16962,0.13088,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0022396,0.16922,0.15079,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00042777,0.16922,0.167,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,1.0756e-05,0.1692,0.18842,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,1.2253e-05,0.16899,0.18977,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00015838,0.1688,0.17224,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0059116,0.16868,0.13351,1,1
4,GO PH REDUCTION,3.4098e-06,0.1686,0.18261,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,6.0079e-05,0.1686,0.18342,1,1
4,GO CYTOKINE PRODUCTION,0.001442,0.16816,0.13909,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.2414e-06,0.16815,0.18234,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0071918,0.1681,0.14095,1,1
4,GO REGULATION OF INSULIN SECRETION,5.5412e-06,0.16808,0.1766,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,3.4098e-06,0.16783,0.17734,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00020178,0.1678,0.18186,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.0033799,0.16751,0.19115,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0042095,0.1675,0.12992,1,1
4,GO ACTION POTENTIAL,6.0079e-05,0.16744,0.18223,1,1
4,GO BILE ACID METABOLIC PROCESS,0.00029511,0.16741,0.19802,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00031414,0.16738,0.19092,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,7.2497e-05,0.16731,0.16175,1,1
4,GO CELLULAR PIGMENTATION,0.00049802,0.16728,0.1468,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0007901,0.16727,0.16245,1,1
4,GO PEPTIDE HORMONE SECRETION,5.0323e-06,0.16721,0.18561,1,1
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.023668,0.16718,0.11664,1,1
4,GO VESICLE TARGETING,0.0029256,0.16708,0.12738,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,7.5001e-05,0.16708,0.17094,1,1
4,GO RESPONSE TO CALCIUM ION,6.4341e-05,0.16704,0.1657,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0012005,0.16703,0.19431,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.01128,0.16697,0.12888,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.6352e-05,0.16692,0.22111,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00074504,0.16681,0.14823,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.017506,0.1668,0.11932,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0011503,0.16662,0.14832,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0030436,0.16653,0.17764,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0020646,0.16636,0.14495,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.029754,0.16626,0.12651,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00030928,0.16624,0.19754,1,1
4,GO B CELL ACTIVATION,0.0012177,0.16603,0.12921,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.031953,0.166,0.13925,1,1
4,GO NECROTIC CELL DEATH,0.00059648,0.16585,0.16939,1,1
4,GO SENSORY PERCEPTION OF TASTE,5.7059e-05,0.16584,0.15907,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00018323,0.16583,0.22877,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0066851,0.16563,0.26665,1,1
4,GO MONOAMINE TRANSPORT,0.00014362,0.16555,0.25639,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00069207,0.16533,0.1863,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00073415,0.16525,0.18207,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,4.7999e-05,0.1651,0.20983,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,3.8246e-05,0.16505,0.19883,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.00059648,0.1647,0.21117,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0089251,0.16468,0.13305,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.011022,0.1643,0.14932,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00022565,0.16429,0.16898,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.001483,0.16419,0.13563,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.022928,0.164,0.1233,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0056255,0.16394,0.18883,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.043025,0.16391,0.17728,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0015463,0.1639,0.15411,1,1
4,GO VESICLE ORGANIZATION,0.00011986,0.16382,0.14029,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.2716e-05,0.16379,0.179,1,1
4,GO RESPONSE TO STEROL,0.00039622,0.16362,0.18629,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00090088,0.16358,0.16702,1,1
4,GO CARBOHYDRATE TRANSPORT,8.8389e-07,0.16355,0.18421,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.001422,0.16349,0.15391,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.051111,0.16342,0.10948,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.023173,0.16336,0.11473,1,1
4,GO ACROSOME REACTION,0.011151,0.16326,0.13486,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0051547,0.16325,0.15555,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0093576,0.1632,0.1579,1,1
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0137,0.16297,0.12617,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0020929,0.16247,0.133,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0056255,0.16235,0.14393,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,3.758e-05,0.1623,0.15838,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.0005056,0.16201,0.14697,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.028852,0.16197,0.11636,1,1
4,GO RESPONSE TO VIRUS,0.0012705,0.16194,0.1465,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0025961,0.16187,0.17177,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.013856,0.16182,0.16348,1,1
4,GO IMMUNE EFFECTOR PROCESS,0.00016361,0.16143,0.16761,1,1
4,GO REGULATION OF HORMONE SECRETION,8.9166e-06,0.16134,0.17074,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0040509,0.1612,0.14237,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00029052,0.16092,0.16571,1,1
4,GO PROTEIN PROCESSING,6.5837e-06,0.16092,0.18751,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.00017457,0.16075,0.18714,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00098255,0.16064,0.20307,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.0034243,0.16063,0.17204,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0030436,0.1606,0.1296,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0028872,0.16044,0.26092,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.011949,0.16036,0.15154,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00096848,0.16033,0.16283,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0087156,0.16002,0.14446,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00011986,0.15985,0.17284,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.016752,0.15982,0.21711,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.043866,0.15978,0.14639,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0038478,0.15956,0.1668,1,1
4,GO WOUND HEALING,0.0050269,0.15951,0.1349,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0059116,0.15944,0.16573,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,5.0323e-06,0.15942,0.14943,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013016,0.15932,0.16278,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.003654,0.15907,0.15863,1,1
4,GO MIDBODY ABSCISSION,3.1494e-05,0.159,0.19956,1,1
4,GO ENDOCYTIC RECYCLING,0.00033955,0.15892,0.15937,1,1
4,GO RESPONSE TO CAFFEINE,0.0042636,0.15891,0.15283,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0030038,0.15888,0.13973,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0104,0.15888,0.15415,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.016568,0.15881,0.12496,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.8839e-05,0.15875,0.18119,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.1304e-06,0.1587,0.15801,1,1
4,GO PEPTIDE SECRETION,1.6654e-06,0.15867,0.17718,1,1
4,GO SPERM CAPACITATION,0.001442,0.15852,0.15879,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.026286,0.15825,0.12358,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0005056,0.15814,0.14727,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0007901,0.15791,0.18078,1,1
4,GO EXOCYTOSIS,1.1165e-05,0.15789,0.17182,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0013069,0.15783,0.17396,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0019023,0.15782,0.17598,1,1
4,GO UBIQUINONE METABOLIC PROCESS,0.0002443,0.15745,0.17398,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0024941,0.15738,0.15495,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028118,0.15728,0.16072,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.001422,0.15706,0.15839,1,1
4,GO HORMONE TRANSPORT,3.4773e-06,0.15699,0.182,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0023957,0.15694,0.11927,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00039018,0.15691,0.15877,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,6.8888e-05,0.15682,0.15237,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0095807,0.15677,0.12668,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.024947,0.15655,0.13657,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0037498,0.15644,0.14167,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.00092737,0.15638,0.17332,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0030038,0.1562,0.15143,1,1
4,GO INCLUSION BODY ASSEMBLY,0.013856,0.15613,0.18635,1,1
4,GO B CELL HOMEOSTASIS,0.0043184,0.15612,0.15287,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0016806,0.15609,0.15069,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.2344e-05,0.15602,0.19521,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0038977,0.1559,0.12943,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.00027284,0.1558,0.17054,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00033955,0.1558,0.15086,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.0756e-05,0.15579,0.16293,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0076401,0.15565,0.13225,1,1
4,GO MEMBRANE FISSION,0.020385,0.15555,0.1492,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.01829,0.15549,0.16583,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.044722,0.15548,0.10888,1,1
4,GO MYELIN ASSEMBLY,0.0042095,0.1554,0.19034,1,1
4,GO VIRION ASSEMBLY,0.00018923,0.15502,0.12682,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0033361,0.15498,0.13661,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.028264,0.15496,0.12301,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0022701,0.15489,0.16196,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0031247,0.15485,0.14759,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0029256,0.15485,0.14629,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.055609,0.15483,0.10947,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0042095,0.15482,0.11913,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00046872,0.15446,0.15982,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.7724e-05,0.15441,0.15563,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,2.2824e-05,0.1544,0.14741,1,1
4,GO INFLAMMATORY RESPONSE,0.00038422,0.1543,0.1424,1,1
4,GO GRANULOCYTE MIGRATION,0.0010408,0.15418,0.14068,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0042636,0.15386,0.12938,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00043435,0.15377,0.13526,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0016122,0.15371,0.18661,1,1
4,GO T CELL LINEAGE COMMITMENT,0.00088789,0.15351,0.16335,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,8.5858e-05,0.15326,0.13585,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.020385,0.15309,0.25229,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0068504,0.15299,0.16091,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00063314,0.15296,0.17975,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00017176,0.15288,0.16935,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.0047198,0.15285,0.17058,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0028872,0.15281,0.14892,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00096848,0.15272,0.1258,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00010497,0.1527,0.19231,1,1
4,GO INTERACTION WITH HOST,0.0011836,0.15241,0.14548,1,1
4,GO RESPONSE TO INSULIN,0.00013016,0.15239,0.13298,1,1
4,GO NEUTROPHIL MIGRATION,0.00092737,0.15237,0.13939,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.028264,0.15232,0.1073,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.036409,0.15227,0.13569,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,2.5884e-05,0.15222,0.1741,1,1
4,GO DEVELOPMENTAL INDUCTION,0.0076401,0.15202,0.13825,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011033,0.15193,0.19626,1,1
4,GO TERPENOID METABOLIC PROCESS,0.01829,0.15192,0.11948,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0026663,0.15179,0.14137,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,4.5684e-06,0.15168,0.1627,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,8.0256e-05,0.15151,0.17671,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.2015e-05,0.15145,0.16619,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0011341,0.15138,0.14206,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00084997,0.15133,0.12526,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.045591,0.15129,0.1067,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00159,0.15128,0.12756,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.040187,0.15121,0.097867,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0062877,0.15112,0.12787,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00072342,0.15105,0.15054,1,1
4,GO POSITIVE REGULATION OF SECRETION,5.7582e-06,0.15103,0.16243,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.00082553,0.15096,0.17607,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.045591,0.15094,0.12703,1,1
4,GO RESPONSE TO THYROID HORMONE,0.024947,0.15093,0.158,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.0029645,0.15075,0.14872,1,1
4,GO CELL JUNCTION ASSEMBLY,0.0056255,0.15071,0.1189,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0137,0.15061,0.11564,1,1
4,GO COAGULATION,0.0038478,0.15024,0.12934,1,1
4,GO REGULATION OF PEPTIDE SECRETION,2.206e-06,0.15011,0.17109,1,1
4,GO REGULATION OF HORMONE LEVELS,3.9102e-06,0.14998,0.1679,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0015038,0.14983,0.2085,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,6.337e-06,0.1498,0.18043,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0021215,0.14956,0.14432,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0067673,0.14944,0.1389,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00010497,0.1493,0.18592,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0012005,0.14912,0.1625,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.042609,0.14911,0.13161,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.024687,0.14904,0.12344,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.038637,0.14895,0.15887,1,1
4,GO CELL CHEMOTAXIS,0.00074504,0.14863,0.14963,1,1
4,GO RESPONSE TO IRON ION,0.001568,0.14843,0.16264,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0065235,0.14842,0.19563,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.00020504,0.14838,0.1613,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00026438,0.14822,0.1561,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0034692,0.14818,0.16781,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.00070238,0.14803,0.14437,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.024428,0.14798,0.12411,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.010895,0.14795,0.12895,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.001071,0.14757,0.11973,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.001235,0.14754,0.14862,1,1
4,GO PROTEIN MANNOSYLATION,0.00062378,0.14739,0.17527,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00049802,0.14728,0.19133,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.00081356,0.14727,0.17005,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00092737,0.1471,0.15706,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0042095,0.14705,0.15739,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0090315,0.14703,0.11962,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00014599,0.147,0.17149,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0046604,0.14673,0.13233,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0069343,0.14672,0.13868,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00099681,0.1467,0.16787,1,1
4,GO VIRAL BUDDING,0.00011596,0.14663,0.15456,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00029052,0.14641,0.14139,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00027284,0.14637,0.13614,1,1
4,GO SYNCYTIUM FORMATION,0.0034692,0.14637,0.15236,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0010408,0.14635,0.12735,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00010673,0.14626,0.15392,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0026663,0.14624,0.13277,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0035146,0.14619,0.12838,1,1
4,GO ACUTE PHASE RESPONSE,0.00044781,0.14586,0.17594,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0073682,0.14586,0.12725,1,1
4,GO GLUCOSE METABOLIC PROCESS,3.3435e-06,0.14585,0.16792,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.0035146,0.14582,0.1398,1,1
4,GO DENDRITE EXTENSION,0.00016901,0.14579,0.23546,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.002631,0.14572,0.14517,1,1
4,GO REGULATION OF CELLULAR PH,8.6579e-07,0.14569,0.16796,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.036409,0.14566,0.12891,1,1
4,GO ORGANELLE FUSION,2.4528e-05,0.1455,0.15547,1,1
4,GO LYSOSOME LOCALIZATION,0.00049053,0.14548,0.15652,1,1
4,GO GLAND DEVELOPMENT,0.0066039,0.14547,0.10748,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.019104,0.14545,0.10906,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0074579,0.14536,0.13649,1,1
4,GO RESPONSE TO PROGESTERONE,0.02128,0.14528,0.12094,1,1
4,GO REGULATION OF APPETITE,0.011151,0.14527,0.10011,1,1
4,GO PLATELET MORPHOGENESIS,0.0024609,0.14511,0.16992,1,1
4,GO VACUOLE ORGANIZATION,1.4163e-06,0.145,0.17566,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.000286,0.14492,0.15411,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,1.5293e-05,0.14489,0.16985,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.022446,0.14469,0.12026,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.01251,0.14465,0.13774,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00027716,0.1446,0.15584,1,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.022686,0.14444,0.13269,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00067188,0.14441,0.13852,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0022396,0.14437,0.1433,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0054872,0.14436,0.11656,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0017277,0.1443,0.18525,1,1
4,GO ORGANIC ANION TRANSPORT,8.4262e-06,0.14418,0.15152,1,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.041789,0.14416,0.10518,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6761e-05,0.14396,0.17531,1,1
4,GO ARACHIDONIC ACID SECRETION,0.0028492,0.14378,0.14742,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,1.9749e-05,0.14377,0.15831,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0019023,0.1437,0.16419,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0047798,0.14364,0.1409,1,1
4,GO CELL CELL ADHESION,0.0027381,0.14352,0.13318,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00022208,0.14349,0.14951,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.05063,0.14345,0.10952,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0007786,0.14337,0.16965,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.01016,0.14321,0.15793,1,1
4,GO EATING BEHAVIOR,0.00029511,0.14302,0.16858,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0099244,0.14301,0.13824,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.00016901,0.14274,0.12611,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0040509,0.1425,0.12544,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.025475,0.14241,0.12165,1,1
4,GO ACID SECRETION,0.00020178,0.1424,0.14857,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.002702,0.14236,0.10269,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.0045438,0.14229,0.20397,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.046474,0.14219,0.088782,1,1
4,GO RESPONSE TO WOUNDING,0.0098086,0.1421,0.12161,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.0038478,0.14195,0.11104,1,1
4,GO RESPONSE TO BACTERIUM,0.00060545,0.14176,0.13621,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00082553,0.14174,0.12091,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,1.0557e-05,0.14163,0.20387,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.01251,0.14158,0.11155,1,1
4,GO ACTIN NUCLEATION,9.6129e-06,0.14156,0.18574,1,1
4,GO GOLGI VESICLE BUDDING,0.00084997,0.14153,0.12718,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.047827,0.14128,0.082913,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00040235,0.14115,0.13835,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.055093,0.1408,0.13541,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.017125,0.14075,0.12007,1,1
4,GO BIOLOGICAL ADHESION,0.011411,0.14073,0.11113,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.022686,0.14072,0.14313,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00062378,0.14052,0.15617,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0044298,0.1405,0.14648,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00057029,0.14037,0.16096,1,1
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023419,0.14018,0.11637,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.026013,0.14004,0.11159,1,1
4,GO RESPONSE TO ALCOHOL,0.0011021,0.14002,0.12235,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.028264,0.13989,0.09701,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0020929,0.1398,0.16107,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00075607,0.13964,0.14953,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.010041,0.1395,0.12966,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.0071051,0.13942,0.12052,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.037139,0.13921,0.12811,1,1
4,GO SECRETION,1.1165e-05,0.13919,0.14925,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.058247,0.13903,0.091043,1,1
4,GO VITAMIN TRANSPORT,0.00159,0.13893,0.15622,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,7.3739e-05,0.1389,0.1309,1,1
4,GO CALCIUM ION IMPORT,0.00061456,0.13851,0.13204,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.9393e-05,0.13842,0.15804,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0017277,0.1384,0.13762,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,6.8888e-05,0.13832,0.15426,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0007901,0.13818,0.15704,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024173,0.13817,0.14905,1,1
4,GO TISSUE HOMEOSTASIS,0.00044781,0.13763,0.1399,1,1
4,GO MEMBRANE REPOLARIZATION,0.0051547,0.13738,0.14065,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.00071283,0.13737,0.13699,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.001483,0.13726,0.13488,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0019819,0.13713,0.13596,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.00090088,0.1371,0.14732,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.0005211,0.13707,0.13953,1,1
4,GO RETINOL METABOLIC PROCESS,0.01251,0.13695,0.1781,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0022701,0.13677,0.12103,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.009139,0.13677,0.13215,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0014624,0.13674,0.12242,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,8.0256e-05,0.13659,0.14638,1,1
4,GO REGULATION OF SECRETION,1.4207e-05,0.13659,0.14735,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.054074,0.13621,0.12081,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.00073415,0.13614,0.13764,1,1
4,GO NADP METABOLIC PROCESS,0.01016,0.13609,0.14941,1,1
4,GO REGULATION OF GLUCONEOGENESIS,3.5022e-05,0.13595,0.17029,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.03902,0.13558,0.10144,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0011021,0.13555,0.14076,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0044298,0.13536,0.2174,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00029511,0.13524,0.1211,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.049681,0.13523,0.13258,1,1
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.02128,0.13522,0.12475,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.001235,0.13515,0.11969,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.3693e-05,0.13502,0.15574,1,1
4,GO REGULATION OF PH,8.8389e-07,0.13494,0.16479,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00030928,0.13489,0.13864,1,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.01016,0.13487,0.14236,1,1
4,GO B CELL DIFFERENTIATION,0.001422,0.13484,0.12775,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00015838,0.13475,0.15676,1,1
4,GO ZINC ION TRANSPORT,0.0085105,0.13469,0.10843,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0017517,0.13463,0.11854,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.013093,0.13424,0.18944,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.037509,0.13397,0.10845,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.00057029,0.13384,0.15295,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0062108,0.13367,0.13947,1,1
4,GO RESPONSE TO NUTRIENT,0.0071051,0.1336,0.11841,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0012005,0.13347,0.16134,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0019023,0.13345,0.14316,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0044864,0.13331,0.14514,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00026438,0.13303,0.135,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0001179,0.1328,0.17962,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.004156,0.13258,0.13765,1,1
4,GO SIGNAL RELEASE,5.6085e-05,0.13254,0.14649,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.022928,0.13253,0.11549,1,1
4,GO LYMPHOCYTE MIGRATION,0.0059852,0.13216,0.11581,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.023919,0.13212,0.10786,1,1
4,GO CHEMICAL HOMEOSTASIS,3.5022e-05,0.13185,0.13105,1,1
4,GO RESPONSE TO ISCHEMIA,0.0024941,0.13179,0.14583,1,1
4,GO COPII COATED VESICLE BUDDING,0.0017517,0.13161,0.11691,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.003607,0.13149,0.15473,1,1
4,GO AMINE METABOLIC PROCESS,1.3878e-06,0.13145,0.17063,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0104,0.13138,0.1318,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00011596,0.13119,0.1642,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.059879,0.1311,0.12434,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.05357,0.1311,0.09181,1,1
4,GO LIPID STORAGE,0.0013826,0.131,0.1557,1,1
4,GO REGULATION OF CELL ADHESION,0.003166,0.13098,0.13692,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.020605,0.13085,0.10758,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.029754,0.1308,0.1504,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0046018,0.13066,0.10818,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00090088,0.13064,0.11921,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.0087156,0.13049,0.13074,1,1
4,GO ADAPTIVE THERMOGENESIS,7.5217e-06,0.13041,0.1649,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.056128,0.12998,0.096237,1,1
4,GO FATTY ACID TRANSPORT,0.0032928,0.12998,0.12407,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.0007901,0.12994,0.14195,1,1
4,GO REGULATION OF CELL MATURATION,0.0037498,0.12988,0.11904,1,1
4,GO HEART PROCESS,0.0025617,0.12956,0.11314,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,3.5646e-05,0.12956,0.13788,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.003607,0.12955,0.11379,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038977,0.1294,0.12516,1,1
4,GO MANGANESE ION TRANSPORT,0.0062108,0.12932,0.13175,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.02128,0.12915,0.16097,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.046921,0.12913,0.092269,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00068191,0.12909,0.17378,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0037016,0.12878,0.1385,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.0019023,0.12856,0.16502,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.059879,0.12854,0.11645,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0053519,0.12848,0.10693,1,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.011411,0.12835,0.12746,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,9.6562e-05,0.12827,0.15803,1,1
4,GO RESPONSE TO STARVATION,6.8888e-05,0.12822,0.14442,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00028155,0.12818,0.12617,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.027973,0.12801,0.091661,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0096941,0.12801,0.10459,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.013093,0.12799,0.11889,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.0012005,0.1278,0.13153,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0035605,0.12763,0.18741,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0042095,0.12753,0.12328,1,1
4,GO FAT CELL DIFFERENTIATION,0.0078263,0.12737,0.11525,1,1
4,GO T CELL PROLIFERATION,0.0025961,0.12725,0.13851,1,1
4,GO ARTERY MORPHOGENESIS,0.054582,0.12718,0.082514,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.01251,0.12707,0.12466,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0012527,0.12704,0.10981,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0023321,0.12698,0.11564,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0013443,0.12698,0.1223,1,1
4,GO NEURON REMODELING,0.046474,0.12697,0.13999,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00022565,0.12671,0.1527,1,1
4,GO GLUCOSE IMPORT,0.0050904,0.1267,0.1087,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0137,0.12667,0.10709,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00029052,0.12654,0.14813,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.037509,0.12647,0.095324,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0023321,0.12646,0.15453,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,5.4184e-05,0.12638,0.12742,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.014658,0.12638,0.12699,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.00010852,0.12624,0.13169,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.035691,0.12618,0.10864,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.046474,0.12612,0.10481,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.057711,0.12589,0.12227,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0059116,0.12582,0.12106,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.013394,0.12576,0.13336,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.0958e-05,0.12567,0.14886,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0010113,0.12561,0.16866,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0012886,0.1256,0.12632,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00028155,0.12551,0.19532,1,1
4,GO PROTEIN DESTABILIZATION,0.00036124,0.12525,0.14198,1,1
4,GO CELL ACTIVATION,0.00081356,0.12522,0.13583,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.014013,0.12498,0.13183,1,1
4,GO RESPONSE TO KETONE,0.0086125,0.12496,0.10233,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,3.2631e-05,0.12485,0.13687,1,1
4,GO CRANIAL NERVE DEVELOPMENT,0.045155,0.12483,0.12478,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.0052197,0.12463,0.10402,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0016122,0.1246,0.11539,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.00061456,0.12448,0.13238,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0071051,0.12444,0.11794,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018898,0.12441,0.11682,1,1
4,GO MACROPHAGE ACTIVATION,0.0010113,0.1244,0.14546,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0028492,0.12438,0.13008,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013633,0.12431,0.13943,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.011949,0.12428,0.11442,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0012177,0.12427,0.13146,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0050269,0.12422,0.10039,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.011022,0.12418,0.10167,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.057179,0.12416,0.085,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.011813,0.12415,0.11472,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.03068,0.12383,0.11084,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.003607,0.12372,0.12631,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00084997,0.12354,0.16458,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.011151,0.12333,0.097346,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.6386e-06,0.12331,0.15364,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.00067188,0.12269,0.14843,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.020166,0.12259,0.1273,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0061347,0.1225,0.13661,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0039481,0.12229,0.13842,1,1
4,GO RESPONSE TO CYTOKINE,0.00098255,0.12219,0.13146,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0038478,0.12214,0.11466,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.032938,0.12181,0.09381,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.051111,0.12178,0.11763,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00035024,0.12159,0.1374,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00014839,0.12132,0.15361,1,1
4,GO RELAXATION OF MUSCLE,0.014494,0.12123,0.13094,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0052854,0.1212,0.13684,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,2.6828e-05,0.12114,0.14918,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00032916,0.12107,0.12382,1,1
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014172,0.12089,0.099951,1,1
4,GO LIPID DROPLET ORGANIZATION,0.00058763,0.12087,0.14554,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,4.4771e-05,0.12085,0.14968,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,8.4424e-05,0.1207,0.13949,1,1
4,GO PROTEIN MATURATION,2.2824e-05,0.12059,0.14635,1,1
4,GO GOLGI RIBBON FORMATION,0.016752,0.12051,0.13011,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013093,0.12043,0.11335,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0086125,0.1202,0.12123,1,1
4,GO T CELL SELECTION,0.0056255,0.12019,0.11147,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.011411,0.1197,0.10712,1,1
4,GO SODIUM ION TRANSPORT,0.00015083,0.11961,0.14017,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00084997,0.1196,0.13728,1,1
4,GO LIPID METABOLIC PROCESS,7.8911e-05,0.11953,0.13225,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0012005,0.11911,0.12616,1,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.01251,0.11905,0.18366,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.012087,0.11895,0.16177,1,1
4,GO METAL ION HOMEOSTASIS,0.00057029,0.11879,0.10899,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.019312,0.11876,0.10304,1,1
4,GO ANION TRANSPORT,1.5576e-05,0.1187,0.1389,1,1
4,GO LIPID HOMEOSTASIS,0.0025617,0.11865,0.13348,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.3948e-05,0.11838,0.15979,1,1
4,GO CYTOKINETIC PROCESS,0.001483,0.11835,0.12727,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0056255,0.11835,0.10414,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.00069207,0.11824,0.11828,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.023419,0.11824,0.11388,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00054518,0.11811,0.12966,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.033271,0.11782,0.10523,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00099681,0.11768,0.14964,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.024687,0.11762,0.10811,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.044722,0.11743,0.12051,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.011678,0.11741,0.12185,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0015038,0.11722,0.12001,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.030368,0.11712,0.12502,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00046872,0.11707,0.12464,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0044298,0.11706,0.11399,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0022095,0.11695,0.11769,1,1
4,GO CARNITINE SHUTTLE,0.006444,0.11687,0.15515,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.020385,0.11679,0.11965,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.0011503,0.11658,0.13326,1,1
4,GO POSITIVE T CELL SELECTION,0.015329,0.1165,0.10777,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.00019229,0.11648,0.11875,1,1
4,GO GLIAL CELL DEVELOPMENT,0.014172,0.11647,0.11,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.030994,0.11644,0.10366,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.019735,0.11641,0.12577,1,1
4,GO ORGANIC ACID TRANSPORT,0.00013673,0.11641,0.13252,1,1
4,GO CATION TRANSPORT,0.00028155,0.11635,0.11515,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.7059e-05,0.11635,0.12689,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.03006,0.11629,0.13436,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,1.8701e-05,0.11626,0.12833,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00046165,0.11601,0.14442,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0032501,0.11599,0.13243,1,1
4,GO T CELL DIFFERENTIATION,0.01499,0.11591,0.089521,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.028852,0.1155,0.08253,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0041031,0.11549,0.13423,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.00027284,0.11543,0.16831,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00024045,0.11532,0.11749,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0021505,0.11528,0.10165,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.0043184,0.11519,0.12525,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00032916,0.11519,0.11883,1,1
4,GO MUSCLE SYSTEM PROCESS,0.0083098,0.11513,0.088341,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.001483,0.11501,0.10662,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.039406,0.115,0.10571,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.030368,0.11496,0.10909,1,1
4,GO INORGANIC ANION TRANSPORT,0.00033955,0.11496,0.11273,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.0010865,0.11492,0.11829,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00046165,0.11459,0.13378,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0028118,0.11453,0.1731,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.0020367,0.11444,0.17068,1,1
4,GO ER OVERLOAD RESPONSE,0.023668,0.11435,0.14786,1,1
4,GO IRON ION TRANSPORT,1.7071e-05,0.11428,0.15994,1,1
4,GO SELECTIVE AUTOPHAGY,0.00036124,0.11415,0.14003,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0056958,0.11414,0.1437,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00072342,0.114,0.10942,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1621e-05,0.11391,0.14114,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.0094686,0.11379,0.14816,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00011406,0.11363,0.12812,1,1
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.031311,0.11361,0.13347,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.03068,0.11347,0.09076,1,1
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.022446,0.11337,0.11707,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00075607,0.11337,0.10316,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.010645,0.11326,0.11105,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.00061456,0.11308,0.093898,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.001442,0.11308,0.11596,1,1
4,GO CYTOKINE SECRETION,0.00046165,0.11292,0.1563,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.022446,0.11285,0.081809,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.006444,0.11285,0.15113,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0093576,0.11278,0.10104,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.006444,0.11274,0.10966,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019229,0.11265,0.12878,1,1
4,GO AGING,0.0033799,0.11259,0.094478,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0054192,0.11258,0.11906,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.016027,0.11243,0.12628,1,1
4,GO ION TRANSPORT,3.3806e-05,0.11236,0.12811,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.00042777,0.11234,0.13901,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.020828,0.11216,0.11467,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0028872,0.11199,0.11078,1,1
4,GO T CELL ACTIVATION,0.0052854,0.11191,0.11103,1,1
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.024687,0.1119,0.11664,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0021798,0.11182,0.12715,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,8.7316e-05,0.11163,0.15616,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.013243,0.1116,0.10849,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0007901,0.1114,0.1201,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.02915,0.11131,0.10295,1,1
4,GO PROTEOLYSIS,0.00054518,0.11105,0.10578,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00080175,0.11095,0.15067,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.020166,0.11078,0.12758,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0032928,0.11075,0.11609,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.01829,0.11071,0.11227,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.016752,0.11065,0.13216,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0055559,0.11055,0.10067,1,1
4,GO RESPONSE TO TESTOSTERONE,0.023668,0.1104,0.10439,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0051547,0.11039,0.12024,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00012186,0.11005,0.12367,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0029645,0.10996,0.13882,1,1
4,GO CERAMIDE TRANSPORT,0.052083,0.10987,0.12361,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.017699,0.10977,0.082586,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0018006,0.10954,0.13327,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.016386,0.10944,0.13943,1,1
4,GO RESPONSE TO HORMONE,0.0050904,0.10936,0.09858,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.003654,0.10931,0.11314,1,1
4,GO ION HOMEOSTASIS,0.00036686,0.10931,0.11098,1,1
4,GO RESPONSE TO FATTY ACID,0.033608,0.10925,0.10176,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0042095,0.10921,0.1103,1,1
4,GO RESPONSE TO ALKALOID,0.00063314,0.10911,0.13213,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.013243,0.10891,0.10458,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.012087,0.10874,0.097041,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.03429,0.10871,0.11598,1,1
4,GO T CELL MIGRATION,0.033608,0.1087,0.11034,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.006444,0.10864,0.096746,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.035691,0.10858,0.10386,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0030436,0.10857,0.10098,1,1
4,GO TRANSITION METAL ION TRANSPORT,3.3806e-05,0.10852,0.13919,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.030368,0.10851,0.12897,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0012005,0.10851,0.12328,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0032928,0.10844,0.11138,1,1
4,GO MUSCLE CELL MIGRATION,0.043025,0.10835,0.11372,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.0096941,0.10819,0.11813,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00099681,0.10801,0.12268,1,1
4,GO DETECTION OF STIMULUS,9.2585e-06,0.10772,0.1306,1,1
4,GO MEMBRANE ORGANIZATION,0.00069207,0.10769,0.10793,1,1
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.049212,0.10758,0.11175,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0030038,0.10742,0.13035,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0038977,0.10739,0.10529,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0081133,0.10709,0.12218,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.029754,0.10708,0.10814,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0084096,0.10696,0.099053,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0050269,0.10667,0.14197,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011341,0.10663,0.12697,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.022928,0.10648,0.12151,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0013255,0.10645,0.11255,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0070192,0.1062,0.094428,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00054518,0.10619,0.11816,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0045438,0.10604,0.12282,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0099244,0.1059,0.12125,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024045,0.10571,0.11973,1,1
4,GO XENOBIOTIC TRANSPORT,0.013243,0.10569,0.13727,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.016568,0.10565,0.084691,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.010279,0.10564,0.11889,1,1
4,GO CHOLESTEROL EFFLUX,0.016752,0.10535,0.1112,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00090088,0.10527,0.184,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0046604,0.10526,0.10433,1,1
4,GO RESPONSE TO COCAINE,0.037509,0.10526,0.10573,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.010522,0.10506,0.11325,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.016938,0.10498,0.1137,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0010408,0.10493,0.10499,1,1
4,GO RESPONSE TO STEROID HORMONE,0.023419,0.10491,0.08898,1,1
4,GO MOLTING CYCLE,0.037139,0.10489,0.08295,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0038478,0.10429,0.10981,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.033271,0.10428,0.082684,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.015501,0.1041,0.10227,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.01251,0.10406,0.10026,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,9.4959e-05,0.10397,0.12706,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,2.0478e-05,0.10389,0.12901,1,1
4,GO ENDOSOME ORGANIZATION,0.00058763,0.10386,0.13325,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.027973,0.10386,0.086079,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.014494,0.10386,0.085669,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.056652,0.10379,0.085433,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.0034692,0.10375,0.1032,1,1
4,GO RESPONSE TO PEPTIDE,0.0028872,0.10373,0.10238,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.01995,0.1037,0.10901,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0063654,0.10367,0.102,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.014658,0.10358,0.10014,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0104,0.10342,0.10488,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00067188,0.10326,0.11383,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0047198,0.10325,0.09623,1,1
4,GO LIPID CATABOLIC PROCESS,0.00023667,0.10311,0.13927,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0007786,0.10299,0.11146,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010279,0.1027,0.10019,1,1
4,GO REGULATION OF MITOPHAGY,0.003607,0.10268,0.14442,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0056958,0.10253,0.10705,1,1
4,GO METAL ION TRANSPORT,0.00084997,0.10251,0.1067,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0012705,0.10235,0.12601,1,1
4,GO PHOTOTRANSDUCTION,0.011151,0.10218,0.061593,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.045591,0.10216,0.12469,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0030839,0.10184,0.10459,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.011022,0.10178,0.084933,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.024687,0.10178,0.12395,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0052197,0.10171,0.11705,1,1
4,GO INTERFERON BETA PRODUCTION,0.046474,0.10167,0.10244,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.027118,0.10166,0.1004,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.006444,0.10164,0.11937,1,1
4,GO VACUOLAR TRANSPORT,0.0011503,0.1016,0.12281,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0066039,0.10145,0.11436,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0015249,0.10117,0.099509,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.03068,0.10112,0.12033,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.012653,0.10109,0.10123,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0010113,0.10109,0.09765,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.019523,0.10083,0.099334,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0030038,0.10081,0.10332,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.0057669,0.10078,0.15328,1,1
4,GO ENDOCYTOSIS,0.012798,0.10074,0.095827,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.015674,0.10071,0.090679,1,1
4,GO TRANSMEMBRANE TRANSPORT,4.9694e-05,0.1004,0.11773,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.023919,0.10027,0.10065,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00027716,0.1002,0.12036,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.05357,0.10001,0.07144,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,6.545e-05,0.10001,0.12265,1,1
4,GO VIRAL LIFE CYCLE,0.001422,0.099965,0.12787,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.038258,0.099956,0.090997,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.017315,0.099619,0.13237,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0066851,0.099588,0.10543,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0046604,0.09934,0.09464,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.016027,0.099323,0.12061,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0058389,0.099252,0.11545,1,1
4,GO GOLGI ORGANIZATION,0.0003557,0.09922,0.1224,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00039622,0.099172,0.11753,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00064263,0.098956,0.10574,1,1
4,GO JNK CASCADE,0.0070192,0.098801,0.10129,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.026286,0.098795,0.086038,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0050904,0.098608,0.1015,1,1
4,GO MUSCLE CELL DIFFERENTIATION,0.046474,0.098389,0.072451,1,1
4,GO RECEPTOR RECYCLING,0.011949,0.098202,0.12003,1,1
4,GO REGULATION OF LIPID STORAGE,0.0075485,0.098179,0.12748,1,1
4,GO REGULATION OF TOR SIGNALING,0.00044103,0.09813,0.12146,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.012087,0.098114,0.10599,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0094686,0.098038,0.093608,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.001422,0.098012,0.11494,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0039992,0.097994,0.11475,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.032278,0.097472,0.081512,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.012653,0.097423,0.14073,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0007786,0.097382,0.10544,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0074579,0.097377,0.087699,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.03429,0.097368,0.10475,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.014658,0.097202,0.11206,1,1
4,GO RESPONSE TO ACTIVITY,0.023173,0.097161,0.094008,1,1
4,GO POLYOL METABOLIC PROCESS,0.0075485,0.097074,0.093277,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0059852,0.096996,0.095657,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.00015331,0.096983,0.11915,1,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.041383,0.09679,0.086127,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.03006,0.096696,0.090786,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0018256,0.096249,0.11732,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.013394,0.09614,0.13717,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0056958,0.096062,0.12963,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0050269,0.096005,0.098661,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.021509,0.095956,0.10998,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.05063,0.095736,0.14058,1,1
4,GO SOMITOGENESIS,0.0065235,0.095647,0.1074,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0090315,0.095639,0.10393,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.01995,0.095556,0.085803,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.014494,0.095518,0.090324,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.052575,0.095179,0.088154,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0054192,0.095061,0.15088,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0056255,0.095027,0.14126,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.012653,0.09501,0.099126,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.020605,0.094978,0.11034,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0012705,0.094922,0.11903,1,1
4,GO PROTEIN DEPOLYMERIZATION,0.023919,0.094879,0.098788,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.0015038,0.09482,0.11655,1,1
4,GO RESPONSE TO ETHANOL,0.0054872,0.09457,0.096729,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00067188,0.09441,0.10288,1,1
4,GO REGULATION OF GROWTH,0.032278,0.094409,0.073728,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00033432,0.094226,0.11721,1,1
4,GO CIRCADIAN RHYTHM,0.0018006,0.094099,0.11022,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00021511,0.093808,0.12319,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0052854,0.093783,0.099319,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.055093,0.093621,0.071435,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0031247,0.093266,0.10621,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.01499,0.093197,0.095599,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0052854,0.093172,0.090726,1,1
4,GO LYMPHOCYTE ACTIVATION,0.011544,0.093097,0.092691,1,1
4,GO IMPORT INTO CELL,0.049212,0.09283,0.08499,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.015674,0.092557,0.088026,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0078263,0.092507,0.12886,1,1
4,GO RESPONSE TO LIPID,0.015501,0.092333,0.091634,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.03006,0.092185,0.065221,1,1
4,GO REGULATION OF TRANSPORT,0.00099681,0.092155,0.096845,1,1
4,GO POTASSIUM ION TRANSPORT,0.0075485,0.092149,0.11985,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.024173,0.09206,0.1388,1,1
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.022928,0.091736,0.098784,1,1
4,GO SPLEEN DEVELOPMENT,0.033948,0.09168,0.087792,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.013394,0.091562,0.10068,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0090315,0.09136,0.11989,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0066039,0.091171,0.11754,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.036409,0.091049,0.1041,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0042636,0.091002,0.090612,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0010113,0.090895,0.1158,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.037139,0.090542,0.11373,1,1
4,GO RESPONSE TO DRUG,0.0084096,0.090387,0.1031,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.025475,0.090196,0.07742,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0047798,0.090132,0.09942,1,1
4,GO CELL CELL RECOGNITION,0.0012705,0.089908,0.13164,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.012798,0.089617,0.086597,1,1
4,GO RESPONSE TO DSRNA,0.010279,0.08931,0.10703,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.032938,0.089143,0.10126,1,1
4,GO ORGANELLE DISASSEMBLY,0.00030449,0.088891,0.11589,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.001568,0.088663,0.096859,1,1
4,GO SOMITE DEVELOPMENT,0.058787,0.088432,0.073186,1,1
4,GO KERATINOCYTE MIGRATION,0.041789,0.088429,0.086821,1,1
4,GO RESPONSE TO ETHER,0.052083,0.088385,0.086164,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.010645,0.088049,0.094336,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.013546,0.087759,0.09828,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.018898,0.087696,0.105,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.049681,0.087335,0.076987,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.040187,0.087192,0.082742,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.001704,0.086917,0.097293,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.020828,0.08668,0.11362,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.0083098,0.086624,0.10607,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.020166,0.086485,0.11015,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040187,0.086258,0.088914,1,1
4,GO SYMBIOTIC PROCESS,0.013243,0.086049,0.074213,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.019104,0.085797,0.088593,1,1
4,GO MALE SEX DIFFERENTIATION,0.032278,0.085779,0.089074,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0013826,0.085662,0.12306,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.014823,0.085435,0.092383,1,1
4,GO TOR SIGNALING,0.0005056,0.085428,0.1042,1,1
4,GO ENDOSOMAL TRANSPORT,0.0037985,0.085173,0.087589,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0018764,0.085165,0.11312,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0045438,0.084884,0.1033,1,1
4,GO REGULATION OF HEMOPOIESIS,0.020166,0.084759,0.084457,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.020605,0.084681,0.086526,1,1
4,GO LYSOSOMAL TRANSPORT,0.019104,0.084551,0.10669,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.052083,0.084543,0.099472,1,1
4,GO OXIDATION REDUCTION PROCESS,0.001568,0.084418,0.10698,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0022095,0.084339,0.10156,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00024045,0.084002,0.1109,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.01585,0.083986,0.086615,1,1
4,GO MESONEPHROS DEVELOPMENT,0.017506,0.083953,0.1066,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0071051,0.083714,0.088716,1,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.047372,0.082922,0.080396,1,1
4,GO PULMONARY VALVE DEVELOPMENT,0.045155,0.082909,0.159,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.024173,0.082445,0.091035,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.023173,0.082439,0.098209,1,1
4,GO SENSORY PERCEPTION,0.0027381,0.082367,0.084835,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0021215,0.082268,0.12794,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0067673,0.082111,0.1286,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0057669,0.082064,0.1145,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0037016,0.082051,0.098413,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.000286,0.081954,0.11143,1,1
4,GO ENSHEATHMENT OF NEURONS,0.059331,0.081757,0.082094,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.030368,0.081505,0.092346,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.036409,0.081275,0.1032,1,1
4,GO CYTOSOLIC TRANSPORT,0.0066039,0.080941,0.09245,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.017125,0.080549,0.081894,1,1
4,GO CELLULAR HOMEOSTASIS,0.0016806,0.080462,0.089899,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.039406,0.079613,0.067436,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0137,0.079598,0.090003,1,1
4,GO HOMEOSTATIC PROCESS,0.0005211,0.079571,0.10069,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.016938,0.07919,0.086444,1,1
4,GO MITOPHAGY,0.0029256,0.079148,0.13325,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00052901,0.079144,0.13777,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.0060595,0.078895,0.097089,1,1
4,GO MACROAUTOPHAGY,0.00041488,0.078505,0.1052,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.016027,0.078329,0.097423,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.010645,0.077878,0.10193,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.059331,0.077798,0.061196,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0083098,0.077474,0.099217,1,1
4,GO LIPID MODIFICATION,0.0046018,0.077084,0.10351,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.02521,0.076918,0.078873,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.012945,0.076915,0.092313,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.02521,0.07628,0.081586,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011678,0.076111,0.094449,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0054192,0.076042,0.083975,1,1
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.028852,0.075983,0.080629,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.0016575,0.07538,0.10202,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0045438,0.07521,0.10531,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.038258,0.075184,0.10201,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.023668,0.074876,0.073206,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0028872,0.074853,0.086184,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012087,0.07458,0.10152,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.012945,0.074189,0.084557,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.040981,0.073858,0.067761,1,1
4,GO CELLULAR RESPIRATION,0.01585,0.073169,0.088978,1,1
4,GO REGULATION OF MAPK CASCADE,0.022686,0.073142,0.087511,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0030038,0.072577,0.13794,1,1
4,GO AEROBIC RESPIRATION,0.02945,0.072538,0.088531,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.021509,0.072503,0.092207,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.028264,0.072225,0.074783,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.015501,0.071896,0.080037,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0063654,0.071844,0.08951,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.010279,0.071004,0.076783,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0089251,0.070205,0.085353,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0067673,0.069735,0.080793,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.014823,0.069431,0.083184,1,1
4,GO SPERM EGG RECOGNITION,0.014013,0.069247,0.090431,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.03068,0.068775,0.08727,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.018091,0.068577,0.09654,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.049681,0.068227,0.067442,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.014013,0.067966,0.074359,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.057179,0.067928,0.05986,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.02915,0.067817,0.073355,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.031311,0.06752,0.073349,1,1
4,GO HEAT GENERATION,0.049212,0.067119,0.10511,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.042609,0.066605,0.090591,1,1
4,GO BODY FLUID SECRETION,0.042609,0.066557,0.084482,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.036772,0.06647,0.069583,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.032278,0.066359,0.063784,1,1
4,GO TRANSLESION SYNTHESIS,0.054074,0.0658,0.066794,1,1
4,GO REGULATION OF AUTOPHAGY,0.0010113,0.065597,0.104,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.049681,0.064559,0.068447,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0076401,0.064519,0.088619,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.011544,0.06376,0.07795,1,1
4,GO APOPTOTIC PROCESS,0.011022,0.063728,0.080758,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.009139,0.063513,0.090895,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.027973,0.063242,0.086468,1,1
4,GO MAINTENANCE OF LOCATION,0.014013,0.062162,0.089048,1,1
4,GO BLASTOCYST DEVELOPMENT,0.0056958,0.061727,0.075551,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.056652,0.061487,0.068662,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.03006,0.061127,0.083426,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0073682,0.060965,0.088494,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0104,0.059311,0.093732,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0073682,0.059117,0.074493,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0092477,0.058949,0.093729,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.049212,0.058876,0.070814,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.042197,0.058717,0.073414,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.012653,0.058641,0.073691,1,1
4,GO ORGANELLE INHERITANCE,0.023919,0.057511,0.084619,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.037882,0.056952,0.061364,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.037509,0.056855,0.065177,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.028852,0.056756,0.092902,1,1
4,GO GOLGI VESICLE TRANSPORT,0.011813,0.053626,0.085972,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.032607,0.052101,0.081728,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0066039,0.05199,0.071519,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0070192,0.051681,0.089263,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.012653,0.050322,0.080237,1,1
4,GO MULTI ORGANISM PROCESS,0.037509,0.047965,0.059866,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.054074,0.045622,0.058109,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.022928,0.045595,0.095287,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.01585,0.045412,0.067748,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.059331,0.044927,0.10455,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.0089251,0.04339,0.085648,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.03429,0.035725,0.053338,1,1
4,GO THIOESTER METABOLIC PROCESS,0.046031,0.032093,0.086668,1,1
4,GO INTRACELLULAR TRANSPORT,0.03429,0.03129,0.052821,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.057179,0.030503,0.057713,1,1
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.016752,0.21354,0.18193,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022446,0.16968,0.1386,1,1
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.3351e-08,0.68229,0.69335,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,6.0205e-08,0.60011,0.63879,1,1
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,9.028e-08,0.58956,0.57491,1,1
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.2042e-09,0.58914,0.57125,1,1
6,GO PREPULSE INHIBITION,3.6567e-07,0.58051,0.52909,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.4371e-06,0.57101,0.54442,1,1
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.8363e-05,0.56806,0.52539,1,1
6,GO VOCALIZATION BEHAVIOR,2.188e-08,0.56696,0.61147,1,1
6,GO COMMISSURAL NEURON AXON GUIDANCE,5.1356e-08,0.56212,0.5886,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.3774e-08,0.55514,0.5407,1,1
6,GO REGULATION OF SYNAPSE MATURATION,3.2784e-06,0.53615,0.50132,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.6407e-09,0.531,0.5613,1,1
6,GO SYNAPTIC MEMBRANE ADHESION,3.8347e-06,0.52321,0.44592,1,1
6,GO FOREBRAIN NEURON FATE COMMITMENT,0.0017277,0.52161,0.4759,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,1.5386e-08,0.51765,0.4827,1,1
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,9.0235e-07,0.51214,0.5195,1,1
6,GO SYNAPSE MATURATION,4.7999e-05,0.51163,0.42694,1,1
6,GO CARDIAC VENTRICLE FORMATION,1.5994e-06,0.50483,0.47286,1,1
6,GO POSTSYNAPSE ASSEMBLY,7.3772e-08,0.50113,0.50858,1,1
6,GO RETINAL ROD CELL DIFFERENTIATION,3.9102e-06,0.49829,0.40531,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,2.3891e-06,0.49605,0.3685,1,1
6,GO NEURON CELL CELL ADHESION,2.5756e-08,0.49465,0.58635,1,1
6,GO ANATOMICAL STRUCTURE REGRESSION,0.00032916,0.49413,0.36322,1,1
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.536e-06,0.4909,0.53335,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,5.1351e-07,0.48405,0.47228,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.1086e-06,0.4811,0.41011,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,3.0302e-06,0.47813,0.4882,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,7.5451e-08,0.46618,0.50764,1,1
6,GO NOSE DEVELOPMENT,7.892e-08,0.45447,0.51303,1,1
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.3769e-07,0.44894,0.4659,1,1
6,GO SYNAPTIC VESICLE CLUSTERING,1.6654e-06,0.44753,0.53101,1,1
6,GO SPINAL CORD PATTERNING,4.1025e-09,0.44584,0.48644,1,1
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00013899,0.44573,0.40244,1,1
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.9563e-06,0.44132,0.39852,1,1
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,4.0678e-07,0.43995,0.47729,1,1
6,GO NEURON FATE SPECIFICATION,2.6981e-08,0.43731,0.50141,1,1
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,3.628e-05,0.43609,0.3772,1,1
6,GO POSITIVE REGULATION OF NEURON MIGRATION,8.5858e-05,0.42935,0.36587,1,1
6,GO NEURONAL ION CHANNEL CLUSTERING,5.4356e-06,0.42926,0.42653,1,1
6,GO LIMB BUD FORMATION,6.7105e-06,0.42874,0.42597,1,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.0868e-08,0.42711,0.38963,1,1
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,1.8318e-07,0.42682,0.40258,1,1
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,2.8001e-06,0.42474,0.41963,1,1
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,5.4184e-05,0.42473,0.35421,1,1
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,8.6579e-07,0.42083,0.49582,1,1
6,GO CARDIAC CHAMBER FORMATION,3.3435e-06,0.41817,0.41246,1,1
6,GO THALAMUS DEVELOPMENT,6.0205e-08,0.41726,0.40993,1,1
6,GO FACIAL NERVE MORPHOGENESIS,0.00018923,0.41717,0.3747,1,1
6,GO MICROTUBULE DEPOLYMERIZATION,2.0776e-06,0.41616,0.33391,1,1
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,9.1829e-05,0.41569,0.36721,1,1
6,GO REGULATION OF NEUROBLAST PROLIFERATION,6.205e-09,0.41163,0.39898,1,1
6,GO CEREBELLAR CORTEX MORPHOGENESIS,7.6792e-10,0.41085,0.37229,1,1
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.484e-09,0.41051,0.42396,1,1
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,5.7536e-08,0.40801,0.44904,1,1
6,GO OTIC VESICLE DEVELOPMENT,9.2585e-06,0.40728,0.36445,1,1
6,GO NEURON FATE COMMITMENT,8.4877e-09,0.40581,0.42221,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.9749e-05,0.40245,0.4586,1,1
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.2032e-06,0.4019,0.41594,1,1
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,9.8716e-08,0.40151,0.35032,1,1
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,4.5822e-08,0.40076,0.49538,1,1
6,GO MALE SEX DETERMINATION,6.6066e-07,0.40015,0.37603,1,1
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.9834e-06,0.39801,0.32423,1,1
6,GO REGULATION OF NEURON MIGRATION,3.9035e-08,0.39788,0.40332,1,1
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.3878e-06,0.39024,0.4048,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0003557,0.38333,0.29353,1,1
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,3.0302e-06,0.38286,0.34908,1,1
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,8.6579e-07,0.38183,0.36318,1,1
6,GO INNERVATION,2.3661e-05,0.38041,0.43516,1,1
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,2.6828e-05,0.38029,0.29971,1,1
6,GO MICROTUBULE ANCHORING AT CENTROSOME,1.0322e-07,0.37834,0.3371,1,1
6,GO PARENTAL BEHAVIOR,2.0853e-05,0.37753,0.41576,1,1
6,GO CEREBELLAR CORTEX FORMATION,6.3569e-09,0.37712,0.36735,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,7.0337e-07,0.3767,0.38133,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,4.0678e-07,0.37506,0.33901,1,1
6,GO TONGUE MORPHOGENESIS,0.00012804,0.3741,0.3422,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,5.1356e-08,0.37394,0.45003,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.6062e-07,0.37147,0.34513,1,1
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,5.332e-06,0.36517,0.39186,1,1
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,9.1205e-09,0.36485,0.41837,1,1
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,2.856e-06,0.3634,0.3719,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,3.9941e-08,0.36318,0.42458,1,1
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,5.6487e-06,0.36308,0.36057,1,1
6,GO REGULATION OF RECEPTOR CLUSTERING,0.00052901,0.36186,0.30628,1,1
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.5359e-06,0.36131,0.47703,1,1
6,GO HISTONE H3 K9 DEMETHYLATION,6.4699e-07,0.36071,0.3359,1,1
6,GO CELL DIFFERENTIATION IN HINDBRAIN,1.3671e-08,0.35788,0.3669,1,1
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,2.7804e-05,0.3563,0.34281,1,1
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,4.4771e-05,0.35546,0.30837,1,1
6,GO ATRIAL SEPTUM MORPHOGENESIS,2.5424e-05,0.3548,0.39021,1,1
6,GO CENTRIOLE CENTRIOLE COHESION,2.9078e-09,0.35382,0.37125,1,1
6,GO EMBRYONIC BRAIN DEVELOPMENT,2.1624e-06,0.35213,0.26603,1,1
6,GO HISTONE H3 K27 METHYLATION,1.6062e-07,0.3498,0.28356,1,1
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.0364e-06,0.34932,0.32084,1,1
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,1.9393e-05,0.34861,0.29963,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,9.028e-08,0.34803,0.45034,1,1
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,8.4424e-05,0.34651,0.29433,1,1
6,GO FOREBRAIN REGIONALIZATION,9.4407e-08,0.34644,0.40639,1,1
6,GO SOMATIC STEM CELL DIVISION,0.00026024,0.34552,0.34053,1,1
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00023294,0.34538,0.28937,1,1
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,5.2445e-07,0.34499,0.34282,1,1
6,GO SPINAL CORD DEVELOPMENT,1.4877e-10,0.34477,0.36818,1,1
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.031311,0.34408,0.19407,1,1
6,GO RESPONSE TO ACETYLCHOLINE,5.0278e-07,0.34347,0.34357,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00022208,0.33923,0.37604,1,1
6,GO FORELIMB MORPHOGENESIS,7.892e-08,0.33866,0.36254,1,1
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,3.9872e-06,0.33619,0.36849,1,1
6,GO PROSTATE GLAND MORPHOGENESIS,0.0019819,0.33555,0.28564,1,1
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.0478e-05,0.33492,0.49168,1,1
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,2.1234e-05,0.33452,0.29494,1,1
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00018323,0.33442,0.33026,1,1
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0025961,0.33392,0.31542,1,1
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.8363e-05,0.33386,0.32997,1,1
6,GO RESPONSE TO L GLUTAMATE,4.1026e-05,0.33364,0.31084,1,1
6,GO RESPONSE TO AUDITORY STIMULUS,4.0314e-05,0.33192,0.36859,1,1
6,GO RECEPTOR CLUSTERING,1.0424e-06,0.33044,0.29158,1,1
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0021215,0.33,0.29117,1,1
6,GO MRNA SPLICE SITE SELECTION,8.0424e-11,0.32981,0.39362,1,1
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,9.6562e-05,0.32908,0.28442,1,1
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,9.9844e-05,0.32885,0.30059,1,1
6,GO HISTONE H3 K9 METHYLATION,9.658e-10,0.32848,0.33499,1,1
6,GO ECTODERMAL PLACODE DEVELOPMENT,4.31e-06,0.32816,0.3881,1,1
6,GO TELENCEPHALON REGIONALIZATION,8.4262e-06,0.32752,0.39166,1,1
6,GO CELL PROLIFERATION IN HINDBRAIN,2.913e-06,0.32572,0.34668,1,1
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,4.2042e-09,0.32489,0.29648,1,1
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,9.795e-06,0.32439,0.31222,1,1
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.00094089,0.32429,0.27455,1,1
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0003557,0.32354,0.2737,1,1
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,8.6579e-07,0.32259,0.33557,1,1
6,GO CELL JUNCTION MAINTENANCE,3.8983e-07,0.32197,0.33845,1,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0020929,0.32169,0.25059,1,1
6,GO HISTONE H3 K36 METHYLATION,6.6717e-09,0.32148,0.35443,1,1
6,GO LONG TERM SYNAPTIC DEPRESSION,1.996e-06,0.32089,0.32266,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,3.2859e-07,0.32088,0.43852,1,1
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,3.758e-05,0.31975,0.30089,1,1
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.5794e-07,0.31903,0.30634,1,1
6,GO GANGLION DEVELOPMENT,0.00014362,0.31862,0.33301,1,1
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,2.342e-06,0.31774,0.3002,1,1
6,GO CELL DIFFERENTIATION IN SPINAL CORD,1.0964e-09,0.31744,0.35836,1,1
6,GO ATRIAL SEPTUM DEVELOPMENT,0.00017457,0.31502,0.28239,1,1
6,GO DORSAL SPINAL CORD DEVELOPMENT,2.8886e-07,0.31441,0.39242,1,1
6,GO INHIBITORY SYNAPSE ASSEMBLY,1.8032e-05,0.3141,0.39963,1,1
6,GO TELENCEPHALON GLIAL CELL MIGRATION,3.6924e-05,0.31333,0.27302,1,1
6,GO NEURAL TUBE PATTERNING,1.3769e-07,0.3128,0.28053,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00037835,0.3121,0.36727,1,1
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0024281,0.31192,0.24714,1,1
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.0323e-06,0.31157,0.28897,1,1
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,3.3806e-05,0.31083,0.30245,1,1
6,GO NEUROBLAST PROLIFERATION,2.188e-08,0.31017,0.32654,1,1
6,GO CELL FATE SPECIFICATION,2.8262e-08,0.30964,0.30318,1,1
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,6.0079e-05,0.3096,0.30163,1,1
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0068504,0.30916,0.27627,1,1
6,GO GLIAL CELL FATE COMMITMENT,0.00094089,0.30835,0.31821,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.2169e-06,0.30797,0.34386,1,1
6,GO BRAIN MORPHOGENESIS,8.8282e-08,0.30754,0.29467,1,1
6,GO DORSAL VENTRAL AXIS SPECIFICATION,7.7586e-05,0.30749,0.29519,1,1
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,1.0756e-05,0.30697,0.3164,1,1
6,GO LEFT RIGHT AXIS SPECIFICATION,0.00084997,0.30676,0.23212,1,1
6,GO CEREBELLAR CORTEX DEVELOPMENT,2.8369e-09,0.30667,0.34151,1,1
6,GO EPITHELIAL CELL MATURATION,6.0759e-07,0.30654,0.31686,1,1
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.6907e-08,0.30619,0.32662,1,1
6,GO NERVE DEVELOPMENT,3.3214e-05,0.30596,0.30186,1,1
6,GO THYROID GLAND DEVELOPMENT,5.8698e-06,0.30591,0.29249,1,1
6,GO STARTLE RESPONSE,8.1138e-06,0.30545,0.33909,1,1
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,4.5558e-05,0.30464,0.30069,1,1
6,GO ACTIN FILAMENT BASED TRANSPORT,3.3214e-05,0.30401,0.26591,1,1
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,1.3196e-05,0.30361,0.2711,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.1196e-06,0.30332,0.28267,1,1
6,GO REGULATION OF COLLATERAL SPROUTING,0.00034485,0.30279,0.26915,1,1
6,GO NEURON MIGRATION,2.3467e-08,0.3026,0.34172,1,1
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,9.1829e-05,0.30238,0.25917,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00095459,0.30231,0.26613,1,1
6,GO GROWTH HORMONE SECRETION,5.5412e-06,0.30191,0.40869,1,1
6,GO PROTEIN LOCALIZATION TO AXON,0.00058763,0.30168,0.35389,1,1
6,GO NEURON PROJECTION GUIDANCE,7.1819e-07,0.29993,0.27618,1,1
6,GO CELL PROLIFERATION IN FOREBRAIN,1.2716e-05,0.2999,0.29685,1,1
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,8.1623e-05,0.29834,0.31033,1,1
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,1.6321e-06,0.29782,0.2801,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0011503,0.2975,0.2534,1,1
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.011949,0.29715,0.2641,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.001442,0.29697,0.23088,1,1
6,GO METENCEPHALON DEVELOPMENT,2.5066e-09,0.29662,0.33079,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,1.2027e-05,0.2966,0.29414,1,1
6,GO RESPONSE TO POTASSIUM ION,4.2487e-05,0.2954,0.31556,1,1
6,GO MYOBLAST MIGRATION,0.0050904,0.29499,0.23538,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,1.8701e-05,0.29458,0.26194,1,1
6,GO SYNAPTIC VESICLE DOCKING,0.0032928,0.29453,0.27788,1,1
6,GO RETROGRADE AXONAL TRANSPORT,2.2505e-06,0.29358,0.3045,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.6162e-06,0.29339,0.27223,1,1
6,GO HINDBRAIN DEVELOPMENT,3.3713e-09,0.29336,0.28733,1,1
6,GO NEURON RECOGNITION,2.9332e-05,0.29304,0.27572,1,1
6,GO SYNAPTIC VESICLE MATURATION,0.0007786,0.29191,0.31496,1,1
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,8.4805e-07,0.29146,0.31875,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0024941,0.29143,0.19223,1,1
6,GO ACROSOME ASSEMBLY,8.2543e-08,0.29139,0.32542,1,1
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,7.2497e-05,0.29125,0.26639,1,1
6,GO SEX DETERMINATION,2.7452e-06,0.29093,0.29426,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.0991e-06,0.29061,0.34119,1,1
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00019229,0.29023,0.28412,1,1
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.01499,0.29008,0.21959,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.7991e-09,0.28983,0.30208,1,1
6,GO HEART VALVE FORMATION,7.2497e-05,0.28958,0.40424,1,1
6,GO NEURAL RETINA DEVELOPMENT,5.4701e-07,0.28954,0.29602,1,1
6,GO PROXIMAL DISTAL PATTERN FORMATION,6.8888e-05,0.28954,0.26659,1,1
6,GO HISTONE H3 K9 MODIFICATION,4.1403e-10,0.28946,0.30959,1,1
6,GO MYELIN MAINTENANCE,0.016027,0.28921,0.21723,1,1
6,GO POSTSYNAPSE ORGANIZATION,7.892e-08,0.28908,0.30917,1,1
6,GO VENTRAL SPINAL CORD DEVELOPMENT,2.188e-08,0.28875,0.31009,1,1
6,GO REGULATION OF MICROTUBULE BINDING,0.00010323,0.28864,0.26812,1,1
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00086244,0.28849,0.25208,1,1
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.7605e-06,0.28844,0.36419,1,1
6,GO COCHLEA MORPHOGENESIS,0.0005789,0.2884,0.23725,1,1
6,GO HIPPO SIGNALING,0.00010852,0.28816,0.24584,1,1
6,GO CRANIAL NERVE MORPHOGENESIS,0.00018323,0.28798,0.28246,1,1
6,GO NOREPINEPHRINE SECRETION,0.00013899,0.28785,0.25824,1,1
6,GO NUCLEUS LOCALIZATION,2.5424e-05,0.28783,0.25579,1,1
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,6.0079e-05,0.28777,0.27355,1,1
6,GO NEPHRON TUBULE FORMATION,9.3381e-05,0.28706,0.28621,1,1
6,GO DIVALENT METAL ION EXPORT,7.8911e-05,0.28672,0.30411,1,1
6,GO REGULATION OF CENTRIOLE REPLICATION,2.5868e-06,0.28526,0.27217,1,1
6,GO NON MOTILE CILIUM ASSEMBLY,1.2281e-06,0.2851,0.25386,1,1
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,1.725e-09,0.28467,0.32527,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.4371e-06,0.28392,0.3156,1,1
6,GO NUCLEAR MIGRATION,2.8814e-05,0.28337,0.26419,1,1
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0037498,0.28281,0.24766,1,1
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.1552e-07,0.28277,0.31075,1,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0029256,0.28189,0.28776,1,1
6,GO NEURON PROJECTION ARBORIZATION,1.5994e-06,0.28179,0.33704,1,1
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00029976,0.28172,0.25472,1,1
6,GO PHOTORECEPTOR CELL MAINTENANCE,3.9035e-08,0.28169,0.26225,1,1
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.0007901,0.28143,0.28014,1,1
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,4.9361e-06,0.28133,0.30033,1,1
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.6877e-06,0.28101,0.30245,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.5713e-07,0.28089,0.2771,1,1
6,GO EXCITATORY SYNAPSE ASSEMBLY,7.5217e-06,0.2799,0.34821,1,1
6,GO REGULATION OF CILIUM ASSEMBLY,9.028e-08,0.27962,0.25415,1,1
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,4.2784e-08,0.27912,0.29499,1,1
6,GO PROTEIN DEMETHYLATION,2.0879e-07,0.27873,0.27732,1,1
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0011836,0.2786,0.23999,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,3.8983e-07,0.27852,0.24496,1,1
6,GO ACTIN CROSSLINK FORMATION,8.4805e-07,0.27842,0.34174,1,1
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.7963e-08,0.2781,0.28853,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,7.105e-06,0.27741,0.23424,1,1
6,GO SYNAPSE ORGANIZATION,2.206e-06,0.27705,0.25485,1,1
6,GO AXON DEVELOPMENT,1.0861e-06,0.27677,0.2525,1,1
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,9.404e-07,0.27664,0.2868,1,1
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.2534e-06,0.27631,0.27936,1,1
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,7.6446e-07,0.27615,0.30323,1,1
6,GO PROTEIN LOCALIZATION TO CILIUM,8.8282e-08,0.27499,0.29874,1,1
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00023294,0.2748,0.31766,1,1
6,GO RESPONSE TO NICOTINE,1.1282e-07,0.27401,0.30262,1,1
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00076726,0.27381,0.30286,1,1
6,GO PANCREAS DEVELOPMENT,1.3056e-06,0.27266,0.29059,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.9228e-07,0.27209,0.25641,1,1
6,GO SYNAPSE ASSEMBLY,1.4454e-06,0.27205,0.28574,1,1
6,GO ASTRAL MICROTUBULE ORGANIZATION,1.8573e-08,0.27194,0.34086,1,1
6,GO SIALYLATION,5.1446e-05,0.27175,0.30117,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.2534e-06,0.27169,0.2643,1,1
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,3.3435e-06,0.27162,0.29685,1,1
6,GO OLIGODENDROCYTE DEVELOPMENT,0.00045468,0.27082,0.20372,1,1
6,GO DENTATE GYRUS DEVELOPMENT,0.00058763,0.27041,0.31398,1,1
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.3878e-06,0.27017,0.27747,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.0343e-10,0.26979,0.29166,1,1
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0002443,0.26897,0.23261,1,1
6,GO REGULATION OF STEM CELL PROLIFERATION,1.6782e-07,0.26882,0.27122,1,1
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.0791e-07,0.26834,0.31242,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.1588e-05,0.26801,0.26005,1,1
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00042777,0.26718,0.23126,1,1
6,GO LYSINE METABOLIC PROCESS,0.0032501,0.2662,0.2036,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,1.1794e-07,0.26566,0.2746,1,1
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.8885e-07,0.26527,0.26587,1,1
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.0478e-05,0.26498,0.23195,1,1
6,GO REGULATION OF AXONOGENESIS,2.5868e-06,0.26455,0.26591,1,1
6,GO KINETOCHORE ORGANIZATION,2.5424e-05,0.26446,0.24956,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,5.9498e-07,0.26381,0.27404,1,1
6,GO TONGUE DEVELOPMENT,0.00032408,0.26375,0.2719,1,1
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0029256,0.26372,0.23009,1,1
6,GO SPERMATID NUCLEUS DIFFERENTIATION,8.6328e-08,0.26344,0.27852,1,1
6,GO LEARNING,4.8198e-07,0.26336,0.26697,1,1
6,GO DENDRITE SELF AVOIDANCE,0.0023637,0.26334,0.19907,1,1
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00014362,0.26317,0.2419,1,1
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00018923,0.26276,0.23821,1,1
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.6514e-08,0.26205,0.28451,1,1
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,6.895e-08,0.262,0.29599,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,3.3713e-09,0.26151,0.28946,1,1
6,GO NEURAL CREST FORMATION,0.00065224,0.26106,0.25005,1,1
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0085105,0.26104,0.17175,1,1
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00014599,0.26048,0.23115,1,1
6,GO REGULATION OF SYNAPSE ASSEMBLY,3.8246e-05,0.26041,0.24962,1,1
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00030449,0.25934,0.20341,1,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00063314,0.25915,0.24998,1,1
6,GO AXONAL FASCICULATION,0.00071283,0.25911,0.25656,1,1
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.1165e-05,0.25881,0.22592,1,1
6,GO GENETIC IMPRINTING,3.9872e-06,0.25863,0.25082,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2954e-05,0.25832,0.28293,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,6.9711e-06,0.25799,0.30536,1,1
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,1.8053e-06,0.25797,0.30198,1,1
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.7488e-06,0.25719,0.29524,1,1
6,GO CELL PART MORPHOGENESIS,5.4701e-07,0.25711,0.24477,1,1
6,GO MAST CELL MIGRATION,0.0023321,0.25702,0.32355,1,1
6,GO ADULT HEART DEVELOPMENT,0.0025617,0.25664,0.18612,1,1
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,8.4415e-08,0.25631,0.28968,1,1
6,GO CELL MIGRATION IN HINDBRAIN,5.3256e-05,0.25619,0.29177,1,1
6,GO REGULATION OF CHROMATIN BINDING,1.8318e-07,0.25595,0.29888,1,1
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.2146e-06,0.25559,0.30006,1,1
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,3.5022e-05,0.25551,0.23293,1,1
6,GO DENDRITE MORPHOGENESIS,8.2543e-08,0.25506,0.30021,1,1
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,5.7051e-07,0.25484,0.31668,1,1
6,GO METANEPHROS MORPHOGENESIS,0.00039018,0.25478,0.23245,1,1
6,GO EMBRYONIC BODY MORPHOGENESIS,6.3249e-05,0.25476,0.27251,1,1
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00020504,0.25427,0.26316,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,8.8796e-05,0.2541,0.19839,1,1
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.4098e-06,0.25398,0.23275,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,1.5386e-08,0.25347,0.27321,1,1
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00095459,0.2534,0.22915,1,1
6,GO SECONDARY HEART FIELD SPECIFICATION,0.0045438,0.25335,0.28358,1,1
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0005133,0.25329,0.29334,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.8396e-06,0.25321,0.27477,1,1
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,3.4796e-08,0.25217,0.27254,1,1
6,GO RESPONSE TO LEUCINE,0.00010323,0.25204,0.27624,1,1
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,6.4592e-06,0.25197,0.24784,1,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,9.795e-06,0.25179,0.27189,1,1
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.001235,0.2516,0.24358,1,1
6,GO PROTEIN POLYGLUTAMYLATION,6.9711e-06,0.25136,0.27089,1,1
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0024941,0.2512,0.23795,1,1
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.9989e-07,0.25047,0.28638,1,1
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,5.7059e-05,0.25044,0.29344,1,1
6,GO NEGATIVE REGULATION OF GLIOGENESIS,1.6321e-06,0.25003,0.29369,1,1
6,GO APICAL PROTEIN LOCALIZATION,7.3803e-06,0.24996,0.28049,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.8723e-07,0.24972,0.31331,1,1
6,GO NEURON PROJECTION ORGANIZATION,1.3442e-05,0.24922,0.24563,1,1
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.9803e-06,0.24911,0.23329,1,1
6,GO RESPONSE TO FORSKOLIN,0.002631,0.24911,0.25478,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,2.8001e-06,0.2487,0.22834,1,1
6,GO DENDRITIC SPINE MORPHOGENESIS,1.536e-06,0.24825,0.2955,1,1
6,GO SYNAPTIC VESICLE LOCALIZATION,2.3239e-05,0.24765,0.25903,1,1
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,3.3806e-05,0.24737,0.28285,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.4472e-05,0.24737,0.23298,1,1
6,GO OVARIAN FOLLICLE DEVELOPMENT,1.9749e-05,0.24716,0.25498,1,1
6,GO CHLORIDE ION HOMEOSTASIS,0.0035146,0.24714,0.21656,1,1
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0037016,0.24708,0.24983,1,1
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00019229,0.24658,0.22452,1,1
6,GO COLLATERAL SPROUTING,0.00013899,0.24648,0.24265,1,1
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.030994,0.24637,0.20424,1,1
6,GO SOMITE DEVELOPMENT,2.342e-06,0.2462,0.21579,1,1
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,1.0958e-05,0.24616,0.29702,1,1
6,GO G0 TO G1 TRANSITION,1.069e-09,0.24595,0.28288,1,1
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.1456e-06,0.2459,0.28067,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,4.7963e-08,0.24581,0.24205,1,1
6,GO INTRACILIARY TRANSPORT,4.9228e-07,0.24563,0.30151,1,1
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00022208,0.24539,0.3342,1,1
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00024045,0.24528,0.22212,1,1
6,GO IRON COORDINATION ENTITY TRANSPORT,8.7316e-05,0.24471,0.24589,1,1
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00074504,0.24466,0.16541,1,1
6,GO CELLULAR COMPONENT MORPHOGENESIS,9.0235e-07,0.24458,0.22797,1,1
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0059852,0.24433,0.15411,1,1
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,3.0395e-05,0.24427,0.26593,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,5.2445e-07,0.24384,0.25441,1,1
6,GO MICROTUBULE ANCHORING,4.31e-06,0.2434,0.2351,1,1
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,7.333e-07,0.24309,0.23263,1,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,1.439e-07,0.24309,0.22292,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,9.1205e-09,0.24238,0.25493,1,1
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,4.6578e-06,0.24231,0.24215,1,1
6,GO NEURON CELLULAR HOMEOSTASIS,0.00098255,0.24212,0.2384,1,1
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.6761e-05,0.24211,0.26825,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS,0.00061456,0.24206,0.31095,1,1
6,GO PEPTIDYL LYSINE DIMETHYLATION,1.7922e-07,0.2419,0.24777,1,1
6,GO DENDRITIC SPINE DEVELOPMENT,2.856e-06,0.24185,0.25881,1,1
6,GO URETER DEVELOPMENT,0.0053519,0.24179,0.30209,1,1
6,GO DORSAL VENTRAL PATTERN FORMATION,2.1595e-09,0.24172,0.29351,1,1
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00030928,0.24172,0.23243,1,1
6,GO NEURAL PRECURSOR CELL PROLIFERATION,1.0279e-08,0.24115,0.26667,1,1
6,GO HISTONE H4 K16 ACETYLATION,9.2118e-07,0.24111,0.22419,1,1
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0023009,0.24098,0.23569,1,1
6,GO APPENDAGE MORPHOGENESIS,9.795e-06,0.24067,0.22441,1,1
6,GO REGULATION OF DENDRITE DEVELOPMENT,1.8318e-07,0.24022,0.2625,1,1
6,GO HINDBRAIN MORPHOGENESIS,3.5606e-08,0.23989,0.26321,1,1
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,2.2286e-07,0.23982,0.27033,1,1
6,GO REGULATION OF EXTENT OF CELL GROWTH,9.6129e-06,0.2397,0.24805,1,1
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.9044e-05,0.23951,0.28157,1,1
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.0169e-05,0.23926,0.2515,1,1
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,8.9166e-06,0.239,0.2138,1,1
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,3.8924e-05,0.23872,0.18674,1,1
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.4861e-06,0.23863,0.2366,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.0279e-08,0.23831,0.24101,1,1
6,GO FOREBRAIN DEVELOPMENT,3.8149e-08,0.23805,0.24568,1,1
6,GO CARDIAC ATRIUM MORPHOGENESIS,6.545e-05,0.23787,0.26629,1,1
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,1.0212e-06,0.23758,0.29404,1,1
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.1375e-08,0.23757,0.29286,1,1
6,GO SEGMENT SPECIFICATION,0.00015583,0.23708,0.28664,1,1
6,GO NEURON MATURATION,1.2027e-05,0.23687,0.25114,1,1
6,GO CRANIAL NERVE DEVELOPMENT,0.00020178,0.23676,0.25527,1,1
6,GO CENTRIOLE ASSEMBLY,5.3562e-07,0.23668,0.26462,1,1
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00070238,0.23663,0.28704,1,1
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,4.0314e-05,0.23658,0.20037,1,1
6,GO REPRODUCTIVE BEHAVIOR,7.2414e-06,0.23649,0.24797,1,1
6,GO LOCALIZATION WITHIN MEMBRANE,8.9166e-06,0.23646,0.22018,1,1
6,GO GABAERGIC NEURON DIFFERENTIATION,0.0083098,0.23623,0.31938,1,1
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00043435,0.23603,0.18414,1,1
6,GO CARDIAC ATRIUM DEVELOPMENT,0.00010152,0.23564,0.23953,1,1
6,GO DENDRITE DEVELOPMENT,1.1794e-07,0.23559,0.26615,1,1
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,3.5646e-05,0.23523,0.20761,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,6.7105e-06,0.23522,0.22166,1,1
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0002443,0.23515,0.22206,1,1
6,GO STEM CELL PROLIFERATION,2.2505e-06,0.23515,0.22523,1,1
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.342e-06,0.23486,0.27254,1,1
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.9498e-07,0.23458,0.21676,1,1
6,GO VENTRICULAR SYSTEM DEVELOPMENT,1.471e-07,0.23417,0.26042,1,1
6,GO REGULATION OF NEURON DIFFERENTIATION,6.4699e-07,0.23398,0.23002,1,1
6,GO REGULATION OF DENDRITE MORPHOGENESIS,1.3468e-07,0.23341,0.28495,1,1
6,GO EXPLORATION BEHAVIOR,0.0094686,0.23303,0.17374,1,1
6,GO KINETOCHORE ASSEMBLY,0.00016901,0.23293,0.22331,1,1
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,1.7071e-05,0.23281,0.25356,1,1
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.026286,0.23281,0.22239,1,1
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,5.3256e-05,0.23271,0.31868,1,1
6,GO MITOCHONDRION DISTRIBUTION,1.3693e-05,0.23271,0.23969,1,1
6,GO CELLULAR RESPONSE TO VITAMIN D,0.00042777,0.23261,0.26429,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,6.4592e-06,0.23246,0.2415,1,1
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,4.4787e-08,0.23226,0.2612,1,1
6,GO CELLULAR COMPONENT MAINTENANCE,1.0004e-06,0.23224,0.26021,1,1
6,GO TUBE FORMATION,6.0991e-06,0.23224,0.19867,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00057029,0.23207,0.2769,1,1
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,2.2926e-08,0.232,0.28453,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.2534e-06,0.23171,0.22317,1,1
6,GO NEGATIVE REGULATION OF DNA REPLICATION,4.3236e-05,0.2317,0.21379,1,1
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.00029052,0.23149,0.19362,1,1
6,GO HIPPOCAMPUS DEVELOPMENT,2.0364e-06,0.23125,0.22744,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0072795,0.23096,0.17593,1,1
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,3.9872e-06,0.23092,0.26035,1,1
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00034485,0.23081,0.22487,1,1
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00021857,0.23074,0.17928,1,1
6,GO FAT CELL PROLIFERATION,0.020605,0.23063,0.14465,1,1
6,GO AXONEME ASSEMBLY,3.0905e-06,0.23057,0.28646,1,1
6,GO OUTER DYNEIN ARM ASSEMBLY,0.0020367,0.23011,0.2311,1,1
6,GO MICROTUBULE SEVERING,1.7154e-07,0.22979,0.29227,1,1
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.02945,0.2295,0.22722,1,1
6,GO POTASSIUM ION HOMEOSTASIS,6.8888e-05,0.22937,0.21918,1,1
6,GO REGULATION OF SYNAPTIC PLASTICITY,1.2482e-05,0.22926,0.24263,1,1
6,GO HINDLIMB MORPHOGENESIS,0.0028118,0.22903,0.18603,1,1
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.2733e-08,0.22833,0.25566,1,1
6,GO NEURON DEVELOPMENT,7.6446e-07,0.22778,0.22129,1,1
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.0044864,0.22754,0.19585,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,1.8723e-07,0.22747,0.20672,1,1
6,GO PRESYNAPSE ORGANIZATION,2.011e-05,0.22728,0.26907,1,1
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00063314,0.22692,0.2099,1,1
6,GO ESTROUS CYCLE,0.00020178,0.22668,0.24207,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,3.0905e-06,0.22654,0.24453,1,1
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,2.2958e-06,0.22649,0.23177,1,1
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00052901,0.226,0.29185,1,1
6,GO NEURAL TUBE DEVELOPMENT,1.1588e-05,0.22549,0.19324,1,1
6,GO REGULATION OF HIPPO SIGNALING,0.0093576,0.22549,0.17523,1,1
6,GO RESPONSE TO VITAMIN A,0.0023637,0.22544,0.20711,1,1
6,GO REPLICATION FORK PROCESSING,1.9044e-05,0.22541,0.2357,1,1
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.011678,0.22506,0.16994,1,1
6,GO SINGLE STRAND BREAK REPAIR,7.6657e-06,0.22504,0.23258,1,1
6,GO STRIATUM DEVELOPMENT,0.0007786,0.22503,0.21333,1,1
6,GO NEURON DIFFERENTIATION,1.9558e-07,0.22499,0.22554,1,1
6,GO EMBRYONIC EYE MORPHOGENESIS,2.011e-05,0.22494,0.25082,1,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,2.8814e-05,0.22492,0.22873,1,1
6,GO REGULATION OF TUBULIN DEACETYLATION,0.0022095,0.2246,0.20904,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0016575,0.22448,0.1982,1,1
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.020605,0.22446,0.25984,1,1
6,GO APPENDAGE DEVELOPMENT,3.6924e-05,0.22409,0.19145,1,1
6,GO SMOOTHENED SIGNALING PATHWAY,1.3174e-07,0.22399,0.23606,1,1
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,2.7452e-06,0.22395,0.26187,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,1.7706e-05,0.22391,0.24604,1,1
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0001803,0.22352,0.21422,1,1
6,GO REGULATION OF CYCLASE ACTIVITY,8.5858e-05,0.22329,0.21642,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,9.795e-06,0.22322,0.27993,1,1
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.012945,0.22303,0.25358,1,1
6,GO REGULATION OF HEAT GENERATION,8.3013e-05,0.22256,0.27,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,2.342e-06,0.2225,0.21671,1,1
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.001483,0.22241,0.17241,1,1
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,3.7356e-07,0.22173,0.26628,1,1
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,7.6657e-06,0.22146,0.34876,1,1
6,GO MICROTUBULE POLYMERIZATION,2.2015e-05,0.22141,0.22405,1,1
6,GO NEUROGENESIS,6.0759e-07,0.2214,0.20944,1,1
6,GO LACTATE METABOLIC PROCESS,0.0023637,0.22138,0.16707,1,1
6,GO DOSAGE COMPENSATION,4.5684e-06,0.22137,0.21771,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00096848,0.22136,0.21794,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING,1.3878e-06,0.22124,0.21815,1,1
6,GO PHOTORECEPTOR CELL DEVELOPMENT,1.1789e-06,0.22116,0.22159,1,1
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0018764,0.2211,0.27831,1,1
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00021511,0.22109,0.22179,1,1
6,GO HEAD DEVELOPMENT,8.4415e-08,0.22074,0.21646,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,1.2604e-07,0.22051,0.26934,1,1
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.013856,0.22043,0.18357,1,1
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00043435,0.21992,0.24259,1,1
6,GO CGMP METABOLIC PROCESS,0.012653,0.2196,0.19724,1,1
6,GO ADULT BEHAVIOR,6.8885e-07,0.21946,0.27072,1,1
6,GO SUBSTANTIA NIGRA DEVELOPMENT,1.1375e-05,0.21924,0.2055,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0013826,0.21912,0.17149,1,1
6,GO LONG TERM SYNAPTIC POTENTIATION,0.00037835,0.21896,0.20728,1,1
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00068191,0.21819,0.22904,1,1
6,GO MITOTIC SISTER CHROMATID COHESION,1.0169e-05,0.21819,0.23836,1,1
6,GO SKELETAL SYSTEM MORPHOGENESIS,8.5858e-05,0.21818,0.18082,1,1
6,GO MICROTUBULE BUNDLE FORMATION,1.9989e-07,0.21814,0.25908,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.0001862,0.2181,0.20851,1,1
6,GO HISTONE H2A UBIQUITINATION,3.8983e-07,0.21808,0.22694,1,1
6,GO HISTONE H4 K5 ACETYLATION,1.0861e-06,0.21786,0.22277,1,1
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,2.0478e-05,0.21785,0.24394,1,1
6,GO MYOTUBE CELL DEVELOPMENT,4.8839e-05,0.21749,0.20376,1,1
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,3.3806e-05,0.21747,0.217,1,1
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.3325e-06,0.21743,0.24067,1,1
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00023667,0.21743,0.19281,1,1
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0045438,0.21734,0.23432,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.475e-06,0.21715,0.20751,1,1
6,GO COCHLEA DEVELOPMENT,1.8053e-06,0.21709,0.27754,1,1
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,4.0314e-05,0.2169,0.26317,1,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,2.8305e-05,0.21682,0.26087,1,1
6,GO REGULATION OF APPETITE,4.7172e-05,0.2168,0.16899,1,1
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00057029,0.21678,0.27331,1,1
6,GO COPULATION,0.00055343,0.21611,0.21472,1,1
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,6.8888e-05,0.21583,0.20414,1,1
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,3.2784e-06,0.21536,0.20439,1,1
6,GO CELLULAR RESPONSE TO X RAY,0.0002443,0.2153,0.16138,1,1
6,GO DENDRITIC TRANSPORT,1.1375e-05,0.21514,0.31524,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,8.1138e-06,0.21461,0.18562,1,1
6,GO SEROTONIN SECRETION,0.0065235,0.2145,0.20551,1,1
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,8.9166e-06,0.21438,0.21664,1,1
6,GO EPITHELIAL TUBE FORMATION,1.2716e-05,0.21421,0.1869,1,1
6,GO ERYTHROCYTE MATURATION,0.00017741,0.21399,0.19175,1,1
6,GO SUBPALLIUM DEVELOPMENT,0.0024941,0.21364,0.22695,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,4.9694e-05,0.21359,0.19542,1,1
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0023321,0.21359,0.1909,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.016205,0.21351,0.16613,1,1
6,GO STEM CELL DIVISION,0.0037498,0.21336,0.17153,1,1
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,1.6418e-07,0.21332,0.21474,1,1
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.8348e-09,0.21304,0.24393,1,1
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,7.333e-07,0.21291,0.223,1,1
6,GO MATING BEHAVIOR,0.00020504,0.21288,0.21794,1,1
6,GO REGULATION OF HISTONE METHYLATION,4.3082e-09,0.21241,0.24031,1,1
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,9.3381e-05,0.21231,0.17224,1,1
6,GO CORPUS CALLOSUM DEVELOPMENT,0.0016806,0.21171,0.24353,1,1
6,GO MITOTIC RECOMBINATION,0.0012886,0.21171,0.19031,1,1
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0010259,0.21147,0.22397,1,1
6,GO SEGMENTATION,5.6085e-05,0.21139,0.1827,1,1
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0086125,0.21106,0.16364,1,1
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.00022927,0.21096,0.20632,1,1
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00034485,0.21074,0.22757,1,1
6,GO REGULATION OF DEVELOPMENTAL GROWTH,1.1806e-05,0.2106,0.17873,1,1
6,GO CEREBRAL CORTEX DEVELOPMENT,5.7536e-08,0.21052,0.25447,1,1
6,GO SULFATION,0.0020092,0.20979,0.17624,1,1
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,1.5037e-07,0.20969,0.2455,1,1
6,GO DIENCEPHALON DEVELOPMENT,9.6562e-05,0.20965,0.23225,1,1
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0037498,0.20938,0.28494,1,1
6,GO DETERMINATION OF ADULT LIFESPAN,0.026561,0.20934,0.11814,1,1
6,GO CILIUM ORGANIZATION,1.7721e-08,0.20904,0.24134,1,1
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,6.8396e-06,0.20881,0.20784,1,1
6,GO CARDIOBLAST DIFFERENTIATION,0.013243,0.20872,0.17493,1,1
6,GO NOREPINEPHRINE TRANSPORT,0.0014022,0.20813,0.21412,1,1
6,GO REGULATION OF GLUTAMATE SECRETION,0.0038478,0.2081,0.2642,1,1
6,GO FOREBRAIN CELL MIGRATION,3.2057e-05,0.2081,0.2318,1,1
6,GO POST ANAL TAIL MORPHOGENESIS,3.5022e-05,0.2078,0.24838,1,1
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00020178,0.20771,0.20681,1,1
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0039992,0.20747,0.27034,1,1
6,GO REGULATION OF HELICASE ACTIVITY,0.00081356,0.20731,0.18469,1,1
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,1.5576e-05,0.2072,0.21087,1,1
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0021798,0.20717,0.15508,1,1
6,GO SYNAPTIC SIGNALING,1.6994e-06,0.20695,0.24135,1,1
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.9711e-06,0.20689,0.20844,1,1
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.00017457,0.2064,0.21343,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,6.5837e-06,0.20622,0.26942,1,1
6,GO RESPONSE TO FOOD,4.3997e-05,0.20615,0.17921,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,2.5424e-05,0.20602,0.29058,1,1
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,6.3249e-05,0.20596,0.23919,1,1
6,GO NEURAL NUCLEUS DEVELOPMENT,1.5674e-06,0.20559,0.27555,1,1
6,GO NEUROTRANSMITTER SECRETION,5.6085e-05,0.20549,0.25144,1,1
6,GO REGULATION OF CELL DEVELOPMENT,3.6877e-06,0.20539,0.18848,1,1
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01849,0.20502,0.13692,1,1
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.7706e-05,0.20424,0.20496,1,1
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00044781,0.20421,0.22085,1,1
6,GO REGULATION OF CELL MORPHOGENESIS,3.4409e-05,0.20415,0.185,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,8.9047e-09,0.20408,0.23602,1,1
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.1119e-05,0.20401,0.24556,1,1
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00012388,0.20401,0.20392,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,6.5906e-08,0.20397,0.24065,1,1
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0051547,0.20384,0.17091,1,1
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.00014839,0.20371,0.21742,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00053704,0.20364,0.22281,1,1
6,GO UTERUS DEVELOPMENT,0.0020929,0.20353,0.20832,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,2.011e-05,0.2034,0.23779,1,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,3.1479e-07,0.20327,0.22639,1,1
6,GO ECTODERM DEVELOPMENT,6.8888e-05,0.20305,0.17645,1,1
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,3.3214e-05,0.2026,0.18553,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY,6.7105e-06,0.20218,0.20744,1,1
6,GO TELENCEPHALON DEVELOPMENT,1.1535e-07,0.20215,0.23382,1,1
6,GO PRO B CELL DIFFERENTIATION,0.00058763,0.20197,0.23235,1,1
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0047798,0.20183,0.17313,1,1
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.2416e-05,0.20167,0.21312,1,1
6,GO HISTONE H3 K14 ACETYLATION,5.9498e-07,0.20165,0.222,1,1
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,1.0169e-05,0.20119,0.19929,1,1
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0013633,0.20118,0.1763,1,1
6,GO EPITHELIAL CELL FATE COMMITMENT,0.007921,0.2008,0.25942,1,1
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,6.2175e-05,0.20075,0.23771,1,1
6,GO SPERM AXONEME ASSEMBLY,0.00010673,0.20073,0.22644,1,1
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,5.2303e-06,0.20048,0.21092,1,1
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.7706e-05,0.20013,0.22287,1,1
6,GO ENDOCRINE SYSTEM DEVELOPMENT,3.628e-05,0.19987,0.21337,1,1
6,GO CELL FATE DETERMINATION,0.01128,0.19956,0.14483,1,1
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00049802,0.19939,0.19328,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.5576e-05,0.19831,0.19944,1,1
6,GO LATERAL VENTRICLE DEVELOPMENT,0.0013255,0.19824,0.24011,1,1
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,5.4184e-05,0.19805,0.18407,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,7.6657e-06,0.19803,0.21731,1,1
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0021505,0.19778,0.237,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,4.3774e-08,0.19768,0.20321,1,1
6,GO NON RECOMBINATIONAL REPAIR,8.5858e-05,0.19745,0.15794,1,1
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,6.2175e-05,0.19719,0.20156,1,1
6,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00038422,0.19716,0.19399,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,1.8053e-06,0.19712,0.21291,1,1
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.022446,0.19711,0.15245,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00022208,0.19693,0.20807,1,1
6,GO POSITIVE REGULATION OF AXONOGENESIS,9.9803e-06,0.19691,0.25531,1,1
6,GO REGULATION OF RECEPTOR INTERNALIZATION,4.1456e-06,0.1969,0.21131,1,1
6,GO EMBRYONIC ORGAN MORPHOGENESIS,5.9834e-06,0.19683,0.20389,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0067673,0.1966,0.18828,1,1
6,GO CENTROSOME DUPLICATION,2.206e-06,0.19643,0.22355,1,1
6,GO HISTONE H3 K4 METHYLATION,7.1726e-09,0.1963,0.24578,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012005,0.19625,0.22523,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0060595,0.196,0.16946,1,1
6,GO L GLUTAMATE IMPORT,0.028264,0.19595,0.1235,1,1
6,GO REGULATION OF ORGANELLE ASSEMBLY,1.064e-06,0.19594,0.1799,1,1
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,3.152e-06,0.19586,0.25711,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,3.9102e-06,0.19576,0.21572,1,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,6.4341e-05,0.19569,0.22428,1,1
6,GO ORGANIC CATION TRANSPORT,0.008211,0.19558,0.1448,1,1
6,GO MESENCHYMAL CELL PROLIFERATION,0.0032928,0.19547,0.20638,1,1
6,GO RENAL VESICLE DEVELOPMENT,0.0071051,0.19531,0.1865,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,1.3878e-06,0.19463,0.24163,1,1
6,GO PROTEIN ACETYLATION,2.634e-09,0.19459,0.19825,1,1
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0011836,0.19451,0.18121,1,1
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,6.2169e-06,0.1945,0.23979,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.0527e-08,0.1945,0.22153,1,1
6,GO FUCOSYLATION,0.02945,0.19438,0.12945,1,1
6,GO PATTERN SPECIFICATION PROCESS,4.1552e-07,0.1942,0.21169,1,1
6,GO CELL MORPHOGENESIS,1.0756e-05,0.19411,0.18849,1,1
6,GO REGULATION OF MICROTUBULE BASED PROCESS,4.9228e-07,0.19407,0.20466,1,1
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.00030928,0.19398,0.21333,1,1
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,3.2631e-05,0.19359,0.19315,1,1
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.016205,0.1934,0.17409,1,1
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,2.2958e-06,0.19334,0.20227,1,1
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0032078,0.19328,0.15353,1,1
6,GO RECOMBINATIONAL REPAIR,3.2784e-06,0.19321,0.19798,1,1
6,GO P BODY ASSEMBLY,1.0212e-06,0.19308,0.20449,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.0958e-05,0.19302,0.20002,1,1
6,GO REGULATION OF MRNA PROCESSING,1.6514e-08,0.19294,0.21993,1,1
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0007901,0.19274,0.23479,1,1
6,GO CAMERA TYPE EYE MORPHOGENESIS,2.913e-06,0.1927,0.2099,1,1
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,1.3693e-05,0.19267,0.16647,1,1
6,GO SOMITOGENESIS,0.00014362,0.19262,0.15989,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00032408,0.19255,0.19824,1,1
6,GO KIDNEY MORPHOGENESIS,4.1026e-05,0.19253,0.19985,1,1
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.3661e-05,0.19227,0.22702,1,1
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.5022e-05,0.19208,0.18023,1,1
6,GO NUCLEOSOME ASSEMBLY,2.6914e-06,0.19183,0.2259,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,0.00073415,0.19179,0.19302,1,1
6,GO INNER EAR MORPHOGENESIS,1.7385e-05,0.19173,0.21084,1,1
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,5.0563e-05,0.19168,0.18281,1,1
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00014129,0.19128,0.21356,1,1
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00020178,0.19115,0.20698,1,1
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0019023,0.1911,0.18208,1,1
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00010323,0.19108,0.21783,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.016568,0.19097,0.16228,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.6418e-07,0.19083,0.21534,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00083767,0.19074,0.18438,1,1
6,GO GROOMING BEHAVIOR,0.00074504,0.19063,0.23595,1,1
6,GO MITOCHONDRION LOCALIZATION,3.2057e-05,0.19062,0.1903,1,1
6,GO INTRACELLULAR MRNA LOCALIZATION,0.0007901,0.1906,0.19194,1,1
6,GO RESPONSE TO ELECTRICAL STIMULUS,0.00022208,0.19047,0.22894,1,1
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.00042128,0.19047,0.1515,1,1
6,GO SENSORY ORGAN MORPHOGENESIS,1.0557e-05,0.1903,0.18078,1,1
6,GO REGULATION OF TORC1 SIGNALING,1.8419e-06,0.19006,0.22444,1,1
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.002702,0.18974,0.15232,1,1
6,GO EMBRYONIC HEMOPOIESIS,0.00020835,0.18944,0.23215,1,1
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.4528e-05,0.18936,0.19219,1,1
6,GO PROTEIN LOCALIZATION TO CHROMATIN,6.5837e-06,0.18932,0.18034,1,1
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.4787e-08,0.18903,0.18487,1,1
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00052901,0.18874,0.22504,1,1
6,GO ENDOCARDIUM DEVELOPMENT,0.00054518,0.18869,0.22342,1,1
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.02174,0.18865,0.15001,1,1
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00036686,0.18855,0.19263,1,1
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00044781,0.18852,0.21662,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,7.8052e-07,0.18851,0.25747,1,1
6,GO INOSITOL METABOLIC PROCESS,0.003654,0.18836,0.18446,1,1
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0032928,0.18824,0.1998,1,1
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00022208,0.18819,0.20654,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,3.357e-07,0.18805,0.22554,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.6129e-08,0.18801,0.19879,1,1
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.019104,0.18794,0.14769,1,1
6,GO REGULATION OF CELL CYCLE ARREST,1.7922e-07,0.18781,0.19219,1,1
6,GO AXON EXTENSION,3.5022e-05,0.18764,0.22565,1,1
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00013232,0.18749,0.1693,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00042777,0.18748,0.19494,1,1
6,GO HETEROCHROMATIN ORGANIZATION,1.9563e-06,0.18743,0.19249,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,8.5858e-05,0.18741,0.19946,1,1
6,GO PALLIUM DEVELOPMENT,1.8318e-07,0.18715,0.22966,1,1
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.2792e-06,0.18702,0.20129,1,1
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.7614e-08,0.18699,0.17935,1,1
6,GO ENERGY HOMEOSTASIS,0.0058389,0.18694,0.1621,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00070238,0.18676,0.17409,1,1
6,GO SYNAPTIC VESICLE EXOCYTOSIS,9.9844e-05,0.18664,0.25165,1,1
6,GO REGULATION OF CIRCADIAN RHYTHM,6.0565e-09,0.18664,0.22443,1,1
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.0076401,0.18662,0.2004,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0065235,0.1866,0.2079,1,1
6,GO DEVELOPMENTAL CELL GROWTH,7.7586e-05,0.18658,0.18994,1,1
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0015038,0.18648,0.21469,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.1034e-07,0.18617,0.18306,1,1
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,5.7582e-06,0.18595,0.18034,1,1
6,GO NEUROTRANSMITTER TRANSPORT,0.00017741,0.18572,0.22746,1,1
6,GO PROTEIN PALMITOYLATION,4.0314e-05,0.18568,0.22721,1,1
6,GO CONVERGENT EXTENSION,0.0034692,0.18554,0.17583,1,1
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0047798,0.18554,0.19646,1,1
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0104,0.18539,0.15647,1,1
6,GO HISTONE H4 ACETYLATION,1.3174e-07,0.18509,0.20226,1,1
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,1.9044e-05,0.18498,0.20167,1,1
6,GO PRESYNAPTIC ENDOCYTOSIS,6.8888e-05,0.18492,0.21399,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00022565,0.18483,0.24272,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,1.9393e-05,0.18448,0.21534,1,1
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00072342,0.18445,0.14641,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0015249,0.18418,0.18784,1,1
6,GO LUNG CELL DIFFERENTIATION,0.0022396,0.18394,0.26539,1,1
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0016347,0.18393,0.19339,1,1
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0019285,0.1839,0.18297,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,6.6578e-05,0.1838,0.23139,1,1
6,GO NEURON PROJECTION EXTENSION,3.0395e-05,0.18378,0.21909,1,1
6,GO REGULATION OF TRANSPOSITION,0.0056958,0.18375,0.19753,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,2.1064e-09,0.18369,0.20762,1,1
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00022565,0.18368,0.16951,1,1
6,GO CELL JUNCTION ORGANIZATION,0.00014362,0.18353,0.17323,1,1
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0013255,0.18353,0.13965,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,5.2344e-05,0.18309,0.19654,1,1
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.4528e-05,0.18297,0.23775,1,1
6,GO NEURAL TUBE FORMATION,9.819e-05,0.18296,0.17109,1,1
6,GO EYE MORPHOGENESIS,4.8416e-06,0.18293,0.19996,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.9044e-05,0.18286,0.20204,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,3.7282e-08,0.18284,0.21385,1,1
6,GO HISTONE H4 DEACETYLATION,0.00070238,0.18275,0.17525,1,1
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,7.6446e-07,0.18256,0.21394,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0013069,0.18252,0.27477,1,1
6,GO REGULATION OF RESPONSE TO FOOD,0.00092737,0.1825,0.16092,1,1
6,GO MEMBRANE DISASSEMBLY,0.03902,0.18244,0.13023,1,1
6,GO MAMMARY GLAND DEVELOPMENT,0.015329,0.18238,0.11658,1,1
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00039622,0.18222,0.15062,1,1
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0005618,0.18217,0.19878,1,1
6,GO CHROMATIN SILENCING,3.0295e-08,0.18216,0.21985,1,1
6,GO PROTEIN ACYLATION,3.1312e-09,0.18181,0.20095,1,1
6,GO GAMETE GENERATION,3.4796e-08,0.18179,0.18315,1,1
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00038422,0.18176,0.25423,1,1
6,GO SYNAPTIC VESICLE RECYCLING,9.1829e-05,0.18175,0.20554,1,1
6,GO TRACHEA DEVELOPMENT,0.046031,0.18155,0.14871,1,1
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0047198,0.18155,0.13578,1,1
6,GO DEMETHYLATION,7.333e-07,0.18143,0.18621,1,1
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,6.9711e-06,0.18138,0.20545,1,1
6,GO REGIONALIZATION,3.0302e-06,0.1812,0.20414,1,1
6,GO INCLUSION BODY ASSEMBLY,0.0071918,0.1811,0.1925,1,1
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,2.971e-06,0.1811,0.20084,1,1
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00013016,0.18092,0.18731,1,1
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0067673,0.18076,0.1779,1,1
6,GO CAMERA TYPE EYE DEVELOPMENT,5.332e-06,0.18066,0.19086,1,1
6,GO RESPONSE TO STEROL,0.0033361,0.18055,0.15884,1,1
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,5.8049e-05,0.18051,0.15114,1,1
6,GO DNA REPLICATION CHECKPOINT,4.2487e-05,0.18044,0.20718,1,1
6,GO LOCOMOTORY BEHAVIOR,1.6761e-05,0.18025,0.23114,1,1
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.015159,0.18024,0.17062,1,1
6,GO HISTONE H2A ACETYLATION,3.6924e-05,0.18019,0.18766,1,1
6,GO SECONDARY PALATE DEVELOPMENT,0.0029256,0.17977,0.21068,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,1.6158e-05,0.17977,0.18722,1,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.00016629,0.17977,0.1927,1,1
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,3.628e-05,0.17971,0.18032,1,1
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,4.3355e-07,0.17959,0.17362,1,1
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001442,0.17955,0.1352,1,1
6,GO TRANSPORT ALONG MICROTUBULE,3.5794e-07,0.17951,0.2045,1,1
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,1.5576e-05,0.17909,0.19117,1,1
6,GO PERICARDIUM DEVELOPMENT,0.032607,0.17909,0.1389,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,9.4959e-05,0.17903,0.18852,1,1
6,GO POST EMBRYONIC DEVELOPMENT,0.00053704,0.17889,0.16879,1,1
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,2.0853e-05,0.17875,0.18319,1,1
6,GO PEPTIDYL LYSINE METHYLATION,9.658e-10,0.17874,0.24421,1,1
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0096941,0.17864,0.19159,1,1
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0007786,0.17842,0.18261,1,1
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.018693,0.17833,0.16995,1,1
6,GO MICROTUBULE BASED TRANSPORT,7.333e-07,0.17823,0.20383,1,1
6,GO CELL PROJECTION ASSEMBLY,6.337e-06,0.17817,0.16835,1,1
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0010408,0.17815,0.15092,1,1
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00075607,0.1778,0.13736,1,1
6,GO MEIOTIC CHROMOSOME SEGREGATION,2.9332e-05,0.17774,0.1924,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,5.8049e-05,0.17771,0.1846,1,1
6,GO OVULATION CYCLE PROCESS,0.0012886,0.1776,0.15691,1,1
6,GO DEVELOPMENTAL GROWTH,0.00011218,0.17753,0.15437,1,1
6,GO FEMALE SEX DIFFERENTIATION,0.00012804,0.17725,0.17012,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00053704,0.17717,0.14809,1,1
6,GO SPECIFICATION OF SYMMETRY,2.5359e-06,0.177,0.16659,1,1
6,GO G2 DNA DAMAGE CHECKPOINT,2.9859e-05,0.177,0.20083,1,1
6,GO SEX DIFFERENTIATION,2.6828e-05,0.17686,0.15926,1,1
6,GO REGULATION OF FEEDING BEHAVIOR,0.00098255,0.17639,0.18312,1,1
6,GO MALE GAMETE GENERATION,5.02e-08,0.17619,0.17776,1,1
6,GO MATING,0.00012804,0.1761,0.17474,1,1
6,GO AXONAL TRANSPORT,6.7724e-05,0.17608,0.20127,1,1
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.048746,0.17604,0.13591,1,1
6,GO OLIGODENDROCYTE DIFFERENTIATION,2.7804e-05,0.17596,0.21655,1,1
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.001071,0.17569,0.1896,1,1
6,GO REGULATION OF CILIUM MOVEMENT,7.3739e-05,0.17567,0.1932,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,4.6578e-06,0.17554,0.19748,1,1
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.4184e-05,0.17526,0.18178,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,5.0563e-05,0.17526,0.24991,1,1
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00043435,0.17525,0.20401,1,1
6,GO MALE SEX DIFFERENTIATION,0.00094089,0.17518,0.1362,1,1
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.029754,0.1749,0.13678,1,1
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.2444e-07,0.1747,0.16071,1,1
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00044103,0.17463,0.1846,1,1
6,GO MULTICELLULAR ORGANISM GROWTH,2.9332e-05,0.17458,0.16469,1,1
6,GO MAINTENANCE OF CELL NUMBER,6.545e-05,0.17431,0.14907,1,1
6,GO GERM CELL DEVELOPMENT,6.2993e-08,0.17418,0.1958,1,1
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0087156,0.17407,0.15401,1,1
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,3.2631e-05,0.17395,0.19084,1,1
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.054582,0.17393,0.11471,1,1
6,GO PEPTIDE HORMONE SECRETION,3.8924e-05,0.17389,0.18357,1,1
6,GO EMBRYONIC PATTERN SPECIFICATION,3.3806e-05,0.17379,0.189,1,1
6,GO MICROTUBULE BASED MOVEMENT,2.0429e-07,0.17368,0.20323,1,1
6,GO NUCLEOSOME ORGANIZATION,7.1819e-07,0.17367,0.20263,1,1
6,GO HISTONE EXCHANGE,0.00036124,0.17362,0.16599,1,1
6,GO ENSHEATHMENT OF NEURONS,0.0017277,0.17339,0.14038,1,1
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00046872,0.17324,0.21233,1,1
6,GO BEHAVIOR,3.2784e-06,0.17323,0.20362,1,1
6,GO CHROMATIN SILENCING AT TELOMERE,4.1751e-05,0.17307,0.18531,1,1
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0042636,0.17302,0.16068,1,1
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.017506,0.17289,0.15184,1,1
6,GO DNA PACKAGING,7.6446e-07,0.17262,0.20026,1,1
6,GO CELL PROJECTION ORGANIZATION,9.404e-07,0.17246,0.19023,1,1
6,GO DNA REPLICATION,3.0905e-06,0.17238,0.18707,1,1
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0060595,0.17237,0.20972,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,2.4837e-07,0.17223,0.19907,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0042095,0.17214,0.15685,1,1
6,GO SEXUAL REPRODUCTION,8.8282e-08,0.17197,0.17038,1,1
6,GO AXIS ELONGATION,0.0059852,0.17196,0.17323,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,2.6362e-08,0.17192,0.21338,1,1
6,GO SISTER CHROMATID COHESION,1.9563e-06,0.17147,0.20982,1,1
6,GO RESPONSE TO NERVE GROWTH FACTOR,6.2175e-05,0.17144,0.20029,1,1
6,GO MISMATCH REPAIR,1.2716e-05,0.17132,0.17543,1,1
6,GO DNA RECOMBINATION,2.8305e-05,0.17129,0.15859,1,1
6,GO SENSORY SYSTEM DEVELOPMENT,3.0905e-06,0.17128,0.18864,1,1
6,GO EMBRYONIC ORGAN DEVELOPMENT,4.7999e-05,0.17128,0.17336,1,1
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,3.9064e-09,0.17126,0.2233,1,1
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00020835,0.17125,0.14174,1,1
6,GO GLIAL CELL PROLIFERATION,0.0043184,0.17114,0.15817,1,1
6,GO MULTICELLULAR ORGANISM REPRODUCTION,6.3359e-07,0.17095,0.15488,1,1
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.8701e-05,0.17066,0.16508,1,1
6,GO CELLULAR RESPONSE TO STEROL,0.0011341,0.17059,0.19142,1,1
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0012527,0.17055,0.2392,1,1
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00022565,0.17031,0.14096,1,1
6,GO ACTIVATION OF GTPASE ACTIVITY,0.0022396,0.17025,0.1272,1,1
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0035605,0.17023,0.16607,1,1
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00025215,0.17008,0.15435,1,1
6,GO MICROTUBULE NUCLEATION,0.00013232,0.17007,0.19859,1,1
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.033271,0.17003,0.10857,1,1
6,GO SERTOLI CELL DEVELOPMENT,0.027686,0.17001,0.14691,1,1
6,GO MEMBRANE DOCKING,9.795e-06,0.16992,0.17125,1,1
6,GO HISTONE METHYLATION,4.5239e-09,0.16963,0.23128,1,1
6,GO HISTONE H3 K9 ACETYLATION,1.9175e-06,0.16947,0.21284,1,1
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0089251,0.16933,0.19772,1,1
6,GO REGULATION OF PROTEIN DEACETYLATION,0.0017277,0.16896,0.139,1,1
6,GO ADHERENS JUNCTION ASSEMBLY,0.012087,0.16892,0.17034,1,1
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0029256,0.16868,0.17984,1,1
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.9228e-07,0.16863,0.20451,1,1
6,GO FOREGUT MORPHOGENESIS,0.00042777,0.16862,0.21333,1,1
6,GO REGULATION OF MRNA POLYADENYLATION,5.0563e-05,0.16861,0.17883,1,1
6,GO REGULATION OF SPINDLE CHECKPOINT,5.8049e-05,0.16845,0.22653,1,1
6,GO MESONEPHROS DEVELOPMENT,0.0020367,0.16825,0.16362,1,1
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.030368,0.16804,0.12195,1,1
6,GO SCHWANN CELL DEVELOPMENT,0.0061347,0.16802,0.15793,1,1
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00086244,0.16793,0.19438,1,1
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,3.4773e-06,0.16788,0.19479,1,1
6,GO REGULATION OF NEURON MATURATION,0.017125,0.16756,0.15965,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,1.2482e-05,0.16741,0.17069,1,1
6,GO HISTONE UBIQUITINATION,1.1086e-06,0.16716,0.17949,1,1
6,GO ADIPOSE TISSUE DEVELOPMENT,0.00037835,0.16692,0.18444,1,1
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00057029,0.16677,0.17997,1,1
6,GO DETECTION OF MECHANICAL STIMULUS,0.0024609,0.16671,0.17844,1,1
6,GO NEPHRON MORPHOGENESIS,0.00020835,0.16659,0.1818,1,1
6,GO EXTRACELLULAR TRANSPORT,0.0044864,0.1664,0.17948,1,1
6,GO MONOAMINE TRANSPORT,0.001071,0.16635,0.2309,1,1
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.001955,0.16632,0.21148,1,1
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.00022927,0.16626,0.1517,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.0169e-05,0.1662,0.19811,1,1
6,GO GLAND DEVELOPMENT,0.0023637,0.16586,0.12585,1,1
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,7.969e-07,0.16579,0.18455,1,1
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.3236e-05,0.16565,0.19738,1,1
6,GO NOTCH RECEPTOR PROCESSING,0.036409,0.1656,0.13183,1,1
6,GO MEIOSIS I CELL CYCLE PROCESS,1.6457e-05,0.16558,0.18611,1,1
6,GO BONE MORPHOGENESIS,0.011678,0.16547,0.14343,1,1
6,GO RNA DESTABILIZATION,0.00014599,0.16506,0.16177,1,1
6,GO DOUBLE STRAND BREAK REPAIR,1.4741e-05,0.16501,0.17045,1,1
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00019541,0.16475,0.17904,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,2.5884e-05,0.16462,0.18799,1,1
6,GO NEUROMUSCULAR PROCESS,4.2487e-05,0.1646,0.20226,1,1
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.00015583,0.16434,0.14792,1,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0034243,0.16429,0.17729,1,1
6,GO ASSOCIATIVE LEARNING,0.00025215,0.16425,0.16988,1,1
6,GO REGULATION OF JUN KINASE ACTIVITY,0.0056255,0.1642,0.11855,1,1
6,GO PROSTATIC BUD FORMATION,0.050154,0.16418,0.19023,1,1
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0054872,0.16418,0.11523,1,1
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,3.2146e-06,0.16358,0.19125,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0027747,0.16351,0.16989,1,1
6,GO RESPONSE TO COCAINE,5.6085e-05,0.16332,0.22179,1,1
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.011544,0.16317,0.13148,1,1
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0030436,0.16315,0.20989,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00026024,0.16308,0.18014,1,1
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.5884e-05,0.16306,0.19006,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.039406,0.16239,0.11345,1,1
6,GO CYTOKINESIS,0.00024819,0.16233,0.13886,1,1
6,GO REGULATION OF PHOSPHATASE ACTIVITY,2.4528e-05,0.16225,0.1636,1,1
6,GO CHONDROCYTE DEVELOPMENT,0.0059116,0.1622,0.17402,1,1
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.0022701,0.16212,0.11909,1,1
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0058389,0.16178,0.14491,1,1
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,6.6578e-05,0.16168,0.15396,1,1
6,GO REGULATION OF DNA REPAIR,3.5038e-07,0.16162,0.1867,1,1
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,2.7078e-07,0.1616,0.19303,1,1
6,GO POSITIVE REGULATION OF MRNA PROCESSING,4.3236e-05,0.16152,0.16908,1,1
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0020646,0.16141,0.12545,1,1
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0062108,0.16085,0.17542,1,1
6,GO HEART MORPHOGENESIS,0.00083767,0.16069,0.15129,1,1
6,GO OVULATION CYCLE,0.0012177,0.16061,0.15392,1,1
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00033432,0.16057,0.15969,1,1
6,GO CENTROSOME SEPARATION,0.0007901,0.1601,0.16864,1,1
6,GO MUSCLE FIBER DEVELOPMENT,0.00022565,0.15976,0.1762,1,1
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0013255,0.15973,0.14692,1,1
6,GO CELL CELL SIGNALING,6.0079e-05,0.15962,0.14618,1,1
6,GO COGNITION,1.2716e-05,0.15958,0.18579,1,1
6,GO SKIN EPIDERMIS DEVELOPMENT,0.0047798,0.15933,0.1265,1,1
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0018764,0.15921,0.16991,1,1
6,GO LEFT RIGHT PATTERN FORMATION,0.009139,0.15912,0.15131,1,1
6,GO LIMBIC SYSTEM DEVELOPMENT,1.6761e-05,0.15912,0.18911,1,1
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.045591,0.15908,0.11507,1,1
6,GO PROTEIN METHYLATION,2.5164e-08,0.15906,0.20706,1,1
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,1.9749e-05,0.15898,0.16427,1,1
6,GO AXO DENDRITIC TRANSPORT,7.8911e-05,0.1588,0.18906,1,1
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.015159,0.15875,0.1814,1,1
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.026286,0.15854,0.16076,1,1
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.059331,0.15851,0.10081,1,1
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,2.8814e-05,0.15851,0.14249,1,1
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,2.3239e-05,0.15845,0.16119,1,1
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.021053,0.15841,0.12823,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0046604,0.15827,0.18594,1,1
6,GO REGULATION OF CHROMOSOME SEGREGATION,6.8888e-05,0.15811,0.17568,1,1
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0027747,0.15797,0.1601,1,1
6,GO MOLTING CYCLE,0.0038478,0.15794,0.12203,1,1
6,GO MICROTUBULE BASED PROCESS,6.7411e-08,0.15775,0.20006,1,1
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0043737,0.15762,0.11151,1,1
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0022095,0.15738,0.15474,1,1
6,GO PROTEIN DEPOLYMERIZATION,0.00017741,0.15721,0.17147,1,1
6,GO ANTEROGRADE AXONAL TRANSPORT,0.0005618,0.15717,0.16726,1,1
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0002443,0.15704,0.14834,1,1
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0010113,0.15694,0.095657,1,1
6,GO HISTONE DEACETYLATION,0.00014362,0.15671,0.16618,1,1
6,GO OPTIC NERVE DEVELOPMENT,0.0078263,0.15665,0.25435,1,1
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.041789,0.15646,0.10593,1,1
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0066851,0.15643,0.12658,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0019023,0.15641,0.19352,1,1
6,GO CELL FATE COMMITMENT,5.5864e-07,0.15637,0.20355,1,1
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.0020092,0.15636,0.2381,1,1
6,GO REGULATION OF CELL SIZE,8.3013e-05,0.15625,0.18257,1,1
6,GO EAR MORPHOGENESIS,6.8888e-05,0.15613,0.17922,1,1
6,GO REGULATION OF MITOPHAGY,0.0016575,0.15601,0.1478,1,1
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0033799,0.15598,0.11411,1,1
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1.8793e-06,0.15586,0.18028,1,1
6,GO REGULATION OF RNA SPLICING,2.8262e-08,0.15584,0.19796,1,1
6,GO MITOTIC SPINDLE ORGANIZATION,8.3013e-05,0.15575,0.17153,1,1
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0037016,0.15573,0.16303,1,1
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0020646,0.15563,0.16883,1,1
6,GO DNA INTEGRITY CHECKPOINT,9.7998e-07,0.15561,0.18547,1,1
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0038977,0.15552,0.14178,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,6.2169e-06,0.15552,0.19535,1,1
6,GO SECRETORY GRANULE ORGANIZATION,0.0013255,0.15539,0.16149,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,2.1234e-05,0.15532,0.15499,1,1
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0059852,0.1553,0.15504,1,1
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.012653,0.15526,0.13486,1,1
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0095807,0.15518,0.12194,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0098086,0.15513,0.13888,1,1
6,GO MITOTIC DNA REPLICATION,0.032938,0.15495,0.13244,1,1
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.009139,0.15495,0.14442,1,1
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,4.6359e-05,0.15486,0.16859,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0041031,0.15459,0.13423,1,1
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00081356,0.15446,0.15387,1,1
6,GO REGULATION OF CYTOKINESIS,6.8888e-05,0.15446,0.17127,1,1
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.01251,0.15444,0.20902,1,1
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0015463,0.15404,0.13676,1,1
6,GO MRNA EXPORT FROM NUCLEUS,7.7586e-05,0.15398,0.1521,1,1
6,GO POLYOL CATABOLIC PROCESS,0.017125,0.15379,0.11925,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0022701,0.15373,0.19366,1,1
6,GO HISTONE DEUBIQUITINATION,7.5001e-05,0.15371,0.181,1,1
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00014362,0.15366,0.19132,1,1
6,GO LIPID TRANSLOCATION,0.024173,0.15339,0.1367,1,1
6,GO MITRAL VALVE DEVELOPMENT,0.0056255,0.15318,0.18051,1,1
6,GO MECHANORECEPTOR DIFFERENTIATION,0.0013069,0.15304,0.17752,1,1
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0011503,0.15296,0.14547,1,1
6,GO SPERMATID DIFFERENTIATION,2.2958e-06,0.15294,0.18066,1,1
6,GO MEIOTIC SPINDLE ORGANIZATION,0.00049053,0.15293,0.19576,1,1
6,GO SCHWANN CELL DIFFERENTIATION,0.0028872,0.15283,0.15257,1,1
6,GO COVALENT CHROMATIN MODIFICATION,8.2903e-10,0.15264,0.2055,1,1
6,GO CHROMOSOME LOCALIZATION,0.0001803,0.15263,0.14184,1,1
6,GO REGULATION OF MRNA 3 END PROCESSING,0.00010852,0.15262,0.1626,1,1
6,GO REGULATION OF LYASE ACTIVITY,0.0018508,0.15254,0.16237,1,1
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.049681,0.15253,0.16982,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00015838,0.15194,0.15797,1,1
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,7.7586e-05,0.15185,0.16182,1,1
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.048285,0.1515,0.15215,1,1
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0043737,0.15137,0.11206,1,1
6,GO GLIAL CELL DIFFERENTIATION,0.00052901,0.15121,0.16203,1,1
6,GO REGULATION OF CELL DIFFERENTIATION,0.00026438,0.15119,0.13296,1,1
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.016386,0.15116,0.15098,1,1
6,GO SENSORY ORGAN DEVELOPMENT,4.7488e-06,0.1511,0.18348,1,1
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0075485,0.15097,0.15369,1,1
6,GO EMBRYONIC MORPHOGENESIS,0.00019857,0.15074,0.14885,1,1
6,GO CHONDROCYTE PROLIFERATION,0.026838,0.15068,0.15569,1,1
6,GO REGULATION OF DNA BINDING,1.3948e-05,0.15041,0.15406,1,1
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.003607,0.15034,0.15906,1,1
6,GO REPRODUCTION,5.0563e-05,0.15029,0.13133,1,1
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,2.8814e-05,0.15024,0.15085,1,1
6,GO REGULATION OF AXON GUIDANCE,0.0034243,0.15009,0.17049,1,1
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.2716e-05,0.14998,0.17651,1,1
6,GO DENDRITE EXTENSION,0.00055343,0.14996,0.22995,1,1
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,5.0323e-06,0.14995,0.17662,1,1
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00032408,0.14994,0.1864,1,1
6,GO STRESS GRANULE ASSEMBLY,0.001442,0.14977,0.17271,1,1
6,GO SYNAPTIC VESICLE TRANSPORT,0.0035146,0.14974,0.15886,1,1
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0012527,0.14952,0.14864,1,1
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0039992,0.14939,0.15567,1,1
6,GO REGULATION OF CHROMATIN ORGANIZATION,1.9465e-08,0.14929,0.1874,1,1
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.024947,0.14919,0.14849,1,1
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00076726,0.14913,0.178,1,1
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00084997,0.14908,0.16894,1,1
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.02174,0.14893,0.16692,1,1
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00018923,0.14892,0.14074,1,1
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.00040857,0.14883,0.13441,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00046165,0.14879,0.15717,1,1
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0019023,0.14867,0.13515,1,1
6,GO ORGANELLE LOCALIZATION,0.00020504,0.14816,0.12862,1,1
6,GO AXIS SPECIFICATION,8.1623e-05,0.14806,0.17373,1,1
6,GO EXIT FROM MITOSIS,0.00099681,0.14788,0.13699,1,1
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.012798,0.14787,0.12057,1,1
6,GO INSULIN SECRETION,0.00024819,0.14783,0.1696,1,1
6,GO RRNA CATABOLIC PROCESS,0.003654,0.14759,0.14424,1,1
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.016205,0.14749,0.11262,1,1
6,GO SPINDLE ORGANIZATION,2.6828e-05,0.14738,0.17177,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0065235,0.14732,0.19978,1,1
6,GO THYMUS DEVELOPMENT,2.1234e-05,0.14719,0.19621,1,1
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,3.152e-06,0.14718,0.17599,1,1
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.00013232,0.14712,0.17442,1,1
6,GO EAR DEVELOPMENT,0.0001179,0.14702,0.16932,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,3.152e-06,0.14701,0.20614,1,1
6,GO CLATHRIN COAT ASSEMBLY,0.026286,0.14699,0.13139,1,1
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0076401,0.14671,0.13413,1,1
6,GO DNA GEOMETRIC CHANGE,0.00013451,0.14662,0.15679,1,1
6,GO REGULATION OF HISTONE MODIFICATION,6.5906e-08,0.1465,0.18108,1,1
6,GO CELL CELL SIGNALING BY WNT,0.0017277,0.1463,0.12087,1,1
6,GO REGULATION OF MEMBRANE POTENTIAL,0.0010558,0.1463,0.15859,1,1
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0019023,0.14599,0.15724,1,1
6,GO CIRCADIAN RHYTHM,2.2824e-05,0.14597,0.15317,1,1
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.02174,0.14586,0.15921,1,1
6,GO TRANSPOSITION,0.0088198,0.14576,0.17977,1,1
6,GO OOGENESIS,2.971e-06,0.14576,0.1825,1,1
6,GO REGULATION OF DNA RECOMBINATION,0.00025215,0.14572,0.14834,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,8.8282e-08,0.1457,0.2127,1,1
6,GO GOLGI RIBBON FORMATION,0.002702,0.1457,0.17913,1,1
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.02915,0.14555,0.14105,1,1
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.028264,0.14512,0.13484,1,1
6,GO MITOTIC SPINDLE ASSEMBLY,0.00087508,0.14509,0.14446,1,1
6,GO RENAL TUBULE DEVELOPMENT,0.014823,0.14488,0.12533,1,1
6,GO REGULATION OF DNA REPLICATION,6.0991e-06,0.14454,0.17214,1,1
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0071918,0.14442,0.16858,1,1
6,GO NEURON PROJECTION REGENERATION,0.0021215,0.14423,0.17469,1,1
6,GO NUCLEAR CHROMOSOME SEGREGATION,3.4098e-06,0.14421,0.17444,1,1
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.011678,0.14419,0.14526,1,1
6,GO HEART VALVE DEVELOPMENT,0.041383,0.14411,0.11704,1,1
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.018091,0.14401,0.13791,1,1
6,GO HORMONE TRANSPORT,0.00045468,0.14395,0.14703,1,1
6,GO NUCLEAR BODY ORGANIZATION,0.00030449,0.14387,0.16896,1,1
6,GO CYTOSKELETON ORGANIZATION,0.00020178,0.14384,0.13619,1,1
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0051547,0.14334,0.13894,1,1
6,GO REGULATION OF SENSORY PERCEPTION,0.001483,0.14325,0.12572,1,1
6,GO REGULATION OF CENTROSOME CYCLE,5.6085e-05,0.14321,0.17574,1,1
6,GO REGULATION OF GTPASE ACTIVITY,0.0052854,0.14321,0.1122,1,1
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00011218,0.1432,0.14264,1,1
6,GO FEAR RESPONSE,0.00057029,0.14314,0.16773,1,1
6,GO RESPONSE TO UV C,0.03006,0.14312,0.10425,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,4.2271e-06,0.14294,0.17327,1,1
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0056958,0.14281,0.11353,1,1
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0022095,0.14267,0.14866,1,1
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0093576,0.14255,0.12693,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.1446e-05,0.14255,0.14595,1,1
6,GO CATECHOLAMINE SECRETION,0.0014624,0.1425,0.26201,1,1
6,GO SMOOTH MUSCLE CONTRACTION,0.022209,0.14249,0.098188,1,1
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,2.2505e-06,0.14243,0.16626,1,1
6,GO CELL CYCLE ARREST,0.00016901,0.14203,0.13762,1,1
6,GO DNA DEPENDENT DNA REPLICATION,3.6877e-06,0.14192,0.19146,1,1
6,GO MRNA METHYLATION,0.0039992,0.14184,0.15286,1,1
6,GO CHROMATIN REMODELING,4.2444e-07,0.14128,0.19201,1,1
6,GO PROTEIN AUTOUBIQUITINATION,0.00027284,0.1412,0.14142,1,1
6,GO DETECTION OF VISIBLE LIGHT,2.0478e-05,0.14119,0.12308,1,1
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.6359e-05,0.14109,0.18165,1,1
6,GO ESTABLISHMENT OF CELL POLARITY,0.00013016,0.14107,0.15872,1,1
6,GO CELLULAR RESPONSE TO UV,0.00036686,0.14068,0.13955,1,1
6,GO CHROMOSOME SEGREGATION,4.9361e-06,0.14065,0.17527,1,1
6,GO REGULATION OF CHROMOSOME SEPARATION,0.0012005,0.14042,0.15187,1,1
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00068191,0.1403,0.15921,1,1
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0016806,0.1403,0.24817,1,1
6,GO LUNG MORPHOGENESIS,0.053071,0.14029,0.10604,1,1
6,GO TORC1 SIGNALING,2.1621e-05,0.14028,0.18626,1,1
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.033608,0.14028,0.182,1,1
6,GO CHROMOSOME SEPARATION,0.00032916,0.14024,0.16709,1,1
6,GO CANONICAL WNT SIGNALING PATHWAY,0.0087156,0.14012,0.10893,1,1
6,GO RNA SPLICING,4.2487e-05,0.14009,0.14403,1,1
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.0061347,0.13996,0.10959,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0053519,0.13981,0.1556,1,1
6,GO MULTI ORGANISM PROCESS,1.5293e-05,0.13972,0.13555,1,1
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00015083,0.13972,0.15334,1,1
6,GO GLIAL CELL DEVELOPMENT,0.0068504,0.1397,0.13307,1,1
6,GO SISTER CHROMATID SEGREGATION,3.3214e-05,0.13957,0.16651,1,1
6,GO MIDBRAIN DEVELOPMENT,6.1119e-05,0.1395,0.14642,1,1
6,GO GENITALIA MORPHOGENESIS,0.059879,0.13948,0.19385,1,1
6,GO REGULATION OF HORMONE SECRETION,0.00037835,0.13946,0.15051,1,1
6,GO METAPHASE PLATE CONGRESSION,0.00070238,0.13928,0.12853,1,1
6,GO HEAT GENERATION,0.00076726,0.13916,0.18497,1,1
6,GO REGULATION OF SPINDLE ASSEMBLY,0.0024609,0.13904,0.13403,1,1
6,GO ER OVERLOAD RESPONSE,0.058247,0.13896,0.11132,1,1
6,GO POSITIVE REGULATION OF DNA REPLICATION,9.9844e-05,0.13895,0.14885,1,1
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.031311,0.13891,0.13135,1,1
6,GO MITOTIC CELL CYCLE CHECKPOINT,8.1361e-07,0.13852,0.18328,1,1
6,GO PROTEIN KINASE C SIGNALING,0.012798,0.1385,0.17027,1,1
6,GO REGULATION OF CELL DIVISION,7.3739e-05,0.13849,0.1499,1,1
6,GO CELL CYCLE DNA REPLICATION,1.4741e-05,0.13847,0.19044,1,1
6,GO MRNA TRANSPORT,0.00010852,0.13846,0.14046,1,1
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00024819,0.13834,0.15902,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,3.3214e-05,0.13831,0.20522,1,1
6,GO REGULATION OF CHROMOSOME ORGANIZATION,1.6321e-06,0.13827,0.15618,1,1
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.017506,0.13823,0.14027,1,1
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00073415,0.13821,0.18088,1,1
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0072795,0.13807,0.14204,1,1
6,GO CHROMATIN ORGANIZATION,1.1533e-09,0.13801,0.20664,1,1
6,GO POSITIVE REGULATION OF RNA SPLICING,4.6359e-05,0.13776,0.16701,1,1
6,GO ACIDIC AMINO ACID TRANSPORT,0.0014624,0.13753,0.16965,1,1
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0005211,0.13738,0.13489,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,2.913e-06,0.13724,0.14683,1,1
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,1.8032e-05,0.13723,0.13407,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0023009,0.13722,0.14373,1,1
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00032916,0.13688,0.19528,1,1
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00048316,0.13687,0.092697,1,1
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,6.2046e-07,0.13668,0.17786,1,1
6,GO REGULATION OF GONAD DEVELOPMENT,0.01849,0.13645,0.14251,1,1
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00040235,0.13641,0.17506,1,1
6,GO HISTONE H3 ACETYLATION,1.2032e-06,0.13637,0.17171,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,7.6657e-06,0.13634,0.15976,1,1
6,GO REGULATION OF PROTEIN ACETYLATION,3.7356e-07,0.13631,0.17654,1,1
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0043737,0.13606,0.11642,1,1
6,GO POSITIVE REGULATION OF CELL DIVISION,0.0005618,0.13598,0.15407,1,1
6,GO SPERM MOTILITY,7.2414e-06,0.13592,0.16974,1,1
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00024819,0.13582,0.17848,1,1
6,GO CELL CYCLE CHECKPOINT,8.8389e-07,0.1357,0.18501,1,1
6,GO ADULT LOCOMOTORY BEHAVIOR,0.0035605,0.13567,0.16153,1,1
6,GO REGULATION OF INSULIN SECRETION,0.00017457,0.13553,0.16968,1,1
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.014494,0.13546,0.11947,1,1
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.8416e-06,0.13527,0.14782,1,1
6,GO REGULATION OF GLUCOSE IMPORT,0.0052197,0.13518,0.12276,1,1
6,GO DETECTION OF LIGHT STIMULUS,0.00016361,0.13505,0.096981,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0088198,0.13499,0.10969,1,1
6,GO NEURAL CREST CELL DIFFERENTIATION,0.0092477,0.13484,0.14641,1,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,7.3739e-05,0.13484,0.13657,1,1
6,GO EPITHELIAL CELL DEVELOPMENT,0.012653,0.13474,0.12631,1,1
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.4861e-06,0.1347,0.14564,1,1
6,GO POSITIVE REGULATION OF HEART GROWTH,0.02915,0.13461,0.10674,1,1
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00029511,0.13459,0.13503,1,1
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0023321,0.13459,0.17551,1,1
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017506,0.13442,0.10322,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.013093,0.13438,0.19461,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE,6.3249e-05,0.13428,0.12763,1,1
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.028264,0.13407,0.090692,1,1
6,GO SINGLE FERTILIZATION,0.00019229,0.13407,0.13585,1,1
6,GO OXIDATIVE DEMETHYLATION,0.0045438,0.13402,0.10685,1,1
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.628e-05,0.13399,0.13477,1,1
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00054518,0.13391,0.15959,1,1
6,GO VIRAL RNA GENOME REPLICATION,0.018091,0.13378,0.10917,1,1
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,3.3806e-05,0.13376,0.17896,1,1
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0094686,0.1337,0.10501,1,1
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00043435,0.13368,0.149,1,1
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0037016,0.13348,0.13437,1,1
6,GO MULTICELLULAR ORGANISM AGING,0.01016,0.13331,0.11586,1,1
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0021798,0.13329,0.18334,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00013232,0.13317,0.14593,1,1
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.00017457,0.13313,0.12992,1,1
6,GO DNA STRAND ELONGATION,0.00013451,0.13309,0.18175,1,1
6,GO DEVELOPMENTAL MATURATION,9.3381e-05,0.13306,0.15901,1,1
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00010852,0.13286,0.19834,1,1
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00075607,0.13278,0.14924,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00073415,0.13273,0.13944,1,1
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0076401,0.13272,0.11495,1,1
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0065235,0.13271,0.15786,1,1
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.017125,0.1326,0.13619,1,1
6,GO DNA CONFORMATION CHANGE,6.337e-06,0.13259,0.17629,1,1
6,GO NEURON APOPTOTIC PROCESS,4.3997e-05,0.13247,0.14292,1,1
6,GO FERTILIZATION,7.0072e-05,0.13246,0.14307,1,1
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0088198,0.13244,0.12609,1,1
6,GO CHROMOSOME CONDENSATION,0.00065224,0.13227,0.16814,1,1
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0046018,0.13226,0.11242,1,1
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.0013443,0.13224,0.16467,1,1
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.4528e-05,0.13196,0.13989,1,1
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.011022,0.13184,0.11413,1,1
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.0025617,0.13179,0.12724,1,1
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014172,0.13173,0.12678,1,1
6,GO RETINOIC ACID METABOLIC PROCESS,0.004156,0.13171,0.19795,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00027284,0.13169,0.11679,1,1
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0019285,0.13169,0.16768,1,1
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.020385,0.1314,0.13558,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.1588e-05,0.13121,0.14531,1,1
6,GO NEUROTRANSMITTER UPTAKE,0.035691,0.13116,0.11552,1,1
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00013899,0.13109,0.13416,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0013826,0.13097,0.20082,1,1
6,GO EMBRYO DEVELOPMENT,6.2175e-05,0.13095,0.1418,1,1
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.0011668,0.1308,0.15489,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.040187,0.13077,0.10239,1,1
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,3.152e-06,0.13076,0.16535,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.00021511,0.13072,0.14127,1,1
6,GO FUCOSE METABOLIC PROCESS,0.031953,0.13063,0.1307,1,1
6,GO VESICLE DOCKING,0.024428,0.1306,0.11137,1,1
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099244,0.13046,0.17727,1,1
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.016027,0.13039,0.099047,1,1
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.001442,0.13024,0.12518,1,1
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00011033,0.13006,0.16939,1,1
6,GO ORGANELLE FISSION,1.8701e-05,0.12982,0.1442,1,1
6,GO EATING BEHAVIOR,0.00048316,0.12966,0.14855,1,1
6,GO RHYTHMIC PROCESS,8.5867e-06,0.12952,0.15891,1,1
6,GO HYPEROSMOTIC RESPONSE,0.00049802,0.12941,0.17352,1,1
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0041031,0.1292,0.17188,1,1
6,GO TELOMERE CAPPING,0.00096848,0.12908,0.12856,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0084096,0.12893,0.1396,1,1
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00070238,0.12888,0.12083,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.021973,0.12884,0.10365,1,1
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0088198,0.12878,0.21754,1,1
6,GO REGULATION OF DEPHOSPHORYLATION,6.6578e-05,0.12873,0.14406,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0024281,0.12868,0.13898,1,1
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00043435,0.12821,0.16805,1,1
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00076726,0.12805,0.14046,1,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.037139,0.12772,0.14784,1,1
6,GO TISSUE MORPHOGENESIS,0.0062108,0.12758,0.10601,1,1
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.00035024,0.12736,0.17339,1,1
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.00042777,0.12729,0.17735,1,1
6,GO MRNA PROCESSING,4.7172e-05,0.12722,0.14508,1,1
6,GO REGULATION OF CENTROSOME DUPLICATION,0.00027716,0.12712,0.16775,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,8.5858e-05,0.12708,0.13398,1,1
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.012367,0.12698,0.13216,1,1
6,GO JNK CASCADE,0.058247,0.12665,0.077156,1,1
6,GO REGULATION OF CELL CYCLE PROCESS,4.6578e-06,0.12655,0.14254,1,1
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.019312,0.12651,0.13311,1,1
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00016361,0.1265,0.14243,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0015249,0.12646,0.15111,1,1
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0017517,0.12636,0.1263,1,1
6,GO GROWTH,0.0011341,0.12635,0.11811,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.01016,0.12635,0.1048,1,1
6,GO DEVELOPMENTAL INDUCTION,0.0035146,0.12628,0.16541,1,1
6,GO LENS FIBER CELL DIFFERENTIATION,0.036048,0.12597,0.1205,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0003557,0.12585,0.12934,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0001862,0.12581,0.12887,1,1
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.007921,0.12576,0.13985,1,1
6,GO REGULATION OF CELL CYCLE,2.6914e-06,0.1257,0.14047,1,1
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00027284,0.12562,0.1437,1,1
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,4.7172e-05,0.12529,0.17316,1,1
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.00076726,0.12517,0.11095,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0028118,0.12507,0.11124,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0098086,0.12505,0.15497,1,1
6,GO DEFINITIVE HEMOPOIESIS,0.011411,0.12484,0.17386,1,1
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.027118,0.12481,0.20428,1,1
6,GO WHITE FAT CELL DIFFERENTIATION,0.001071,0.12475,0.18232,1,1
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,1.9989e-07,0.12468,0.16982,1,1
6,GO REGULATION OF FATTY ACID OXIDATION,0.034636,0.12455,0.12002,1,1
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.010645,0.12447,0.12786,1,1
6,GO HISTONE H3 DEACETYLATION,8.7316e-05,0.12445,0.18904,1,1
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.021973,0.12444,0.15037,1,1
6,GO FILOPODIUM ASSEMBLY,0.0054192,0.12439,0.16049,1,1
6,GO SKELETAL SYSTEM DEVELOPMENT,0.0092477,0.12439,0.10311,1,1
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0093576,0.12435,0.11464,1,1
6,GO REGULATION OF SPINDLE ORGANIZATION,0.00076726,0.12424,0.14188,1,1
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0034692,0.12418,0.16966,1,1
6,GO REGULATION OF SYSTEM PROCESS,0.0021505,0.12397,0.1282,1,1
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.00022927,0.12382,0.16885,1,1
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00098255,0.12381,0.12434,1,1
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0094686,0.12291,0.13661,1,1
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.022928,0.12285,0.17014,1,1
6,GO MEMBRANE BIOGENESIS,0.003166,0.1228,0.19811,1,1
6,GO ANIMAL ORGAN MATURATION,0.008211,0.12251,0.14361,1,1
6,GO DNA REPLICATION INITIATION,0.00033955,0.12242,0.16847,1,1
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.034984,0.12234,0.11356,1,1
6,GO ORGANELLE ASSEMBLY,9.086e-06,0.12227,0.14026,1,1
6,GO ERYTHROCYTE DEVELOPMENT,0.020828,0.12225,0.10832,1,1
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.0060595,0.1222,0.10899,1,1
6,GO CHROMOSOME ORGANIZATION,4.2784e-08,0.12199,0.17452,1,1
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0020929,0.12188,0.14252,1,1
6,GO NERVOUS SYSTEM PROCESS,3.5646e-05,0.12162,0.14744,1,1
6,GO POSITIVE REGULATION OF GROWTH,0.00030449,0.12156,0.13871,1,1
6,GO MITOTIC CELL CYCLE,0.0001862,0.12153,0.1254,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0059852,0.12145,0.14184,1,1
6,GO GLIOGENESIS,0.00075607,0.12113,0.14709,1,1
6,GO ERROR PRONE TRANSLESION SYNTHESIS,1.7385e-05,0.12111,0.17649,1,1
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0014624,0.12108,0.14222,1,1
6,GO PROTEIN DEPHOSPHORYLATION,0.0007786,0.12107,0.11252,1,1
6,GO CELL DIVISION,2.4528e-05,0.121,0.14939,1,1
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.037882,0.12089,0.10937,1,1
6,GO EXCRETION,0.014013,0.12083,0.10864,1,1
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.03429,0.1207,0.1096,1,1
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,9.9803e-06,0.12041,0.13893,1,1
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.1119e-05,0.12027,0.12028,1,1
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0011836,0.12017,0.13564,1,1
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0013633,0.11965,0.13379,1,1
6,GO MESENCHYME DEVELOPMENT,0.014013,0.11962,0.11716,1,1
6,GO FEMALE GAMETE GENERATION,2.7312e-05,0.11953,0.14124,1,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0010865,0.11941,0.1017,1,1
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.0395e-05,0.1194,0.13438,1,1
6,GO NUCLEOTIDE EXCISION REPAIR,0.02174,0.11931,0.077834,1,1
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0015463,0.11928,0.11879,1,1
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00059648,0.11927,0.152,1,1
6,GO REGULATION OF MITOTIC CELL CYCLE,6.7724e-05,0.11921,0.12085,1,1
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.013546,0.11917,0.092326,1,1
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.00039622,0.11915,0.12947,1,1
6,GO CARDIAC SEPTUM DEVELOPMENT,0.01585,0.11911,0.13711,1,1
6,GO HEART DEVELOPMENT,0.0037985,0.11904,0.11473,1,1
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.017699,0.11882,0.20274,1,1
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.0083098,0.11881,0.11662,1,1
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.01849,0.11875,0.13632,1,1
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.004964,0.1187,0.11481,1,1
6,GO RESPONSE TO IRON ION,0.024947,0.11866,0.12138,1,1
6,GO SODIUM ION HOMEOSTASIS,0.0088198,0.11843,0.11875,1,1
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,5.3256e-05,0.11817,0.13097,1,1
6,GO TRANSMISSION OF NERVE IMPULSE,0.0029645,0.11816,0.19623,1,1
6,GO MITOTIC CYTOKINESIS,0.013546,0.11816,0.10152,1,1
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0023321,0.11815,0.1784,1,1
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.030368,0.1181,0.11714,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0015038,0.11807,0.12769,1,1
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0017517,0.11805,0.11943,1,1
6,GO HISTONE MONOUBIQUITINATION,4.0314e-05,0.11804,0.16462,1,1
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.033608,0.11796,0.097114,1,1
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.043444,0.11786,0.11484,1,1
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0047798,0.11778,0.13494,1,1
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.031311,0.11775,0.07867,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,1.5576e-05,0.11763,0.20774,1,1
6,GO FEEDING BEHAVIOR,0.001118,0.1175,0.15553,1,1
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00046165,0.11738,0.12776,1,1
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.004964,0.11737,0.13197,1,1
6,GO MITOTIC NUCLEAR DIVISION,7.3739e-05,0.11718,0.15071,1,1
6,GO RESPONSE TO UV,0.00029976,0.11706,0.1327,1,1
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026858,0.11703,0.11425,1,1
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.003607,0.11694,0.12017,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE,6.8885e-07,0.11683,0.14549,1,1
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.012945,0.11679,0.088341,1,1
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0043184,0.11666,0.13667,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.043025,0.11655,0.10849,1,1
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.036409,0.11654,0.083109,1,1
6,GO CELL CYCLE,9.6129e-06,0.11649,0.13688,1,1
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.016027,0.11619,0.10996,1,1
6,GO VIRAL LATENCY,0.022928,0.1161,0.1124,1,1
6,GO CELL CYCLE PROCESS,1.7385e-05,0.11609,0.14004,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0021215,0.11585,0.16812,1,1
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.048285,0.11581,0.11856,1,1
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,4.1026e-05,0.11573,0.13536,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,1.8419e-06,0.1157,0.15062,1,1
6,GO HOMOLOGOUS RECOMBINATION,0.00054518,0.11546,0.18331,1,1
6,GO MEIOTIC CELL CYCLE,1.3693e-05,0.11533,0.16532,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00096848,0.11531,0.10142,1,1
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0033361,0.11524,0.10632,1,1
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0025277,0.11511,0.12734,1,1
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.001422,0.11507,0.14272,1,1
6,GO REGULATION OF HISTONE DEACETYLATION,0.037509,0.11506,0.10671,1,1
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00084997,0.11495,0.1107,1,1
6,GO DENDRITIC SPINE MAINTENANCE,0.031311,0.11475,0.14995,1,1
6,GO ACROSOME REACTION,0.0054872,0.11471,0.15515,1,1
6,GO ENDOTHELIUM DEVELOPMENT,0.014172,0.11459,0.13726,1,1
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.033948,0.11452,0.084347,1,1
6,GO RESPONSE TO LIGHT STIMULUS,9.9844e-05,0.11407,0.12061,1,1
6,GO PROTEIN MANNOSYLATION,0.030368,0.1139,0.11314,1,1
6,GO DETECTION OF ABIOTIC STIMULUS,4.1026e-05,0.11382,0.14506,1,1
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.010645,0.1137,0.10055,1,1
6,GO DNA DEALKYLATION,0.0080166,0.11351,0.12241,1,1
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.021053,0.11342,0.10895,1,1
6,GO REGULATION OF EXOCYTOSIS,0.00076726,0.11332,0.15527,1,1
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00014839,0.11328,0.1892,1,1
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.039406,0.11326,0.1592,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00061456,0.11314,0.10499,1,1
6,GO DNA REPAIR,4.5558e-05,0.11297,0.14193,1,1
6,GO POSITIVE REGULATION OF MITOPHAGY,0.035691,0.11283,0.098483,1,1
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0049019,0.11278,0.089004,1,1
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.032607,0.11269,0.092458,1,1
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0081133,0.11266,0.15061,1,1
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0087156,0.11266,0.10289,1,1
6,GO RETINA HOMEOSTASIS,0.00029511,0.11265,0.12179,1,1
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0033361,0.1126,0.12528,1,1
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,1.2716e-05,0.11256,0.1581,1,1
6,GO HISTONE PHOSPHORYLATION,0.0073682,0.11246,0.10956,1,1
6,GO RNA EXPORT FROM NUCLEUS,0.0021798,0.11239,0.12065,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,2.8262e-08,0.11216,0.17593,1,1
6,GO SENSORY PERCEPTION OF PAIN,0.0016347,0.11214,0.13391,1,1
6,GO RNA POLYADENYLATION,0.017506,0.11208,0.11007,1,1
6,GO GOLGI ORGANIZATION,0.051595,0.11158,0.075417,1,1
6,GO DEPHOSPHORYLATION,0.0012886,0.11123,0.10736,1,1
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.0039481,0.11118,0.19687,1,1
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.010279,0.111,0.10935,1,1
6,GO PROTEIN INSERTION INTO MEMBRANE,0.0023009,0.11089,0.10732,1,1
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.043444,0.11068,0.086617,1,1
6,GO REGULATION OF PHOSPHORYLATION,0.057711,0.11056,0.071099,1,1
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.011022,0.11044,0.086006,1,1
6,GO REGULATION OF CELL MATURATION,0.02128,0.11043,0.087102,1,1
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.00081356,0.11041,0.1113,1,1
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0030038,0.10989,0.097369,1,1
6,GO PHOTOPERIODISM,0.00031907,0.10952,0.16427,1,1
6,GO MEMBRANE HYPERPOLARIZATION,0.011544,0.10945,0.19543,1,1
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.022209,0.10935,0.086658,1,1
6,GO LIPID PHOSPHORYLATION,0.001422,0.10919,0.13075,1,1
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0024281,0.10908,0.13526,1,1
6,GO ENERGY RESERVE METABOLIC PROCESS,0.057711,0.1084,0.084765,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,5.5127e-05,0.10835,0.17544,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0026663,0.10822,0.11741,1,1
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.003654,0.10805,0.12327,1,1
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.02174,0.10792,0.10455,1,1
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.014823,0.10783,0.098407,1,1
6,GO CYTOSOLIC TRANSPORT,0.01849,0.10781,0.099956,1,1
6,GO DNA DEMETHYLATION,0.0035146,0.10777,0.14746,1,1
6,GO CELLULAR RESPONSE TO STARVATION,0.01016,0.10775,0.10546,1,1
6,GO CALCINEURIN MEDIATED SIGNALING,0.00084997,0.10763,0.16517,1,1
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00019541,0.10746,0.16608,1,1
6,GO REGULATION OF GROWTH,0.002631,0.10734,0.10873,1,1
6,GO MESODERM DEVELOPMENT,0.0072795,0.10724,0.10021,1,1
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00013899,0.10722,0.21429,1,1
6,GO RESPONSE TO STARVATION,0.01128,0.10711,0.10322,1,1
6,GO DNA METHYLATION OR DEMETHYLATION,6.1119e-05,0.10709,0.13293,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0043737,0.10704,0.096472,1,1
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.4184e-05,0.10692,0.12633,1,1
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0054872,0.10688,0.097585,1,1
6,GO POSTREPLICATION REPAIR,0.0051547,0.1068,0.090792,1,1
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.012653,0.10651,0.09606,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0010865,0.10594,0.13035,1,1
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.03068,0.10585,0.13654,1,1
6,GO MUSCLE TISSUE DEVELOPMENT,0.0052197,0.10579,0.095891,1,1
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.036048,0.10577,0.12103,1,1
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00025215,0.10572,0.11847,1,1
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.003166,0.10556,0.098024,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.024428,0.10553,0.11167,1,1
6,GO CELL CYCLE PHASE TRANSITION,0.00055343,0.10528,0.11225,1,1
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.011813,0.10519,0.13933,1,1
6,GO NUCLEUS ORGANIZATION,0.0020092,0.1051,0.10905,1,1
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00091404,0.10499,0.11334,1,1
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.0042636,0.10489,0.12305,1,1
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020385,0.10489,0.098279,1,1
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.023668,0.10449,0.086982,1,1
6,GO SIGNAL RELEASE,0.00049802,0.10442,0.13847,1,1
6,GO MITOTIC CELL CYCLE ARREST,0.019312,0.10441,0.14664,1,1
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0074579,0.10435,0.099803,1,1
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0030839,0.10428,0.15642,1,1
6,GO CELL VOLUME HOMEOSTASIS,0.018898,0.104,0.11571,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION,0.007921,0.10398,0.091268,1,1
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.024428,0.10381,0.092327,1,1
6,GO MUSCLE ORGAN MORPHOGENESIS,0.014013,0.1038,0.11341,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.046031,0.10363,0.1082,1,1
6,GO MUSCLE ORGAN DEVELOPMENT,0.0033799,0.10362,0.10376,1,1
6,GO RECEPTOR INTERNALIZATION,0.013394,0.1036,0.10986,1,1
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.0028872,0.10359,0.095245,1,1
6,GO NEGATIVE REGULATION OF SIGNALING,0.016752,0.10358,0.085706,1,1
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00072342,0.10354,0.14161,1,1
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0011503,0.10337,0.13003,1,1
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.055093,0.10323,0.096834,1,1
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0038478,0.10301,0.10625,1,1
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.027118,0.10298,0.083388,1,1
6,GO APOPTOTIC DNA FRAGMENTATION,0.00010497,0.1029,0.13673,1,1
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,4.4771e-05,0.10284,0.14231,1,1
6,GO REGULATION OF PROTEIN SUMOYLATION,0.0025617,0.10282,0.1243,1,1
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.026013,0.10255,0.096502,1,1
6,GO ANATOMICAL STRUCTURE MATURATION,0.00071283,0.10232,0.12864,1,1
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00072342,0.10172,0.15585,1,1
6,GO PEPTIDYL THREONINE MODIFICATION,0.0013255,0.10154,0.11837,1,1
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0059116,0.10147,0.096197,1,1
6,GO RNA STABILIZATION,0.0035146,0.10145,0.13085,1,1
6,GO POSITIVE REGULATION OF CELL GROWTH,0.0030839,0.1014,0.11999,1,1
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.023668,0.10128,0.079983,1,1
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.049681,0.10117,0.069149,1,1
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0045438,0.10099,0.10606,1,1
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.046474,0.10059,0.075058,1,1
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.051595,0.10025,0.083944,1,1
6,GO PROTEIN POLYUBIQUITINATION,0.0076401,0.10022,0.086274,1,1
6,GO RESPONSE TO ETHER,0.016938,0.10011,0.11598,1,1
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.059331,0.1001,0.11892,1,1
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.03429,0.10003,0.088903,1,1
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0080166,0.099848,0.097091,1,1
6,GO MACROMOLECULE DEACYLATION,0.0003557,0.099842,0.14003,1,1
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.022446,0.099798,0.097496,1,1
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019023,0.099788,0.13845,1,1
6,GO NUCLEAR PORE ORGANIZATION,0.057711,0.099697,0.12342,1,1
6,GO REGULATION OF BINDING,0.022209,0.099577,0.085785,1,1
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00023294,0.099465,0.16248,1,1
6,GO REGULATION OF HISTONE UBIQUITINATION,0.015159,0.099436,0.098608,1,1
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0090315,0.099254,0.10583,1,1
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.045591,0.099207,0.088699,1,1
6,GO RNA LOCALIZATION,0.0137,0.099117,0.087718,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.03006,0.098988,0.071719,1,1
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0083098,0.098631,0.11766,1,1
6,GO NEURON DEATH,0.0014022,0.098567,0.11532,1,1
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.051111,0.098325,0.071628,1,1
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.016205,0.0983,0.10188,1,1
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0042636,0.098257,0.073232,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.018091,0.098141,0.10763,1,1
6,GO REGULATION OF SECRETION,0.0054872,0.097908,0.10373,1,1
6,GO MRNA 3 END PROCESSING,0.00031414,0.09782,0.1445,1,1
6,GO REGULATION OF SODIUM ION TRANSPORT,0.029754,0.097667,0.10683,1,1
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0061347,0.09763,0.11923,1,1
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.016568,0.097617,0.10425,1,1
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.017315,0.097449,0.087938,1,1
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0054872,0.09736,0.10052,1,1
6,GO DNA METHYLATION,0.00067188,0.097303,0.12982,1,1
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0044864,0.097184,0.12421,1,1
6,GO PHOTOTRANSDUCTION,0.0029645,0.097126,0.073262,1,1
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.031631,0.096812,0.084409,1,1
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0085105,0.096462,0.094663,1,1
6,GO LIPOPROTEIN METABOLIC PROCESS,0.059879,0.095742,0.070012,1,1
6,GO VESICLE LOCALIZATION,0.020166,0.095654,0.09126,1,1
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00095459,0.095497,0.12413,1,1
6,GO DNA METABOLIC PROCESS,7.2497e-05,0.095473,0.12237,1,1
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.011022,0.095348,0.13882,1,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0137,0.095023,0.088123,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0033799,0.095008,0.11969,1,1
6,GO SENSORY PERCEPTION,0.0024941,0.094928,0.095559,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.6562e-05,0.094628,0.12503,1,1
6,GO RESPONSE TO MONOSACCHARIDE,0.027401,0.094607,0.086396,1,1
6,GO REGULATION OF HAIR CYCLE,0.040981,0.094328,0.10225,1,1
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.052083,0.094297,0.10116,1,1
6,GO SNRNA TRANSCRIPTION,0.0032501,0.094238,0.098293,1,1
6,GO POSITIVE REGULATION OF TOR SIGNALING,0.0005056,0.093945,0.14844,1,1
6,GO LYSOSOMAL TRANSPORT,0.019312,0.093593,0.10168,1,1
6,GO ENDOSOMAL TRANSPORT,0.031631,0.093539,0.081472,1,1
6,GO RESPONSE TO CARBOHYDRATE,0.055609,0.093349,0.074148,1,1
6,GO SODIUM ION TRANSPORT,0.013856,0.093326,0.10096,1,1
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013394,0.093147,0.095619,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.013546,0.093085,0.090551,1,1
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.01128,0.092801,0.084854,1,1
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.036048,0.092477,0.087705,1,1
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0075485,0.092419,0.099908,1,1
6,GO REGULATION OF HORMONE LEVELS,0.012653,0.092347,0.095798,1,1
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.032938,0.092257,0.11226,1,1
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.036772,0.091765,0.13678,1,1
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.001955,0.091595,0.087342,1,1
6,GO ORGAN GROWTH,0.015501,0.091501,0.09515,1,1
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.036772,0.091465,0.08504,1,1
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0068504,0.091413,0.095103,1,1
6,GO CELLULAR RESPONSE TO RADIATION,0.00081356,0.091327,0.098127,1,1
6,GO PEPTIDYL SERINE MODIFICATION,0.0018006,0.091232,0.11461,1,1
6,GO REGULATION OF TRANSFERASE ACTIVITY,0.048285,0.091194,0.07384,1,1
6,GO REGULATION OF DNA METABOLIC PROCESS,3.3214e-05,0.090949,0.12783,1,1
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0048405,0.090949,0.12264,1,1
6,GO CELL GROWTH,0.0056958,0.090795,0.11038,1,1
6,GO IMPORT INTO NUCLEUS,0.0104,0.090741,0.092449,1,1
6,GO REGULATION OF PEPTIDE TRANSPORT,0.012798,0.090675,0.084055,1,1
6,GO PEPTIDE SECRETION,0.027973,0.090289,0.083569,1,1
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0094686,0.090041,0.08062,1,1
6,GO VACUOLAR TRANSPORT,0.03902,0.089818,0.081709,1,1
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.046031,0.089815,0.083012,1,1
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.043025,0.089745,0.08001,1,1
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019285,0.089668,0.11101,1,1
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0016347,0.08954,0.11305,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.000662,0.08927,0.14435,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0070192,0.089259,0.099155,1,1
6,GO REGULATION OF TOR SIGNALING,0.00090088,0.088831,0.13215,1,1
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.051111,0.088497,0.075323,1,1
6,GO PROTEIN SUMOYLATION,0.0001862,0.08803,0.1391,1,1
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0080166,0.087812,0.10595,1,1
6,GO REGULATION OF NUCLEAR DIVISION,0.00015331,0.087812,0.12811,1,1
6,GO REGULATION OF PEPTIDE SECRETION,0.02945,0.08769,0.084353,1,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.024687,0.087372,0.086464,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.02945,0.086953,0.13787,1,1
6,GO REGULATION OF TRANSPORT,0.015674,0.086911,0.08402,1,1
6,GO NUCLEAR EXPORT,0.0020929,0.08675,0.11516,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00044103,0.086642,0.10889,1,1
6,GO ACTIVATION OF JNKK ACTIVITY,0.026286,0.086431,0.13469,1,1
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.037509,0.086365,0.10193,1,1
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0057669,0.086048,0.11991,1,1
6,GO DNA MODIFICATION,0.0005211,0.085731,0.10345,1,1
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0067673,0.085592,0.092824,1,1
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.058247,0.085489,0.07562,1,1
6,GO METHYLATION,0.00081356,0.085443,0.12006,1,1
6,GO POSITIVE REGULATION OF NEURON DEATH,0.035336,0.085357,0.096872,1,1
6,GO NCRNA TRANSCRIPTION,0.0071918,0.084936,0.094243,1,1
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.042197,0.084608,0.067495,1,1
6,GO MUSCLE CELL DIFFERENTIATION,0.012798,0.084554,0.09997,1,1
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0063654,0.084466,0.16047,1,1
6,GO REGULATION OF CELLULAR LOCALIZATION,0.0057669,0.084339,0.094699,1,1
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.029754,0.083894,0.081263,1,1
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.048746,0.083709,0.074221,1,1
6,GO NEGATIVE REGULATION OF BINDING,0.0086125,0.083664,0.10138,1,1
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0032928,0.08345,0.11475,1,1
6,GO GENE SILENCING,0.00020504,0.082995,0.12257,1,1
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0020092,0.082764,0.095315,1,1
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.3196e-05,0.082763,0.13495,1,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010645,0.082758,0.087103,1,1
6,GO RESPONSE TO PROSTAGLANDIN E,0.032607,0.082614,0.10899,1,1
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.02945,0.082344,0.085031,1,1
6,GO DNA CATABOLIC PROCESS,7.6283e-05,0.081431,0.1307,1,1
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.014172,0.081221,0.12183,1,1
6,GO RESPONSE TO RADIATION,0.0012886,0.080964,0.098477,1,1
6,GO EXECUTION PHASE OF APOPTOSIS,0.0086125,0.080362,0.089118,1,1
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.017894,0.079631,0.097036,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.010279,0.079159,0.087691,1,1
6,GO ACTIVATION OF MAPKK ACTIVITY,0.038258,0.079094,0.10814,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.010522,0.078463,0.088945,1,1
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046031,0.078355,0.074891,1,1
6,GO THYROID HORMONE METABOLIC PROCESS,0.051111,0.078074,0.13736,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00099681,0.078072,0.1028,1,1
6,GO RESPONSE TO ESTRADIOL,0.035691,0.077756,0.089399,1,1
6,GO MUSCLE STRUCTURE DEVELOPMENT,0.023668,0.07758,0.085487,1,1
6,GO RNA DECAPPING,0.026838,0.077426,0.090465,1,1
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.036409,0.077188,0.11529,1,1
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02915,0.077007,0.13512,1,1
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.052083,0.07683,0.08334,1,1
6,GO CELLULAR RESPONSE TO ALCOHOL,0.034636,0.07656,0.099805,1,1
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.033948,0.076366,0.085627,1,1
6,GO METAL ION TRANSPORT,0.047827,0.076264,0.075458,1,1
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.013856,0.076093,0.096747,1,1
6,GO BASE EXCISION REPAIR,0.011151,0.075612,0.091393,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0030436,0.074719,0.10262,1,1
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.034636,0.074432,0.063515,1,1
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.03006,0.074416,0.079689,1,1
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00086244,0.074279,0.12494,1,1
6,GO STEM CELL DIFFERENTIATION,0.0054192,0.074271,0.095981,1,1
6,GO CATION TRANSPORT,0.043444,0.074005,0.078483,1,1
6,GO NUCLEAR TRANSPORT,0.0021215,0.073951,0.10814,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.012945,0.073463,0.12925,1,1
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.021509,0.073429,0.071804,1,1
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.017506,0.073241,0.079165,1,1
6,GO ION TRANSMEMBRANE TRANSPORT,0.043866,0.073082,0.078958,1,1
6,GO RESPONSE TO ACTIVITY,0.052575,0.073014,0.077859,1,1
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.040981,0.072602,0.066464,1,1
6,GO REGULATION OF ATP METABOLIC PROCESS,0.058787,0.072154,0.077385,1,1
6,GO PROTEIN HOMOOLIGOMERIZATION,0.058787,0.07179,0.0669,1,1
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.021053,0.071399,0.097403,1,1
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00029511,0.071121,0.13088,1,1
6,GO RNA 3 END PROCESSING,0.027686,0.070129,0.085384,1,1
6,GO REGULATION OF GLIAL CELL MIGRATION,0.033608,0.069658,0.092763,1,1
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0016347,0.069553,0.096434,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.018693,0.068807,0.077179,1,1
6,GO MRNA METABOLIC PROCESS,0.016568,0.068631,0.076356,1,1
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.05357,0.068306,0.079351,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.026013,0.068026,0.06998,1,1
6,GO TRANSLESION SYNTHESIS,0.020605,0.06775,0.08659,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015674,0.067416,0.085352,1,1
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015329,0.06725,0.079351,1,1
6,GO MITOPHAGY,0.019104,0.067174,0.10496,1,1
6,GO REGULATION OF MACROAUTOPHAGY,0.052083,0.06671,0.06988,1,1
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.022446,0.066585,0.097393,1,1
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.014172,0.066153,0.089721,1,1
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.039406,0.065469,0.093972,1,1
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.023919,0.064688,0.083105,1,1
6,GO TOR SIGNALING,0.0040509,0.063786,0.10784,1,1
6,GO CATION TRANSMEMBRANE TRANSPORT,0.043866,0.06377,0.080224,1,1
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.026286,0.062302,0.07718,1,1
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.044292,0.062225,0.079298,1,1
6,GO POSITIVE REGULATION OF BINDING,0.051111,0.062023,0.07104,1,1
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.054582,0.062021,0.05989,1,1
6,GO CELLULAR SENESCENCE,0.032607,0.061317,0.091106,1,1
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.027401,0.061291,0.074901,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.026286,0.060975,0.13526,1,1
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.040582,0.060315,0.073808,1,1
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.018091,0.058042,0.090864,1,1
6,GO PROTEIN POLYMERIZATION,0.015159,0.057435,0.10167,1,1
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.049212,0.0545,0.068959,1,1
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.028264,0.052507,0.0693,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.012653,0.049696,0.087874,1,1
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.051595,0.038765,0.070138,1,1
